0001013762-16-001358.txt : 20160304 0001013762-16-001358.hdr.sgml : 20160304 20160304161649 ACCESSION NUMBER: 0001013762-16-001358 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 76 CONFORMED PERIOD OF REPORT: 20151231 FILED AS OF DATE: 20160304 DATE AS OF CHANGE: 20160304 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DRONE AVIATION HOLDING CORP. CENTRAL INDEX KEY: 0001178727 STANDARD INDUSTRIAL CLASSIFICATION: AIRCRAFT [3721] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-150332 FILM NUMBER: 161485441 BUSINESS ADDRESS: STREET 1: 11651 CENTRAL PARKWAY #118 CITY: JACKSONVILLE STATE: FL ZIP: 32224 BUSINESS PHONE: 904-834-4400 MAIL ADDRESS: STREET 1: 11651 CENTRAL PARKWAY #118 CITY: JACKSONVILLE STATE: FL ZIP: 32224 FORMER COMPANY: FORMER CONFORMED NAME: MACROSOLVE INC DATE OF NAME CHANGE: 20020725 10-K 1 f10k2015_droneaviation.htm ANNUAL REPORT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Fiscal Year Ended December 31, 2015

 

Commission File No. 333-150332

 

DRONE AVIATION HOLDING CORP.

(Exact name of registrant as specified in its charter)

 

Nevada   46-5538504

(State or other jurisdiction of

incorporation or organization)

  

(I.R.S. Employer

Identification No.)

 

11651 Central Parkway #118

Jacksonville FL

   32224
(Address of principal executive office)   (Zip Code)

 

(904) 834-4400

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Securities registered pursuant to Section 12(g) of the Act:  None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined by Rule 405 of the Securities Act. Yes ☐    No ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes ☒    No ☐

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐    No ☒

 

Note: The Company is a voluntary filer but has filed all reports it would have been required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months if it was a mandatory filer.

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒    No ☐

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  ☒

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

  

 Large accelerated filer ☐  Accelerated filer ☐
 Non-accelerated filer ☐  Smaller reporting company ☒
(Do not check if a smaller reporting company)  

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐   No ☒

 

The aggregate market value of the voting common equity held by non-affiliates as of June 30, 2015, based on the closing sales price of the Common Stock as quoted on the OTCQX was $18,981.074.

 

As of March 4, 2016, there were 5,461,553 shares of registrant’s common stock outstanding.

 

 

 

 

 

 

TABLE OF CONTENTS

 

    PAGE
PART I      
     
Item 1. Business 1
Item 1A. Risk Factors 6
Item 1B. Unresolved Staff Comments 11
Item 2. Properties 11
Item 3. Legal Proceedings 11
Item 4. Mine Safety Disclosures 11
   
PART II  
     
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 12
Item 6. Selected Financial Data 12
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 13
Item 7A. Quantitative and Qualitative Disclosures about Market Risk 16
Item 8. Financial Statements and Supplementary Data 16
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosures 16
Item 9A. Controls and Procedures 16
Item 9B. Other Information 17
   
PART III    
   
Item 10. Directors, Executive Officers and Corporate Governance 18
Item 11. Executive Compensation 21
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 25
Item 13. Certain Relationships and Related Transactions, and Director Independence 26
Item 14. Principal Accounting Fees and Services 26
     
PART IV      
     
Item 15. Exhibits, Financial Statement Schedules 27
   
  Signatures 31

 

 

 

 

Cautionary Note Regarding Forward Looking Statements

 

This Annual Report on Form 10-K (the “Annual Report”) contains ‘‘forward-looking statements’’ that represent our beliefs, projections and predictions about future events. All statements other than statements of historical fact are ‘‘forward-looking statements’’, including any projections of earnings, revenue or other financial items, any statements of the plans, strategies and objectives of management for future operations, any statements concerning proposed new projects or other developments, any statements regarding future economic conditions or performance, any statements of management’s beliefs, goals, strategies, intentions and objectives, and any statements of assumptions underlying any of the foregoing. Words such as ‘‘may’’, ‘‘will’’, ‘‘should’’, ‘‘could’’, ‘‘would’’, ‘‘predicts’’, ‘‘potential’’, ‘‘continue’’, ‘‘expects’’, ‘‘anticipates’’, ‘‘future’’, ‘‘intends’’, ‘‘plans’’, ‘‘believes’’, ‘‘estimates’’ and similar expressions, as well as statements in the future tense, identify forward-looking statements.

 

These statements are necessarily subjective and involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from any future results, performance or achievements described in or implied by such statements. Actual results may differ materially from expected results described in our forward-looking statements, including with respect to correct measurement and identification of factors affecting our business or the extent of their likely impact, the accuracy and completeness of the publicly available information with respect to the factors upon which our business strategy is based or the success of our business. Furthermore, industry forecasts are likely to be inaccurate, especially over long periods of time. Factors that may cause actual results, our performance or achievements, or industry results, to differ materially from those contemplated by such forward-looking statements include without limitation:

 

  ● competition in the market for tethered drone based products;
     
  ● our ability to develop brand awareness and industry reputation;
     
  ● our ability to adapt to rapid evolution in technology and industry standards;
     
  ● our ability to attract and retain management and skilled personnel;
     
  ● our growth and marketing strategies;
     
  ● anticipated trends in our business;
     
  ● our future results of operations;
     
  ● our lack of profitable operations in recent periods;
     
  ● market conditions in the tethered drone industry;
     
  ● the impact of government regulation;
     
  ● emerging viable and sustainable markets for tethered drone products;
     
  ● significant errors or security flaws in our products and services;
     
  ● insufficient protection for our intellectual property;
     
  ● Our ability to enforce our intellectual property;
     
  ● claims of infringement on third party intellectual property;
     
  ● pricing pressures in the tethered drone market;
     
  ● our financial position, business strategy and other plans and objectives for future operations;
     
  ● economic conditions in the U.S. and worldwide; and
     
  ● the ability of our management team to execute its plans to meet its goals

 

Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of whether, or the times by which, our performance or results may be achieved. Forward-looking statements are based on information available at the time those statements are made and management’s belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause such differences include, but are not limited to, those factors discussed under the headings ‘‘Risk factors’’, ‘‘Management’s discussion and analysis of financial condition and results of operations’’, ‘‘Business’’ and elsewhere in this report.

 

 

 

 

PART I

 

Item 1.  Business

 

Organization

 

We are a Nevada corporation formed on April 17, 2014, as a wholly-owned subsidiary of MacroSolve, Inc., an Oklahoma corporation (“MacroSolve”). Effective April 30, 2014, MacroSolve merged with and into our Company, with our Company as the surviving entity, for purposes of moving our state of incorporation from Oklahoma to Nevada (the “Redomestication”). Any references to “Drone Aviation,” “we,” “us,” “DAC”, or the “Company” or any similar references relating to periods before the Redomestication shall be construed as references to MacroSolve, being the previous parent company of Drone Aviation.

 

Upon consummation of a share exchange with Drone Aviation Corp. (“Drone”) on June 3, 2014 (the “Share Exchange”), Drone became our wholly-owned subsidiary and we began a new line of business in the tethered drone space. On March 26, 2015, we filed a Plan of Merger in the State of Nevada, pursuant to which Drone was merged into our Company which is the surviving corporation.

 

Our principal executive offices are located at 11651 Central Parkway #118, Jacksonville, FL 32224 and our phone number is (904) 834-4400.

 

Corporate Structure

 

Our current corporate structure is set forth below:

 

 O:\1 Pre-Sub\2016\Feb\Night\24\Drone\f10k2015_droneaviation

 

Business Overview

 

We are focused on the business of the design, development, marketing and sale of lighter-than air (“LTA”) advanced aersostats, tethered drones, and land-based intelligence, surveillance and reconnaissance (“ISR”) solutions. We, through our wholly owned subsidiary, Lighter Than Air Systems Corp. (“LTAS”), which was acquired on June 3, 2014 upon consummation of a Share Exchange with Drone Aviation Corp., a wholly-owned subsidiary which was merged into Drone Aviation on March 26, 2015, are focused on the development of tethered aerostats known as the Winch Aerostat Small Platform (“WASP”) as well as certain other tethered drone products including the WATT electric tethered drone launched on March 2, 2015. The WATT is our first model of a new line of commercial-grade electric tethered drones designed to provide secure and reliable aerial monitoring for extended durations while being tethered to the ground via a high strength armored tether.

 

Products

 

We, through our wholly owned subsidiary, LTAS, are focused on the development of tethered aerostats known as the WASP and certain other tethered drone based products, including the recently announced WATT tethered drone. The tethered aerostat system is a lighter-than-air, compact aerostat platform either self-contained on a trailer that can be towed by a Military All-Terrain Vehicle, or MATV, or Mine Resistant Ambush Protected, or MRAP, or other standard vehicle, or it can operate from the bed of a pickup truck. It is designed to provide semi-persistent, mobile, real-time day/night high definition footage for intelligence, surveillance and reconnaissance (“ISR”), detection of improvised explosive devices (“IEDs”), border security and other governmental and civilian uses. The WASP is a mobile, tactical-sized aerostat capable of carrying a variety of payloads in support of military operations. All of our products can also be utilized for disaster response missions, by supporting two-way and cellular communications, and act as a repeater or provide wireless networking.

 

 1 

 

 

The aerostat systems have a tethered envelope filled with helium gas, either a stabilized ISR payload or communications payload, portable ground control station and a datalink between the ground station and the envelope. Hovering at up to 2,000 ft. above the ground, the systems provide surveillance and communications capabilities with relatively low acquisition and maintenance costs.  The systems require an operational crew of a minimum of two personnel, relatively simple maintenance procedures and a quick retrieval and helium top-off for re-inflation.

 

The WASP is a mobile, tactical-sized aerostat capable of carrying a variety of payloads in support of military operations helping troops in the field have a tactical edge while communicating over greater distances. The WASP leverages aerostat technology to elevate network payloads to an advantaged height to enable persistent network connectivity while reducing risk to units conducting missions.

 

In 2014, BAE systems procured two WASP systems which were delivered to the U.S. Space and Missile Defense Command (“SMDC”). The WASP Systems provided to the SMDC/Army Forces Strategic Command participated in the U.S. Army's Network Integration Evaluation (“NIE”) 14.1 where they were a “System Under Evaluation,” meaning that they were used to test other new systems. The two WASPs returned to NIE 14.2 which took place at Fort Bliss, TX and White Sands Missile Range, NM during April and May 2014, as a “Baseline System” following their successful mission at NIE 14.1. The NIE 14.2 exercises were intended to evaluate joint force network capabilities; improve unified land operations with communications nodes based on aircraft and unmanned aerial vehicles (UAVs); integrate networking technologies into the armored brigade combat team; develop ways to deliver, collect and process integrated, multi-source intelligence to front-line warfighters; and make field command posts more mobile and efficient. The NIE 14.2 exercises also involved beyond-line-of-sight communications; expeditionary signal brigade tropospheric scatter communications; network intrusion prevention; cellular communications; electromagnetic spectrum operation; condition based maintenance; and operational energy solutions.

 

In 2015, the U.S. Army-owned WASP tactical aerostats also successfully completed the DoD Enterprise Challenge 2015 (“EC15”), a program created to explore how various technologies could collect, send and retrieve data from the field through a secure, interconnected network of multiple agencies, partners and organizations, providing access to real-time data and video. During EC15, the WASP systems were used to capture and relay real-time, high definition video to various handheld devices, tablet computers and other deployed systems. In September 2015, the WASP systems also took part in the latest Army NIE exercise, NIE 16.1 which focused on new technologies assessments including coalition network capabilities, expeditionary command posts, operational energy capabilities, and manned/unmanned teaming (air and ground robotics). As a result of its performance, DAC will continue to support the U.S. Army-owned WASP systems for future exercises scheduled for 2016.

 

On March 2, 2015 we announced that we had officially launched WATT, our first model of a new line of commercial-grade electric tethered drones designed to provide secure and reliable aerial monitoring for extended durations while being tethered to the ground via a high strength armored tether. Our tethered electric drone product line consists of electrically powered drones connected to a ground-based software controlled winch via a safe and secure armored tether line. The concept of the tethered drone system is built on the strength of our years of developing tethered solutions for our aerostat products and combining that with the advantages of multi-rotor copters. The end result is a robust capability designed to be used in almost all weather environments and controlled with the push of a button. The initial tethered drone known as the WATT is being designed to take off, hover and land via remote control while being connected by a unique tether technology where all data, controls and endurance are built into the tether. The same components and systems that our military customers rely on in our launcher systems are being incorporated into the self-contained copter system in order to produce a heavier-than-air, tethered product offering. The WATT is a complete turnkey system that can be launched within minutes of unpacking from a standard case stored in a host vehicle. Once launched, WATT is designed to hover in a stationary position directly above its launch site at one of several preset altitudes of up to 300 ft. for up to 8 hours where a highly stabilized military-grade/broadcast quality HD video imager can provide a 360° live aerial monitoring feed directly through the tether to its host vehicle or to a network of mobile devices such as tablets or laptop computers. Compact and lightweight, the WATT system features the ability to draw power from both its host vehicle or independently provide up to 8 hours of operation through its own ground power equipment that is specially designed to be transported and deployed from commercial vehicles such as TV production trucks, first responder vehicles or even common agriculture/infrastructure equipment thanks to its standard 120v adapter.

  

Market

 

The market for our LTAS and tethered drones has grown significantly over the last several years following the recent proposed guidelines by the FAA for commercial drone use for which our tethered drone product line is designed to comply. The military has transformed into a smaller, more agile fighting force in need of a network of technologies to provide improved observation, communication and precision targeting of combat troop locations, which are often embedded in dense population centers or dispersed in remote locations.  Our products are intended to provide critical observation and communication capabilities serving the increased demand for ISR and communications, including real-time tactical reconnaissance, tracking, combat assessment and geographic data, while reducing the risks to our troops in theatre. Finally, in a highly constrained fiscal environment, we believe the typically lower acquisition and use/maintenance costs of LTA aerostats and tethered drones make them more appealing when compared to their heavier than air manned or larger LTA unmanned system alternatives.

 

 2 

 

 

The markets for our systems on a stand-alone basis and/or combined with other payloads relates to the following applications, among others:

 

Governmental Markets:

 

  ● International, Federal, state and local governments as well as U.S. and foreign government agencies, including U.S. Department of Defense (DoD), U.S. Drug Enforcement Agency (DEA), U.S. Homeland Security, Customs and Border Patrol, Environmental Protection Agency (EPA), U.S. Department of State, Federal Emergency Management Agency (FEMA), U.S. and state Departments of Transportation, Penitentiaries, and Police forces;
     
  ● Military, including U.S. Army Space and Missile Defense Agency (SMDC) and U.S. Air Force installations;
     
  ● Intelligence, reconnaissance and surveillance (ISR), including Joint Improvised Explosive Device Defeat Organization (JIEDDO);
     
  ● Border security monitoring, including U.S. Homeland Security, to deter and detect illegal entry;
     
  ● Drug enforcement along U.S. borders;
     
  ● Monitoring environmental pollution and sampling air emissions; and
     
  ● Vehicle Traffic monitoring, including aerial speed enforcement by state and local law enforcement agencies.

 

Commercial Markets:

 

  ● TV and Media Production Mobile communications systems, expanding on-site reporting capabilities to include aerial videography and photography;
     
  ● Agriculture monitoring, including monitoring crop health, field monitoring to reduce costs and increase yields;
     
  ● Security for large events, including crowd management;
     
  ● Natural disaster instant infrastructure to support first responders;
     
  ● Oil pipeline monitoring and exploration; and
     
  ● Atmospheric and climate research.

 

Distribution

 

We sell our products directly to end customers. In addition, our products are included in the GSA Schedule, which allows government customers to directly negotiate and acquire products and services from commercially-listed suppliers.

 

Competition

 

We believe that the principal competitive factors in the markets for the LTAS aerostat systems include product performance, features, acquisition cost, lifetime operating cost, including maintenance and support, ease of use, integration with existing equipment, size, mobility, quality, reliability, customer support, brand and reputation.  

 

We believe the current market competitors to the WASP aerostat systems include a large number of not only small “mom and pop” tethered aerostat and balloon companies but large defense contractors, among them: TCOM, Raytheon, Lockheed Martin, ISL, ILC Dover, Compass Systems, Raven Aerostar and American Blimp Corporation.  We believe there are numerous "hobbycraft" drone companies such as DJI and Parrot offering hobby grade free flying drones for pleasure use, as well as many larger drone manufactures such as Northrup Grumman and Boeing, offering military grade free flying drones to the U.S. Government. There are very few commercial grade tethered drone competitors for our tethered drone systems which remain tethered to the ground via a high strength armored tether, but among them are Elistair located in Lyon, France and Cyphy Works Inc. located in Danvers, MA.

 

Many of our LTA competitors have received considerable funding from government or government-related sources to develop and build LTA aerostats.  Most of these organizations and many of our other competitors have greater financial, technical, manufacturing, marketing and sales resources and capabilities than we do. We anticipate increasing competition as a result of defense industry consolidation, which has enabled companies to enhance their competitive position and ability to compete against us.  In addition, other companies may introduce competing aerostats or solutions based on alternative technologies that may adversely affect our competitive position.  As a result, our products may become less or non-competitive or obsolete.

 

Technology, Research and Development

 

We conduct the development, commercialization and construction of the WATT tethered drone and WASP aerostat systems in-house. 

 

 3 

 

 

Our research and development efforts are largely focused on the tethered drone systems and aerostat systems.  We have developed a “non-military spec” aerostat system for use in more commercial or governmental applications that does not require the level of durability and ruggedness of the current militarized model and we continue to work on different models with different payloads for various applications.

 

The concept of the WATT system is built on the strength of our years of developing tethered solutions for our aerostat products combined with the advantages of rotor copters. The end result is a robust capability that is designed to be utilized in almost all weather environments and controlled with the push of a button. The DAC tethered drone is designed to take off, hover and land via remote control all while being connected by a unique tether technology where all data, controls and endurance are built into the tether. The same components and systems that our military customers rely on from our launcher systems are incorporated into the self-contained DAC tethered drone system in order to produce a unique heavier than air, tethered product offering.

 

For the year ended December 31, 2015, we spent $744,452, and for the year ended December 31, 2014, we spent $142,011 on research and development activities.

 

Partners

 

We are party to several agreements with partners and distributors to assist us with the marketing and sales of various products, as we currently have limited in-house sales capabilities. Current relationships include:

 

●A sales and distribution partnership with U.S. government prime contractor ADS Inc.
   
●Signed in March 2015, a 3 year sales, marketing and integration partnership with L3 for a “L3-Branded” WASP targeting prime contract customers.

 

Intellectual Property

 

We review each of our intellectual properties and make a determination as to the best means to protect such property, by trademark, by copyright, by patent, by trade secret, or otherwise. We believe that we have taken appropriate steps to protect our intellectual properties, based on our evaluation of the factors unique to each such property, but cannot guarantee that this is the case. The United States Patent and Trademark Office issued U.S. Patent No. 7,822,816 to MacroSolve. The patent covers certain mobile information collection systems across all wireless networks, smart phones, tablets, and rugged mobile devices, regardless of carrier and manufacturer. In September 2011, MacroSolve filed a continuation of U.S. Patent No. 7,822,816 which is assigned number 12/910,706. On March 7, 2014, the United States Patent and Trademark Office (“USPTO”) sent MacroSolve an office action related to an ex parte reexamination of the ‘816 patent which rejected all the claims in the patent. As a result of the office action, the ‘816 patent was deemed unlikely to produce future revenues.

 

On September 18 and 19, 2014, we filed provisional patent application numbers “62/052,289” and “62/052,946” entitled “Tethered Portable Aerial Media broadcast System” based on the tethered drone system. On September 18, 2015, we filed a utility patent application claiming a priority date of the two provisional patent applications and having application Serial Number “14858467” entitled “Apparatus and Methods for Tethered Aerial Platform and System”. On July 7, 2015 we filed a provisional patent application number “62/189,341” entitled “Apparatus, Methods and System for Tethered Aerial Platform”. Our success and ability to compete depends in part on our ability to develop and maintain our intellectual property and proprietary technology and to operate without infringing on the proprietary rights of others. As we continue the development of the tethered drone and aerostat systems, we expect that we will rely on patents, trade secrets, copyrights, trademarks, non-disclosure agreements and other contractual provisions. We have also registered the trademark Blimp in a Box.  In certain cases, when appropriate, we opt to protect our intellectual property through trade secrets as opposed to filing for patent protection in order to preserve confidentiality.  All of our employees are subject to non-disclosure agreements and other contractual provisions to establish and maintain our proprietary rights.

 

Dependence on a Few Customers and Regulatory Matters

 

We believe there is a large, growing market for our commercial tethered drones internationally as well as in the U.S. With the recent proposed guidelines for commercial drone use in the U.S. by the FAA, we anticipate a growing U.S. market for commercial drone applications that our tethered drones can serve. Until the FAA officially adopts and publishes these guidelines, we are restricted to operating our tethered drones in the National Air Space (NAS) under either FAA granted exemptions or Certificate of Authorizations. We are currently engaged with commercial and research organizations in order to determine how our tethered drones can be operated under FAA exemptions or COA's until the FAA formally adopts a policy for commercial drone use in the NAS. We are currently evaluating various international markets where the FAA does not control the airspace where our tethered drones can potentially be operated by potential customers. We anticipate that the majority of our LTA based revenue at least in the foreseeable future will come from U.S. government and government-related entities, including both the DoD and other departments and agencies.  Government programs that we may seek to participate in must compete with other programs for consideration during Congress’s budget and appropriations hearings, and may be affected by changes not only in political power and appointments but also general economic conditions and other factors beyond our control.  Reductions, extensions or terminations in a program that we are seeking to participate in or overall defense spending could adversely affect our ability to generate revenues and realize any profits.  We cannot predict whether potential changes in security, defense and intelligence priorities will afford opportunities for our business in terms of research and development or product contracts, but any reduction in government spending on such programs could negatively impact our ability to generate revenues.

 

We have registered as a contractor with the U.S. Government and are required to comply with and will be affected by laws and regulations relating to the award, administration and performance of U.S. contracts.  Government contract laws and regulations affect how we will do business with customers, and in some instances, will impose added costs on our business.  A violation of specific laws and regulations could result in the imposition of fines and penalties, the termination of any then existing contracts or the inability to bid on future contracts.

 

 4 

 

 

Since our LTA systems are tethered to the ground they are required to comply with regulations enforced by the FAA, which currently does not allow any commercial untethered flights by free flying drones in commercial airspace in the U.S. without prior FAA clearance certifications or an FAA Certificate of Waiver or Authorization (COA) that are difficult and time-consuming to obtain. 

International sales of our products may also be subject to U.S. laws, regulations and policies like the United States Department of State restrictions on the transfer of technology, International Traffic in Arms Regulations (ITAR) and other export laws and regulations and may be subject to first obtaining licenses, clearances or authorizations from various regulatory entities.   This may limit our ability to sell our products abroad and the failure to comply with any of these regulations could adversely affect our ability to conduct business and generate revenues as well as increase our operating costs.  Our products may also be subject to regulation by the National Telecommunications and Information Administration and the Federal Communications Commission, which regulate wireless communications. 

Sources and Availability of Components 

Certain materials and equipment for our products are custom made for those products and are available only from either a single or limited number of suppliers. Failure of a supplier could cause delays in delivery of the products if another supplier cannot promptly be found or if the quality of such replacement supplier’s components is inferior or unacceptable.  

Employees 

We have four full-time employees and two part-time consultants that comprise our executive management and accounting team. LTAS has five full-time and fourteen part-time employees. We have no labor union contracts and believe relations with our employees are satisfactory. 

Recent Developments  

  ☐ On February 2, 2016, we announced a follow-up order from the United States Environmental Protection Agency (EPA) for an aerostat and related airborne equipment and operator training.

  ☐ On January 25, 2015, we announced a partnership for sales, operating, training and support of the WATT-200 tethered drone with Measure UAS, Inc. Measure has been granted a 333 exemption by the Federal Aviation Administration (FAA) to operate the WATT-200 for their Drone as a Service operations.

  ☐ On January 11, 2016 we announced a joint sales partnership with Skyfire Consulting, a drone services and consulting company serving first responders nationwide. The companies presented the WATT line of tethered drones at the annual Fire-Rescue East 2016 Conference in Daytona Beach, Florida in January 2016.

  ☐ On January 6, 2016 our common stock commenced trading on the OTCQX Market.

  ☐ On July 20, 2015, we closed an asset purchase agreement for the purchase of substantially all the assets of Adaptive Flight, Inc., (“AFI”). The Asset Purchase Agreement was entered into by and among the Company, AFI, the shareholders of AFI, and Drone AFS Corp., a Nevada corporation formed by the Company for the purpose of effecting the asset purchase. AFI was in the business of designing and developing flight control systems for unmanned aerial vehicles. Among the assets we acquired are commercial software licenses for the “GUST” (Georgia Tech UAV Simulation Tool) autopilot system, and other transferable licenses which include flight simulation and fault tolerant flight control algorithms.

  ☐ In July, 2015, the U.S. Army-owned WASP tactical aerostats successfully completed the DoD Enterprise Challenge 2015 (“EC15”) providing real-time situational awareness to participating ground forces and personnel. As a result of its performance, DAC will continue to support the U.S. Army-owned WASP systems for future exercises scheduled for 2016. The Enterprise Challenge program was created to explore how various technologies could collect, send and retrieve data from the field through a secure, interconnected network of multiple agencies, partners and organizations, providing access to real-time data and video. The WASP systems were used to capture and relay real-time, high definition video to various handheld devices, tablet computers and other deployed systems.

   ☐

We provided two WASP systems and six aerostats in 2013 to BAE Systems to support the U.S. Army Space and Missile Defense Command (SMDC). We delivered self-contained, compact, trailer-mounted aerostat launcher system and aerostats, which are undergoing testing and evaluation for various mission profiles to support and enhance critical communications for the Army. In 2015 we were contracted for parts and services related to enhancing and supporting these two WASP systems owned and operated by the SMDC. The upgrades and services were designed to expand the payload weight capability of the WASP systems in order to integrate specialized wireless electronics, advanced optics and a communication package provided by L-3 Communications Systems-West. 

In June 2015, we formed a working group with L-3 CS-West to form a technical integration plan of their technology into the WASP and jointly market the integrated solutions. The group will focus on upgrading the WASP system through the integration of electro-optical and infrared (EO/IR) imaging tactical surveillance system coupled to an L-3 CS-West communications package, which will provide secure high-definition video imagery to ground-based devices such as L-3’s Remote Operations Video Enhanced Receiver (ROVER).

  ☐ In August 2015, we provided the Unites States Environmental Protection Agency (EPA) with customized winch systems and related equipment for use at the Agency’s National Risk Management Research Laboratory (NRMRL) as part of the EQA’s on-going emission sampling program utilizing tethered aerostats.

  ☐ In October 2015, we provided two customized WASP systems to specialized defense contractor Troll Systems, jointly working with Troll to integrate the L-3 Wescam MX-10 advanced optical sensor system into the WASP platform for an international customer.   

 

 5 

 

 

Item 1A.  Risk Factors 

 

Investors should carefully consider the risks described below as well as other information provided in this document, including information in the section of this document entitled “Information Regarding Forward Looking Statements.” The Company’s business, financial condition or results of operations could be materially adversely affected, the value of the Company’s common stock could decline and investors may lose all or part of their investment as a result of these risks.

 

Risks Related to Our Business and Industry

 

Product development is a long, expensive and uncertain process.

 

The development of LTAS aerostats and tethered drones ISR systems is a costly, complex and time-consuming process, and the investment in product development often involves a long wait until a return, if any, is achieved on such investment.  We continue to make significant investments in research and development relating to our aerostats ISR systems, and tethered powered drones.  Investments in new technology and processes are inherently speculative. Technical obstacles and challenges we encounter in our research and development process may result in delays in or abandonment of product commercialization, may substantially increase the costs of development, and may negatively affect our results of operations.

 

Successful technical development of our products does not guarantee successful commercialization.

 

Even if we successfully complete the technical development for one or all of our product development programs, we may still fail to develop a commercially successful product for a number of reasons, including among others the following:

 

  ● failure to obtain the required regulatory approvals for their use;
     
  ● prohibitive production costs;
     
  ● competing products;
     
  ● lack of innovation of the product;
     
  ● ineffective distribution and marketing;
     
  ● lack of sufficient cooperation from our partners; and
     
  ● demonstrations of the products not aligning with or meeting customer needs.

 

Although we have sold our WASP aerostat systems and various other aerostat ISR systems and components, our success in the market for the products we develop will depend largely on our ability to prove our products’ capabilities.  Upon demonstration, our aerostats, tethered drones ISR systems may not have the capabilities they were designed to have or that we believed they would have.  Furthermore, even if we do successfully demonstrate our products’ capabilities, potential customers may be more comfortable doing business with a larger, more established, more proven company than us. Moreover, competing products may prevent us from gaining wide market acceptance of our products.  We may not achieve significant revenue from new product investments for a number of years, if at all.

 

Our potential customers are likely to be government or government-related entities that are subject to appropriations by Congress and reduced funding for defense procurement and research and development programs would likely adversely impact our ability to generate revenues.

 

We anticipate that the majority of our revenue (for our aerostats and tethered drone sales) at least in the foreseeable future will come from U.S. government and government-related entities, including both the Department of Defense (“DoD”) and other departments and agencies.  Government programs that we may seek to participate in and contracts for aerostats or tethered drones must compete with other programs for consideration during Congress’ budget and appropriations hearings, and may be affected by changes not only in political power and appointments but also general economic conditions and other factors beyond our control.  Reductions, extensions or terminations in a program that we are seeking to participate in or overall defense or other spending could adversely affect our ability to generate revenues and realize any profits.  We cannot predict whether potential changes in security, defense, communications and intelligence priorities will afford opportunities for our business in terms of research and development or product contracts, but any reduction in government spending on such programs could negatively impact our ability to generate revenues.

  

Some of our products may be subject to governmental regulations pertaining to exportation.

 

International sales of our products may be subject to U.S. laws, regulations and policies like the International Traffic in Arms Regulations (ITAR) and other export laws and regulations and may be subject to first obtaining licenses, clearances or authorizations from various regulatory entities.   If we are not allowed to export our products or the clearance process is burdensome, our ability to generate revenue would be adversely affected.  The failure to comply with any of these regulations could adversely affect our ability to conduct our business and generate revenues as well as increasing our operating costs.

 

 6 

 

 

We compete with companies that have significantly more resources than we have and already have received government contracts for the development of aerostats and tethered drones.

 

A number of our competitors have received considerable funding from government or government-related sources to develop various aerostats and tethered drones.  Most of these organizations and many of our other competitors have greater financial, technical, manufacturing, marketing and sales resources and capabilities than we do.  Our products will compete not only with other tethered aerostats, but also with heavier-than-air fixed wing aircraft, manned aircraft, communications satellites and balloons.  We anticipate increasing competition as a result of defense industry consolidation, which has enabled companies to enhance their competitive position and ability to compete against us.  In addition, other companies may introduce competing aerostats or solutions based on alternative technologies that may adversely affect our competitive position.  As a result, our products may become less or non-competitive or obsolete.  If we are not able to compete successfully against our current and future competitors, we may fail to generate revenues and our financial condition would be adversely affected.

  

We may pursue strategic transactions in the future, which could be difficult to implement, disrupt our business or change our business profile significantly.

 

We intend to consider potential strategic transactions, which could involve acquisitions of businesses or assets, joint ventures or investments in businesses, products or technologies that expand, complement or otherwise relate to our current or future business. We may also consider, from time to time, opportunities to engage in joint ventures or other business collaborations with third parties to address particular market segments. These activities create risks such as, among others,: (i) the need to integrate and manage the businesses and products acquired with our own business and products, (ii) additional demands on our resources, systems, procedures and controls, (iii) disruption of our ongoing business, and (iv) diversion of management’s attention from other business concerns. Moreover, these transactions could involve: (a) substantial investment of funds or financings by issuance of debt or equity securities; (b) substantial investment with respect to technology transfers and operational integration; and (c) the acquisition or disposition of product lines or businesses. Also, such activities could result in one-time charges and expenses and have the potential to either dilute the interests of existing shareholders or result in the issuance of, or assumption of debt. Such acquisitions, investments, joint ventures or other business collaborations may involve significant commitments of financial and other resources of our company. Any such activity may not be successful in generating revenue, income or other returns to us, and the resources committed to such activities will not be available to us for other purposes. Moreover, if we are unable to access capital markets on acceptable terms or at all, we may not be able to consummate acquisitions, or may have to do so on the basis of a less than optimal capital structure. Our inability: (i) to take advantage of growth opportunities for our business or for our products or (ii) to address risks associated with acquisitions or investments in businesses, may negatively affect our operating results. Additionally, any impairment of goodwill or other intangible assets acquired in an acquisition or in an investment, or charges to earnings associated with any acquisition or investment activity, may materially reduce our earnings.   These future acquisitions or joint ventures may not result in their anticipated benefits and we may not be able to properly integrate acquired products, technologies or businesses, with our existing products and operations or combine personnel and cultures.  Failure to do so could deprive us of the intended benefits of those acquisitions.

 

If we fail to protect our intellectual property rights, we could lose our ability to compete in the marketplace.

 

Our intellectual property and proprietary rights are important to our ability to remain competitive and for the success of our products and our business. Patent protection can be limited and not all intellectual property is or can be patented. We rely on a combination of patent, trademark, copyright, and trade secret laws as well as confidentiality agreements and procedures, non-competition agreements and other contractual provisions to protect our intellectual property, other proprietary rights and our brand.  We have little protection when we must rely on trade secrets and nondisclosure agreements.   Our intellectual property rights may be challenged, invalidated or circumvented by third parties. We may not be able to prevent the unauthorized disclosure or use of our technical knowledge or other trade secrets by employees or competitors. Furthermore, our competitors may independently develop technologies and products that are substantially equivalent or superior to our technologies and/or products, which could result in decreased revenues.  Moreover, the laws of foreign countries may not protect our intellectual property rights to the same extent as the laws of the U.S. Litigation may be necessary to enforce our intellectual property rights which could result in substantial costs to us and substantial diversion of management attention. If we do not adequately protect our intellectual property, our competitors could use it to enhance their products.  Our inability to adequately protect our intellectual property rights could adversely affect our business and financial condition, and the value of our brand and other intangible assets.

   

Other companies may claim that we infringe their intellectual property, which could materially increase our costs and harm our ability to generate future revenue and profit.

 

We do not believe our product technologies infringe the proprietary rights of any third party, but claims of infringement are becoming increasingly common and third parties may assert infringement claims against us.  It may be difficult or impossible to identify, prior to receipt of notice from a third party, the trade secrets, patent position or other intellectual property rights of a third party, either in the United States or in foreign jurisdictions. Any such assertion may result in litigation or may require us to obtain a license for the intellectual property rights of third parties.  If we are required to obtain licenses to use any third party technology, we would have to pay royalties, which may significantly reduce any profit on our products.  In addition, any such litigation could be expensive and disruptive to our ability to generate revenue or enter into new market opportunities.  If any of our products are found to infringe other parties’ proprietary rights and we are unable to come to terms regarding a license with such parties, we may be forced to modify our products to make them non-infringing or to cease production of such products altogether.

 

 7 

 

 

The nature of our business involves significant risks and uncertainties that may not be covered by insurance or indemnity.

 

We develop and sell products where insurance or indemnification may not be available, including:

 

  ● Designing and developing products using advanced and unproven technologies and aerostats and tethered drones in intelligence and homeland security applications that are intended to operate in high demand, high risk situations; and

 

  ● Designing and developing products to collect, distribute and analyze various types of information.

 

Failure of certain of our products could result in loss of life or property damage.  Certain products may raise questions with respect to issues of civil liberties, intellectual property, trespass, conversion and similar concepts, which may raise new legal issues.  Indemnification to cover potential claims or liabilities resulting from a failure of technologies developed or deployed may be available in certain circumstances but not in others.  We are not able to maintain insurance to protect against all operational risks and uncertainties.   Substantial claims resulting from an accident, failure of our product, or liability arising from our products in excess of any indemnity or insurance coverage (or for which indemnity or insurance is not available or was not obtained) could harm our financial condition, cash flows, and operating results.  Any accident, even if fully covered or insured, could negatively affect our reputation among our customers and the public, and make it more difficult for us to compete effectively.

 

If we are unable to recruit and retain key management, technical and sales personnel, our business would be negatively affected.

 

For our business to be successful, we need to attract and retain highly qualified technical, management and sales personnel. The failure to recruit additional key personnel when needed with specific qualifications and on acceptable terms or to retain good relationships with our partners might impede our ability to continue to develop, commercialize and sell our products.  To the extent the demand for skilled personnel exceeds supply, we could experience higher labor, recruiting and training costs in order to attract and retain such employees.  The loss of any members of our management team may also delay or impair achievement of our business objectives and result in business disruptions due to the time needed for their replacements to be recruited and become familiar with our business.  We face competition for qualified personnel from other companies with significantly more resources available to them and thus may not be able to attract the level of personnel needed for our business to succeed.

 

Economic conditions in the U.S. and worldwide could adversely affect our revenues.

 

Our revenues and operating results depend on the overall demand for our technologies and services. If the U.S. and worldwide economies weaken, either alone or in tandem with other factors beyond our control (including war, political unrest, shifts in market demand for our services, actions by competitors, etc.), we may not be able to maintain or expand the growth of our revenue.

  

We have experienced losses which may continue and which may negatively impact our ability to achieve our business objectives.

 

We incurred a net loss of $8,975,862 for the year ended December 31, 2015 and we experienced negative cash flow from operations. We can provide no assurance that we can achieve profitability or sustain cash flow positive operations on a quarterly or annual basis in the future.  Our operations are subject to the risks and competition inherent in the establishment of a business enterprise. Revenues and profits, if any, will depend upon various factors, including whether we will be able to continue expansion of our revenue. We may not achieve our business objectives and the failure to achieve such goals would have an adverse impact on us.

 

If we are unable to obtain additional funding when needed, our business operations will be harmed and if we do obtain additional financing our then existing shareholders may suffer substantial dilution.

 

Although we believe we not currently require additional funds to sustain our operations and institute our business plan, we have historically required additional funds to continue operations and may again in the future.  We do not have any contracts or commitments for additional funding, and there can be no assurance that financing will be available in amounts or on terms acceptable to us, if at all, if needed. The inability to obtain additional capital will restrict our ability to grow and may reduce our ability to conduct business operations. If we are unable to obtain additional financing to finance a revised growth plan, we will likely be required to curtail such plans or cease our business operations. Any additional equity financing may involve substantial dilution to our then existing shareholders.

 

If we fail to protect our intellectual property rights, our ability to pursue the development of our technologies and products would be negatively affected.

 

Our success will depend in part on our ability to obtain patents and maintain adequate protection of our technologies. Some foreign countries lack rules and methods for defending intellectual property rights and do not protect proprietary rights to the same extent as the United States. We have not filed for any patent protection rights outside the United States and many companies have had difficulty protecting their proprietary rights in these foreign countries. We may not be able to prevent misappropriation of our proprietary rights.

 

 8 

 

 

We are currently seeking patent protection for the WATT system. On September 18 and 19, 2014, we filed provisional patent application numbers “62/052,289” and “62/052,946” entitled “Tethered Portable Aerial Media broadcast System” based on the tethered drone system. On September 18, 2015, we filed a utility patent application claiming a priority date of the two provisional patent applications and having application Serial Number “14858467” entitled “Apparatus and Methods for Tethered Aerial Platform and System”. On July 7, 2015 we filed a provisional patent application number “62/189,341” entitled “Apparatus, Methods and System for Tethered Aerial Platform”. However, the patent process is subject to numerous risks and uncertainties, and there can be no assurance that we will be successful in protecting our technologies by obtaining and enforcing patents. These risks and uncertainties include the following: patents that may be issued or licensed may be challenged, invalidated, or circumvented, or otherwise may not provide any competitive advantage; our competitors, many of which have substantially greater resources than us and many of which have made significant investments in competing technologies, may seek, or may already have obtained, patents that will limit, interfere with, or eliminate our ability to make, use, and license our technologies either in the United States or in international markets; there may be significant pressure on the United States government and other international governmental bodies to limit the scope of patent protection both inside and outside the United States for technologies that prove successful as a matter of public policy regarding security concerns; countries other than the United States may have less restrictive patent laws than those upheld by United States courts, allowing foreign competitors the ability to exploit these laws to create, develop, and market competing products.

 

Moreover, any patents issued to us may not provide us with meaningful protection, or others may challenge, circumvent or narrow our patents. Third parties may also independently develop technologies similar to ours or design around any patents on our technologies.

 

In addition, the PTO and patent offices in other jurisdictions have often required that patent applications concerning software inventions be limited or narrowed substantially to cover only the specific innovations exemplified in the patent application, thereby limiting the scope of protection against competitive challenges. Thus, even if we or our licensors are able to obtain patents, the patents may be substantially narrower than anticipated.

 

Our success depends on our patents, patent applications that may be licensed exclusively to us and other patents to which we may obtain assignment or licenses. We may not be aware, however, of all patents, published applications or published literature that may affect our business either by blocking our ability to commercialize our products, by preventing the patentability of future products or services to us or our licensors, or by covering the same or similar technologies that may invalidate our patents, limit the scope of our future patent claims or adversely affect our ability to market our products and services.

 

In addition to patents, we rely on a combination of trade secrets, confidentiality, nondisclosure and other contractual provisions, and security measures to protect our confidential and proprietary information. These measures may not adequately protect our trade secrets or other proprietary information. If they do not adequately protect our rights, third parties could use our technology, and we could lose any competitive advantage we may have. In addition, others may independently develop similar proprietary information or techniques or otherwise gain access to our trade secrets, which could impair any competitive advantage we may have.

 

Patent protection and other intellectual property protection are crucial to the success of our business and prospects, and there is a substantial risk that such protections will prove inadequate.

 

Risks Relating to our Common Stock and its Market Value

 

The price of our common stock may be volatile.

 

The trading price of our common stock may be highly volatile and could be subject to fluctuations in response to a number of factors beyond our control. Some of these factors are:

 

  ● dilution caused by our issuance of additional shares of common stock and other forms of equity securities, which we expect to make in connection with future capital financings to fund our operations and growth, to attract and retain valuable personnel and in connection with future strategic partnerships with other companies;
     
  ● our results of operations and the performance of our competitors;
     
  ● the public’s reaction to our press releases, our other public announcements and our filings with the Securities and Exchange Commission;
     
  ● changes in earnings estimates or recommendations by research analysts who follow, or may follow, us or other companies in our industry;
     
  ● changes in general economic conditions;
     
  ● changes in the valuation of similarly situated companies, both in our industry and in other industries;
     
  ● actions of our historical equity investors, including sales of common stock by our directors and executive officers;

 

 9 

 

 

  ● actions by institutional investors trading in our stock;
     
  ● disruption of our operations;
     
  ● any major change in our management team;
     
  ● significant sales of our common stock;
     
  ● other developments affecting us, our industry or our competitors; and
     
  ● U.S. and international economic, legal and regulatory factors unrelated to our performance.

 

These and other factors are largely beyond our control, and the impact of these risks, singly or in the aggregate, may result in material adverse changes to the market price of our common stock and/or our results of operations and financial condition.

  

There is a limited market for our common stock which may make it more difficult for you to dispose of your stock.

 

Our common stock is quoted on the OTCQX under the symbol “DRNE”. However, this is an unorganized, inter-dealer, over-the-counter market which provides significantly less liquidity than The NASDAQ Capital Market or other national securities exchanges. These factors may have an adverse impact on the trading and price of our common stock.

   

Sales of substantial amounts of our common stock in the public market could harm the market price of our common stock.

 

The sale of a substantial number of shares of our common stock by stockholders could adversely affect the market price of our shares.  As of March 4, 2016, we had approximately 6,400 registered stockholders and many more beneficial holders, most of whom have held their shares for the required holding periods under Rule 144 promulgated pursuant to the Securities Act and thus hold freely tradable shares.  The shares issued pursuant to conversions under our Series A, B, B-1, D, E, F and G Preferred Stock on November 20, 2015 and January 12, 2016 are either immediately freely tradable pursuant to Rule 144 promulgated pursuant to the Securities Act, or subject to a 180 day lock-up agreements. If such shares are sold, or if it is perceived they will be sold, the trading price of our common stock could decline. Because investors may be more reluctant to purchase shares of our common stock following substantial sales or issuances, the resale of these shares of common stock could impair our ability to raise capital in the near term.

  

We have not paid dividends in the past and do not expect to pay dividends in the future. Any return on investment may be limited to the value of our common stock.

 

We have never paid cash dividends on our common stock and do not anticipate paying cash dividends in the foreseeable future. The payment of dividends on our common stock will depend on earnings, financial condition and other business and economic factors affecting it at such time as the Board of Directors may consider relevant.

 

Our common stock is subject to the “penny stock” rules of the SEC and the trading market in our securities is limited, which makes transactions in our stock cumbersome and may reduce the value of an investment in our stock.

 

The SEC has adopted Rule 15g-9 which establishes the definition of a “penny stock,” for the purposes relevant to us, as any equity security that has a market price of less than $5.00 per share or with an exercise price of less than $5.00 per share, subject to certain exceptions. For any transaction involving a penny stock, unless exempt, the rules require:

 

  ● that a broker or dealer approve a person's account for transactions in penny stocks; and

 

  ● the broker or dealer receive from the investor a written agreement to the transaction, setting forth the identity and quantity of the penny stock to be purchased.

 

In order to approve a person's account for transactions in penny stocks, the broker or dealer must:

 

  ● obtain financial information and investment experience objectives of the person; and

 

  ● make a reasonable determination that the transactions in penny stocks are suitable for that person and the person has sufficient knowledge and experience in financial matters to be capable of evaluating the risks of transactions in penny stocks.

 

 10 

 

 

The broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prescribed by the SEC relating to the penny stock market, which, in highlight form:

 

  ● sets forth the basis on which the broker or dealer made the suitability determination; and

 

  ● that the broker or dealer received a signed, written agreement from the investor prior to the transaction.

 

Generally, brokers may be less willing to execute transactions in securities subject to the "penny stock" rules. This may make it more difficult for investors to dispose of our common stock and cause a decline in the market value of our stock.

 

FINRA sales practice requirements may also limit a shareholder’s ability to buy and sell our stock.

 

In addition to the “penny stock” rules described above, FINRA has adopted rules that require that in recommending an investment to a customer, a broker-dealer must have reasonable grounds for believing that the investment is suitable for that customer. Prior to recommending speculative low priced securities to their non-institutional customers, broker-dealers must make reasonable efforts to obtain information about the customer’s financial status, tax status, investment objectives and other information. Under interpretations of these rules, FINRA believes that there is a high probability that speculative low priced securities will not be suitable for at least some customers. The FINRA requirements make it more difficult for broker-dealers to recommend that their customers buy our common stock, which may limit stockholders’ ability to buy and sell our stock and have an adverse effect on the market for our shares.

 

Item 1B.  Unresolved Staff Comments

 

None.

 

Item 2.  Properties

 

We maintain our mailing address at 11651 Central Parkway #118, Jacksonville, Florida 32224 which is also our primary physical location. Several of our management employees work remotely. We have entered into a 60 month operating lease for 5,533 square feet of office and manufacturing space at 11651 Central Parkway #118, Jacksonville, Florida 32224. The lease commenced February 1, 2015 and we took occupancy in June 2015. We also lease an executive office in Aventura, Florida for an executive on a month-to-month basis.

 

Item 3.  Legal Proceedings.

 

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business.  We are currently party to the following material legal proceedings:

 

MacroSolve, Inc. v Newegg Inc. (U.S.D.C. E.D. TX) case No. 6:12-cv-46-MSS-KNM

 

On January 30, 2012, MacroSolve, Inc. filed suit against Newegg, Inc. in the United States District Court Eastern District of Texas alleging infringement of one or more claims of United States Patent #7,822,816. On March 7, 2014, the United States Patent and Trademark Office (“USPTO”) sent MacroSolve, Inc. an office action related to an ex parte reexamination of the ‘816 patent, which rejected all the claims in the patent (the “USPTO Office Action”). As a result of the USPTO Office Action, on March 31, 2014, the Company dismissed its patent enforcement case against Newegg Inc. with prejudice. On April 6, 2015, the court denied the motion by Newegg for recovery of defendant legal fees of approximately $400,000 from the Company. On April 24, 2015, Newegg filed a Notice of Appeal with the United States Court of Appeals for the Federal Circuit. On August 19, 2015, the Company filed a Brief of Appellee MacroSolve, Inc. with the United States Court of Appeals for the Federal Circuit and on September 8, 2015, Newegg filed a Reply Brief. Oral arguments occurred on February 1, 2016. The Federal Circuit decision affirming the district court’s denial of fees came down on February 9, 2016 in the form of a Rule 36 (‘summary affirmance”) per curiam decision. Newegg has ninety days to file a petition for the U.S. Supreme Court to review. The Company has prevailed in this matter but should the case be accepted by the Supreme Court and the Company not prevail in that venue, the judgment would be borne by the former MacroSolve directors who sold their loans on April 17, 2014.

 

Item 4.  Mine Safety Disclosures.

 

Not applicable.

  

 11 

 

 

PART II

 

Item 5. Market For Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

 

Market Information

 

The Company’s common stock has been quoted on the OTCQX under the ticker symbol “DRNE” since January 6, 2016, and previously was quoted on the OTCQB under the ticker symbol “DRNE” and the OTC Pink under the ticker symbol MCVE.

 

The following sets forth the range of the bid prices for our common stock for the quarters for the prior two fiscal years. Such prices represent inter-dealer quotations, do not represent actual transactions, and do not include retail mark-ups, markdowns or commissions. Such prices were determined from information provided by a majority of the market makers for the Company’s common stock.

 

    2015       2014 
    Sales Price       Sales Price 
    High       Low   High    Low     
Quarter Ended                
March 31  $24.00   $9.20    $ N/A       $ N/A     
June 30   14.40    8.40    43.60   $26.00 
September 30   11.60    6.00    52.00   $14.80 
December 31   6.80    3.12    17.60   $6.00 

  

Holders

 

As of March 4, 2016, there were 115 stockholders of record and approximately 6,400 beneficial holders of the Company’s common stock.

 

Dividends

 

We have not declared any common stock dividends to date. We have no present intention of paying any cash dividends on our common stock in the foreseeable future, as we intend to use earnings, if any, to generate growth. The payment by us of dividends, if any, in the future, rests within the discretion of our Board of Directors and will depend, among other things, upon our earnings, our capital requirements and our financial condition, as well as other relevant factors. There are no material restrictions in our certificate of incorporation or bylaws that restrict us from declaring dividends.

 

Equity Compensation Plan Information

 

The following table provides information as of December 31, 2015, regarding our compensation plans under which equity securities are authorized for issuance:

 

Plan category  Number of
securities to
be issued
upon
exercise of
outstanding
options		   Weighted-average
exercise
price of
outstanding
options		   Securities
remaining
available
for future
issuance
under equity
compensation
plans (excluding
securities
reflected
in column (a))		 
   (a)   (b)   (c) 
Equity compensation plans approved by security holders   120,000   $5.00    130,000 
Equity compensation plans not approved by security holders   287,500    6.63    0 
Total   407,500   $6.19    130,000 

 

Recent Sales of Unregistered Securities

 

The Company has previously disclosed all recent sales of unregistered securities on Current Reports on Form 8-K. There have been no recent sales of unregistered securities that have not been previously disclosed.

 

Item 6. Selected Financial Data.

 

Not required under Regulation S-K for “smaller reporting companies.”

 

 12 

 

 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Introduction

 

The following discussion and analysis of financial condition and results of operations should be read in conjunction with our historical financial statements and the notes to those statements that appear elsewhere in this report.  Certain statements in the discussion contain forward-looking statements based upon current expectations that involve risks and uncertainties, such as plans, objectives, expectations and intentions.  Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors, including those set forth under “Item 1A.  Risk Factors.” and elsewhere in this report.

 

Business Overview

 

For this information please see Part 1, Item 1 “Business.”

 

Results of Operations

 

Year Ended December 31, 2015 Compared to Year Ended December 31, 2014 (all references are to fiscal years).

 

Total Net Revenues: Total net revenues decreased approximately $386,000, or 45.0%, to approximately $472,000 in 2015 from approximately $858,000 for 2014. Sources of revenue in 2015 were derived primarily from small aerostat systems. Sources of revenue in 2014 included several large aerostat systems, cameras and accessories.  

 

Cost of Revenues and Gross Profit:  Cost of revenues for 2015 decreased approximately $392,000, or 58.1%, from approximately $675,000 in 2014 to approximately $283,000 in 2015, primarily consisting of materials, parts and labor associated with the sale of small aerostat systems. The resulting gross profit for 2015 of approximately $190,000 was a decrease of approximately $7,000, or 3.6% from the gross profit for 2014 of approximately $183,000 in line with the lower net revenue. Gross profit margins were 40% and 21% for 2015 and 2014, respectively. The cameras sold in 2014 were low margin which contributed to the lower gross profit margin in the prior year.

 

General and Administrative Expenses: General and administrative expenses increased by approximately $7,259,000, or 381%, to approximately $9,164,000 in 2015 from approximately $1,905,000 in 2014.   The Company put an executive management team in place following the June 3, 2014 business combination and reverse merger discussed above which represents approximately $766,000 of the 2015 expenses. Management also received equity awards, including stock and options, valued at approximately $5,318,000 in non-cash expense. The Company incurred approximately $381,000 in financial advisory and investor relations expenses in 2015, including a placement agent warrant valued at $246,000 issued in association with the common stock sold in 2015. The Company paid its directors a total of $281,000, including $123,500 in non-cash equity. The Company established a Strategic Advisory Board in August 2014. The advisors were compensated with stock at the end of their first year of service and $213,000 non-cash pro-rata expense has been recorded in 2015. Legal expense was approximately $187,000 primarily related to the general corporate and securities matters, fundraising, and AFI asset acquisition. Research and development costs of approximately $744,000 were incurred in 2015, primarily related to the WATT tethered drone system. The Company invested approximately $210,000 in marketing and promotions, approximately $85,000 in occupancy costs, approximately $75,000 in accounting fees and approximately $136,000 in travel and related costs. The Company recorded $161,500 in expense related to the contingent liability associated with the possible issuance of additional stock in connection with the AFI asset acquisition.

 

Loss from Operations: Loss from operations for 2015 of approximately $8,974,000 was an increase of approximately $7,252,000 or (421) % over the loss from operations in 2014 of approximately $1,722,000, which resulted primarily due to the increase in G&A expenses of approximately $7,259,000.

 

Other Income and Expense: Total other expenses of approximately $2,000 in 2015 were approximately $399,000 or 99.6 % less than the total other expense of approximately $401,000 in 2014.  This decrease is primarily due to a $351,000 non-cash expense for derivative accounting under ASC 815-15 “Derivative and Hedging” and $43,000 loss on sale of securities held for resale which occurred in 2014.

 

Net Loss: Net loss of approximately $8,976,000 in 2015 was approximately $6,852,000 or (322.7)% greater than the net loss in 2014 of approximately $2,123,000 primarily due to the factors previously discussed.

 

There was no provision for income taxes for the fiscal years ended 2015 and 2014 due to a valuation allowance of $1,434,996 and $497,501 recorded for the years ended December 31, 2015 and 2014 on the total tax provision, as we believed that it is more likely than not that the tax asset will not be utilized during the next year.

 

Liquidity and Capital Resources

 

As of December 31, 2015, the Company had total current assets of approximately $2,917,000 and total current liabilities of approximately $366,000 for working capital of approximately $2,551,000. As of December 31, 2015, the Company had cash and cash equivalents of approximately $2,660,000 and an accumulated deficit of approximately $11,139,000 since operations commenced in 2014.

 

 13 

 

 

Although there was a net loss of $8,975,862 in 2015, the Company's independent registered public accounting firm's audit report for the year ended December 31, 2015, included herein, did not contain a qualified opinion or an explanatory paragraph regarding the Company's ability to continue as a going concern. The accompanying financial statements have been prepared assuming that the Company continues as a going concern and contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The ability of the Company to continue as a going concern on a long-term basis will be dependent upon its ability to create and market innovative services and to sustain adequate working capital to finance its operations.

 

We have historically financed our operations through operating revenues and sales of equity securities to accredited investors.    While we currently believe we have sufficient capital to continue our operations for the next 12 months, we may incur greater expenses than we currently anticipate.  As a result, we could deplete our cash and working capital more rapidly than expected, which could result in our need to raise additional working capital through sale of equity securities or debt financing.

 

Sources and Uses of Cash

 

   Years Ended Dec 31, 
   2015   2014 
         
Cash flows (used in) operating activities  $(2,865,685)  $(1,302,279)
Cash flows (used in) provided by investing activities   (329,227)   1,529,098 
Cash flows provided by financing activities   4,484,750    1,143,077 
Net increase in cash and cash equivalents  $1,289,838   $1,369,896 

 

Operating Activities:

 

Net cash used in operating activities during the year ended December 31, 2015 was approximately $2,866,000, which was a decrease in operating cash flow of approximately $1,563,000 or (120.1) % from approximately $1,302,000 net cash used in operating activities during the year ended December 31, 2014. The 2015 net loss of approximately $8,976,000 was $6,852,000 greater than the 2014 loss of approximately $2,123,000. $5,593,000 of the increase is related to the increase in non-cash stock based compensation to $5,935,000 in 2015 from $342,000 in 2014. Research and development costs increased $602,000 in 2015 to $744,000 from $142,000 in 2014. Amortization expense increased $72,000 in 2015 to $104,000 from $32,000 in 2014 primarily due to expensing the remaining balance of the customer list acquired in June 2014.

 

Investing Activities:

 

Net cash used in investing activities during the year ended December 31, 2015 was approximately $329,000, which was a decrease of approximately $1,858,000 or (121.5) % from approximately $1,529,000 net cash provided in investing activities during the year ended December 31, 2014. In 2015, the Company purchased approximately $129,000 in furniture and equipment and expended $200,000 on the AFI asset acquisition. In 2014, the Company recognized approximately $1,693,000 cash from the reverse merger and $169,000 cash from sale of available-for-sale securities and spent approximately $28,000 on furniture and equipment. 

 

Financing Activities:

 

Net cash provided by financing activities was approximately $4,485,000 in 2015 compared with approximately $1,143,000 cash provided by financing activities for the same period in 2014, an increase of approximately $3,3342,000 or 292.3%.  In 2015, the Company received approximately $3,485,000 cash proceeds from the sale of common stock for cash as well as $1,000,000 cash proceeds from the sale of Series G preferred stock.

 

During 2015, the Company experienced negative cash flow from operations. Significant negative cash flow from operations is likely to occur in 2016 as the Company continues development of the WATT family of tethered drone products, followed by commercialization. Although we currently have adequate funds to sustain our operations in the near term, we may require additional funds to continue operations depending upon the level of interest in the Company’s new and existing product offerings. We have no current plans to raise additional funds; however, if we need to raise additional funds through the issuance of equity, equity-related or convertible debt securities in the future, these securities may have rights, preferences or privileges senior to those of the rights of holders of our common stock and they may experience additional dilution. We cannot predict whether additional financing will be available to us on favorable terms when required, or at all. The issuance of additional common stock may have the effect of further diluting the proportionate equity interest and voting power of holders of our common stock.  Historically, we have financed our cash needs by private placements of our securities. There is no assurance that we will be able to obtain financing on terms consistent with our past financings or satisfactory to us, if at all.

 

As of December 31, 2015, the Company has common stock outstanding as well as Convertible Preferred Stock Series A, C, D, F and G and we have $110,000 in debt that consists of a note from the Oklahoma Technology Commercialization Center which relates to the former MacroSolve business and is under review.

 

 14 

 

 

Off-Balance Sheet Arrangements

 

We do not have any off balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, revenues, and results of operations, liquidity or capital expenditures.

 

Critical Accounting Policies and Estimates

 

The Company’s accounting policies are more fully described in Note 1 of the Financial Statements. As disclosed in Note 1, the preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions about future events that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ significantly from those estimates. The Company believes that the following discussion addresses the Company’s most critical accounting policies, which are those that are most important to the portrayal of the Company’s financial condition and results of operations and require management’s most difficult, subjective and complex judgments.

 

Accounts Receivable and Credit Policies:

 

Trade accounts receivable consist of amounts due from the sale of tethered aerostats, accessories, spare parts and delivery and installation of aerostats.  Accounts receivable are uncollateralized customer obligations due under normal trade terms requiring payment within 30 days of receipt of the invoice.  The Company provides an allowance for doubtful accounts equal to the estimated uncollectible amounts based on historical collection experience and a review of the current status of trade accounts receivable.  At December 31, 2015 and 2014, the Company deems $0 and $0 as uncollectible, respectively.

 

Revenue Recognition and Unearned Income:

 

The Company recognizes revenue when all four of the following criteria are met: 1) persuasive evidence of an arrangement exists; 2) delivery has occurred and title has transferred or services have been rendered; 3) our price to the buyer is fixed or determinable; and 4) collectability is reasonably assured. We record unearned revenue as a liability and their associated costs of sales as work in process inventory. In 2015, the Company recognized $7,896 in revenue from a 2014 sale that was delivered in 2015. There is a balance of $83,288 in accounts receivable at December 31, 2015 for sales on account.

 

Long-Lived Assets:

 

The Company accounts for long-lived assets in accordance with the provisions of ASC 360-10-35, “Impairment or Disposal of Long-lived Assets”.  This Statement requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.  Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset.  If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. The Company acquired the LTAS customer list in 2014. The fair value of the customer list was determined by using a discounted cash flow model and $135,550 was recorded on the date of business combination The Company recorded $31,941 of amortization expense for the year ended December 31, 2014 leaving a remaining carrying amount of $103,609. The Company recorded another $37,935 amortization expense for the year ended December 31, 2015. After comparing the acquired customer list to the actual customers who placed orders following the acquisition of LTAS, the Company determined that the customer list was impaired at December 31, 2015 and amortized the remaining balance of $65,674 in 2015.

 

On July 20, 2015, the Company, through its wholly-owned subsidiary Drone AFS Corp., a Nevada corporation formed July 9, 2015, entered into an agreement to acquire exclusive commercial software licenses for the “GUST” (Georgia Tech UAV Simulation Tool) autopilot system from Adaptive Flight, Inc. Through the purchase of the assets of privately held Adaptive Flight Inc. (AFI), the Company is assuming the transferable licenses from the Georgia Tech Research Corporation which include flight simulation tools and fault tolerant flight control algorithms. In addition, the company acquired AFI’s dedicated flight computer and additional related hardware and airframes. The Company paid $100,000 in immediately available funds and $100,000 to be held in escrow. In addition, the Company issued 150,000 shares of unregistered common stock valued at $8.40 per share, on a post-reverse split basis, on the date of agreement, to be held in escrow. The asset acquisition did not qualify as a business combination under ASC 805-10 and has been accounted for as a regular asset purchase.

 

The Company accounts for goodwill and intangible assets in accordance with ASC 350 "Intangibles Goodwill and Other". ASC 350 requires that goodwill and other intangibles with indefinite lives be tested for impairment annually or on an interim basis if events or circumstances indicate that the fair value of an asset has decreased below its carrying value.

 

Derivative Financial Instruments:

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes option pricing model, in accordance with ASC 815-15 “Derivative and Hedging” to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

 

 15 

 

  

Stock-Based Compensation:

 

The Company accounts for stock-based compensation in accordance with ASC 718, “Compensation-Stock Compensation”. ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period.

 

Recently Issued Accounting Pronouncements

 

Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company's financial statements.

  

Item 7A. Quantitative and Qualitative Disclosures About Market Risk.

 

Not required under Regulation S-K for “smaller reporting companies.”

 

Item 8. Financial Statements and Supplementary Data.

 

Our financial statements, together with the independent registered public accounting firm’s report of MaloneBailey LLP, begin on page F-1, immediately after the signature page.

 

Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.

 

None.

 

Item 9A. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

(a) Evaluation of disclosure controls and procedures.

 

Our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

  

Based on management’s evaluation, our chief executive officer and chief financial officer concluded that, as of December 31, 2015, our disclosure controls and procedures are designed at a reasonable assurance level and are effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure. 

 

(b) Management’s Annual Report on Internal Control Over Financial Reporting.

 

Management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Exchange Act Rule 13a-15(f). Management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

 

 16 

 

 

Our management assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2015. Based on that assessment, our management has determined that as of December 31, 2015, the Company’s internal control over financial reporting was not effective for the purposes for which it is intended. Specifically, management’s evaluation was based on the following material weaknesses which existed as of December 31, 2015:

 

(1)   Financial Reporting Systems:  The Company did not maintain a fully integrated financial consolidation and reporting system throughout the period and as a result, adjustments were required in order to produce financial statements for external reporting purposes.

 

(2)   Segregation of Duties:  The Company did not effectively segregate certain accounting duties due to the small size of its accounting staff.

 

This annual report does not include an attestation report by MaloneBailey LLP, our independent registered public accounting firm regarding internal control over financial reporting.  As a smaller reporting company, our management's report was not subject to attestation by our registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit us to provide only management's report in this annual report.

 

Changes in internal control over financial reporting.

 

We regularly review our system of internal control over financial reporting and make changes to our processes and systems to improve controls and increase efficiency. Changes may include such activities as implementing new, more efficient systems, consolidating activities, and migrating processes. There were no changes in our internal control over financial reporting that occurred during the three months ended December 31, 2015 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Item 9B. Other Information.

 

None. 

 

 17 

 

 

PART III

 

Item 10. Directors, Executive Officers, and Corporate Governance

 

The following table sets forth the names and ages of the members of our Board of Directors and our executive officers and the positions held by each. The board of directors elects our executive officers annually. A majority vote of the directors who are in office is required to fill vacancies. Each director is elected for the term of one year, and until his or her successor is elected and qualified, or until his or her earlier resignation or removal.  

 

NAME   AGE   TITLE
Kevin Hess   49   Chief Executive Officer and Director
Felicia Hess   47   Chief Operating Officer
Daniyel Erdberg   37   President
Kendall Carpenter   59   Chief Financial Officer Executive Vice President, Secretary and Treasurer
Jay H. Nussbaum   71   Chairman of the Board of Directors
Wayne Jackson   85   Director and Chairman of the Compensation Committee
Michael Haas   29   Director and Chairman of the Audit Committee

 

Executive Biographies:

 

Kevin Hess, 49, was appointed our Chief Executive Officer and one of our directors on October 2, 2015. Mr. Hess has 20 years of technology experience comprising electronic systems design for DoD programs, image processing and analytics for companies such as Hughes, Kodak and Dainippon. Mr. Hess has been integrally involved with Lighter Than Air Systems Corp. as an engineer and consultant since its founding in 2009, overseeing the development of its proprietary aerostat and drone products. Mr. Hess has also been a principle in Aerial Products Corp., an aerial surveillance solutions provider. As an IT executive at Fortune 250 companies, Mr. Hess has performed lead roles in software development, application architecture, mission-critical infrastructure, and multi-million dollar project sponsorship and oversight. Mr. Hess continues to leverage his background and education in computer science, having attended the Harvard Business School residence PMD program to further his strong track record of technology innovation and financial management. Mr. Hess brings his unique talents to the design, manufacturing and support of the Company's solutions. Mr. Hess is married to Felicia Hess. Mr. Hess’s technology industry experience qualifies him to serve on the board of directors.

 

Felicia Hess, 47, was appointed our Chief Executive Officer and one of our directors upon the closing of the Share Exchange on June 3, 2014.  She resigned those positions on October 2, 2015 and was appointed Chief Operating Officer that same day. Ms. Hess served as a director of World Surveillance Group Inc. (“WSGI”), a developer of lighter-than-air aerostats and unmanned aerial systems, from March 2013 through May 2014. In addition, Ms. Hess was the President and a Director of Lighter Than Air Systems Corp., a wholly owned subsidiary of World Surveillance Group Inc. (“WSGI”), specializing in advanced custom designed intelligence, reconnaissance and surveillance (“ISR”) solutions from March 2013 to May 2014 when Drone acquired LTAS and Ms. Hess remained the President of LTAS following such acquisition. Ms. Hess was the President of LTAS since its inception in September 2009. From 2007-2009, Ms. Hess served as Director of Marketing and Business Development for Aerial Products Corp., an aerial surveillance solutions provider. Prior to that Ms. Hess served as Vice President in financial services marketing and membership services at Cendant Corp., where she integrated financial software to further web site development and customer acquisition for some of the nation’s largest financial institutions.  

 

Daniyel Erdberg, 37, was appointed our Chief Operating Officer upon the closing of the Share Exchange on June 3, 2014. He resigned that position on October 2, 2015 and was appointed President that same day. Mr. Erdberg served as Director of Business Development at WSGI, a developer of lighter-than-air aerostats and unmanned aerial systems, from 2010 through May 2014 where he worked with LTAS, a wholly owned subsidiary of WSGI, specializing in advanced custom designed IRS solutions.  Mr. Erdberg successfully worked with LTAS's aerial surveillance solutions for various government and commercial customers. Over the past 13 years, Mr. Erdberg has been involved in operations of companies involved in various sectors of technology including software development, telecommunications, wireless networking and unmanned aerial systems. Mr. Erdberg graduated from Florida International University with a Bachelors of Administration in International Business.

 

Kendall W. Carpenter, CPA, CGMA, CMA, 59, joined MacroSolve in 2006 as Controller. She was promoted to Executive Vice President and Chief Financial Officer in 2008 and transitioned to Drone Aviation in 2014. Ms. Carpenter is also the Corporate Secretary and Treasurer. Ms. Carpenter’s previous experience includes Division Controller with Allied Waste Industries (AW), over 10 years’ experience as top financial officer of an enterprise software company with an international customer base and over 8 years’ public accounting experience. Ms. Carpenter graduated with a Bachelor of Science degree in Accounting from Oklahoma State University and has earned the professional designations of Certified Public Accountant, Chartered Global Management Accountant and Certified Management Accountant.

 

Jay H. Nussbaum, 71, joined our Board of Directors on June 1, 2015. He has extensive executive experience and expertise in government and commercial sales and management. Mr. Nussbaum is the Founder of Agilex Technologies, Inc. and served as its Vice Chairman and Chief Operating Officer from 2006 to March 2015, when it was acquired by Accenture Federal Services, a provider of mission and technology solutions to the national security, healthcare and public sectors of the U.S. government. He previously served as Executive Vice President of Oracle Service Industries (“Oracle”), under Oracle's Chairman and CEO Larry Ellison, where he oversaw Government, Education, Health, Communications, Utilities and Financial Services operations. He also served as Global Head of Sales, Marketing and Business Development for Citigroup Global Transaction Services, and as President of Integrated Systems Operation at Xerox Corp. Mr. Nussbaum has been a Director of Grand Slam Acquisition Corp. since October 24, 2007, an Independent Director of Victory Acquisition Corp. since January 12, 2007 and a Director at Agilex Technologies, Inc. since 2006. Mr. Nussbaum’s government and commercial sales and management experience qualifies him to serve on the board of directors.

 

 18 

 

 

Wayne Jackson, 85, was appointed our Chairman of the Board of Directors upon closing of the Share Exchange on June 3, 2014. General Jackson served as a Director of World Surveillance Group Inc., a developer of lighter-than-air aerostats and unmanned aerial systems from April 2009 until February 6, 2015. General Jackson had a 37-year career with the United States Army, Air Force and Navy, retiring from active duty in 1984. During his military career, General Jackson served in various overseas theaters of operations and in a variety of assignments. He commanded Aviation, Civil Affairs, Infantry, Military Intelligence, Signal Corps and Special Forces units, as well as holding two General Office Commands and a position as the Director of Counterintelligence and Security, Headquarters Department of the Army. In addition, General Jackson also served as Chief, Division of Probation Administrative Office of the United States Court, Washington, D.C. General Jackson has been awarded the Parachute Badge, the Expert Infantry Badge and the Master Aviator Badge. His decorations include the Distinguished Service Medal, the Meritorious Service Medal, the Army Commendation Medal and several other military awards and decorations. General Jackson has remained an active member of the defense and intelligence communities and contributes military experience relevant to our products and target customers. For these reasons, we believe General Jackson has the requisite set of skills and experience to serve as a valuable member of our board of directors and its committees on which he serves.

 

Michael Haas, 29, Michael Haas served as our interim President from April 17, 2014 until June 3, 2014 and has served as a member of our Board of Directors since April 17, 2014. Since April 2010, Mr. Haas has been the Assistant Vice President of Morningstar, Inc., in Horsham, Pennsylvania.  Between 2007 and 2010, Mr. Haas was an Associate at KPMG, LLP in Philadelphia, Pennsylvania.  Mr. Haas received his Bachelor of Science Degree in Finance from Villanova University in 2007. Mr. Haas was chosen to be a member of our Board of Directors based on his general corporate knowledge and experience.

  

Family Relationships

 

Our CEO, Kevin Hess, is married to Felicia Hess, who is employed as the Chief Operating Officer for our Company.

 

Meetings of the Board of Directors

 

During the fiscal year ended December 31, 2015, our board of directors held eleven (11) meetings and approved certain actions by unanimous written consent. The board as a whole carries out the functions of the nominating committee.  We expect our directors to attend all board and committee meetings and to spend the time needed and meet as frequently as necessary to properly discharge their responsibilities.

 

Board Committees

 

Effective January 28, 2015, we have two board committees, the audit and compensation committees. The board as a whole carries out the functions of the nominating committee, and such “independent director” determination has been made pursuant to the committee independence standards.

 

Audit Committee

 

The Board of Directors has adopted a written charter for the Audit Committee. Our Audit Committee is responsible for (1) the integrity of our financial reporting process, systems of internal controls and financial statements and reports; (2) the compliance by us with legal and regulatory requirements; (3) the appointment, compensation and oversight of our independent auditor for the purpose of preparing or issuing an audit report or related work.  The Audit Committee is comprised of Chairman Mike Haas, Jay Nussbaum and General Wayne Jackson. Mr. Haas is our audit committee financial expert.

 

Compensation Committee

 

Our Board of Directors has adopted a written charter setting forth the authority and responsibilities of the Compensation Committee. Our Compensation Committee has responsibility for assisting the Board of Directors in, among other things, evaluating and making recommendations regarding the compensation of our executive officers and directors, assuring that the executive officers are compensated effectively in a manner consistent with our stated compensation strategy, producing an annual report on executive compensation in accordance with the rules and regulations promulgated by the SEC, periodically evaluating the terms and administration of our incentive plans and benefit programs and monitoring of compliance with the legal prohibition on loans to our directors and executive officers. The Compensation Committee is comprised of Chairman Wayne Jackson, Jay Nussbaum and Michael Haas.

 

 19 

 

 

Involvement in Certain Legal Proceedings

 

On January 30, 2012, MacroSolve, Inc. filed suit against Newegg, Inc. in the United States District Court Eastern District of Texas alleging infringement of one or more claims of United States Patent #7,822,816. On March 7, 2014, the United States Patent and Trademark Office (“USPTO”) sent MacroSolve, Inc. an office action related to an ex parte reexamination of the ‘816 patent, which rejected all the claims in the patent (the “USPTO Office Action”). As a result of the USPTO Office Action, on March 31, 2014, the Company dismissed its patent enforcement case against Newegg Inc. with prejudice. On April 6, 2015, the court denied the motion by Newegg for recovery of defendant legal fees of approximately $400,000 from the Company. On April 24, 2015, Newegg filed a Notice of Appeal with the United States Court of Appeals for the Federal Circuit. On August 19, 2015, the Company filed a Brief of Appellee MacroSolve, Inc. with the United States Court of Appeals for the Federal Circuit and on September 8, 2015, Newegg filed a Reply Brief. Oral arguments occurred on February 1, 2016. The Federal Circuit decision affirming the district court’s denial of fees came down on February 9, 2016 in the form of a Rule 36 (‘summary affirmance”) per curiam decision. Newegg has ninety days to file a petition for the U.S. Supreme Court to review. The Company has prevailed in this matter but should the case be accepted by the Supreme Court and the Company not prevail in that venue, the judgment would be borne by the former MacroSolve directors who sold their loans on April 17, 2014.

 

Except as disclosed above, there are no material proceedings to which any director, officer or affiliate of the Company, any owner of record or beneficially of more than five percent of any class of voting securities of the Company, or any associate of any such director, officer, affiliate of the Company, or security holder is a party adverse to the Company or any of its subsidiaries or has a material interest adverse to the Company or any of its subsidiaries

 

Our Directors and Executive Officers have not been involved in any of the following events during the past ten years:

 

  1. any bankruptcy petition filed by or against such person or any business of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time;
     
  2. any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);
     
  3. being subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining him from or otherwise limiting his involvement in any type of business, securities or banking activities or to be associated with any person practicing in banking or securities activities;
     
  4. being found by a court of competent jurisdiction in a civil action, the Securities and Exchange Commission or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated;
     
  5. being subject of, or a party to, any federal or state judicial or administrative order, judgment decree, or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation of any federal or state securities or commodities law or regulation, any law or regulation respecting financial institutions or insurance companies, or any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or
     
  6. being subject of or party to any sanction or order, not subsequently reversed, suspended, or vacated, of any self-regulatory organization, any registered entity or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

  

Board Leadership Structure and Role in Risk Oversight

 

Since the consummation of the share exchange in June 2014, we have separated the roles of Chairman of the Board and Chief Executive Officer. Although the separation of roles has been appropriate for us during that time period, in the view of the Board of Directors, the advisability of the separation of these roles depends upon the specific circumstances and dynamics of our leadership.

 

Our Board of Directors is primarily responsible for overseeing our risk management processes. The Board of Directors receives and reviews periodic reports from management, auditors, legal counsel, and others, as considered appropriate regarding our Company’s assessment of risks. The Board of Directors focuses on the most significant risks facing our Company and our Company’s general risk management strategy, and also ensures that risks undertaken by our Company are consistent with the Board’s appetite for risk. While the Board oversees our Company, our Company’s management is responsible for day-to-day risk management processes. We believe this division of responsibilities is the most effective approach for addressing the risks facing our Company and that our Board leadership structure supports this approach.

 

 20 

 

 

Section 16(a) Beneficial Owner Reporting Compliance

 

Because we do not have a class of securities registered under Section 12 of the Exchange Act, our executive officers and directors and persons who own more than 10% of our common stock are not required to file reports pursuant to Section 16(a) of the Exchange Act.

 

Code of Ethics

 

The Company has adopted a code of business conduct and ethics that applies to all its directors, officers (including its chief executive officer, chief financial officer and any person performing similar functions) and employees. The Company has made its Code of Conduct available on its website at ir/droneaviationcorp.com. 

 

Item 11. Executive Compensation.

 

The following table provides certain summary information concerning compensation awarded to, earned by or paid to the Company’s Chief Executive Officer, the two highest paid executive officers and up to two other highest paid individuals whose total annual salary and bonus exceeded $100,000 for fiscal years 2015 and 2014.

 

Name and Principal Position  Year 

Salary

($)

  

Bonus

($)

  

Stock

Awards

($)(7)

  

Option

Awards

($)(6)

   Non-Equity Incentive Plan Compensation ($)   Change in Pension Value and Non-Qualified Deferred Compensation Earnings
($)		   All Other Compensation ($)  

Total

($)

 
James McGill,  2014   15,833    50,000    35,500    0    0    0    0    101,333 
Chief Executive Officer, President and Director (1)                                           
                                            
Kevin Hess, 

2015

   

144,167

    

100,000

    

0

    

769,308

    

0

    

0

    

1,370

    

1,014,845

 
Chief Executive Officer and Director (2)  2014   70,000    40,000    0    0    0    0    0    110,000 
                                            
Kendall Carpenter, 

2015

   

143,333

    

15,000

    

167,900

    

256,436

    

0

    

0

    

0

    

582,669

 
Executive Vice President, Chief Financial Officer and Secretary (3)  2014   150,000    50,000    0    0    0    0    0    222,500 
                                            
Felicia Hess, 

2015

   

150,000

    

15,000

    

587,650

    

741,087

    

0

    

0

    

11,123

    

1,504,860

 
Chief Operating Officer (4)  2014    87,500     25,000    0    0    0    0     23,650     136,150 
                                            
Daniyel Erdberg, 

2015

   

140,000

    

100,000

    

587,650

    

755,198

    

0

    

0

    

500

    

1,583,348

 
President (5)  2014   81,666    49,000    0    0    0    0    0    130,666 

 

(1) For services valued at $35,500 in 2014, Mr. McGill received 63,828 shares of restricted stock valued at $0.01 upon vesting of restricted stock awards. On April 17, 2014, Mr. McGill resigned as Chief Executive Officer, President and a director of the Company and forfeited his vested and unvested options.  
   
(2) Mr. Hess because Chief Executive Officer and Director on October 2, 2015. He previously served as Director of Engineering. For services in 2015, Mr. Hess received a fully-vested option under the 2015 Stock Option Plan to acquire 15,000 shares of common stock at a strike price of $5.00. Mr. Hess also received a fully-vested option in 2015 to acquire 75,000 shares of common stock at a strike price of $6.00 per share. These options expire between May and December, 2018.  Mr. Hess recognized additional compensation of $1,370 in 2015 for personal use of company vehicle, grossed up for taxes.  

 

 21 

 

 

(3) For services in 2015, Mrs. Carpenter received a fully-vested option under the 2015 Stock Option Plan to acquire 5,000 shares of common stock at a strike price of $5.00. Mrs. Carpenter also received a fully-vested option in 2015 to acquire 25,000 shares of common stock at a strike price of $6.00 per share. These options expire between May and December, 2018. For services in 2015, Mrs. Carpenter received 25,000 shares of common stock subject to performance-based vesting. The shares were valued at $6.72 per share on the date of grant. On April 16, 2014, Ms. Carpenter forfeited her vested and unvested MacroSolve options.  
   
(4) For services in 2015, Mrs. Hess received a fully-vested option under the 2015 Stock Option Plan to acquire 5,000 shares of common stock at a strike price of $5.00. Mrs. Hess also received a fully-vested option in 2015 to acquire 75,000 shares of common stock at a strike price of $6.00 per share. These options expire between May and December, 2018. For services in 2015, Mrs. Hess received 87,500 shares of common stock subject to performance-based vesting. The shares were valued at $6.72 per share on the date of grant. Mrs. Hess was appointed as Chief Executive Officer and director of the Company on June 3, 3014. On October 2, 2015, Mrs. Hess resigned as COO and director and was appointed Chief Operating Officer. Mrs. Hess served as President of related party Lighter Than Air Systems through June 3, 2014. Mrs. Hess recognized additional compensation of $11,123 and $23,650 in 2015 and 2014, respectively, for personal use of company vehicle, grossed up for taxes.  
   

(5)

 

 For services in 2015, Mr. Erdberg received a fully-vested option under the 2015 Stock Option Plan to acquire 10,000 shares of common stock at a strike price of $5.00. Mr. Erdberg also received a fully-vested option in 2015 to acquire 75,000 shares of common stock at a strike price of $6.00 per share. These options expire between May and December, 2018. For services in 2015, Mr. Edberg received 87,500 shares of common stock subject to performance-based vesting. The shares were valued at $6.72 per share on the date of grant. Mr. Erdberg also received a $500 car allowance in December, 2015.  
   
(6) In accordance with FASB ASC Topic 718, options granted and vested in 2015 were expensed at $2,822,132.  
   
(7) Fair market value of stock awards based on the market closing price on the date of grant.  

 

Employment Contracts and Termination of Employment and Change-In-Control Arrangements

 

Kevin Hess Employment Agreement.  On May 18, 2015, we entered into an employment agreement with Kevin Hess (the “Hess Employment Agreement”), whereby Mr. Hess agreed to serve as our Director of Engineering for a period of two (2) years, subject to renewal, in consideration for an annual salary of $130,000.  Additionally, Mr. Hess is eligible for an annual cash bonus in an amount equal to up to one hundred percent (100%) of his then-current base salary if we meet or exceed criteria adopted by the Compensation Committee of the Board of Directors. Mr. Hess shall also be eligible for grants of awards under stock option or other equity incentive plans of our Company as our Compensation Committee or, in the absence thereof, our Board of Directors may from time to time determine and shall be entitled to participate in all benefits plans we provide to our senior executives.  Mr. Hess is also entitled to the use of a company-owned vehicle. We shall reimburse Mr. Hess for all reasonable expenses incurred in the course of his employment.  In the event Mr. Hess’ employment is terminated without Cause or by Mr. Hess with Good Reason (as such terms are defined in the Hess Employment Agreement), Mr. Hess shall be entitled to receive severance benefits equal to six months of his then-current base salary, continued coverage under our benefit plans for a period of twelve months and payment of his pro-rated earned annual bonus. Mr. Hess has also agreed to a one (1) year non-competition and non-solicitation provision. On October 2, 2015, the Company entered into an amendment to the employment agreement between the Company and Kevin Hess, pursuant to which Kevin Hess was appointed as the Chief Executive Officer and Director of the Company with an increase of his annual salary to $200,000.

 

Felicia Hess Employment Agreement.  On May 18, 2015, we entered into an employment agreement with Felicia Hess (the “Hess Employment Agreement”), whereby Ms. Hess agreed to serve as our Chief Executive Officer and director for a period of two (2) years, subject to renewal, in consideration for an annual salary of $150,000.  Additionally, Ms. Hess is eligible for an annual cash bonus in an amount equal to up to one hundred percent (100%) of her then-current base salary if we meet or exceed criteria adopted by the Compensation Committee of the Board of Directors. Ms. Hess shall also be eligible for grants of awards under stock option or other equity incentive plans of our Company as our Compensation Committee or, in the absence thereof, our Board of Directors may from time to time determine and shall be entitled to participate in all benefits plans we provide to our senior executives.  Ms. Hess is also entitled to the use of a company-owned vehicle. We shall reimburse Ms. Hess for all reasonable expenses incurred in the course of her employment.  In the event Ms. Hess’ employment is terminated without Cause or by Ms. Hess with Good Reason (as such terms are defined in the Hess Employment Agreement), Ms. Hess shall be entitled to receive severance benefits equal to six months of her then-current base salary, continued coverage under our benefit plans for a period of twelve months and payment of her pro-rated earned annual bonus. Ms. Hess has also agreed to a one (1) year non-competition and non-solicitation provision. On October 2, 2015, the Company entered into an amendment to the employment agreement between the Company and Felicia Hess, pursuant to which Felicia Hess resigned as Chief Executive Officer and Director as was appointed to serve as the Chief Operating Officer of the Company.

 

 22 

 

 

Daniyel Erdberg Employment Agreement.  On May 18, 2015, we entered into an employment agreement with Daniyel Erdberg (the “Erdberg Employment Agreement”), whereby Mr. Erdberg agreed to serve as our Chief Operating Officer for a period of two (2) years, subject to renewal, in consideration for an annual salary of $140,000.  Additionally, Mr. Erdberg is eligible for an annual cash bonus in an amount equal to up to one hundred percent (100%) of his then-current base salary if we meet or exceed criteria adopted by the Compensation Committee of the Board of Directors. Mr. Erdberg shall also be eligible for grants of awards under stock option or other equity incentive plans of our Company as the Compensation Committee or, in the absence thereof, our Board of Directors, may from time to time determine and shall be entitled to participate in all benefits plans we provide to our executives. We shall reimburse Mr. Erdberg for all reasonable expenses incurred in the course of his employment. Mr. Erdberg was granted a $500 per month car allowance by the Board of Directors in December 2015. In the event Mr. Erdberg’s employment is terminated without Cause or by Mr. Erdberg with Good Reason (as such terms are defined in the Erdberg Employment Agreement), Mr. Erdberg shall be entitled to receive severance benefits equal to six months of his then-current base salary, continued coverage under our benefit plans for a period of twelve months and payment of his pro-rated earned annual bonus. Mr. Erdberg has also agreed to a one (1) year non-competition and non-solicitation provision. On October 2, 2015, the Company entered into an amendment to the employment agreement between the Company and Daniyel Erdberg, pursuant to which Daniyel Erdberg shall serve as the President of the Company.

 

Kendall Carpenter Employment Agreement.  On May 18, 2015, we entered into an employment agreement with Kendall Carpenter (the “Carpenter Employment Agreement”) whereby Ms. Carpenter agreed to serve as our Chief Financial Officer, Executive Vice President, Corporate Secretary and Corporate Treasurer for a period of two (2) years, subject to renewal, in consideration for an annual salary of $140,000. Additionally, Ms. Carpenter is eligible for an annual cash bonus in an amount equal to up to one hundred percent (100%) of her then-current base salary if we meet or exceed criteria adopted by the Compensation Committee of the Board of Directors. Ms. Carpenter shall also be eligible for grants of awards under stock option or other equity incentive plans of our Company as the Compensation Committee or, in the absence thereof, our Board of Directors, may from time to time determine and shall be entitled to participate in all benefits plans we provide to our executives. We shall reimburse Ms. Carpenter for all reasonable expenses incurred in the course of her employment. In the event Ms. Carpenter’s employment is terminated without Cause or by Ms. Carpenter with Good Reason (as such terms are defined in the Carpenter Employment Agreement), Ms. Carpenter shall be entitled to receive severance benefits equal to six months of her then-current base salary, continued coverage under our benefit plans for a period of twelve months and payment of her pro-rated earned annual bonus. Ms. Carpenter has also agreed to a one (1) year non-competition and non-solicitation provision.

 

 23 

 

 

Outstanding Equity Awards at Fiscal Year-End

 

The following table sets forth outstanding equity awards to our named executive officers as of December 31, 2015.

 

   Option awards  Stock awards 
Name  Number of securities underlying unexercised options (#) exercisable   Number of securities underlying unexercised options (#) unexercisable   Equity incentive plan awards: Number of securities underlying unexercised unearned options
(#)		   Option exercise price
($)		   Option expiration date  Number of shares or units of stock that have not vested
(#)		   Market value of shares of units of stock that have not vested
($)		   Equity incentive plan awards: Number of unearned shares, units or other rights that have not vested
(#)		   Equity incentive plan awards: Market or payout value of unearned shares, units or other rights that have not vested
($)		 
(a)  (b)   (c)   (d)   (e)   (f)  (g)   (h)   (i)   (j) 
Kevin Hess                                           
Option Grant   75,000    0    0   $6.00    05/18/2018   0    0    0    0 
Option Grant   15,000    0    0   $5.00   12/10/2018   0    0    0    0 
                                            
Felicia Hess                                           
Option Grant   75,000    0    0   $6.00   05/18/2018   0    0    0    0 
Option Grant   5,000    0    0   $5.00   12/10/2018   0    0    0    0 
Stock Grant   0    0    0   $0       87,500   $282,625    0    0 
                                            
Kendall Carpenter                                           
Option Grant   25,000    0    0   $6.00   05/18/2018   0    0    0    0 
Option Grant   5,000    0    0   $5.00   12/10/2018   0    0    0    0 
Stock Grant   0    0    0   $0       25,000   $80,750    0    0 
                                            
Daniyel Erdberg                                           
Option Grant   75,000    0    0   $6.00   05/18/2018   0    0    0    0 
Option Grant   10,000    0    0   $5.00   12/10/2018   0    0    0    0 
Stock Grant   0    0    0   $0       87,500   $282,625    0    0 

 

 24 

 

 

Director Compensation

 

The following table sets forth director compensation for the fiscal year ended December 31, 2015 (excluding compensation to the Company’s executive officers set forth in the summary compensation table above) paid by the Company. 

 

Name  Fees Earned 
or Paid in Cash		   Stock
Awards
($)		   Option
Awards
($)		   Total
($)		 
Michael Haas  $31,500   $0   $0   $31,500 
Wayne Jackson (1)  $14,000   $0   $0   $14,000 
Jay H. Nussbaum (2)  $28,000   $1,836,500   $141,104   $2,005,604 
                     
Total:  $73,500   $1,836,500   $141,104   $2,051,104 

 

(1) General Jackson was appointed on June 3, 2014. 
   
(2) Mr. Nussbaum was appointed on June 1, 2015.  Mr. Nussbaum signed a twenty-four month Director Agreement in June 2015 and received 50,000 shares of common stock (on a post-reverse split basis) subject to 24 months vesting with prorated forfeiture for early termination. The shares were valued at $10.80 per share on the date of grant. The Company has recognized $157,500 in costs during 2015 associated with this grant.  For services in 2015, Mr. Nussbaum received 250,000 shares of common stock (on a post-reverse split basis) subject to performance-based vesting which occurred on February 4, 2016. The shares were valued at $6.72 per share, or $1,679,000, on the date of grant. For services in 2015, Mr. Nussbaum received a fully-vested option under the 2015 Stock Option Plan to acquire 50,000 shares of common stock at a strike price of $5.00 valued at $109,038. This option expires December, 2018.

 

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

 

The following table sets forth the number of and percent of the Company's common stock beneficially owned by:

 

  ● all directors,
     
  ● our executive officers,
     
  ● our directors and executive officers as a group, and
     
  ● persons or groups known by us to own beneficially 5% or more of our Common Stock or our Preferred Stock having voting rights:

 

The business address of each of the beneficial owners listed below is c/o Drone Aviation Holding Corp. 11651 Central Parkway #118, Jacksonville FL 32224.

 

    Title of Class   Number of
Shares
Beneficially
Owned (1)		     Percentage
of Class (2)		  
Dr. Phillip Frost   Common Stock     785,000       14.4 %
                     
Jay Nussbaum   Common Stock     600,000 (3)     10.9 %
                     
Kevin Hess   Common Stock     90,000 (4)     1.6 %
                     
Felicia Hess   Common Stock     485,000 (5)     8.8 %
                     
Daniyel Erdberg   Common Stock     352,500 (6)     6.4 %
                     
Wayne Jackson   n/a     0       0  
                     
Michael Haas   n/a     0       0  
                     
Kendall Carpenter   Common Stock     57,334 (7)     *  
                     
Officers and Directors as a Group (7 persons)   Common Stock     2,369,834       27.3 %

 

* Denotes less than 1%

 

(1)

This column represents the total number of votes each named stockholder is entitled to vote upon matters presented to the shareholders for a vote.

 

 25 

 

 

(2) The percentages in the table have been calculated on the basis of treating as outstanding for a particular person, all shares of our capital stock outstanding on March 4, 2016. On March 4, 2016, there were 5,461,553 shares of our common stock outstanding. To calculate a stockholder's percentage of beneficial ownership, we include in the numerator and denominator the common stock outstanding and all shares of our common stock issuable to that person in the event of the exercise of outstanding options and other derivative securities owned by that person which are exercisable within 60 days of March 4, 2016. Common stock options and derivative securities held by other stockholders are disregarded in this calculation. Therefore, the denominator used in calculating beneficial ownership among our stockholders may differ. Unless we have indicated otherwise, each person named in the table below has sole voting power and investment power for the shares listed opposite such person's name.
   
(3) Represents 550,000 shares of common stock and 50,000 shares underlying vested options with a strike price of $5.00 which expire December 10, 2018.
   
(4) Represents shares underlying 90,000 vested options with a strike price of $5.00 - $6.00 which expire between May and December 2018.
   
(5) Represents 405,000 shares of common stock and 80,000 shares underlying vested options with a strike price of $5.00 - $6.00 which expire between May and December 2018.
   
(6) Represents 267,500 shares of common stock and 85,000 shares underlying vested options with a strike price of $5.00 - $6.00 which expire between May and December 2018.
   
(7) Represents 27,334 shares of common stock and 30,000 vested options with a strike price of $5.00 - $6.00 which expire between May and December 2018.

 

Item 13.  Certain Relationships and Related Transactions, and Director Independence.

 

Certain Relationships and Related Transactions

 

Other than as disclosed below, during the last two fiscal years, there have been no transactions, in which any director, executive officer or beneficial holder of more than 5% of the outstanding common or preferred stock, or any of their respective relatives, spouses, associates or affiliates, has had or will have any direct or material indirect interest. We have no policy regarding entering into transactions with affiliated parties.

   

The accounts payable due to related party at December 31, 2015 was comprised of $6,000 director fees which were paid in January 2016. The accounts payable due to related party at December 31, 2014 includes allocated rent and utility charges, aerostat envelopes, truck expenses and labor charges due Aerial Products Corp (“APC”) of $2,181. APC is a related party, controlled by Felicia Hess, the Chief Operating Officer of our Company. APC shared the manufacturing facilities with LTAS and provided aerostat envelopes and manufacturing labor to LTAS until June 30, 2014 when the APC labor pool transitioned to our Company. Total charges from APC to LTAS during the years ended December 31, 2015 and 2014 were $7,549 and $19,242 respectively. The Company purchased used fixed assets from APC for $6,500 during the year ended December 31, 2015.

 

Director Independence

 

We are not required to have any independent members of the board of directors. The board of directors has determined that, as defined in the Marketplace Rules of The NASDAQ Stock Market, Wayne Jackson and Michael Haas are our independent directors.

 

Item 14.  Principal Accountant Fees and Services. 

The Audit Committee pre-approves all auditing services and all permitted non-auditing services (including the fees and terms thereof) to be performed by our independent registered public accounting firm. 

Audit Fees 

Audit fees consist of fees billed for services associated with the annual audit and reviews of the Company’s quarterly reports on Form 10-Q and the Company’s statutory and regulatory filings. For the year ended December 31, 2015, the fees for audit services totaled approximately $45,000. For the year ended December 31, 2014, the fees for audit services totaled approximately $32,500. 

Audit-Related Fees 

We incurred fees to our independent auditors of $0 and $0 for audit-related fees during the fiscal years ended December 31, 2015 and 2014, respectively. 

Tax Fees 

We incurred fees to our independent auditors of $0 and $0 for tax fees during the fiscal years ended December 31, 2015 and 2014, respectively. 

All Other Fees 

We incurred no other fees to our independent auditors during the fiscal years ended December 31, 2015 and 2014, respectively. 

 

 26 

 

 

PART IV

 

Item 15. Exhibits and Financial Statement Schedules.

 

(a) The following documents are filed as a part of this report or incorporated herein by reference:

 

  (1) Our Financial Statements are listed on page F-1 of this Annual Report.
     
  (2) Financial Statement Schedules: None.

 

(b) Exhibits:

 

2.01   Agreement and Plan of Merger entered into by and between MacroSolve, Inc. and Drone Aviation Holding Corp., dated April 30, 2014 filed as an exhibit to the Current Report on Form 8-K, filed with the Securities and Exchange Commission (the “Commission”) on May 5, 2014 and incorporated herein by reference
     
2.02   Articles of Merger filed with the Secretary of State of the State of Nevada filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on May 5, 2014 and incorporated herein by reference
     
2.03   Certificate of Merger filed with the Secretary of State of the State of Oklahoma filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on May 5, 2014 and incorporated herein by reference
     
3.01     Articles of Incorporation, filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on May 5, 2014 and incorporated herein by reference.
     
3.02     Bylaws, filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on May 5, 2014 and incorporated herein by reference.
     
3.03     Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on May 5, 2014 and incorporated herein by reference.
     
3.03     Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on May 5, 2014 and incorporated herein by reference.
     
3.04   Certificate of Designation of Preferences, Rights and Limitations of Series B-1 Convertible Preferred Stock filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on May 5, 2014 and incorporated herein by reference
     
3.04   Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on May 5, 2014 and incorporated herein by reference
     
3.05   Certificate of Designation of Preferences, Rights and Limitations of Series D Convertible Preferred Stock filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 5, 2014 and incorporated herein by reference
     
3.06   Certificate of Designation of Preferences, Rights and Limitations of Series E Convertible Preferred Stock filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 5, 2014 and incorporated herein by reference
     
3.07   Certificate of Designation of Preferences, Rights and Limitations of Series F Convertible Preferred Stock filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on August 28, 2014 and incorporated herein by reference
     
3.08   Certificate of Designation of Preferences, Rights and Limitations of Series G Convertible Preferred Stock filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 3, 2015 and incorporated herein by reference
     
 3.09   Certificate of Amendment to Designation of Preferences, Rights and Limitations of Series G Convertible Preferred Stock filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 3, 2015 and incorporated herein by reference

 

 27 

 

 

3.10   Certificate of Amendment to Designation of Preferences, Rights and Limitations of Series E Convertible Preferred Stock filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 3, 2015 and incorporated herein by reference
     
 3.11   Certificate of Amendment to Designation of Preferences, Rights and Limitations of Series F Convertible Preferred Stock filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 3, 2015 and incorporated herein by reference
     
3.12                 Certificate of Amendment to Articles of Incorporation filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on October 30, 2015 and incorporated herein by reference          
     

10.01

 

   Form of Subscription Agreement filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on May 5, 2014 and incorporated herein by reference  
     

10.02

 

   Share Exchange Agreement filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 5, 2014 and incorporated herein by reference
     

10.03

 

   Employment Agreement dated June 3, 2014 between the Company and Felicia Hess filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 5, 2014 and incorporated herein by reference
     

10.04

 

   Employment Agreement dated June 3, 2014 between the Company and Daniyel Erdberg filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 5, 2014 and incorporated herein by reference
     

10.05

 

   Form of Indemnification Agreement filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 5, 2014 and incorporated herein by reference
     

10.06

 

   Form of Lockup Agreement filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 5, 2014 and incorporated herein by reference  
     

10.07

 

   Form of Subscription Agreement filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 5, 2014 and incorporated herein by reference
     

10.08

 

   Form of Warrant filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 5, 2014 and incorporated herein by reference
     

10.09

 

   Sublease Agreement dated April 28, 2014 by and between Aerial Products Corp. and LTAS filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 5, 2014 and incorporated herein by reference  
     

10.10

 

   Independent Contractor Agreement dated July 29, 2013 by and among US Technik, Inc., LTAS and World Surveillance Group, Inc. filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 5, 2014 and incorporated herein by reference  
     

10.11

 

   Form of Subscription Agreement filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on August 28, 2014 and incorporated herein by reference
     

10.12

 

   Charter of Strategic Advisory Board filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on August 28, 2014 and incorporated herein by reference  
     

10.13

 

   Form of Strategic Advisory Board Agreement filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on August 28, 2014 and incorporated herein by reference
     
10.14   Plan of Merger filed as an exhibit to the Annual Report on Form 10-K, filed with the Commission on March 31, 2015 and incorporated herein by reference.
     
10.15   Employment Agreement dated May 18, 2015 between the Company and Felicia Hess filed as an exhibit to the Quarterly Report on Form 10-Q, filed with the Commission on May 15, 2015 and incorporated herein by reference
     
10.16     Employment Agreement dated May 18, 2015 between the Company and Kendall Carpenter filed as an exhibit to the Quarterly Report on Form 10-Q, filed with the Commission on May 15, 2015 and incorporated herein by reference

 

 28 

 

 

10.17     Employment Agreement dated May 18, 2015 between the Company and Kendall Carpenter filed as an exhibit to the Quarterly Report on Form 10-Q, filed with the Commission on May 15, 2015 and incorporated herein by reference
     
10.18       Form of Subscription Agreement filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 3, 2015 and incorporated herein by reference
     
10.19   Director Agreement between the Company and Jay Nussbaum, dated June 1, 2105, and filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 3, 2015 and incorporated herein by reference
     
10.20     Asset Purchase Agreement filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on July 21, 2015 and incorporated herein by reference
     
10.21     Escrow Agreement filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on July 21, 2015 and incorporated herein by reference
     
10.22     Lockup Agreement filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on July 21, 2015 and incorporated herein by reference
     
10.23     Bill of Sale and Assignment and Assumption Agreement filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on July 21, 2015 and incorporated herein by reference
     
10.24   Intellectual Property Assignment Agreement filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on July 21, 2015 and incorporated herein by reference
     
10.25     Form of License Agreement filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on July 21, 2015 and incorporated herein by reference
     
10.26   Form of Consulting Agreement filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on July 21, 2015 and incorporated herein by reference
     
10.27     Form of Placement Agent Warrant filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on November 23, 2015 and incorporated herein by reference
     
10.28   Form of Common Stock Purchase Agreement filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on November 23, 2015 and incorporated herein by reference
     
10.29     Form of Series A Preferred Stock Conversion and Lockup Agreement filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on November 23, 2015 and incorporated herein by reference
     
10.30   Form of Series B Preferred Stock Conversion and Lockup Agreement filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on November 23, 2015 and incorporated herein by reference
     
10.31     Form of Series C Preferred Stock Conversion and Lockup Agreement filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on November 23, 2015 and incorporated herein by reference
     
10.32   Form of Series D Preferred Stock Conversion and Lockup Agreement filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on November 23, 2015 and incorporated herein by reference
     
10.33     Form of Series E Preferred Stock Conversion Agreement filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on November 23, 2015 and incorporated herein by reference .
     
10.34   Form of Series F Preferred Stock Conversion Agreement filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on November 23, 2015 and incorporated herein by reference
     
10.35     Form of Series G Preferred Stock Conversion Agreement filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on November 23, 2015 and incorporated herein by reference

 

 29 

 

 

10.36   Form of Series B-1 Preferred Stock Exchange Agreement filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on November 23, 2015 and incorporated herein by reference
     
10.37   Drone Aviation Holding Corp. 2015 Equity Incentive Plan filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on September 11, 2015 and incorporated herein by reference
     
21.1  

List of Subsidiaries filed as an exhibit to this Annual Report on Form 10-K.

     
14.01   Code of Business Conduct and Ethics filed as an exhibit to the Annual Report on Form 10-K, filed with the Commission on March 31, 2015 and incorporated herein by reference.
     
31.1   Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
31.2   Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     

32.1

  

Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 

     
101 INS   XBRL Instance Document
     
101 SCH   XBRL Taxonomy Extension Schema Document
     
101 CAL   XBRL Taxonomy Calculation Linkbase Document
     
101 LAB   XBRL Taxonomy Labels Linkbase Document
     
101 PRE   XBRL Taxonomy Presentation Linkbase Document
     
101 DEF   XBRL Taxonomy Extension Definition Linkbase Document

 

 30 

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  DRONE AVIATION HOLDING CORP.
     
Date: March 4, 2016 By: /s/ KEVIN HESS
    Kevin Hess
    Chief Executive Officer (Principal Executive Officer)
     
Date: March 4, 2016 By:  /s/ KENDALL CARPENTER
    Kendall Carpenter
    Chief Financial Officer (Principal Financial and Accounting Officer)

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons in the capacities and on the dates indicated.


 

Name   Position   Date
         
/s/ KEVIN HESS   Chief Executive Officer and Director   March 4, 2016
Kevin Hess   (principal executive officer)    
         
/s/ KENDALL CARPENTER   Chief Financial Officer   March 4, 2016
Kendall Carpenter   (principal financial and accounting officer)     
         
/s/ JAY NUSSBAUM   Chairman   March 4, 2016
Jay Nussbaum        
         
/s/ WAYNE JACKSON   Director   March 4, 2016
Wayne Jackson        
         
/s/ MICHAEL HAAS   Director   March 4, 2016
Michael Haas      

 

 31 

 

 

 

 

 

 

 

 

 

 

 

DRONE AVIATION HOLDING CORP.

 

 

 

Financial Statements Together With

Report of Independent Registered Public Accounting Firm

 

 

 

For the Years Ended December 31, 2015 and 2014

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 F-1 

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors

Drone Aviation Holding Corp.

Jacksonville, FL

 

We have audited the accompanying consolidated balance sheets of Drone Aviation Holding Corp. and its subsidiaries (collectively the “Company”) as of December 31, 2015 and 2014, and the related consolidated statements of operations, stockholders’ equity and cash flows for each of the years then ended. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits.

 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform an audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

 

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Drone Aviation Holding Corp. and its subsidiaries as of December 31, 2015 and 2014 and the results of their operations and their cash flows for each of the years then ended, in conformity with accounting principles generally accepted in the United States of America.

 

/s/ MaloneBailey, LLP

www.malonebailey.com

Houston, Texas

March 4, 2016

 

 F-2 

 

 

DRONE AVIATION HOLDING CORP.

CONSOLIDATED BALANCE SHEETS

   12/31/2015   12/31/2014 
         
ASSETS        
         
CURRENT ASSETS:        
Cash  $2,659,734   $1,369,896 
Accounts receivable - trade   83,288    30,170 
Inventory   118,795    39,404 
Prepaid expenses and deposits   55,624    50,169 
           
Total current assets   2,917,441    1,489,639 
           
PROPERTY AND EQUIPMENT, at cost:   163,291    34,064 
Less - accumulated depreciation   (26,995)   (7,040)
           
Net property and equipment   136,296    27,024 
           
OTHER ASSETS:          
Goodwill   99,799    99,799 
Intangible assets, net   1,460,000    103,609 
           
 Total other assets   1,559,799    203,408 
           
TOTAL ASSETS  $4,613,536   $1,720,071 
           
LIABILITIES AND STOCKHOLDERS' EQUITY          
           
CURRENT LIABILITIES:          
 Accounts payable - trade and accrued liabilities  $242,257   $64,383 
 Accounts payable due to related party   6,000    2,181 
 Deferred revenue   7,896    - 
 Note Payable - Oklahoma Technology Commercialization Center- Current   110,000    110,000 
           
 Total current liabilities   366,153    176,564 
           
           
TOTAL LIABILITIES  $366,153   $176,564 
           
COMMITMENTS AND CONTINGENCIES   -    - 
           
STOCKHOLDERS' EQUITY (DEFICIT):          
Convertible Preferred stock, Series A, $.0001 par value; authorized 595,000 shares; 101,100 and 396,750 shares issued and outstanding, at December 31, 2015 and December 31, 2014, respectively  $10   $40 
Convertible Preferred stock, Series B, $.0001 par value; authorized 324,671 shares; 0 and 324,671 shares issued and outstanding, at December 31, 2015 and December 31, 2014, respectively   -    32 
Convertible Preferred stock, Series B-1, $.0001 par value; authorized 156,231 shares; 0 and 68,731 shares issued and outstanding, at December 31, 2015 and December 31, 2014, respectively   -    7 
Convertible Preferred stock, Series C, $.0001 par value; authorized 355,000 shares; 73,387 and 345,400 shares issued and outstanding, at December 31, 2015 and December 31, 2014, respectively   7    35 
Convertible Preferred stock, Series D, $.0001 par value; authorized 36,050,000 shares; 2,000,000 and 36,050,000 shares issued and outstanding, at December 31, 2015 and December 31, 2014, respectively   200    3,605 
Convertible Preferred stock, Series E, $.0001 par value; authorized 5,400,000 shares; 0 and 5,400,000 shares issued and outstanding, at December 31, 2015 and December 31, 2014, respectively   -    540 
Convertible Preferred stock, Series F, $.0001 par value; authorized 3,300,999 shares; 1,999,998 and 3,300,999 shares issued and outstanding, at December 31, 2015 and December 31, 2014, respectively   200    330 
Convertible Preferred stock, Series G, $.0001 par value; authorized 8,000,000 shares; 2,000,000 and 0 shares issued and outstanding, at December 31, 2015 and December 31, 2014, respectively   200    - 
Common stock, $.0001 par value; authorized 300,000,000 shares; 5,125,585 and 926,953 shares issued and outstanding, at December 31, 2015 and December 31, 2014, respectively   513    93 
Additional paid-in capital   15,385,523    3,702,233 
Retained Earnings (Deficit)   (11,139,270)   (2,163,408)
           
Total stockholders' equity   4,247,383    1,543,507 
           
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY  $4,613,536   $1,720,071 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 F-3 

 

 

DRONE AVIATION HOLDING CORP.

CONSOLIDATED STATEMENTS OF OPERATIONS

 

For the Years Ended December 31,  2015   2014 
         
Revenues  $472,159   $858,054 
           
Cost of good sold   282,753    675,253 
           
Gross profit   189,406    182,801 
           
General and administrative expense   9,163,556    1,904,793 
           
Loss from operations   (8,974,150)   (1,721,992)
           
Other income (expense)          
Loss on sale and impairment of securities held for resale   -    (42,821)
Loss on derivative liability   -    (350,969)
Income tax expense   -    (5,571)
Interest income   192    235 
Interest expense   (1,904)   (2,372)
           
Total other expense   (1,712)   (401,498)
           
NET LOSS   (8,975,862)   (2,123,490)
           
Deemed dividend on Series G convertible preferred stock   80,000    - 
Deemed dividend on Series F convertible preferred stock   -    192,558 
           
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS   (9,055,862)   (2,316,048)
           
Weighted average number of common shares outstanding - basic and diluted   2,034,421    394,683 
           
Basic and diluted net loss per share  $(4.45)  $(5.87)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 F-4 

 

 

DRONE AVIATION HOLDING CORP.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

 

For the Years Ended December 31, 2015 and 2014

 

   Common Stock   Preferred Stock Series A   Preferred Stock Series B   Preferred Stock Series B-1   Preferred Stock Series C   Preferred Stock
Series D		   Preferred Stock Series E   Preferred Stock Series F   Preferred Stock Series G  

Additional

Paid-in		   Accumulated     
   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Total 
Predecessor                                                                                    
BALANCE, at December 31, 2013   -   $-    -   $-    -   $-    -   $-    -   $-    -   $-    -   $-    -   $-    -   $-   $-   $-   $- 
                                                                                                          
Net Loss                                                                                                  (2,123,490)   (2,123,490)
Net loss from LTAS from 1/1/14 to 5/5/14                                                                                                  (39,918)   (39,918)
Common stock of Drone Aviation Corp issued for cash   201,250    20                                            26,050,000    2,605                                  650,702         653,327 
Drone Aviation Corp stock issued to LTAS upon business combination                                                     10,000,000    1,000                                  78,000         79,000 
Reverse merger adjustment   98,018    10    595,000    60    324,671    32    156,231    16    355,000    36              5,400,000    540                        (368,316)        (367,622)
Common stock issued for warrant exercises   42,500    4                                                                                    16,996         17,000 
Proceeds from Series F preferred stock issued for cash                                                                         3,300,999    330              822,420         822,750 
Redemption of Series B-1 preferred stock                                 (87,500)   (9)                                                     (349,991)        (350,000)
Shares issued for service - third party   56,250    6                                                                                    341,661         341,667 
Cashless exercise of Series E preferred stock attached warrants   9,310    1                                                                                    (1)        - 
Derivative liability written off to APIC due to warrant exercise                                                                                             2,510,793         2,510,793 
Beneficial conversion feature of Series F preferred stock                                                                                             192,558         192,558 
Deemed dividend on Series F preferred stock                                                                                             (192,558)        (192,558)
Conversion of Series A preferred stock to common stock   495,625    50    (198,250)   (20)                                                                         (30)        - 
Conversion of Series C preferred stock to common stock   24,000    2                                  (9,600)   (1)                                           (1)        - 
                                                                                                          
BALANCE, at December 31, 2014   926,953   $93    396,750   $40    324,671    32    68,731    7    345,400    35    36,050,000    3,605    5,400,000    540    3,300,999    330    -    -   $3,702,233   $(2,163,408)  $1,543,507 
                                                                                                          
Net Loss                                                                                                  (8,975,862)   (8,975,862)
Conversion of Series A preferred stock to common stock   739,125    74    (295,650)   (30)                                                                         (44)        - 
Conversion of Series B preferred stock to common stock   8,117    1              (324,671)   (32)                                                               31         - 
Conversion of Series B1 preferred stock to common stock   55,000    5                        (68,731)   (7)                                                     2         - 
Conversion of Series C preferred stock to common stock   680,033    68                                  (272,013)   (28)                                           (40)        - 
Conversion of Series D preferred stock to common stock   851,250    85                                            (34,050,000)   (3,405)                                 3,320         - 
Conversion of Series E preferred stock to common stock   135,000    14                                                      (5,400,000)   (540)                       526         - 
Conversion of Series F preferred stock to common stock   32,525    3                                                                (1,301,001)   (130)             127         - 
Conversion of Series G preferred stock to common stock   50,000    5                                                                          (2,000,000)   (200)   195         - 
Proceeds from Series G preferred stock issued for cash                                                                                   4,000,000    400    999,600         1,000,000 
Beneficial conversion feature on preferred stock Series G                                                                                             80,000         80,000 
Deemed dividend on Series G preferred stock                                                                                             (80,000)        (80,000)
Proceeds from common stock issued for cash   745,000    75                                                                                    3,484,675         3,484,750 
Common stock issued to Series E, F and G holders   252,525    25                                                                                    (25)        - 
Stock Based Compensation - ASC 505 Adj for 2014 share issuance                                                                                             213,333         213,333 
Stock Based Compensation - Shares Issuance to Employee   500,000    50                                                                                    2,575,210         2,575,260 
Stock Based Compensation - options and warrants                                                                                             3,146,395         3,146,395 
Common stock issued for asset acquisition   150,000    15                                                                                    1,259,985         1,260,000 
Common stock issued due to reverse split rounding   57    -                                                                                              - 
                                                                                                          
BALANCE, at December 31, 2015   5,125,585   $513    101,100   $10    -    -    -    -    73,387    7    2,000,000    200    -    -    1,999,998    200    2,000,000    200   $15,385,523   $(11,139,270)  $4,247,383 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 F-5 

 

 

DRONE AVIATION HOLDING CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

For the Years Ended December 31,  2015   2014 
OPERATING ACTIVITIES:        
Net loss  $(8,975,862)  $(2,123,490)
Adjustments to reconcile net loss to net cash used in operating activities:          
Loss on disposal and impairment of available-for-sale securities   -    42,821 
Loss on derivative liability   -    350,969 
Allowance for inventory obsolescence   18,589    - 
Depreciation   19,955    2,477 
Amortization   37,935    31,941 
Impairment of intangible assets   65,674    - 
Stock based compensation   5,934,988    341,667 
Changes in current assets and liabilities:          
Accounts receivable   (53,118)   104,880 
Inventory   (97,980)   70,177 
Prepaid expenses and other current assets   (5,455)   (11,385)
Accounts payable and accrued expense   177,874    (132,363)
Due from related party   3,819    20,027 
Deferred revenue   7,896    - 
           
Net cash used in operating activities   (2,865,685)   (1,302,279)
           
INVESTING ACTIVITIES:          
Cash paid on business combination, net   -    (304,639)
Cash from reverse merger   -    1,692,896 
Cash from sales of available-for-sale securities   -    168,704 
Cash paid on intangible asset acquisition   (200,000)     
Cash paid on furniture and equipment   (129,227)   (27,863)
           
Net cash (used in) provided by investing activities   (329,227)   1,529,098 
           
FINANCING ACTIVITIES:          
Proceeds from common stock issued for cash   3,484,750    653,327 
Proceeds from Series G preferred stock issued for cash   1,000,000    - 
Proceeds from warrant exercises   -    17,000 
Proceeds from Series F preferred stock issued for cash   -    822,750 
Redemption of Series B-1 preferred stock   -    (350,000)
           
Net cash provided by financing activities   4,484,750    1,143,077 
           
NET (DECREASE) INCREASE IN CASH   1,289,838    1,369,896 
           
CASH, beginning of period   1,369,896    - 
           
CASH, end of period  $2,659,734   $1,369,896 
           
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:          
Cash paid during the years ended December 31:          
Interest  $1,904   $2,371 
Income taxes  $159   $5,571 
           
Noncash investing and financing activities for the years ended December 31:          
Common stock issued for asset acquisition  $1,260,000   $- 
Conversion of Series A preferred stock to common stock  $74   $50 
Conversion of Series B preferred stock to common stock  $1   $- 
Conversion of Series B-1 preferred stock to common stock  $5   $- 
Conversion of Series C preferred stock to common stock  $68   $2 
Conversion of Series D preferred stock to common stock  $85   $- 
Conversion of Series E preferred stock to common stock  $14   $- 
Conversion of Series F preferred stock to common stock  $3   $- 
Conversion of Series G preferred stock to common stock  $5   $- 
Common stock issued to Series E, F and G holders  $25   $- 
Cashless exercise of Series E preferred stock attached warrants  $-   $1 
Derivative liability written off to APIC due to warrant exercise  $-   $2,510,793 
Reverse merger adjustment  $-   $(2,060,518)
Deemed dividend beneficial conversion feature on convertible preferred stock  $80,000   $192,558 
Business combination adjustment  $-   $79,000 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 F-6 

 

 

Drone Aviation Holding Corp.

Notes to Consolidated Financial Statements

 

For the Years ended December 31, 2015 and 2014

 

1.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Description of Business:

 

Drone Aviation Holding Corp. (“Drone” or “Company”) develops and manufactures cost-effective, compact and rapidly deployable aerial platforms including lighter-than-air aerostats and electric-powered drones designed to provide government and commercial customers with enhanced surveillance and communication capabilities. Utilizing a proprietary tether system, the Company's products are designed to provide prolonged operational duration capabilities combined with improved reliability, uniquely fulfilling critical requirements in military, law enforcement and commercial and industrial applications.

 

Basis of Presentation:

 

The accompanying financial statements of the Company were prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

 

Principal of Consolidation:

 

Our consolidated financial statements as of December 31, 2015 include the accounts of Drone Aviation Holding Corp. and its subsidiaries: Drone AFS Corp. and Lighter Than Air Systems Corp. Our consolidated financial statements as of December 31, 2014 include the accounts of Drone Aviation Holding Corp. and its subsidiaries: Drone Aviation Corp. and Lighter Than Air Systems Corp.

 

Reclassifications:

 

Certain prior year amounts have been combined and reclassified to conform to the current year presentation.

 

Use of Estimates:

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.

 

Concentration of Credit Risk:

 

Financial instruments which potentially subject the Company to concentrations of credit risk consist of cash and trade receivables. The Company places its cash with high credit quality financial institutions. At times such cash may be in excess of the FDIC limit. With respect to trade receivables, the Company routinely assesses the financial strength of its customers and, as a consequence, believes that the receivable credit risk exposure is limited.

 

Cash Equivalents:

 

Cash equivalents are represented by operating accounts or money market accounts maintained with insured financial institutions, including all highly-liquid investments with maturities of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2015 and 2014.

 

 F-7 

 

 

Accounts Receivable and Credit Policies:

 

Trade accounts receivable consist of amounts due from the sale of tethered aerostats, accessories, spare parts and delivery and installation of aerostats.  Accounts receivable are uncollateralized customer obligations due under normal trade terms requiring payment within 30 days of receipt of the invoice.  The Company provides an allowance for doubtful accounts equal to the estimated uncollectible amounts based on historical collection experience and a review of the current status of trade accounts receivable.  At December 31, 2015 and 2014, the Company characterized $0 and $0 as uncollectible, respectively.

 

Marketable Securities:

 

All marketable securities are classified as available-for-sale securities. Available-for-sale securities are carried at fair value with resulting unrealized gains and losses, reported as a component of accumulated other comprehensive loss. The Company did not have any available-for-sale securities at December 31, 2015.

 

Inventories

 

Inventories are stated at the lower of cost or market, using the first-in first-out method. Cost includes materials, labor and manufacturing overhead related to the purchase and production of inventories. We regularly review inventory quantities on hand, future purchase commitments with our supplies, and the estimated utility of our inventory. If the review indicates a reduction in utility below carrying value, we reduce our inventory to a new cost basis through a charge to cost of goods sold.

 

Property and Equipment:

 

Property and equipment is recorded at cost when acquired.  Depreciation is provided principally on the straight-line method over the estimated useful lives of the related assets, which is 3-7 years for equipment, furniture and fixtures, hardware and software.   Property and equipment consists of the following at December 31, 2015 and 2014:

 

 

 

  2015   2014 
  Shop Machinery and equipment  $80,889   $19,954 
  Computers and electronics   28,911    12,075 
  Office furniture and fixtures   33,977    2,035 
  Leasehold improvements   19,514    - 
      163,291    34,064 
  Less - accumulated depreciation   (26,995)   (7,040)
     $136,296   $27,024 

 

Expenditures for maintenance and repairs are charged to expense as incurred, whereas expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized.

 

During the year ended December 31, 2015 and 2014, the Company purchased $129,227 and $27,863 of furniture and equipment, respectively.

 

The Company recognized $19,955 and $2,477 of depreciation expense for the year ended December 31, 2015 and 2014, respectively,

 

 F-8 

 

 

Long-Lived Assets & Goodwill:

 

The Company accounts for long-lived assets in accordance with the provisions of ASC 360-10-35, “Impairment or Disposal of Long-lived Assets”.  This Statement requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.  Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset.  If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.  The Company acquired the LTAS customer list in 2014. The fair value of the customer list was determined by using a discounted cash flow model and $135,550 was recorded on the date of business combination. The Company recorded $31,941 of amortization expense for the year ended December 31, 2014 leaving a remaining carrying amount of $103,609. The Company recorded another $37,935 amortization expense for the year ended December 31, 2015. After comparing the acquired customer list to the actual customers who placed orders following the acquisition of LTAS, the Company determined that the customer list was impaired at December 31, 2015 and amortized the remaining balance of $65,674 in 2015.

 

The Company accounts for goodwill and intangible assets in accordance with ASC 350 "Intangibles Goodwill and Other". ASC 350 requires that goodwill and other intangibles with indefinite lives be tested for impairment annually or on an interim basis if events or circumstances indicate that the fair value of an asset has decreased below its carrying value. The Company performed impairment analysis using the qualitative analysis under ASC 350-20 and noted no impairment issues for 2015.

 

Derivative Financial Instruments:

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes option pricing model, in accordance with ASC 815-15 “Derivative and Hedging” to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

 

Beneficial Conversion Features:

 

The Company evaluates the embedded conversion feature within its convertible debt instruments under ASC 815-15 and ASC 815-40 to determine if the conversion feature meets the definition of a liability and therefore need to bifurcate the conversion feature and account for it as a separate derivative liability. The intrinsic value of a beneficial conversion feature inherent to a convertible note payable, which is not bifurcated and accounted for separately from the convertible note payable and may not be settled in cash upon conversion, is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual term, the unamortized discount is expensed in the period of retirement to interest expense. In general, the beneficial conversion feature is measured by comparing the effective conversion price, after considering the relative fair value of detachable instruments included in the financing transaction, if any, to the fair value of the common shares at the commitment date to be received upon conversion.

 

Fair Value of Financial Instruments:

 

The Company measures its financial assets and liabilities in accordance with the requirements of FASB ASC 820, “Fair Value Measurements and Disclosures”. ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

 

Level 1– Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.

 

 F-9 

 

 

Level 2 – Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.

 

Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.

  

Revenue Recognition and Unearned Revenue:

 

The Company recognizes revenue when all four of the following criteria are met: 1) persuasive evidence of an arrangement exists; 2) delivery has occurred and title has transferred or services have been rendered; 3) our price to the buyer is fixed or determinable; and 4) collectability is reasonably assured. We record unearned revenue as a liability and their associated costs of sales as work in process inventory. In 2015, the Company deferred recognizing $7,896 in revenue from a 2015 sale that was delivered in January 2016. There is a balance of $83,288 in accounts receivable at December 31, 2015 for sales on account.

 

Income Taxes:

 

The Company accounts for income taxes utilizing ASC 740, “Income Taxes” (SFAS No. 109).  ASC 740 requires the measurement of deferred tax assets for deductible temporary differences and operating loss carry forwards, and of deferred tax liabilities for taxable temporary differences.  Measurement of current and deferred tax liabilities and assets is based on provisions of enacted tax law.  The effects of future changes in tax laws or rates are not included in the measurement.  The Company recognizes the amount of taxes payable or refundable for the current year and recognizes deferred tax liabilities and assets for the expected future tax consequences of events and transactions that have been recognized in the Company’s financial statements or tax returns.  The Company has recorded a 100% valuation allowance against net deferred tax assets due to uncertainty of their ultimate realization.  Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.

 

Employee Stock-Based Compensation:

 

The Company accounts for stock-based compensation in accordance with ASC 718, “Compensation-Stock Compensation”. ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period.

 

Non-Employee Stock-Based Compensation:

 

The Company accounts for stock-based compensation in accordance with the provision of ASC 505, “Equity Based Payments to Non-Employees” (“ASC 505”), which requires that such equity instruments are recorded at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instruments vest.

 

 F-10 

 

 

Related Parties:

 

A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party.

 

The accounts payable due to related party at December 31, 2015 was comprised of $6,000 director fees which were paid in January 2016. The accounts payable due to related party at December 31, 2014, includes allocated rent and utility charges, aerostat envelopes, truck expenses and labor charges due Aerial Products Corp (“APC”) was $2,181. APC is a related party, controlled by a current employee of the Company. APC shared the manufacturing facilities with LTAS and provided aerostat envelopes and manufacturing labor to LTAS until June 30, 2014 when the APC labor pool transitioned to the Company. Total charges from APC to LTAS during the years ended December 31, 2015 and 2014 were $7,549 and $19,242 respectively. Additionally, the Company purchased used fixed assets from APC for $6,500 during the year ended December 31, 2015.

 

Earnings or Loss per Share:

 

The Company accounts for earnings per share pursuant to ASC 260, Earnings per Share, which requires disclosure on the financial statements of "basic" and "diluted" earnings (loss) per share. Basic earnings (loss) per share are computed by dividing net income (loss) by the weighted average number of common shares outstanding for the year. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding plus common stock equivalents (if dilutive) related to stock options and warrants for each year. As there was a net loss for the years ended December 31, 2015 and 2014, basic and diluted losses per share are the same for both years.

 

Recent Accounting Pronouncements

 

Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company's financial statements.

 

2.MERGER BETWEEN MACROSOLVE, INC. AND DRONE AVIATION HOLDING CORP

 

On April 14, 2014, holders of the majority of MacroSolve, Inc. (“MacroSolve) common stock approved a plan of merger whereby MacroSolve would merge with Drone Aviation Holding Corp., its newly created wholly-owned Nevada subsidiary, for the purpose of changing the Company’s state of domicile from Oklahoma to Nevada (the “Redomestication”). Pursuant to the Redomestication, each of MacroSolve’s shareholders received one share of common stock, par value $0.0001 per share of Drone Aviation Holding Corp. for every 50.56186 shares of MacroSolve’s common stock held by them (the Merger Exchange Rate). The Redomestication was effective on April 30, 2014. All per share amounts referenced herein give effect to the Merger Exchange Rate.

 

Prior to the Redomestication, MacroSolve had 198,219,132 shares of common stock issued and outstanding. Subsequent to the Redomestication, as a result of the Merger Exchange Ratio described above, the Company had approximately 3,920,700 [98,017 on a post-reverse basis] shares of common stock issued and outstanding on April 30, 2014.

 

On April 30, 2014 as a result of the Redomestication, MacroSolve’s outstanding shares of Series C, D and D-1 preferred stock were exchanged for shares of the post-Redomestication Company’s shares of Series A, B and B-1 preferred stock, with 595,000 shares, 324,671 shares and 156,231 shares issued respectively.

 

 F-11 

 

 

3.DRONE AVIATION CORP AQUISITION OF LIGHTER THAN AIR SYSTEMS

 

On March 31, 2014, DAC was incorporated in the state of Nevada. During April and May 2014, investors purchased 34,100,000 shares of DAC common stock for an aggregate purchase price of $653,327. On May 5, 2014, DAC entered into a securities exchange agreement with World Surveillance Group, Inc. (WSGI) to acquire 100% of WSGI’s interest in its subsidiary, Lighter Than Air Systems (LTAS). LTAS provides critical aerial and land-based surveillance and communications solutions to government and commercial customers. DAC paid $335,000 and issued 10,000,000 shares of its common stock valued at the market price on the date of issuance, and the fair value of the shares was determined to be $79,000, or a total of $414,000, to WSGI as consideration for LTAS. Since DAC acquired cash of $30,361 from LTAS, as shown in the following table, the net cash amount DAC paid is $304,639.

 

In accordance with ASC 805-10 Business Combination and purchase acquisition accounting, DAC initially allocated the consideration to the net tangible and identifiable intangible assets, based on their estimated fair values as of the date of acquisition. Goodwill represents the excess of the purchase price over the fair value of the underlying net tangible and intangible assets. The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date.

 

  Property and equipment  $1,638 
  Accounts receivable   135,050 
  Cash in bank   30,361 
  Due from related party   20,650 
  Prepaid expenses   1,381 
  Inventory   109,581 
  Intangible asset   135,550 
  Current liabilities   (120,010)
  Goodwill   99,799 
  Total purchase price  $414,000 

 

Intangible asset is in relation to the acquired customer list with a useful life of five years. The fair value of the customer list was determined by using a discounted cash flow model and $135,550 was recorded on the date of business combination. The Company recorded $31,941 of amortization expense for the year ended December 31, 2014. The Company recorded another $37,935 amortization expense for the year ended December 31, 2015. After comparing the acquired customer list to the actual customers who placed orders following the acquisition of LTAS, the Company determined that the customer list was impaired at December 31, 2015 and amortized the remaining balance of $65,674 in 2015.

 

The consolidated financial statements included herein are presented for the period from January 1, 2014 to May 5, 2014 since LTAS is considered Drone’s predecessor. LTAS has a net loss of $39,918 during the period from January 1, 2014 to May 5, 2014.

 

4. DRONE AVIATION HOLDING CORP. AND DRONE AVIATION CORP. SECURITIES EXCHANGE, REVERSE MERGER AND RECAPITALIZATION

 

On June 3, 2014, the Company entered into a Securities Exchange Agreement with Drone Aviation Corp. (DAC).  Upon closing of the transaction, the holders of 100% of DAC’s outstanding common stock transferred such 44,100,000 outstanding shares to the Company in exchange for an aggregate of 8,050,000 [201,250 post-reverse] shares of the Company’s common stock and 36,050,000 shares of the Company’s Series D Preferred Stock, or a total of 44,100,000 [1,102,500 post-reverse] shares of common stock and common stock equivalents of the Company. Pursuant to the terms of the Securities Exchange Agreement, certain shareholders of DAC who, as a result of receiving the shares of common stock would hold in excess of 3.33% of the Company’s issued and outstanding common stock on a post-closing basis, elected to receive shares of the Company’s Series D Preferred Stock. At the closing of the transaction, the Company had 3,920,700 [98,017 post-reverse] shares of common stock outstanding, 595,000 shares of Series A Preferred Stock outstanding, 324,671 shares of Series B Preferred Stock outstanding, 156,231 shares of Series B-1 Preferred Stock outstanding and 355,000 shares of Series C Preferred Stock outstanding.

 

As a result of the Securities Exchange described above, DAC and its subsidiary, LTAS, became our wholly owned subsidiaries.

 

 F-12 

 

 

For accounting purposes, this transaction is being accounted for as a reverse merger and has been treated as a recapitalization of Drone Aviation Holding Corp. with Drone Aviation Corp. considered the accounting acquirer, and the financial statements of the accounting acquirer became the financial statements of the registrant. The 44,100,000 [1,102,500 post-reverse] shares issued to shareholders of DAC and its designees in conjunction with the securities exchange transaction have been presented as outstanding for all periods. The historical consolidated financial statements include the operations of the accounting acquirer for all periods presented.

 

On June 3, 2014, the assets and liabilities of Drone Aviation Holding Corp. carried onto the books were:

 

  Cash in bank  $1,692,896 
  Available-for-sale securities   211,525 
  Prepaid expenses   37,403 
  Current liabilities   (39,622) 
  Derivative liabilities   (2,159,824)
  Note payable   (110,000) 
  Total  $367,622 

 

On March 26, 2015 Drone Aviation Corp. merged into Drone Aviation Holding Corp.

 

Series E Preferred Private Placement

 

On June 3, 2014, prior to the reverse merger, the Company sold an aggregate of 2,700,000 units in a private placement of its securities to certain investors at a purchase price of $0.50 per unit pursuant to subscription for an aggregate purchase price of $1,350,000. Each unit consists of one share of the Company’s Series E Convertible Preferred Stock, par value $0.0001 per share, each of which is convertible into one-fortieth share, on a post-reverse split basis, of Common Stock, with such rights and designations as set forth in the Certificate of Designation; and a three year warrant to purchase one share of Common Stock at an exercise price of $40.00 per share. All the warrants were exercised on August 26, 2014. On June 2, 2015, the holders of Series E received an additional 2,700,000 units due to the Most Favored Nations provision associated with their initial investment.

 

5.DRONE AVIATION HOLDING CORP ASSET ACQUISITION OF ADAPTIVE, FLIGHT, INC.

 

On July 20, 2015, the Company, through its wholly-owned subsidiary Drone AFS Corp., purchased substantially all the assets of Adaptive Flight, Inc. (AFI), a Georgia corporation. The Company purchased assets including but not limited to intellectual property and licenses and permits, including commercial software licenses for the “GUST” (Georgia Tech UAV Simulation Tool) autopilot system, and other transferable licenses which include flight simulation and fault tolerant flight control algorithms. The Company paid $100,000 in immediately available funds and $100,000 to be held in escrow. In addition, the Company issued 150,000 shares of unregistered common stock valued at $8.40 per share, on a post-reverse split basis, on the date of agreement, to be held in escrow.

 

The Company has a milestone of twelve months to complete a technology Integration Plan, the non-completion of which may result in the return of the purchased assets and termination of the Company’s obligations to release the escrow cash and shares. Additional milestones include exclusive, no-cost and perpetual licenses to all contributing intellectual property included or related to the purchased assets. As such time as all milestones are met, one-half of the escrow shares will be released to AFI. Upon termination of the escrow agreement, anticipated to be twelve months from the closing of the asset purchase, if all milestones have been met, the remaining escrow shares will be released to AFI; but if all milestones have not been met, the escrow cash and escrow shares will be released to the Company and the purchased assets will be returned to AFI. According to the terms of the Escrow Agreement, if the escrow share value is less than $1,400,000, the Company must issue an additional number of unregistered shares, not to exceed 50,000 shares. At December 31, 2015, the value of the 150,000 shares was $3.23 per share, or $484,500. The Company recorded $161,500 as an additional liability and expense at December 31, 2015 for the cost of 50,000 shares at $3.23 per share. The liability will be reevaluated at the end of each quarter and adjusted through the profit and loss statement as necessary.

 

The asset acquisition did not qualify as a business combination under ASC 805-10 and has been accounted for as a regular asset purchase.

 

 F-13 

 

 

6. SHAREHOLDERS’ EQUITY

 

On October 29, 2015 a 1:40 the Company effected a 1-for-40 reverse split of its common stock. The reverse split has been applied retroactively for disclosure purposes.

 

For the year ended December 31, 2015

 

The Company issued a total of 4,198,632 common shares during the 2015, adjusted for the October 29, 2015 1:40 reverse split, described further as follows:

 

The Company issued 215,750 shares of common stock between January 1 and March 31, 2015 pursuant to conversions of an aggregate of 86,300 shares of Series A preferred stock.

 

The Company issued 200,573 shares of common stock between April 1 and June 30, 2015 pursuant to conversions of an aggregate of 80,229 shares of Series A preferred stock.

 

The Company issued 25,500 shares of common stock between July 1 and September 30, 2015 pursuant to conversions of an aggregate of 10,200 shares of Series A preferred stock.

 

The Company issued 297,302 shares of common stock between October 1 and December 31, 2015 pursuant to conversions of an aggregate of 118,921 shares of Series A preferred stock.

 

The Company issued 1 share of common stock between July 1 and September 30, 2015 pursuant to conversions of an aggregate of 20 shares of Series B preferred stock.

 

The Company issued 8,116 shares of common stock between October 1 and December 31, 2015 pursuant to conversions of an aggregate of 324,651 shares of Series B preferred stock.

 

The Company issued 50,000 shares of common stock between April 1 and June 30, 2015 pursuant to conversions of an aggregate of 20,000 shares of Series C preferred stock.

 

The Company issued 25,000 shares of common stock between July 1 and September 30, 2015 pursuant to conversions of an aggregate of 10,000 shares of Series C preferred stock.

 

The Company issued 605,033 shares of common stock between October 1 and December 31, 2015 pursuant to conversions of an aggregate of 242,013 shares of Series C preferred stock.

 

The Company issued 210,000 shares of common stock between April 1 and June 30, 2015 pursuant to conversions of an aggregate of 8,400,000 shares of Series D preferred stock.

 

The Company issued 140,000 shares of common stock between July 1 and September 30, 2015 pursuant to conversions of an aggregate of 5,600,000 shares of Series D preferred stock.

 

The Company issued 501,250 shares of common stock between October 1 and December 31, 2015 pursuant to conversions of an aggregate of 20,050,000 shares of Series D preferred stock.

 

The Company issued 50,000 shares of common stock between July 1 and September 30, 2015 pursuant to conversions of an aggregate of 2,000,000 shares of Series E preferred stock.

 

The Company issued 85,000 shares of common stock between October 1 and December 31, 2015 pursuant to conversions of an aggregate of 3,400,000 shares of Series E preferred stock.

 

 F-14 

 

 

The Company issued 32,525 shares of common stock between October 1 and December 31, 2015 pursuant to conversions of an aggregate of 1,301,000 shares of Series F preferred stock

 

The Company issued 50,000 shares of common stock between October 1 and December 31, 2015 pursuant to conversions of an aggregate of 2,000,000 shares of Series G preferred stock

 

On June 1, 2015, the Company issued 50,000 shares of restricted common stock with monthly vesting provisions to the Chairman of the Board for twenty-four months services pursuant to a Director Agreement. The Chairman can earn a pro rata portion of the shares, calculated on a twenty-four month vesting period, in the event the Chairman relinquishes his position and board seat prior to the expiration date of the Director Agreement. The Company recognized a total of $157,500 expense for the pro rata portion of shares earned by the Chairman during 2015.

 

On August 27, 2014, the Company issued 50,000 shares of restricted common stock with monthly vesting provisions to two members of its Strategic Advisory Board for twelve months services. The advisors can earn a pro rata portion of the shares, calculated based on the twelve-month vesting period, in the event the service agreements are terminated prior to the expiration date as described in the agreements. The Company recognized a total of $213,333 expense for the pro rata portion of shares earned by the two advisors during 2015 and has recognized a total of $340,000 since August 27, 2014. The shares became fully vested on August 27, 2015.

 

On July 20, 2015, the Company issued 150,000 shares of restricted common stock valued at $1,260,000 to acquire assets from Adaptive Flight, Inc. as described above.

 

On September 4, 2015, the Company issued 450,000 shares of restricted common stock to four management employees and one director pursuant to stock award agreements. The shares will vest upon consummation of a $4,000,000 equity or debt financing provided that the holder remains engaged by the Company through the vesting date. Stock based compensation of $2,417,760 was recognized in 2015 based on management’s estimate that the shares will be fully vested by February 4, 2016 when the Board deemed vesting occurred with the issuance of $4,000,000 in common stock on November 20, 2015.

 

On November 17 and 19, 2015, the Company sold an aggregate of 745,000 shares of restricted common stock for a purchase price of $5.00 per share in a Private Placement for cash proceeds of $3,484,750 net of $240,250 financing fees. In connection with this sale, the Company issued an aggregate of 70,000 additional shares of common stock to holders of Series E preferred stock pursuant to the ‘most favored nations’ provisions governing the Series E preferred stock. Additionally, pursuant to the terms of the Series F preferred stock and Series G preferred stock, the Company was required to obtain consent to issue securities at a per share purchase price less than the purchase price of the Series F and Series G. In consideration for the consents, the company issued an aggregate of 182,525 shares of restricted common stock to the holders of Series F and Series G preferred stock.

 

On November 20, 2015, the Company entered into an Exchange Agreement with the holder of its outstanding shares of Series B-1 preferred stock pursuant to which the holder exchanged 68,731 shares of Series B-1 preferred stock for 55,000 shares of restricted common stock.

 

On October 29, 2015, the Company issued an aggregate of 57 restricted shares to various investors due to round factors associated with implementing the 1:40 reverse split.

 

For the year ended December 31, 2014

 

The Company issued 95,250 shares of common stock between June 3 and June 30, 2014, on a post-reverse split basis, pursuant to conversions of 38,100 shares of Series A Preferred Stock.

 

The Company issued 246,625 shares of common stock between July 1 and September 30, 2014, on a post-reverse split basis, pursuant to conversions of 98,650 shares of Series A Preferred Stock.

 

 F-15 

 

 

The Company issued 153,750 shares of common stock between October 1 and December 31, 2014, on a post-reverse split basis, pursuant to conversions of 61,500 shares of Series A Preferred Stock.

 

On July 1, 2014, the Company entered into a twelve-month consulting agreement for investor relations, marketing and public relations services. Pursuant to such agreement, the Company is obligated to pay the consultant for his services stock compensation of 6,250 shares of common stock, on a post-reverse split basis, immediately deliverable and an additional 6,250 shares of common stock deliverable after six months if the agreement is still in force. The 6,250 shares delivered in July were valued at $215,000. The agreement was terminated in December 2014 prior to the six month anniversary and, as a result, the Company is not obligated to deliver the remaining 6,250 shares of common stock.

 

On July 21, 2014, the Company issued a total of 42,500 shares of common stock, on a post-reverse split basis, to two consulting firms which held warrants issued on May 19, 2014 for services which were exercised at a $.40 strike price, on a post-reverse split basis, or a total of $17,000.

 

The Company issued 24,000 shares of common stock, on a post-reverse split basis, on August 25, 2014 pursuant to the conversion of 9,600 shares of Series C Preferred Stock.

 

On August 26, 2014, the Company issued an aggregate of 9,310 shares of restricted common stock, on a post-reverse split basis, to seven investors pursuant to the exercise of 100% of the warrants associated with Series E Preferred Stock.

 

On August 27, 2014, the Company issued 50,000 shares of restricted common stock, on a post-reverse split basis, with monthly vesting provisions to two members of its newly-formed Strategic Advisory Board for twelve months of service. The advisors can earn a pro rata portion of the shares, calculated based on the twelve-month vesting period, in the event the service agreements are terminated prior to the expiration date as described in the agreements. The Company recognized a total of $126,667 expense for the pro rata portion of shares earned by the two advisors during the year ended December 31, 2014.

 

7. PREFERRED STOCK

 

For the year ended December 31, 2015

 

All of the preferred stock of the Company is convertible into common shares. The Series A and Series C stock conversion ratio is 1 to 2.5 common shares on a post-split basis. The Series B, B-1, D, E, F and G stock conversion ratio is 1 to 0.025 common shares on a post-split basis. The conversion price of Series B stock may be adjusted if a ‘dilutive triggering event’ occurs which could happen if the Company were to sell or issue common stock, warrants or convertible securities without consideration or for a consideration per share less than the conversion price in effect immediately prior to such sale or issue (dilutive triggering price). In such case, the Series B conversion price would be reduced to a price equal to the dilutive triggering price. All preferred stock has voting rights equal to the number of shares it would have on an ‘as if converted’ basis subject to any ownership limitations governing such preferred shares. All preferred stock is entitled to dividends rights equal to the number of shares it would have on an ‘as if converted’ basis. None of the preferred stock is redeemable, participating nor callable.

 

The Company analyzed the embedded conversion option for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the conversion option should be classified as equity.

 

The Company analyzed the conversion option for beneficial conversion features consideration under ASC 470-20 “Convertible Securities with Beneficial Conversion Features” and noted Series F stock contained a beneficial conversion feature. The intrinsic value of the beneficial conversion feature was determined to be $192,558. The beneficial conversion feature was fully amortized and recorded as a deemed dividend during the year ended December 31, 2014. The Series G stock issued during current quarter also contained a beneficial conversion feature. The intrinsic value of the beneficial conversion feature was determined to be $80,000. The beneficial conversion feature was fully amortized and recorded as a deemed dividend during the year ended December 31, 2015.

 

 F-16 

 

 

On October 29, 2015 a 1:40 reverse split of the Company stock occurred and the effect has been applied retroactively for disclosure purposes.

 

During 2015, eight investors in Series A preferred stock converted a total of 295,650 shares of Series A for an aggregate of 739,126 shares of restricted common stock in accordance with their conversion rights which includes a blocker with respect to individual ownership percentages. During the same period, both investors in Series B preferred stock converted a total of 324,671 shares of Series B for 8,117 shares of restricted common stock, six investors in Series C preferred stock converted a total of 272,013 shares of Series C for an aggregate of 680,033 shares of restricted common stock, thirteen investors in Series D preferred stock converted a total of 34,050,000 shares of Series D for an aggregate of 851,250 shares of restricted common stock, seven investors in Series E preferred stock converted a total of 5,400,000 shares of Series E for an aggregate of 135,000 shares of restricted common stock, three investors in Series F preferred stock converted a total of 1,301,001 shares of Series F for an aggregate of 32,525 shares of restricted common stock, and six investors in Series G preferred stock converted a total of 2,000,000 shares of Series G for an aggregate of 50,000 shares of restricted common stock, all in accordance with their conversion rights which includes a blocker with respect to individual ownership percentages.

 

On November 20, 2015, the Company entered into an Exchange Agreement with the holder of its outstanding shares of Series B-1 preferred stock pursuant to which the holder exchanged 68,731 shares of Series B-1 preferred stock for 55,000 shares of restricted common stock.

 

Series G Preferred Private Placement

 

On June 2, 2015, the Company sold an aggregate of 4,000,000 units in a private placement of its securities to certain investors at a purchase price of $0.25 per unit pursuant to subscription for an aggregate purchase price of $985,725, net of $14,275 financing fees. Each unit consists of one share of the Company’s Series G Convertible Preferred Stock, par value $0.0001 per share, each of which is convertible into 0.025 shares of Common Stock on a post-split basis.

 

On June 2, 2015, as a result of the sale of the Series G Preferred Stock, the Company issued 2,700,000 shares of Series E Convertible Preferred Stock, which are convertible into an aggregate of 67,500 shares of Common Stock on a post-split basis, to existing holders of Series E Preferred Stock, in connection with certain anti-dilution rights associated with their purchase of such shares. The additional share issuance was treated as a ‘stock split’ and was retrospectively reflected as of December 31, 2014.

 

On June 2, 2015, the Company received the consent of the holders of a majority of its Series F Convertible Preferred Stock to consummate the Series G Private Placement, as required under the terms of that investment. In consideration for the foregoing consent, the Company issued all holders of its Series F Preferred Stock an aggregate of an additional 2,200,666 shares of Series F Preferred Stock, which are convertible into an aggregate of 55,017 shares of common stock on a post-split basis. The additional share issuance was treated as a ‘stock split’ and was retrospectively reflected as of December 31, 2014.

 

Common Stock Private Placement

 

On November 17 and 19, 2015, the Company sold an aggregate of 745,000 shares of restricted common stock for a purchase price of $5.00 per share in a Private Placement. In connection with this sale, the Company issued an aggregate of 70,000 additional shares of common stock to holders of Series E preferred stock pursuant to the ‘most favored nations’ provisions governing the Series E preferred stock. Additionally, pursuant to the terms of the Series F preferred stock and Series G preferred stock, the Company was required to obtain consent to issue securities at a per share purchase price less than the purchase price of the Series F and Series G. In consideration for the consents, the company issued an aggregate of 182,525 shares of restricted common stock to the holders of Series F and Series G preferred stock.

 

 F-17 

 

 

For the year ended December 31, 2014

 

Between June 4 and June 30, 2014, seven holders of Series A Preferred Stock converted a total of 38,100 shares of Series A Preferred Stock for 95,250 shares of common stock, on a post-reverse split basis, in accordance with their conversion rights which includes a blocker with respect to individual ownership percentages.

 

Between July 1 and September 30, 2014, seven holders of Series A Preferred Stock converted a total of 98,650 shares for 246,625 shares of common stock, on a post-reverse split basis, in accordance with their conversion rights which includes a blocker with respect to individual ownership percentages.

 

Between October 1 and December 31, 2014, five holders of Series A Preferred Stock converted a total of 61,500 shares for 153,750 shares of common stock, on a post-reverse split basis, in accordance with their conversion rights which includes a blocker with respect to individual ownership percentages.

 

The Series B-1 Preferred Stock contains a liquidation provision whereas in the event of a fundamental transaction (such as the merger which occurred on June 3, 2014), the shareholder has the option to receive a preferential amount of cash equal to 400% of the stated value per share. On June 6, 2014, the sole holder of Series B-1 stock liquidated 87,500 shares for $350,000 leaving a remaining balance of 68,731 shares of Series B-1 preferred outstanding.

 

The Company issued 24,000 shares of common stock, on a post-reverse split basis, on August 25, 2014 pursuant to the conversion of 9,600 shares of Series C Preferred Stock.

 

Series F Preferred Private Placement

 

On August 27, 2014, the Company sold an aggregate of 1,100,333 units in a private placement of its securities to certain investors at a purchase price of $0.75 per unit pursuant to subscription for an aggregate purchase price of $822,750, net of $2,500 financing fees. Each unit consists of one share of the Company’s Series F Convertible Preferred Stock, par value $0.0001 per share, each of which is convertible into one-fortieth share of Common Stock, on a post-reverse split basis, with such rights and designations as set forth in the Certificate of Designation. The Company evaluated the convertible preferred stock under FASB ASC 470-20-30 and determined it contained a beneficial conversion feature. The intrinsic value of the beneficial conversion feature was determined to be $192,558. The beneficial conversion feature was fully amortized and recorded as a deemed dividend.

 

8. EMPLOYEE STOCK OPTIONS

 

For the year ended December 31, 2015

 

On October 29, 2015 a 1:40 reverse split of the Company stock occurred and the effect has been applied retroactively for disclosure purposes.

 

During 2015, the Company granted 842,500 common stock options to employees and a director for service provided. Of these, 250,000 options were immediately vested and were granted with an exercise price of $6.00 and the expiration date is May 18, 2018. Another 105,000 options were immediately vested and were granted with an exercise price of $5.00 and the expiration date of December 10, 2018. Another 250,000 options vest over two years or upon the up listing of the Company’s common stock and were granted with an exercise price of $6.00 and the expiration date is June 1, 2018. These 250,000 options were surrendered and cancelled on September 4, 2015. A director received two options. The first was for 75,000 shares vesting over two years and was granted with an exercise price of $10.00 and the expiration date is June 1, 2018. The second was for 125,000 shares with vesting tied to performance and was granted with an exercise price of $10.00 and the expiration date is June 1, 2018. These two director options were surrendered and cancelled on September 4, 2015. Stock based compensation was reversed for costs previously recognized on the total 450,000 surrendered and cancelled unvested options. Another option for 37,500 shares vesting over three years was granted with an exercise price of $10.80 and the expiration date is May 4, 2019.

 

The Company uses the Black-Scholes option pricing model to estimate the fair value of stock-based awards on the date of grant.

 

 F-18 

 

 

The following table summarizes the assumptions used to estimate the fair value of stock options granted during 2015:

 

     2015 
       
  Expected dividend yield   0%
  Expected volatility   116% – 131%
  Risk-free interest rate   0.79% – 1.25%
  Expected life of options   2.43 – 3.00 years 

 

Under the Black-Scholes option price model, fair value of the options granted is estimated at $3,013,531. During 2015, $2,822,132 compensation expense was recognized and the remaining $191,399 will be recognized over the next three years.

 

The following table represents stock option activity as of and for the period ended December 31, 2015:

 

    

 

 

Number of Options

  

Weighted

Average

Exercise Price

  

 

Contractual Life in Years

  

 

 

Intrinsic

Value

 
  Outstanding – December 31, 2014   -   $0.00           
  Exercisable – December 31, 2014   -   $0.00        $0.00 
  Granted   842,500   $7.04           
  Exercised or Vested   -   $0.00           
  Cancelled or Expired   450,000   $7.78           
  Outstanding – December 31, 2015   392,500   $6.19    2.62      
  Exercisable – December 31, 2015   355,000   $5.70    2.55   $0.00 

 

For the year ended December 31, 2014

 

On April 30, 2014, the effective date of the Redomestication and effective date of the Merger Exchange Ratio, there were a total of 920 vested and 618 unvested options, on a post-reverse split basis, carried over to the reverse merger with DAC on June 3, 2014 with strike prices ranging from $66.80 to $5,056. During September 2014, the holders of these options voluntarily agreed to terminate their options. At December 31, 2014 there are no outstanding options.

 

9. WARRANTS

 

For the year ended December 31, 2015

 

On October 29, 2015 a 1:40 reverse split of the Company stock occurred and the effect has been applied retroactively for disclosure purposes.

 

For the year 2015, 52,500 common stock purchase warrants were granted to two consultants and a vendor for service provided. One consultant was granted 25,000 warrants with exercise price of $10.00, vesting over two years and the expiration date is June 16, 2018. The other consultant was granted 12,500 warrants with exercise price of $10.00, vesting over one year and the expiration date is June 25, 2018. These same two consultants and the vendor each received 5,000 warrants with exercise price of $5.00, immediately vested and an expiration date of December 10, 2018.

 

 F-19 

 

 

On November 20, 2015, the Company issued 70,000 warrants with exercise price of $5.00, immediately vested and the expiration date of November 20, 2020 to the placement agent in the common stock private placement.

 

The Company uses the Black-Scholes warrant pricing model to estimate the fair value of warrants as of December 31, 2015.

 

The following table summarizes the assumptions used to estimate the fair value of warrants granted during 2015:

 

      2015 
        
  Expected dividend yield   0%
  Expected volatility   116% – 121%
  Risk-free interest rate   .87% – 1.70%
  Expected life of warrants   2.4 – 5 years 

 

Under the Black-Scholes warrant price model, fair value of the warrants granted is estimated at $347,201. During 2015, $324,263 compensation expense was recognized.

 

For the year ended December 31, 2014

 

On April 30, 2014, the effective date of the Redomestication and effective date of the Merger Exchange Ratio, there were a total of 16,842 warrants, on a post-reverse split basis, carried over to the reverse merger with DAC on June 3, 2014 with strike prices ranging from $101.2 to $662.8. A total of 4,717 of these warrants with strike prices of $202.4 expired between July and September 2014 leaving a total of 12,125 outstanding warrants.

 

During May 2014, the Company issued a total of 42,500 warrants on a post-reverse split basis for services. The warrants have a term of three years, and exercise price of $0.40. The 42,500 warrants were exercised in July 2014 for a total of $17,000. As further described above in Note 4, on June 3, 2014, the Company issued 67,500 warrants on a post-reverse split basis to purchase one share of common stock at an exercise price of $40.00 per warrant share to investors who purchased Series E Preferred Stock. The exercise price of $40.00 per warrant may be adjusted any time during the first twenty-four months from issuance under the terms of a Favored Nations Provision contained in the warrant. If at any time during that twenty-four month period the Company should issue common stock or convertible securities at a price lower than $40.00 per share, unless the warrant holder consents to such lower price issuance, then the exercise price of the warrant shall be automatically reduced to reflect such other lower price and the number of warrant securities shall be adjusted to reflect such lower price. The warrants expire on June 3, 2017. In August 2014, all seven investors holding the warrants attached to Series E Preferred Stock executed cashless exercises of their warrants resulting in the issuance of 9,310 shares of restricted common stock on a post-reverse split basis.

 

Because the 42,500 warrants issued on June 3, 2014 have full reset adjustments tied to future issuances of equity securities by the Company, they are subject to derivative liability treatment under ASC 815-40-15 “Determining whether an Instrument (or Embedded feature) is Indexed to an Entity’s Own Stock.” ASC 815-40-15 requires as of the date the warrant is issued, the derivative liability to be measured at fair value and re-evaluated at the end of each reporting period.

 

As of June 3, 2014, the fair value of the warrants derivative liability was $2,159,824 – see Note #4. On August 26, 2014, when the warrants were exercised, the Company determined the fair value of the derivative liability to be $2,510,793, and upon warrant exercise, the derivative liability was written off to additional paid in capital.

 

 F-20 

 

 

As a result of the warrant exercises, as of December 31, 2014, the fair value of the warrants derivative liability is $0, and the Company recognized a loss on derivative liability of $350,969 for the year ended December 31, 2014. The fair value of the derivative liability was estimated at the date of grant and the date of warrant exercised using a Black-Scholes option pricing model.

 

The following table represents warrant activity as of and for the period ended December 31, 2015 and 2014:

 

    

Number of Warrants

  

Weighted

Average

Exercise Price

  

Contractual Life in Years

  

Intrinsic

Value

 
  Outstanding – December 31, 2014   12,129   $206.86    2.04      
  Exercisable – December 31, 2014   12,129   $206.86    2.04   $0.00 
  Granted   122,500   $6.53           
                      
  Forfeited or Expired   (420)  $250.35           
  Outstanding – December 31, 2015   134,209   $23.87    3.66      
  Exercisable – December 31, 2015   104,209   $27.87    4.01   $0.00 

  

10. INVENTORIES

 

Inventories consisted of the following:

 

     2015   2013 
  Raw Materials  $26,358   $18,944 
  Work in progress   3,817    1,369 
  Finished Goods   107,209    19,091 
  Less valuation allowance   (18,589)   - 
     $118,795   $39,404 

 

11. PREPAID EXPENSES

 

Prepaid expenses consisted of the following:

 

     2015   2014 
  Prepaid insurance  $25,517   $23,114 
  Prepaid services   24,192    15,225 
  Prepaid rent and security deposit   5,915    11,830 
     $55,624   $50,169 

 

 F-21 

 

 

12. INVESTMENT IN SECURITIES HELD FOR RESALE

 

The Company owned common stock in DecisionPoint Systems, Inc. (DPSI), MEDL Mobile Holdings, Inc. (MEDL) and Endexx Corporation (EDXC) as a result of certain 2012 and 2013 business transactions of MacroSolve. These securities were revalued at fair market value on June 3, 2014 as part of the reverse merger accounting. During the second quarter, the Company sold 607,284 shares of DPSI and 147,692 shares of MEDL, representing all of its holdings in those securities, with losses of $21,635 and $3,686 recorded respectively. The Company received a total of $168,704 net cash proceeds from the sales. The Company holds 125,000 shares of EDXC, but has been unable to liquidate the shares due to issues with Endexx Corporation not being a fully-reporting company. The Company has determined that the EDXC shares are impaired and has charged off the $17,500 carrying value. A total of $42,821 was recorded as loss on sale of securities for the year ended December 31, 2014.

 

13. OKLAHOMA TECHNOLOGY COMMERCIALIZATION CENTER

 

At the time of the April 30, 2014 Redomestication, MacroSolve had an $110,000 past-due balance on its refundable award from the State of Oklahoma Technology Business Finance Program which includes accrued interest (imputed at 14.27%) through September 2007 after which interest no longer accrued. The Company has not made any reductions in the award so it is in default. The Company has proposed a settlement to be released from the debt that is unrelated to the current operations and is awaiting a response.

 

14. INCOME TAXES

 

The Company uses the liability method, where deferred tax assets and liabilities are determined based on the expected future tax consequences of temporary differences between the carrying amounts of assets and liabilities for financial and income tax reporting purposes.

 

During the post-reverse merger period of June 4, 2014 through December 31, 2014, the Company incurred a net loss, and, therefore, had no tax liability. Lighter Than Air Systems paid $5,571 in income taxes during 2014 for two short period returns, including the periods of March 29, 2013 through December 31, 2013 and January 1, 2014 through June 3, 2014 when it was a subsidiary of WSGI. The net deferred asset generated by the loss carry-forward has been fully reserved. The cumulative net operating loss carry-forward is approximately $4,220,577 for 2015 and will begin expiring in 2034. Section 382 of the Internal Revenue Code generally imposes an annual limitation on the amount of net operating loss carryforwards that may be used to offset taxable income when a corporation has undergone significant changes in its stock ownership. The $4,220,577 estimate of net operating loss carry-forward is calculated after we consider the effect of Section 382.

 

Deferred tax assets consist of the tax effect of NOL carry-forwards. The Company has provided a full valuation allowance on the deferred tax assets because of the uncertainty regarding its realizability. Deferred tax assets consist of the following:

 

    

December 31, 2015

  

December 31, 2014

 
  Net operating loss carry-forwards  $1,434,996   $497,501 
  Valuation allowance   (1,434,996)   (497,501)
     $-0-   $-0- 

 

15. COMMITMENTS AND CONTINGENCIES

 

On November 17, 2014, the Company entered into a 60 month lease for 5,533 square feet of office and manufacturing space at 11651 Central Parkway Suite 118, Jacksonville Florida, with an anticipated lease commencement date of February 1, 2015. The actual commencement date was July 1, 2015 and the lease was amended to 61 months expiring July 31, 2020. The monthly rent, including operating expenses and sales tax, for each year of the initial lease term is estimated to be $5,915. Anticipated total rent during the term of the lease is as follows:

 

Year 2016 - $ 71,854
Year 2017 - $ 73,619
Year 2018 - $ 75,437
Year 2019 - $ 77,309
Year 2020 - $ 45,651

 

 F-22 

 

 

On January 1, 2015, the Company entered into an agreement to lease executive office space for its President in Aventura, Florida. The monthly cost is expected to be $1,437 per month on a month-to-month basis with a sixty-day notice to cancel the agreement.

 

Rent expense in 2015 and 2014 were $76,492, and $37,557, respectively, and consisted of reimbursements for home offices and reimbursements made in 2014 to a related party which leased the Company’s former shared office and manufacturing space.

 

As of December 31, 2015, the Company is a party in a pending motion by Newegg Inc. for recovery of defendant legal fees of approximately $400,000 from the Company in the matter of MacroSolve, Inc. v Newegg Inc. (U.S.D.C.E.D. TX) case No 6:12-cv-46-MSS-KNM. Should the company not prevail in that matter, the judgment would be borne by the former MacroSolve directors who sold their loans on April 17, 2014. Other than that matter, there are no material claims, actions, suits, proceedings inquiries, labor disputes or investigations pending.

 

16. CONCENTRATIONS

 

Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of trade receivables.  The Company performs ongoing credit evaluations of its customers and generally does not require collateral related to its receivables. At December 31, 2015, accounts receivable from two customers comprised 100% of the company’s total accounts receivable-trade. Revenues from two customers approximated 71% of total revenues for 2015. At December 31, 2014, accounts receivable from one customer comprised approximately 100% of the Company’s total accounts receivable-trade. Revenues from four customers approximated 92% of total revenues for 2014.

 

17. SUBSEQUENT EVENTS

 

The Company issued a total of 335,968 shares of common stock between January 1- March 4, 2016, described further as follows:

 

The Company issued 2,500 shares of common stock between January 1- March 4, 2016 pursuant to conversions of an aggregate of 1,000 shares of Series A preferred stock.

 

The Company issued 183,468 shares of common stock between January 1- March 4, 2016 pursuant to conversions of an aggregate of 73,387 shares of Series C preferred stock.

 

The Company issued 50,000 shares of common stock between January 1- March 4, 2016 pursuant to conversions of an aggregate of 2,000,000 shares of Series D preferred stock.

 

The Company issued 50,000 shares of common stock between January 1- March 4, 2016 pursuant to conversions of an aggregate of 1,999,998 shares of Series F preferred stock.

 

The Company issued 50,000 shares of common stock between January 1- March 4, 2016 pursuant to conversions of an aggregate of 2,000,000 shares of Series F preferred stock.

 

 

 

F-23

 

 

 EX-21 2 f10k2015ex21_drone.htm LIST OF SUBSIDIARIES FILED AS AN EXHIBIT TO THIS ANNUAL REPORT ON FORM 10-K

EXHIBIT 21

 

SUBSIDIARIES

 

Drone Aviation Holding Corp., a Nevada corporation, had the domestic and international subsidiaries shown below as of March 4, 2016.

 

 

Name of Subsidiary Jurisdiction Where Incorporated
Lighter Than Air Systems Corporation Florida
Drone AFS Corp. Nevada

  

 EX-31.1 3 f10k2015ex31i_drone.htm CERTIFICATION

EXHIBIT 31.1

 

CERTIFICATION

 

I, Kevin Hess, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of Drone Aviation Holding Corp.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15 (f) and 15 (d)-15(f)) for the registrant and have:

 

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) designed such internal control over financing reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect the registrant’s internal control over the financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

  /s/ Kevin Hess
  Chief Executive Officer
  (Principal Executive Officer)

 

Date: March 4, 2016

 EX-31.2 4 f10k2015ex31ii_drone.htm CERTIFICATION

EXHIBIT 31.2

 

CERTIFICATION

 

I, Kendall Carpenter, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of Drone Aviation Holding Corp.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15 (f) and 15 (d)-15(f)) for the registrant and have:

 

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) designed such internal control over financing reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect the registrant’s internal control over the financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

  /s/ Kendall Carpenter
  Chief Financial Officer
  (Principal Financial Officer)

 

Date: March 4, 2016

 EX-32.1 5 f10k2015ex32i_drone.htm CERTIFICATION

EXHIBIT 32.1

 

Certification

Pursuant To Section 906 of the Sarbanes-Oxley Act Of 2002

(Subsections (A) And (B) Of Section 1350, Chapter 63 of Title 18, United States Code)

 

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Drone Aviation Holding Corp. (the “Company”), does hereby certify, that:

 

The Annual Report on Form 10-K for the fiscal year ended December, 2015 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

  /s/ Kevin Hess
  Chief Executive Officer
   (Principal Executive Officer)
   
Dated: March 4, 2016  
   
  /s/ Kendall Carpenter
 

Chief Financial Officer

(Principal Financial Officer)
   
Dated: March 4, 2016  

 

 GRAPHIC 6 image_001.jpg GRAPHIC begin 644 image_001.jpg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end EX-101.INS 7 drne-20151231.xml XBRL INSTANCE FILE 0001178727 2012-12-31 0001178727 2013-12-31 0001178727 us-gaap:CommonStockMember 2013-12-31 0001178727 us-gaap:SeriesAPreferredStockMember 2013-12-31 0001178727 us-gaap:SeriesBPreferredStockMember 2013-12-31 0001178727 us-gaap:SeriesCPreferredStockMember 2013-12-31 0001178727 us-gaap:SeriesDPreferredStockMember 2013-12-31 0001178727 us-gaap:SeriesEPreferredStockMember 2013-12-31 0001178727 us-gaap:SeriesFPreferredStockMember 2013-12-31 0001178727 us-gaap:SeriesAPreferredStockMember us-gaap:PredecessorMember 2013-12-31 0001178727 us-gaap:SeriesBPreferredStockMember us-gaap:PredecessorMember 2013-12-31 0001178727 drne:SeriesBOnePreferredStockMember us-gaap:PredecessorMember 2013-12-31 0001178727 us-gaap:SeriesCPreferredStockMember us-gaap:PredecessorMember 2013-12-31 0001178727 us-gaap:SeriesDPreferredStockMember us-gaap:PredecessorMember 2013-12-31 0001178727 us-gaap:SeriesEPreferredStockMember us-gaap:PredecessorMember 2013-12-31 0001178727 us-gaap:SeriesFPreferredStockMember us-gaap:PredecessorMember 2013-12-31 0001178727 us-gaap:SeriesGPreferredStockMember us-gaap:PredecessorMember 2013-12-31 0001178727 us-gaap:CommonStockMember us-gaap:PredecessorMember 2013-12-31 0001178727 us-gaap:AdditionalPaidInCapitalMember us-gaap:PredecessorMember 2013-12-31 0001178727 us-gaap:RetainedEarningsMember us-gaap:PredecessorMember 2013-12-31 0001178727 us-gaap:SeriesGPreferredStockMember 2013-12-31 0001178727 us-gaap:CommonStockMember drne:LighterThanAirSystemsMember 2014-03-01 2014-03-31 0001178727 drne:MacrosolveIncMember 2014-04-11 2014-04-14 0001178727 2014-04-30 0001178727 us-gaap:SeriesAPreferredStockMember 2014-04-30 0001178727 us-gaap:SeriesBPreferredStockMember 2014-04-30 0001178727 drne:MacrosolveIncMember 2014-04-30 0001178727 drne:SeriesBOnePreferredStockMember 2014-04-30 0001178727 us-gaap:WarrantMember 2014-04-30 0001178727 us-gaap:EmployeeStockOptionMember 2014-04-30 0001178727 us-gaap:EmployeeStockOptionMember 2014-04-28 2014-04-30 0001178727 drne:LighterThanAirSystemsMember 2014-05-05 0001178727 us-gaap:CommonStockMember 2014-01-01 2014-05-05 0001178727 drne:LighterThanAirSystemsMember 2014-01-01 2014-05-05 0001178727 us-gaap:WarrantMember 2014-05-01 2014-05-31 0001178727 us-gaap:CommonStockMember 2014-06-03 0001178727 us-gaap:WarrantMember us-gaap:MaximumMember 2014-06-03 0001178727 us-gaap:MinimumMember us-gaap:WarrantMember 2014-06-03 0001178727 drne:DroneAviationCorpMember 2014-06-03 0001178727 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2014-06-03 0001178727 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2014-06-03 0001178727 us-gaap:PreferredStockMember drne:SeriesBOnePreferredStockMember 2014-06-03 0001178727 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2014-06-03 0001178727 us-gaap:PrivatePlacementMember 2014-06-03 0001178727 us-gaap:NoteWarrantMember 2014-06-03 0001178727 us-gaap:PrivatePlacementMember us-gaap:SeriesEPreferredStockMember 2014-06-03 0001178727 us-gaap:MinimumMember us-gaap:EmployeeStockOptionMember 2014-06-03 0001178727 us-gaap:MaximumMember us-gaap:EmployeeStockOptionMember 2014-06-03 0001178727 us-gaap:WarrantMember 2014-06-02 2014-06-03 0001178727 us-gaap:PrivatePlacementMember 2014-06-02 2014-06-03 0001178727 us-gaap:WarrantMember us-gaap:SeriesEPreferredStockMember 2014-06-02 2014-06-03 0001178727 us-gaap:CommonStockMember drne:DroneAviationCorpMember 2014-06-02 2014-06-03 0001178727 us-gaap:SeriesDPreferredStockMember drne:DroneAviationCorpMember 2014-06-02 2014-06-03 0001178727 drne:SeriesBOnePreferredStockMember 2014-06-06 0001178727 drne:DecisionPointSystemsMember 2014-04-01 2014-06-30 0001178727 drne:MedlMobileHoldingsIncMember 2014-04-01 2014-06-30 0001178727 drne:DecisionPointSystemsMember 2014-06-30 0001178727 drne:MedlMobileHoldingsIncMember 2014-06-30 0001178727 us-gaap:SeriesAPreferredStockMember 2014-06-30 0001178727 us-gaap:SeriesAPreferredStockMember 2014-06-04 2014-06-30 0001178727 drne:ConsultingAgreementMember 2014-06-19 2014-07-01 0001178727 2014-07-20 2014-07-21 0001178727 us-gaap:SeriesCPreferredStockMember 2014-08-25 0001178727 us-gaap:SeriesCPreferredStockMember 2014-08-01 2014-08-25 0001178727 us-gaap:SeriesEPreferredStockMember 2014-08-21 2014-08-26 0001178727 us-gaap:WarrantMember 2014-08-21 2014-08-26 0001178727 us-gaap:SeriesEPreferredStockMember 2014-08-21 2014-08-26 0001178727 us-gaap:SeriesFPreferredStockMember us-gaap:PrivatePlacementMember 2014-08-27 0001178727 2014-08-01 2014-08-27 0001178727 us-gaap:SeriesFPreferredStockMember us-gaap:PrivatePlacementMember 2014-08-01 2014-08-27 0001178727 drne:StrategicAdvisoryBoardMembersMember 2014-08-01 2014-08-27 0001178727 us-gaap:SeriesAPreferredStockMember 2014-07-02 2014-09-30 0001178727 us-gaap:SeriesAPreferredStockMember 2014-09-30 0001178727 2014-11-17 0001178727 2014-11-01 2014-11-17 0001178727 us-gaap:SeriesAPreferredStockMember 2014-10-01 2014-12-31 0001178727 2014-01-01 2014-12-31 0001178727 us-gaap:SeriesAPreferredStockMember 2014-01-01 2014-12-31 0001178727 us-gaap:SeriesBPreferredStockMember 2014-01-01 2014-12-31 0001178727 us-gaap:SeriesCPreferredStockMember 2014-01-01 2014-12-31 0001178727 us-gaap:SeriesDPreferredStockMember 2014-01-01 2014-12-31 0001178727 us-gaap:SeriesEPreferredStockMember 2014-01-01 2014-12-31 0001178727 us-gaap:SeriesFPreferredStockMember 2014-01-01 2014-12-31 0001178727 us-gaap:CommonStockMember us-gaap:PredecessorMember 2014-01-01 2014-12-31 0001178727 us-gaap:AdditionalPaidInCapitalMember us-gaap:PredecessorMember 2014-01-01 2014-12-31 0001178727 us-gaap:RetainedEarningsMember us-gaap:PredecessorMember 2014-01-01 2014-12-31 0001178727 drne:SeriesBOnePreferredStockMember 2014-01-01 2014-12-31 0001178727 us-gaap:WarrantMember 2014-01-01 2014-12-31 0001178727 drne:StrategicAdvisoryBoardMembersMember 2014-01-01 2014-12-31 0001178727 us-gaap:AccountsReceivableMember 2014-01-01 2014-12-31 0001178727 us-gaap:SalesRevenueNetMember 2014-01-01 2014-12-31 0001178727 us-gaap:SeriesGPreferredStockMember 2014-01-01 2014-12-31 0001178727 2014-12-31 0001178727 us-gaap:CommonStockMember 2014-12-31 0001178727 us-gaap:SeriesAPreferredStockMember 2014-12-31 0001178727 us-gaap:SeriesBPreferredStockMember 2014-12-31 0001178727 us-gaap:SeriesCPreferredStockMember 2014-12-31 0001178727 us-gaap:SeriesDPreferredStockMember 2014-12-31 0001178727 us-gaap:SeriesEPreferredStockMember 2014-12-31 0001178727 us-gaap:SeriesFPreferredStockMember 2014-12-31 0001178727 us-gaap:SeriesAPreferredStockMember us-gaap:PredecessorMember 2014-12-31 0001178727 us-gaap:SeriesBPreferredStockMember us-gaap:PredecessorMember 2014-12-31 0001178727 drne:SeriesBOnePreferredStockMember us-gaap:PredecessorMember 2014-12-31 0001178727 us-gaap:SeriesCPreferredStockMember us-gaap:PredecessorMember 2014-12-31 0001178727 us-gaap:SeriesDPreferredStockMember us-gaap:PredecessorMember 2014-12-31 0001178727 us-gaap:SeriesEPreferredStockMember us-gaap:PredecessorMember 2014-12-31 0001178727 us-gaap:SeriesFPreferredStockMember us-gaap:PredecessorMember 2014-12-31 0001178727 us-gaap:SeriesGPreferredStockMember us-gaap:PredecessorMember 2014-12-31 0001178727 us-gaap:CommonStockMember us-gaap:PredecessorMember 2014-12-31 0001178727 us-gaap:AdditionalPaidInCapitalMember us-gaap:PredecessorMember 2014-12-31 0001178727 us-gaap:RetainedEarningsMember us-gaap:PredecessorMember 2014-12-31 0001178727 drne:SeriesBOnePreferredStockMember 2014-12-31 0001178727 us-gaap:EmployeeStockOptionMember 2014-12-31 0001178727 us-gaap:NoteWarrantMember 2014-12-31 0001178727 us-gaap:SeriesAPreferredStockMember 2014-12-31 0001178727 us-gaap:SeriesGPreferredStockMember 2014-12-31 0001178727 us-gaap:SeriesAPreferredStockMember 2015-01-01 2015-03-31 0001178727 us-gaap:SeriesAPreferredStockMember 2015-03-31 0001178727 drne:DirectorAgreementMember 2015-05-30 2015-06-01 0001178727 us-gaap:SeriesFPreferredStockMember 2015-06-02 0001178727 us-gaap:SeriesGPreferredStockMember us-gaap:PrivatePlacementMember 2015-06-02 0001178727 drne:SeriesEConvertiblePreferredStockMember 2015-06-02 0001178727 us-gaap:PrivatePlacementMember us-gaap:SeriesEPreferredStockMember 2015-05-25 2015-06-02 0001178727 us-gaap:SeriesGPreferredStockMember us-gaap:PrivatePlacementMember 2015-05-25 2015-06-02 0001178727 drne:SeriesEConvertiblePreferredStockMember 2015-05-25 2015-06-02 0001178727 us-gaap:SeriesAPreferredStockMember 2015-04-01 2015-06-30 0001178727 us-gaap:SeriesCPreferredStockMember 2015-04-01 2015-06-30 0001178727 us-gaap:SeriesDPreferredStockMember 2015-04-01 2015-06-30 0001178727 2015-06-30 0001178727 us-gaap:SeriesAPreferredStockMember 2015-06-30 0001178727 us-gaap:SeriesCPreferredStockMember 2015-06-30 0001178727 us-gaap:SeriesDPreferredStockMember 2015-06-30 0001178727 drne:GeorgiaTechUavSimulationToolMember 2015-07-20 0001178727 drne:GeorgiaTechUavSimulationToolMember 2015-07-01 2015-07-20 0001178727 drne:AdaptiveFlightIncMember 2015-07-18 2015-07-20 0001178727 drne:StockAwardAgreementsMember 2015-09-02 2015-09-04 0001178727 drne:EmployeesandDirectorMember 2015-09-02 2015-09-04 0001178727 us-gaap:SeriesAPreferredStockMember 2015-07-01 2015-09-30 0001178727 us-gaap:SeriesCPreferredStockMember 2015-07-01 2015-09-30 0001178727 us-gaap:SeriesEPreferredStockMember 2015-07-01 2015-09-30 0001178727 us-gaap:SeriesDPreferredStockMember 2015-07-01 2015-09-30 0001178727 us-gaap:SeriesBPreferredStockMember 2015-07-01 2015-09-30 0001178727 us-gaap:SeriesAPreferredStockMember 2015-09-30 0001178727 us-gaap:SeriesCPreferredStockMember 2015-09-30 0001178727 us-gaap:SeriesEPreferredStockMember 2015-09-30 0001178727 us-gaap:SeriesDPreferredStockMember 2015-09-30 0001178727 us-gaap:SeriesBPreferredStockMember 2015-09-30 0001178727 us-gaap:WarrantMember 2015-10-01 2015-10-29 0001178727 2015-10-24 2015-10-29 0001178727 2015-10-27 2015-10-29 0001178727 us-gaap:CommonStockMember 2015-10-27 2015-10-29 0001178727 us-gaap:PrivatePlacementMember 2015-11-17 0001178727 us-gaap:PrivatePlacementMember 2015-11-15 2015-11-17 0001178727 us-gaap:PrivatePlacementMember us-gaap:SeriesEPreferredStockMember 2015-11-15 2015-11-17 0001178727 us-gaap:SeriesFPreferredStockMember us-gaap:PrivatePlacementMember 2015-11-15 2015-11-17 0001178727 us-gaap:SeriesGPreferredStockMember us-gaap:PrivatePlacementMember 2015-11-15 2015-11-17 0001178727 us-gaap:PrivatePlacementMember 2015-11-19 0001178727 us-gaap:PrivatePlacementMember 2015-11-18 2015-11-19 0001178727 us-gaap:PrivatePlacementMember us-gaap:SeriesEPreferredStockMember 2015-11-18 2015-11-19 0001178727 us-gaap:SeriesFPreferredStockMember us-gaap:PrivatePlacementMember 2015-11-18 2015-11-19 0001178727 us-gaap:SeriesGPreferredStockMember us-gaap:PrivatePlacementMember 2015-11-18 2015-11-19 0001178727 us-gaap:SeriesEPreferredStockMember us-gaap:PrivatePlacementMember us-gaap:RestrictedStockMember 2015-11-18 2015-11-19 0001178727 us-gaap:WarrantMember 2015-11-20 0001178727 us-gaap:WarrantMember 2015-11-01 2015-11-20 0001178727 2015-10-01 2015-12-31 0001178727 us-gaap:SeriesAPreferredStockMember 2015-10-01 2015-12-31 0001178727 us-gaap:SeriesCPreferredStockMember 2015-10-01 2015-12-31 0001178727 us-gaap:SeriesEPreferredStockMember 2015-10-01 2015-12-31 0001178727 us-gaap:SeriesDPreferredStockMember 2015-10-01 2015-12-31 0001178727 us-gaap:SeriesBPreferredStockMember 2015-10-01 2015-12-31 0001178727 us-gaap:SeriesFPreferredStockMember 2015-10-01 2015-12-31 0001178727 us-gaap:SeriesGPreferredStockMember 2015-10-01 2015-12-31 0001178727 2015-01-01 2015-12-31 0001178727 us-gaap:CommonStockMember 2015-01-01 2015-12-31 0001178727 us-gaap:SeriesAPreferredStockMember 2015-01-01 2015-12-31 0001178727 us-gaap:SeriesBPreferredStockMember 2015-01-01 2015-12-31 0001178727 us-gaap:SeriesCPreferredStockMember 2015-01-01 2015-12-31 0001178727 us-gaap:SeriesDPreferredStockMember 2015-01-01 2015-12-31 0001178727 us-gaap:SeriesEPreferredStockMember 2015-01-01 2015-12-31 0001178727 us-gaap:SeriesFPreferredStockMember 2015-01-01 2015-12-31 0001178727 us-gaap:CommonStockMember us-gaap:PredecessorMember 2015-01-01 2015-12-31 0001178727 us-gaap:AdditionalPaidInCapitalMember us-gaap:PredecessorMember 2015-01-01 2015-12-31 0001178727 us-gaap:RetainedEarningsMember us-gaap:PredecessorMember 2015-01-01 2015-12-31 0001178727 drne:SeriesBOnePreferredStockMember 2015-01-01 2015-12-31 0001178727 us-gaap:WarrantMember 2015-01-01 2015-12-31 0001178727 us-gaap:EmployeeStockOptionMember 2015-01-01 2015-12-31 0001178727 us-gaap:PrivatePlacementMember 2015-01-01 2015-12-31 0001178727 us-gaap:NoteWarrantMember 2015-01-01 2015-12-31 0001178727 us-gaap:MinimumMember us-gaap:EmployeeStockOptionMember 2015-01-01 2015-12-31 0001178727 us-gaap:MaximumMember us-gaap:EmployeeStockOptionMember 2015-01-01 2015-12-31 0001178727 us-gaap:CommonStockMember drne:DroneAviationCorpMember 2015-01-01 2015-12-31 0001178727 us-gaap:SeriesAPreferredStockMember 2015-01-01 2015-12-31 0001178727 drne:StrategicAdvisoryBoardMembersMember 2015-01-01 2015-12-31 0001178727 us-gaap:AccountsReceivableMember 2015-01-01 2015-12-31 0001178727 us-gaap:SalesRevenueNetMember 2015-01-01 2015-12-31 0001178727 us-gaap:SeriesGPreferredStockMember 2015-01-01 2015-12-31 0001178727 drne:GeorgiaTechUavSimulationToolMember 2015-01-01 2015-12-31 0001178727 drne:StockAwardAgreementsMember 2015-01-01 2015-12-31 0001178727 drne:EmployeesandDirectorMember 2015-01-01 2015-12-31 0001178727 us-gaap:CustomerListsMember 2015-01-01 2015-12-31 0001178727 drne:EndexxCorporationMember 2015-01-01 2015-12-31 0001178727 us-gaap:OfficeEquipmentMember us-gaap:MinimumMember 2015-01-01 2015-12-31 0001178727 us-gaap:OfficeEquipmentMember us-gaap:MaximumMember 2015-01-01 2015-12-31 0001178727 us-gaap:FurnitureAndFixturesMember us-gaap:MinimumMember 2015-01-01 2015-12-31 0001178727 us-gaap:FurnitureAndFixturesMember us-gaap:MaximumMember 2015-01-01 2015-12-31 0001178727 drne:HardwareAndSoftwareMember us-gaap:MinimumMember 2015-01-01 2015-12-31 0001178727 drne:HardwareAndSoftwareMember us-gaap:MaximumMember 2015-01-01 2015-12-31 0001178727 us-gaap:SeriesEPreferredStockMember us-gaap:PrivatePlacementMember 2015-01-01 2015-12-31 0001178727 us-gaap:SeriesFPreferredStockMember us-gaap:PrivatePlacementMember 2015-01-01 2015-12-31 0001178727 us-gaap:SeriesGPreferredStockMember us-gaap:PrivatePlacementMember 2015-01-01 2015-12-31 0001178727 us-gaap:MaximumMember us-gaap:NoteWarrantMember 2015-01-01 2015-12-31 0001178727 us-gaap:MinimumMember us-gaap:NoteWarrantMember 2015-01-01 2015-12-31 0001178727 us-gaap:DirectorMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2015-01-01 2015-12-31 0001178727 us-gaap:DirectorMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2015-01-01 2015-12-31 0001178727 us-gaap:DirectorMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2015-01-01 2015-12-31 0001178727 drne:EmployeesandDirectorMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2015-01-01 2015-12-31 0001178727 drne:EmployeesandDirectorMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2015-01-01 2015-12-31 0001178727 drne:EmployeesandDirectorMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2015-01-01 2015-12-31 0001178727 us-gaap:WarrantMember drne:ConsultantOneMember 2015-01-01 2015-12-31 0001178727 us-gaap:WarrantMember drne:ConsultantMember 2015-01-01 2015-12-31 0001178727 us-gaap:WarrantMember drne:VendorMember 2015-01-01 2015-12-31 0001178727 us-gaap:WarrantMember drne:ConsultantTwoMember 2015-01-01 2015-12-31 0001178727 2015-12-31 0001178727 us-gaap:CommonStockMember 2015-12-31 0001178727 us-gaap:SeriesAPreferredStockMember 2015-12-31 0001178727 us-gaap:SeriesBPreferredStockMember 2015-12-31 0001178727 us-gaap:SeriesCPreferredStockMember 2015-12-31 0001178727 us-gaap:SeriesDPreferredStockMember 2015-12-31 0001178727 us-gaap:SeriesEPreferredStockMember 2015-12-31 0001178727 us-gaap:SeriesFPreferredStockMember 2015-12-31 0001178727 us-gaap:SeriesAPreferredStockMember us-gaap:PredecessorMember 2015-12-31 0001178727 us-gaap:SeriesBPreferredStockMember us-gaap:PredecessorMember 2015-12-31 0001178727 drne:SeriesBOnePreferredStockMember us-gaap:PredecessorMember 2015-12-31 0001178727 us-gaap:SeriesCPreferredStockMember us-gaap:PredecessorMember 2015-12-31 0001178727 us-gaap:SeriesDPreferredStockMember us-gaap:PredecessorMember 2015-12-31 0001178727 us-gaap:SeriesEPreferredStockMember us-gaap:PredecessorMember 2015-12-31 0001178727 us-gaap:SeriesFPreferredStockMember us-gaap:PredecessorMember 2015-12-31 0001178727 us-gaap:SeriesGPreferredStockMember us-gaap:PredecessorMember 2015-12-31 0001178727 us-gaap:CommonStockMember us-gaap:PredecessorMember 2015-12-31 0001178727 us-gaap:AdditionalPaidInCapitalMember us-gaap:PredecessorMember 2015-12-31 0001178727 us-gaap:RetainedEarningsMember us-gaap:PredecessorMember 2015-12-31 0001178727 drne:MacrosolveIncMember 2015-12-31 0001178727 drne:SeriesBOnePreferredStockMember 2015-12-31 0001178727 us-gaap:EmployeeStockOptionMember 2015-12-31 0001178727 drne:LighterThanAirSystemsMember 2015-12-31 0001178727 drne:DroneAviationCorpMember 2015-12-31 0001178727 us-gaap:NoteWarrantMember 2015-12-31 0001178727 us-gaap:SeriesAPreferredStockMember 2015-12-31 0001178727 us-gaap:SeriesCPreferredStockMember 2015-12-31 0001178727 us-gaap:SeriesEPreferredStockMember 2015-12-31 0001178727 us-gaap:SeriesGPreferredStockMember 2015-12-31 0001178727 us-gaap:SeriesDPreferredStockMember 2015-12-31 0001178727 drne:GeorgiaTechUavSimulationToolMember 2015-12-31 0001178727 us-gaap:SeriesBPreferredStockMember 2015-12-31 0001178727 us-gaap:CommonStockMember 2015-12-31 0001178727 us-gaap:SeriesFPreferredStockMember 2015-12-31 0001178727 us-gaap:SeriesGPreferredStockMember 2015-12-31 0001178727 2016-03-04 0001178727 us-gaap:SubsequentEventMember us-gaap:CommonStockMember 2016-01-01 2016-03-04 0001178727 us-gaap:SeriesAPreferredStockMember us-gaap:SubsequentEventMember us-gaap:CommonStockMember 2016-01-01 2016-03-04 0001178727 us-gaap:SeriesCPreferredStockMember us-gaap:SubsequentEventMember us-gaap:CommonStockMember 2016-01-01 2016-03-04 0001178727 us-gaap:SeriesDPreferredStockMember us-gaap:SubsequentEventMember us-gaap:CommonStockMember 2016-01-01 2016-03-04 0001178727 us-gaap:SeriesFPreferredStockMember us-gaap:SubsequentEventMember us-gaap:CommonStockMember 2016-01-01 2016-03-04 0001178727 drne:SeriesFPreferredStockOneMember us-gaap:SubsequentEventMember us-gaap:CommonStockMember 2016-01-01 2016-03-04 iso4217:USD xbrli:shares iso4217:USDxbrli:shares xbrli:pure drne:Firms iso4217:USDxbrli:pure utr:sqft DRONE AVIATION HOLDING CORP. 0001178727 drne false --12-31 10-K 2015-12-31 2015 FY No Yes No Smaller Reporting Company 18981.074 5461553 1369896 2659734 30170 83288 39404 118795 50169 55624 1489639 2917441 34064 163291 7040 26995 27024 136296 99799 99799 103609 1460000 203408 1559799 1720071 4613536 64383 242257 2181 6000 7896 110000 110000 176564 366153 176564 366153 40 32 35 3605 540 330 7 10 7 200 200 200 93 513 3702233 15385523 -2163408 -11139270 -19474 1543507 3708 40 32 35 3605 270 330 40 32 7 35 3605 540 330 93 3702233 -2163408 4247383 40 35 3605 330 200 513 15385523 -11139270 1720071 4613536 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 595000 324671 355000 36050000 5400000 3300999 156231 8000000 595000 324671 355000 36050000 5400000 3300999 156231 8000000 595000 324671 156231 1100333 396750 324671 345400 36050000 5400000 3300999 68731 0 2200666 101100 0 73387 2000000 0 1999998 0 2000000 595000 324671 156231 355000 396750 324671 345400 36050000 5400000 3300999 68731 0 101100 0 73387 2000000 0 1999998 0 2000000 0.0001 0.0001 300000000 300000000 3920700 198219132 44100000 926953 5125585 98017 1102500 4198632 3920700 198219132 3920700 44100000 926953 5125585 98017 98017 1102500 858054 472159 675253 282753 182801 189406 1904793 9163556 -1721992 -8974150 21635 -3686 -42821 350969 5571 235 192 2372 1904 -401498 -1712 39918 -2123490 -2123490 -8975862 -8975862 192558 -80000 192558 80000 -192558 -2316048 -9055862 394683 2034421 -5.87 -4.45 68731 37078114 396750 324671 345400 36050000 2700000 3300999 396750 324671 68731 345400 36050000 5400000 3300999 926953 396750 345400 36050000 3300999 2000000 5125585 -39918 -39918 653327 2605 20 650702 26050000 201250 745000 745000 335968 2500 183468 50000 50000 50000 335000 79000 1000 78000 10000000 34100000 10000000 -367622 60 32 36 540 10 -368316 16 595000 324671 355000 5400000 98018 156231 17000 4 16996 42500 822750 822750 330 822420 3300999 -350000 -349991 -9 -87500 17000 215000 17000 341667 6 341661 25 -25 42500 6250 42500 56250 252525 1 -1 9310 2510793 2510793 192558 192558 -192558 -192558 -20 50 -30 -30 74 -44 -198250 495625 -295650 739125 -1 2 -1 -28 68 -40 -9600 24000 -272013 680033 1 -32 31 8117 -324671 5 2 -7 55000 -68731 -3405 85 3320 -34050000 851250 -540 14 526 -5400000 135000 -130 3 127 -1301001 32525 5 195 -200 50000 -2000000 1000000 999600 400 4000000 80000 80000 -80000 -80000 3484750 75 3484675 745000 25 -25 252525 213333 213333 2575260 50 2575210 500000 3146395 3146395 1260000 15 1259985 150000 18589 2477 19955 31941 37935 103609 341667 5934988 2417760 -104880 53118 -70177 97980 11385 5455 -132363 177874 -20027 -3819 7896 -1302279 -2865685 304639 1692896 168704 200000 27863 129227 1529098 -329227 653327 3484750 17000 350000 1143077 4484750 1369896 1289838 2371 1904 5571 159 1260000 50 74 1 5 2 68 85 14 3 5 25 1 2510793 2510793 -2060518 192558 80000 79000 <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0px; margin-bottom: 0px; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>1.</b></font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b><u>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</u></b></font></td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Description of Business:</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Drone Aviation Holding Corp. (&#8220;Drone&#8221; or &#8220;Company&#8221;) develops and manufactures cost-effective, compact and rapidly deployable aerial platforms including lighter-than-air aerostats and electric-powered drones designed to provide government and commercial customers with enhanced surveillance and communication capabilities. Utilizing a proprietary tether system, the Company's products are designed to provide prolonged operational duration capabilities combined with improved reliability, uniquely fulfilling critical requirements in military, law enforcement and commercial and industrial applications.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Basis of Presentation:</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 4.5pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The accompanying financial statements of the Company were prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;).</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Principal of Consolidation:</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Our consolidated financial statements as of December 31, 2015 include the accounts of Drone Aviation Holding Corp. and its subsidiaries: Drone AFS Corp. and Lighter Than Air Systems Corp. Our consolidated financial statements as of December 31, 2014 include the accounts of Drone Aviation Holding Corp. and its subsidiaries: Drone Aviation Corp. and Lighter Than Air Systems Corp.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Reclassifications:</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Certain prior year amounts have been combined and reclassified to conform to the current year presentation.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Use of Estimates:</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Actual results could differ from those estimates.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Concentration of Credit Risk:</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Financial instruments which potentially subject the Company to concentrations of credit risk consist of cash and trade receivables. The Company places its cash with high credit quality financial institutions. At times such cash may be in excess of the FDIC limit. With respect to trade receivables, the Company routinely assesses the financial strength of its customers and, as a consequence, believes that the receivable credit risk exposure is limited.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Cash Equivalents:</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Cash equivalents are represented by operating accounts or money market accounts maintained with insured financial institutions, including all highly-liquid investments with maturities of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2015 and 2014.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Accounts Receivable and Credit Policies:</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Trade accounts receivable consist of amounts due from the sale of tethered aerostats, accessories, spare parts and delivery and installation of aerostats.&#160;&#160;Accounts receivable are uncollateralized customer obligations due under normal trade terms requiring payment within 30 days of receipt of the invoice.&#160;&#160;The Company provides an allowance for doubtful accounts equal to the estimated uncollectible amounts based on historical collection experience and a review of the current status of trade accounts receivable.&#160;&#160;At December 31, 2015 and 2014, the Company characterized $0 and $0 as uncollectible, respectively.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Marketable Securities:</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">All marketable securities are classified as available-for-sale securities. Available-for-sale securities are carried at fair value with resulting unrealized gains and losses, reported as a component of accumulated other comprehensive loss. The Company did not have any available-for-sale securities at December 31, 2015.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Inventories</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Inventories are stated at the lower of cost or market, using the first-in first-out method. Cost includes materials, labor and manufacturing overhead related to the purchase and production of inventories. We regularly review inventory quantities on hand, future purchase commitments with our supplies, and the estimated utility of our inventory. If the review indicates a reduction in utility below carrying value, we reduce our inventory to a new cost basis through a charge to cost of goods sold.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Property and Equipment:</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Property and equipment is recorded at cost when acquired.&#160;&#160;Depreciation is provided principally on the straight-line method over the estimated useful lives of the related assets, which is 3-7 years for equipment, furniture and fixtures, hardware and software.&#160;&#160;&#160;Property and equipment consists of the following at December 31, 2015 and 2014:</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"> <p style="font: 10pt/normal 'times new roman', times, serif; margin-top: 0px; margin-bottom: 0px; font-stretch: normal;"></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin-top: 0px; margin-bottom: 0px; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> </td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2015</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2014</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"> <td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Shop Machinery and equipment</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">80,889</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">19,954</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Computers and electronics</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">28,911</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">12,075</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Office furniture and fixtures</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">33,977</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2,035</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Leasehold improvements</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">19,514</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">-</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">163,291</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">34,064</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Less - accumulated depreciation</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">(26,995</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">)</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">(7,040</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">)</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">136,296</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">27,024</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Expenditures for maintenance and repairs are charged to expense as incurred, whereas expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">During the year ended December 31, 2015 and 2014, the Company purchased $129,227 and $27,863 of furniture and equipment, respectively.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company recognized $19,955 and $2,477 of depreciation expense for the year ended December 31, 2015 and 2014, respectively,</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Long-Lived Assets &amp; Goodwill:</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company accounts for long-lived assets in accordance with the provisions of ASC 360-10-35, &#8220;Impairment or Disposal of Long-lived Assets&#8221;.&#160;&#160;This Statement requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.&#160;&#160;Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset.&#160;&#160;If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.&#160;&#160;The Company acquired the LTAS customer list in 2014. The fair value of the customer list was determined by using a discounted cash flow model and $135,550 was recorded on the date of business combination. The Company recorded $31,941 of amortization expense for the year ended December 31, 2014 leaving a remaining carrying amount of $103,609. The Company recorded another $37,935 amortization expense for the year ended December 31, 2015. After comparing the acquired customer list to the actual customers who placed orders following the acquisition of LTAS, the Company determined that the customer list was impaired at December 31, 2015 and amortized the remaining balance of $65,674 in 2015.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company accounts for goodwill and intangible assets in accordance with ASC 350 "Intangibles Goodwill and Other". ASC 350 requires that goodwill and other intangibles with indefinite lives be tested for impairment annually or on an interim basis if events or circumstances indicate that the fair value of an asset has decreased below its carrying value. The Company performed impairment analysis using the qualitative analysis under ASC 350-20 and noted no impairment issues for 2015.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Derivative Financial Instruments:</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes option pricing model, in accordance with ASC 815-15 &#8220;Derivative and Hedging&#8221; to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Beneficial Conversion Features:</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company evaluates the embedded conversion feature within its convertible debt instruments under ASC 815-15 and ASC 815-40 to determine if the conversion feature meets the definition of a liability and therefore need to bifurcate the conversion feature and account for it as a separate derivative liability.&#160;<font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The intrinsic value of a beneficial conversion feature inherent to a convertible note payable, which is not bifurcated and accounted for separately from the convertible note payable and may not be settled in cash upon conversion, is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual term, the unamortized discount is expensed in the period of retirement to interest expense. In general, the beneficial conversion feature is measured by comparing the effective conversion price, after considering the relative fair value of detachable instruments included in the financing transaction, if any, to the fair value of the common shares at the commitment date to be received upon conversion.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Fair Value of Financial Instruments:</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company measures its financial assets and liabilities in accordance with the requirements of FASB ASC 820, &#8220;Fair Value Measurements and Disclosures&#8221;. ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Level 1&#8211; Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Level 2 &#8211; Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Level 3 &#8211; Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management&#8217;s best estimate of fair value.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 13.5pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Revenue Recognition and Unearned Revenue:</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company recognizes revenue when all four of the following criteria are met: 1) persuasive evidence of an arrangement exists; 2) delivery has occurred and title has transferred or services have been rendered; 3) our price to the buyer is fixed or determinable; and 4) collectability is reasonably assured. We record unearned revenue as a liability and their associated costs of sales as work in process inventory. In 2015, the Company deferred recognizing $7,896 in revenue from a 2015 sale that was delivered in January 2016. There is a balance of $83,288 in accounts receivable at December 31, 2015 for sales on account.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; color: #000000; text-transform: none; text-indent: -18pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Income Taxes:</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company accounts for income taxes utilizing ASC 740, &#8220;Income Taxes&#8221; (SFAS No. 109).&#160;&#160;ASC 740 requires the measurement of deferred tax assets for deductible temporary differences and operating loss carry forwards, and of deferred tax liabilities for taxable temporary differences.&#160;&#160;Measurement of current and deferred tax liabilities and assets is based on provisions of enacted tax law.&#160;&#160;The effects of future changes in tax laws or rates are not included in the measurement.&#160;&#160;The Company recognizes the amount of taxes payable or refundable for the current year and recognizes deferred tax liabilities and assets for the expected future tax consequences of events and transactions that have been recognized in the Company&#8217;s financial statements or tax returns.&#160;&#160;The Company has recorded a 100% valuation allowance against net deferred tax assets due to uncertainty of their ultimate realization.&#160;&#160;Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; color: #000000; text-transform: none; text-indent: -18pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Employee Stock-Based Compensation:</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company accounts for stock-based compensation in accordance with ASC 718, &#8220;Compensation-Stock Compensation&#8221;. ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Non-Employee Stock-Based Compensation:</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company accounts for stock-based compensation in accordance with the provision of ASC 505, &#8220;Equity Based Payments to Non-Employees&#8221; (&#8220;ASC 505&#8221;), which requires that such equity instruments are recorded at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instruments vest.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Related Parties:</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The accounts payable due to related party at December 31, 2015 was comprised of $6,000 director fees which were paid in January 2016. The accounts payable due to related party at December 31, 2014, includes allocated rent and utility charges, aerostat envelopes, truck expenses and labor charges due Aerial Products Corp (&#8220;APC&#8221;) was $2,181. APC is a related party, controlled by a current employee of the Company. APC shared the manufacturing facilities with LTAS and provided aerostat envelopes and manufacturing labor to LTAS until June 30, 2014 when the APC labor pool transitioned to the Company. Total charges from APC to LTAS during the years ended December 31, 2015 and 2014 were $7,549 and $19,242 respectively. Additionally, the Company purchased used fixed assets from APC for $6,500 during the year ended December 31, 2015.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 13.5pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Earnings or Loss per Share:</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company accounts for earnings per share pursuant to ASC 260, Earnings per Share, which requires disclosure on the financial statements of "basic" and "diluted" earnings (loss) per share. Basic earnings (loss) per share are computed by dividing net income (loss) by the weighted average number of common shares outstanding for the year. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding plus common stock equivalents (if dilutive) related to stock options and warrants for each year. As there was a net loss for the years ended December 31, 2015 and 2014, basic and diluted losses per share are the same for both years.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Recent Accounting Pronouncements</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company's financial statements.</font></p> <div><table style="font: 10pt/normal 'times new roman', times, serif; width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0px; margin-bottom: 0px; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 0.5in;"><font style="letter-spacing: -0.1pt;"><b>2.</b></font></td><td style="text-align: justify;"><font style="letter-spacing: -0.1pt;"><b><u>MERGER BETWEEN MACROSOLVE, INC. AND DRONE AVIATION HOLDING CORP</u></b></font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;"><b>&#160;</b></font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">On April 14, 2014, holders of the majority of MacroSolve, Inc. (&#8220;MacroSolve) common stock approved a plan of merger whereby MacroSolve would merge with Drone Aviation Holding Corp., its newly created wholly-owned Nevada subsidiary, for the purpose of changing the Company&#8217;s state of domicile from Oklahoma to Nevada (the &#8220;Redomestication&#8221;). Pursuant to the Redomestication, each of MacroSolve&#8217;s shareholders received one share of common stock, par value $0.0001 per share of Drone Aviation Holding Corp. for every 50.56186 shares of MacroSolve&#8217;s common stock held by them (the Merger Exchange Rate). The Redomestication was effective on April 30, 2014. All per share amounts referenced herein give effect to the Merger Exchange Rate.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Prior to the Redomestication, MacroSolve had 198,219,132 shares of common stock issued and outstanding. Subsequent to the Redomestication, as a result of the Merger Exchange Ratio described above, the Company had approximately 3,920,700 [98,017 on a post-reverse basis] shares of common stock issued and outstanding on April 30, 2014.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;">On April 30, 2014 as a result of the Redomestication, MacroSolve&#8217;s outstanding shares of Series C, D and D-1 preferred stock were exchanged for shares of the post-Redomestication Company&#8217;s shares of Series A, B and B-1 preferred stock, with 595,000 shares, 324,671 shares and 156,231 shares issued respectively.</p></div> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0px; margin-bottom: 0px; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>3.</b></font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b><u>DRONE AVIATION CORP AQUISITION OF LIGHTER THAN AIR SYSTEMS</u></b></font></td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">On March 31, 2014, DAC was incorporated in the state of Nevada. During April and May 2014, investors purchased 34,100,000 shares of DAC common stock for an aggregate purchase price of $653,327. On May 5, 2014, DAC entered into a securities exchange agreement with World Surveillance Group, Inc. (WSGI) to acquire 100% of WSGI&#8217;s interest in its subsidiary, Lighter Than Air Systems (LTAS). LTAS provides critical aerial and land-based surveillance and communications solutions to government and commercial customers. DAC paid $335,000 and issued 10,000,000 shares of its common stock valued at the market price on the date of issuance, and the fair value of the shares was determined to be $79,000, or a total of $414,000, to WSGI as consideration for LTAS. Since DAC acquired cash of $30,361 from LTAS, as shown in the following table, the net cash amount DAC paid is $304,639.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">In accordance with ASC 805-10 Business Combination and purchase acquisition accounting, DAC initially allocated the consideration to the net tangible and identifiable intangible assets, based on their estimated fair values as of the date of acquisition. Goodwill represents the excess of the purchase price over the fair value of the underlying net tangible and intangible assets. The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"> <td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Property and equipment</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">1,638</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Accounts receivable</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">135,050</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Cash in bank</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">30,361</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Due from related party</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">20,650</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Prepaid expenses</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">1,381</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Inventory</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">109,581</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Intangible asset</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">135,550</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Current liabilities</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">(120,010</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">)</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Goodwill</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">99,799</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Total purchase price</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">414,000</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Intangible asset is in relation to the acquired customer list with a useful life of five years. The fair value of the customer list was determined by using a discounted cash flow model and $135,550 was recorded on the date of business combination. The Company recorded $31,941 of amortization expense for the year ended December 31, 2014. The Company recorded another $37,935 amortization expense for the year ended December 31, 2015. After comparing the acquired customer list to the actual customers who placed orders following the acquisition of LTAS, the Company determined that the customer list was impaired at December 31, 2015 and amortized the remaining balance of $65,674 in 2015.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The consolidated financial statements included herein are presented for the period from January 1, 2014 to May 5, 2014 since LTAS is considered Drone&#8217;s predecessor. LTAS has a net loss of $39,918 during the period from January 1, 2014 to May 5, 2014.</font></p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; text-align: justify; text-indent: 0pt; padding-right: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>4.</b></font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: 0pt; padding-right: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b><u>DRONE AVIATION HOLDING CORP. AND DRONE AVIATION CORP. SECURITIES EXCHANGE, REVERSE MERGER AND RECAPITALIZATION</u></b></font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: -4.5pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">On June 3, 2014, the Company entered into a Securities Exchange Agreement with Drone Aviation Corp. (DAC).&#160;&#160;Upon closing of the transaction, the holders of 100% of DAC&#8217;s outstanding common stock transferred such 44,100,000 outstanding shares to the Company in exchange for an aggregate of 8,050,000 [201,250 post-reverse] shares of the Company&#8217;s common stock and 36,050,000 shares of the Company&#8217;s Series D Preferred Stock, or a total of 44,100,000 [1,102,500 post-reverse] shares of common stock and common stock equivalents of the Company. Pursuant to the terms of the Securities Exchange Agreement, certain shareholders of DAC who, as a result of receiving the shares of common stock would hold in excess of 3.33% of the Company&#8217;s issued and outstanding common stock on a post-closing basis, elected to receive shares of the Company&#8217;s Series D Preferred Stock.&#160;At the closing of the transaction, the Company had 3,920,700 [98,017 post-reverse] shares of common stock outstanding, 595,000 shares of Series A Preferred Stock outstanding, 324,671 shares of Series B Preferred Stock outstanding, 156,231 shares of Series B-1 Preferred Stock outstanding and 355,000 shares of Series C Preferred Stock&#160;outstanding.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">As a result of the Securities Exchange described above, DAC and its subsidiary, LTAS, became our wholly owned subsidiaries.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">For accounting purposes, this transaction is being accounted for as a reverse merger and has been treated as a recapitalization of Drone Aviation Holding Corp. with Drone Aviation Corp. considered the accounting acquirer, and the financial statements of the accounting acquirer became the financial statements of the registrant. The 44,100,000 [1,102,500 post-reverse] shares issued to shareholders of DAC and its designees in conjunction with the securities exchange transaction have been presented as outstanding for all periods. The historical consolidated financial statements include the operations of the accounting acquirer for all periods presented.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">On June 3, 2014, the assets and liabilities of Drone Aviation Holding Corp. carried onto the books were:</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; padding-left: 0pt; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Cash in bank</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">1,692,896</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Available-for-sale securities</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">211,525</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Prepaid expenses</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">37,403</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Current liabilities</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; font-stretch: normal;">(<font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">39,622</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;">)<font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Derivative liabilities</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; font-stretch: normal;">(<font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2,159,824</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;">)</td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Note payable</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">(<font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">110,000</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;">)<font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Total</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">367,622</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; text-align: justify; color: #000000; text-transform: none; text-indent: -13.5pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0pt 0px 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">On March 26, 2015 Drone Aviation Corp. merged into Drone Aviation Holding Corp.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0pt 0px 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><i>&#160;</i></font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><i>Series E Preferred Private Placement</i></font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0pt 0px 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">On June 3, 2014, prior to the reverse merger, the Company sold an aggregate of 2,700,000 units in a private placement of its securities to certain investors at a purchase price of $0.50 per unit pursuant to subscription for an aggregate purchase price of $1,350,000. Each unit consists of one share of the Company&#8217;s Series E Convertible Preferred Stock, par value $0.0001 per share, each of which is convertible into one-fortieth share, on a post-reverse split basis, of Common Stock, with such rights and designations as set forth in the Certificate of Designation; and a three year warrant to purchase one share of Common Stock at an exercise price of $40.00 per share. All the warrants were exercised on August 26, 2014. On June 2, 2015, the holders of Series E received an additional 2,700,000 units due to the Most Favored Nations provision associated with their initial investment.</font></p> <table style="font: 10pt/normal times new roman, times, serif; width: 100%; margin-top: 0px; margin-bottom: 0px; font-size-adjust: none; font-stretch: normal;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal times new roman, times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"><td style="font: 10pt/normal times new roman, times, serif; width: 0.25in; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal times new roman, times, serif; font-size-adjust: none; font-stretch: normal;"><b>5.</b></font></td><td style="font: 10pt/normal times new roman, times, serif; text-align: justify; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal times new roman, times, serif; font-size-adjust: none; font-stretch: normal;"><b><u>DRONE AVIATION HOLDING CORP ASSET ACQUISITION OF ADAPTIVE, FLIGHT, INC. </u></b></font></td></tr></table><p style="font: 10pt/normal times new roman, times, serif; margin: 0px 0px 0px 18pt; text-align: justify; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal times new roman, times, serif; font-size-adjust: none; font-stretch: normal;"><b>&#160;</b></font></p><p style="font: 10pt/normal times new roman, times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; font-size-adjust: none; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal times new roman, times, serif; font-size-adjust: none; font-stretch: normal;">On July 20, 2015, the Company, through its wholly-owned subsidiary Drone AFS Corp., purchased substantially all the assets of Adaptive Flight, Inc. (AFI), a Georgia corporation. The Company purchased assets including but not limited to intellectual property and licenses and permits, including commercial software licenses for the &#8220;GUST&#8221; (Georgia Tech UAV Simulation Tool) autopilot system, and other transferable licenses which include flight simulation and fault tolerant flight control algorithms. The Company paid $100,000 in immediately available funds and $100,000 to be held in escrow. In addition, the Company issued 150,000 shares of unregistered common stock valued at $8.40 per share, on a post-reverse split basis, on the date of agreement, to be held in escrow. </font></p><p style="font: 10pt/normal times new roman, times, serif; margin: 0px 0pt 0px 0.25in; text-align: justify; font-size-adjust: none; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal times new roman, times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal times new roman, times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; font-size-adjust: none; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal times new roman, times, serif; font-size-adjust: none; font-stretch: normal;">The Company has a milestone of twelve months to complete a technology Integration Plan, the non-completion of which may result in the return of the purchased assets and termination of the Company&#8217;s obligations to release the escrow cash and shares. Additional milestones include exclusive, no-cost and perpetual licenses to all contributing intellectual property included or related to the purchased assets. As such time as all milestones are met, one-half of the escrow shares will be released to AFI. Upon termination of the escrow agreement, anticipated to be twelve months from the closing of the asset purchase, if all milestones have been met, the remaining escrow shares will be released to AFI; but if all milestones have not been met, the escrow cash and escrow shares will be released to the Company and the purchased assets will be returned to AFI. According to the terms of the Escrow Agreement, if the escrow share value is less than $1,400,000, the Company must issue an additional number of unregistered shares, not to exceed 50,000 shares. At December 31, 2015, the value of the 150,000 shares was $3.23 per share, or $484,500. The Company recorded $161,500 as an additional liability and expense at December 31, 2015 for the cost of 50,000 shares at $3.23 per share. The liability will be reevaluated at the end of each quarter and adjusted through the profit and loss statement as necessary.</font></p><p style="font: 10pt/normal times new roman, times, serif; margin: 0px 0pt 0px 0.25in; text-align: justify; font-size-adjust: none; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal times new roman, times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal times new roman, times, serif; margin: 0px 0pt 0px 0.25in; text-align: justify; font-size-adjust: none; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal times new roman, times, serif; font-size-adjust: none; font-stretch: normal;">The asset acquisition did not qualify as a business combination under ASC 805-10 and has been accounted for as a regular asset purchase.</font></p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; text-align: justify; text-indent: 0pt; padding-right: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>6.</b></font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: 0pt; padding-right: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b><u>SHAREHOLDERS&#8217; EQUITY</u><strike></strike></b></font></td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">On October 29, 2015 a 1:40 the Company effected a 1-for-40 reverse split of its common stock. The reverse split has been applied retroactively for disclosure purposes.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>For the year ended December 31, 2015</b></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company issued a total of 4,198,632 common shares during the 2015, adjusted for the October 29, 2015 1:40 reverse split, described further as follows:</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company issued 215,750 shares of common stock between January 1 and March 31, 2015 pursuant to conversions of an aggregate of 86,300 shares of Series A preferred stock.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company issued 200,573 shares of common stock between April 1 and June 30, 2015 pursuant to conversions of an aggregate of 80,229 shares of Series A preferred stock.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company issued 25,500 shares of common stock between July 1 and September 30, 2015 pursuant to conversions of an aggregate of 10,200 shares of Series A preferred stock.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company issued 297,302 shares of common stock between October 1 and December 31, 2015 pursuant to conversions of an aggregate of 118,921 shares of Series A preferred stock.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company issued 1 share of common stock between July 1 and September 30, 2015 pursuant to conversions of an aggregate of 20 shares of Series B preferred stock.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company issued 8,116 shares of common stock between October 1 and December 31, 2015 pursuant to conversions of an aggregate of 324,651 shares of Series B preferred stock.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company issued 50,000 shares of common stock between April 1 and June 30, 2015 pursuant to conversions of an aggregate of 20,000 shares of Series C preferred stock.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company issued 25,000 shares of common stock between July 1 and September 30, 2015 pursuant to conversions of an aggregate of 10,000 shares of Series C preferred stock.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company issued 605,033 shares of common stock between October 1 and December 31, 2015 pursuant to conversions of an aggregate of 242,013 shares of Series C preferred stock.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company issued 210,000 shares of common stock between April 1 and June 30, 2015 pursuant to conversions of an aggregate of 8,400,000 shares of Series D preferred stock.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company issued 140,000 shares of common stock between July 1 and September 30, 2015 pursuant to conversions of an aggregate of 5,600,000 shares of Series D preferred stock.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company issued 501,250 shares of common stock between October 1 and December 31, 2015 pursuant to conversions of an aggregate of 20,050,000 shares of Series D preferred stock.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company issued 50,000 shares of common stock between July 1 and September 30, 2015 pursuant to conversions of an aggregate of 2,000,000 shares of Series E preferred stock.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company issued 85,000 shares of common stock between October 1 and December 31, 2015 pursuant to conversions of an aggregate of 3,400,000 shares of Series E preferred stock.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company issued 32,525 shares of common stock between October 1 and December 31, 2015 pursuant to conversions of an aggregate of 1,301,000 shares of Series F preferred stock</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company issued 50,000 shares of common stock between October 1 and December 31, 2015 pursuant to conversions of an aggregate of 2,000,000 shares of Series G preferred stock</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">On June 1, 2015, the Company issued 50,000 shares of restricted common stock with monthly vesting provisions to the Chairman of the Board for twenty-four months services pursuant to a Director Agreement. The Chairman can earn a pro rata portion of the shares, calculated on a twenty-four month vesting period, in the event the Chairman relinquishes his position and board seat prior to the expiration date of the Director Agreement. The Company recognized a total of $157,500 expense for the pro rata portion of shares earned by the Chairman during 2015.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">On August 27, 2014, the Company issued 50,000 shares of restricted common stock with monthly vesting provisions to two members of its Strategic Advisory Board for twelve months services. The advisors can earn a pro rata portion of the shares, calculated based on the twelve-month vesting period, in the event the service agreements are terminated prior to the expiration date as described in the agreements. The Company recognized a total of $213,333 expense for the pro rata portion of shares earned by the two advisors during 2015 and has recognized a total of $340,000 since August 27, 2014. The shares became fully vested on August 27, 2015.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">On July 20, 2015, the Company issued 150,000 shares of restricted common stock valued at $1,260,000 to acquire assets from Adaptive Flight, Inc. as described above.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">On September 4, 2015, the Company issued 450,000 shares of restricted common stock to four management employees and one director pursuant to stock award agreements. The shares will vest upon consummation of a $4,000,000 equity or debt financing provided that the holder remains engaged by the Company through the vesting date. Stock based compensation of $2,417,760 was recognized in 2015 based on management&#8217;s estimate that the shares will be fully vested by February 4, 2016 when the Board deemed vesting occurred with the issuance of $4,000,000 in common stock on November 20, 2015.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">On November 17 and 19, 2015, the Company sold an aggregate of 745,000 shares of restricted common stock for a purchase price of $5.00 per share in a Private Placement for cash proceeds of $3,484,750 net of $240,250 financing fees. In connection with this sale, the Company issued an aggregate of 70,000 additional shares of common stock to holders of Series E preferred stock pursuant to the &#8216;most favored nations&#8217; provisions governing the Series E preferred stock. Additionally, pursuant to the terms of the Series F preferred stock and Series G preferred stock, the Company was required to obtain consent to issue securities at a per share purchase price less than the purchase price of the Series F and Series G. In consideration for the consents, the company issued an aggregate of 182,525 shares of restricted common stock to the holders of Series F and Series G preferred stock.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">On November 20, 2015, the Company entered into an Exchange Agreement with the holder of its outstanding shares of Series B-1 preferred stock pursuant to which the holder exchanged 68,731 shares of Series B-1 preferred stock for 55,000 shares of restricted common stock.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">On October 29, 2015, the Company issued an aggregate of 57 restricted shares to various investors due to round factors associated with implementing the 1:40 reverse split.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>For the year ended December 31, 2014</b></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company issued 95,250 shares of common stock between June 3 and June 30, 2014, on a post-reverse split basis, pursuant to conversions of 38,100 shares of Series A Preferred Stock.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company issued 246,625 shares of common stock between July 1 and September 30, 2014, on a post-reverse split basis, pursuant to conversions of 98,650 shares of Series A Preferred Stock.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company issued 153,750 shares of common stock between October 1 and December 31, 2014, on a post-reverse split basis, pursuant to conversions of 61,500 shares of Series A Preferred Stock.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">On July 1, 2014, the Company entered into a twelve-month consulting agreement for investor relations, marketing and public relations services. Pursuant to such agreement, the Company is obligated to pay the consultant for his services stock compensation of 6,250 shares of common stock, on a post-reverse split basis, immediately deliverable and an additional 6,250 shares of common stock deliverable after six months if the agreement is still in force. The 6,250 shares delivered in July were valued at $215,000. The agreement was terminated in December 2014 prior to the six month anniversary and, as a result, the Company is not obligated to deliver the remaining 6,250 shares of common stock.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">On July 21, 2014, the Company issued a total of 42,500 shares of common stock, on a post-reverse split basis, to two consulting firms which held warrants issued on May 19, 2014 for services which were exercised at a $.40 strike price, on a post-reverse split basis, or a total of $17,000.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company issued 24,000 shares of common stock, on a post-reverse split basis, on August 25, 2014 pursuant to the conversion of 9,600 shares of Series C Preferred Stock.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">On August 26, 2014, the Company issued an aggregate of 9,310 shares of restricted common stock, on a post-reverse split basis, to seven investors pursuant to the exercise of 100% of the warrants associated with Series E Preferred Stock.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">On August 27, 2014, the Company issued 50,000 shares of restricted common stock, on a post-reverse split basis, with monthly vesting provisions to two members of its newly-formed Strategic Advisory Board for twelve months of service. The advisors can earn a pro rata portion of the shares, calculated based on the twelve-month vesting period, in the event the service agreements are terminated prior to the expiration date as described in the agreements. The Company recognized a total of $126,667 expense for the pro rata portion of shares earned by the two advisors during the year ended December 31, 2014.</font></p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"><tr style="vertical-align: top; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;"><td style="text-align: justify; padding-left: 0pt; text-indent: 0pt; width: 0.25in; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;"><b>7.</b></font></td><td style="text-align: justify; padding-left: 0pt; text-indent: 0pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;"><b><u>PREFERRED STOCK</u></b></font></td></tr></table><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify; text-indent: 13.5pt;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;"><b>For the year ended December 31, 2015</b></font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">All of the preferred stock of the Company is convertible into common shares. The Series A and Series C stock conversion ratio is 1 to 2.5 common shares on a post-split basis. The Series B, B-1, D, E, F and G stock conversion ratio is 1 to 0.025 common shares on a post-split basis. The conversion price of Series B stock may be adjusted if a &#8216;dilutive triggering event&#8217; occurs which could happen if the Company were to sell or issue common stock, warrants or convertible securities without consideration or for a consideration per share less than the conversion price in effect immediately prior to such sale or issue (dilutive triggering price). In such case, the Series B conversion price would be reduced to a price equal to the dilutive triggering price. All preferred stock has voting rights equal to the number of shares it would have on an &#8216;as if converted&#8217; basis subject to any ownership limitations governing such preferred shares. All preferred stock is entitled to dividends rights equal to the number of shares it would have on an &#8216;as if converted&#8217; basis. None of the preferred stock is redeemable, participating nor callable.</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">The Company analyzed the embedded conversion option for derivative accounting consideration under ASC 815-15 &#8220;Derivatives and Hedging&#8221; and determined that the conversion option should be classified as equity.</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">The Company analyzed the conversion option for beneficial conversion features consideration under ASC 470-20 &#8220;Convertible Securities with Beneficial Conversion Features&#8221; and noted Series F stock contained a beneficial conversion feature. The intrinsic value of the beneficial conversion feature was determined to be $192,558. The beneficial conversion feature was fully amortized and recorded as a deemed dividend during the year ended December 31, 2014. The Series G stock issued during current quarter also contained a beneficial conversion feature. The intrinsic value of the beneficial conversion feature was determined to be $80,000. The beneficial conversion feature was fully amortized and recorded as a deemed dividend during the year ended December 31, 2015.</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">On October 29, 2015 a 1:40 reverse split of the Company stock occurred and the effect has been applied retroactively for disclosure purposes.</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">During 2015, eight investors in Series A preferred stock converted a total of 295,650 shares of Series A for an aggregate of 739,126 shares of restricted common stock in accordance with their conversion rights which includes a blocker with respect to individual ownership percentages. During the same period, both investors in Series B preferred stock converted a total of 324,671 shares of Series B for 8,117 shares of restricted common stock, six investors in Series C preferred stock converted a total of 272,013 shares of Series C for an aggregate of 680,033 shares of restricted common stock, thirteen investors in Series D preferred stock converted a total of 34,050,000 shares of Series D for an aggregate of 851,250 shares of restricted common stock, seven investors in Series E preferred stock converted a total of 5,400,000 shares of Series E for an aggregate of 135,000 shares of restricted common stock, three investors in Series F preferred stock converted a total of 1,301,001 shares of Series F for an aggregate of 32,525 shares of restricted common stock, and six investors in Series G preferred stock converted a total of 2,000,000 shares of Series G for an aggregate of 50,000 shares of restricted common stock, all in accordance with their conversion rights which includes a blocker with respect to individual ownership percentages.</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">On November 20, 2015, the Company entered into an Exchange Agreement with the holder of its outstanding shares of Series B-1 preferred stock pursuant to which the holder exchanged 68,731 shares of Series B-1 preferred stock for 55,000 shares of restricted common stock.</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;"><i>Series G Preferred Private Placement</i></font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;"><i>&#160;</i></font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">On June 2, 2015, the Company sold an aggregate of 4,000,000 units in a private placement of its securities to certain investors at a purchase price of $0.25 per unit pursuant to subscription for an aggregate purchase price of $985,725, net of $14,275 financing fees. Each unit consists of one share of the Company&#8217;s Series G Convertible Preferred Stock, par value $0.0001 per share, each of which is convertible into 0.025 shares of Common Stock on a post-split basis.</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">On June 2, 2015, as a result of the sale of the Series G Preferred Stock, the Company issued 2,700,000 shares of Series E Convertible Preferred Stock, which are convertible into an aggregate of 67,500 shares of Common Stock on a post-split basis, to existing holders of Series E Preferred Stock, in connection with certain anti-dilution rights associated with their purchase of such shares. The additional share issuance was treated as a &#8216;stock split&#8217; and was retrospectively reflected as of December 31, 2014.</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">On June 2, 2015, the Company received the consent of the holders of a majority of its Series F Convertible Preferred Stock to consummate the Series G Private Placement, as required under the terms of that investment. In consideration for the foregoing consent, the Company issued all holders of its Series F Preferred Stock an aggregate of an additional 2,200,666 shares of Series F Preferred Stock, which are convertible into an aggregate of 55,017 shares of common stock on a post-split basis. The additional share issuance was treated as a &#8216;stock split&#8217; and was retrospectively reflected as of December 31, 2014.</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;"><i>Common Stock Private Placement</i></font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">On November 17 and 19, 2015, the Company sold an aggregate of 745,000 shares of restricted common stock for a purchase price of $5.00 per share in a Private Placement. In connection with this sale, the Company issued an aggregate of 70,000 additional shares of common stock to holders of Series E preferred stock pursuant to the &#8216;most favored nations&#8217; provisions governing the Series E preferred stock. Additionally, pursuant to the terms of the Series F preferred stock and Series G preferred stock, the Company was required to obtain consent to issue securities at a per share purchase price less than the purchase price of the Series F and Series G. In consideration for the consents, the company issued an aggregate of 182,525 shares of restricted common stock to the holders of Series F and Series G preferred stock.</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;"><b>For the year ended December 31, 2014</b></font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">Between June 4 and June 30, 2014, seven holders of Series A Preferred Stock converted a total of 38,100 shares of Series A Preferred Stock for 95,250 shares of common stock, on a post-reverse split basis, in accordance with their conversion rights which includes a blocker with respect to individual ownership percentages.</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">Between July 1 and September 30, 2014, seven holders of Series A Preferred Stock converted a total of 98,650 shares for 246,625 shares of common stock, on a post-reverse split basis, in accordance with their conversion rights which includes a blocker with respect to individual ownership percentages.</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">Between October 1 and December 31, 2014, five holders of Series A Preferred Stock converted a total of 61,500 shares for 153,750 shares of common stock, on a post-reverse split basis, in accordance with their conversion rights which includes a blocker with respect to individual ownership percentages.</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">The Series B-1 Preferred Stock contains a liquidation provision whereas in the event of a fundamental transaction (such as the merger which occurred on June 3, 2014), the shareholder has the option to receive a preferential amount of cash equal to 400% of the stated value per share. On June 6, 2014, the sole holder of Series B-1 stock liquidated 87,500 shares for $350,000 leaving a remaining balance of 68,731 shares of Series B-1 preferred outstanding.</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">The Company issued 24,000 shares of common stock, on a post-reverse split basis, on August 25, 2014 pursuant to the conversion of 9,600 shares of Series C Preferred Stock.</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;"><i>Series F Preferred Private Placement</i></font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify; background-color: white;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0pt 0pt 0.25in; text-align: justify;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">On August 27, 2014, the Company sold an aggregate of 1,100,333 units in a private placement of its securities to certain investors at a purchase price of $0.75 per unit pursuant to subscription for an aggregate purchase price of $822,750, net of $2,500 financing fees. Each unit consists of one share of the Company&#8217;s Series F Convertible Preferred Stock, par value $0.0001 per share, each of which is convertible into one-fortieth share of Common Stock, on a post-reverse split basis, with such rights and designations as set forth in the Certificate of Designation. The Company evaluated the convertible preferred stock under FASB ASC 470-20-30 and determined it contained a beneficial conversion feature. The intrinsic value of the beneficial conversion feature was determined to be $192,558. The beneficial conversion feature was fully amortized and recorded as a deemed dividend.</font></p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; text-align: justify; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>8.</b></font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b><u>EMPLOYEE STOCK OPTIONS</u></b></font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>For the year ended December 31, 2015</b></font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">On October 29, 2015 a 1:40 reverse split of the Company stock occurred and the effect has been applied retroactively for disclosure purposes.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">During 2015, the Company granted 842,500 common stock options to employees and a director for service provided. Of these, 250,000 options were immediately vested and were granted with an exercise price of $6.00 and the expiration date is May 18, 2018. Another 105,000 options were immediately vested and were granted with an exercise price of $5.00 and the expiration date of December 10, 2018. Another 250,000 options vest over two years or upon the up listing of the Company&#8217;s common stock and were granted with an exercise price of $6.00 and the expiration date is June 1, 2018. These 250,000 options were surrendered and cancelled on September 4, 2015. A director received two options. The first was for 75,000 shares vesting over two years and was granted with an exercise price of $10.00 and the expiration date is June 1, 2018. The second was for 125,000 shares with vesting tied to performance and was granted with an exercise price of $10.00 and the expiration date is June 1, 2018. These two director options were surrendered and cancelled on September 4, 2015.<font style="color: red;">&#160;</font>Stock based compensation was reversed for costs previously recognized on the total 450,000 surrendered and cancelled unvested options. Another option for 37,500 shares vesting over three years was granted with an exercise price of $10.80 and the expiration date is May 4, 2019.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company uses the Black-Scholes option pricing model to estimate the fair value of stock-based awards on the date of grant.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"></font><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The following table summarizes the assumptions used to estimate the fair value of stock options granted during 2015:</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2015</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; font-stretch: normal;" colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: -10pt; padding-left: 10pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Expected dividend yield</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 188px; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: -10pt; padding-left: 10pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Expected volatility</font></td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">116% &#8211; 131</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: -10pt; padding-left: 10pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Risk-free interest rate</font></td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0.79% &#8211; 1.25</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: -10pt; padding-left: 10pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Expected life of options</font></td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2.43&#160;&#8211;&#160;3.00&#160;years</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Under the Black-Scholes option price model, fair value of the options granted is estimated at $3,013,531. During 2015, $2,822,132 compensation expense was recognized and the remaining $191,399 will be recognized over the next three years.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The following table represents stock option activity as of and for the period ended December 31, 2015:</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; text-decoration: none; vertical-align: bottom; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; text-decoration: none; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-bottom: 1.5pt; padding-left: 0pt; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-left: 0pt; text-decoration: none; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Number of Options</font></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-left: 0pt; text-decoration: none; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; text-decoration: none; font-stretch: normal;"></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Weighted</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Average</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: center; text-decoration: none; margin-top: 0px; margin-bottom: 0px; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Exercise Price</font></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-left: 0pt; text-decoration: none; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Contractual Life in Years</font></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-left: 0pt; text-decoration: none; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Intrinsic</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Value</font></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Outstanding &#8211; December 31, 2014</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">-</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0.00</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Exercisable &#8211; December 31, 2014</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">-</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0.00</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0.00</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Granted</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">842,500</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">7.04</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Exercised or Vested</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">-</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0.00</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Cancelled or Expired</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">450,000</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">7.78</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Outstanding &#8211; December 31, 2015</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">392,500</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">6.19</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2.62</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Exercisable &#8211; December 31, 2015</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">355,000</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">5.70</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2.55</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0.00</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>For the year ended December 31, 2014</b></font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">On April 30, 2014, the effective date of the Redomestication and effective date of the Merger Exchange Ratio, there were a total of 920 vested and 618 unvested options, on a post-reverse split basis, carried over to the reverse merger with DAC on June 3, 2014 with strike prices ranging from $66.80 to $5,056. During September 2014, the holders of these options voluntarily agreed to terminate their options. At December 31, 2014 there are no outstanding options.</font></p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; text-align: justify; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>9.</b></font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b><u>WARRANTS</u></b></font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: -4.5pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>For the year ended December 31, 2015</b></font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">On October 29, 2015 a 1:40 reverse split of the Company stock occurred and the effect has been applied retroactively for disclosure purposes.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">For the year 2015, 52,500 common stock purchase warrants were granted to two consultants and a vendor for service provided. One consultant was granted 25,000 warrants with exercise price of $10.00, vesting over two years and the expiration date is June 16, 2018. The other consultant was granted 12,500 warrants with exercise price of $10.00, vesting over one year and the expiration date is June 25, 2018. These same two consultants and the vendor each received 5,000 warrants with exercise price of $5.00, immediately vested and an expiration date of December 10, 2018.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"></font><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">On November 20, 2015, the Company issued 70,000 warrants with exercise price of $5.00, immediately vested and the expiration date of November 20, 2020 to the placement agent in the common stock private placement.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company uses the Black-Scholes warrant pricing model to estimate the fair value of warrants as of December 31, 2015.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The following table summarizes the assumptions used to estimate the fair value of warrants granted during 2015:</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: -10pt; padding-bottom: 1.5pt; padding-left: 10pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2015</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: -10pt; padding-left: 10pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: -10pt; padding-left: 10pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Expected dividend yield</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 188px; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: -10pt; padding-left: 10pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Expected volatility</font></td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">116% &#8211; 121</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: -10pt; padding-left: 10pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Risk-free interest rate</font></td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">.87% &#8211; 1.70</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: -10pt; padding-left: 10pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Expected life of warrants</font></td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2.4 &#8211; 5 years</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Under the Black-Scholes warrant price model, fair value of the warrants granted is estimated at $347,201. During 2015, $324,263 compensation expense was recognized.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0pt 0px 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>For the year ended December 31, 2014</b></font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0pt 0px 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">On April 30, 2014, the effective date of the Redomestication and effective date of the Merger Exchange Ratio, there were a total of 16,842 warrants, on a post-reverse split basis, carried over to the reverse merger with DAC on June 3, 2014 with strike prices ranging from $101.2 to $662.8. A total of 4,717 of these warrants with strike prices of $202.4 expired between July and September 2014 leaving a total of 12,125 outstanding warrants.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0pt 0px 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">During May 2014, the Company issued a total of 42,500 warrants on a post-reverse split basis for services. The warrants have a term of three years, and exercise price of $0.40. The 42,500 warrants were exercised in July 2014 for a total of $17,000. As further described above in Note 4, on June 3, 2014, the Company issued 67,500 warrants on a post-reverse split basis to purchase one share of common stock at an exercise price of $40.00 per warrant share to investors who purchased Series E Preferred Stock. The exercise price of $40.00 per warrant may be adjusted any time during the first twenty-four months from issuance under the terms of a Favored Nations Provision contained in the warrant. If at any time during that twenty-four month period the Company should issue common stock or convertible securities at a price lower than $40.00 per share, unless the warrant holder consents to such lower price issuance, then the exercise price of the warrant shall be automatically reduced to reflect such other lower price and the number of warrant securities shall be adjusted to reflect such lower price. The warrants expire on June 3, 2017. In August 2014, all seven investors holding the warrants attached to Series E Preferred Stock executed cashless exercises of their warrants resulting in the issuance of 9,310 shares of restricted common stock on a post-reverse split basis.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0pt 0px 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Because the 42,500 warrants issued on June 3, 2014 have full reset adjustments tied to future issuances of equity securities by the Company, they are subject to derivative liability treatment under ASC 815-40-15 &#8220;Determining whether an Instrument (or Embedded feature) is Indexed to an Entity&#8217;s Own Stock.&#8221; ASC 815-40-15 requires as of the date the warrant is issued, the derivative liability to be measured at fair value and re-evaluated at the end of each reporting period.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0pt 0px 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">As of June 3, 2014, the fair value of the warrants derivative liability was $2,159,824 &#8211; see Note #4. On August 26, 2014, when the warrants were exercised, the Company determined the fair value of the derivative liability to be $2,510,793, and upon warrant exercise, the derivative liability was written off to additional paid in capital.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"></font><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">As a result of the warrant exercises, as of December 31, 2014, the fair value of the warrants derivative liability is $0, and the Company recognized a loss on derivative liability of $350,969 for the year ended December 31, 2014. The fair value of the derivative liability was estimated at the date of grant and the date of warrant exercised using a Black-Scholes option pricing model.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The following table represents warrant activity as of and for the period ended December 31, 2015 and 2014:</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Number of Warrants</font></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Weighted</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Average</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Exercise Price</font></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Contractual Life in Years</font></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Intrinsic</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Value</font></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Outstanding &#8211; December 31, 2014</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">12,129</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">206.86</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2.04</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Exercisable &#8211; December 31, 2014</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">12,129</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">206.86</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2.04</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0.00</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Granted</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">122,500</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">6.53</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Forfeited or Expired</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">(420</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">)</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">250.35</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Outstanding &#8211; December 31, 2015</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">134,209</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">23.87</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">3.66</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Exercisable &#8211; December 31, 2015</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">104,209</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">27.87</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">4.01</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0.00</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"></font></td></tr></table> <div><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; text-align: justify; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>10.</b></font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b><u>INVENTORIES</u></b></font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0.25in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Inventories consisted of the following:</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2015</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2013</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Raw Materials</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">26,358</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">18,944</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Work in progress</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">3,817</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">1,369</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Finished Goods</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">107,209</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">19,091</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Less valuation allowance</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">(18,589</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">)</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">-</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">118,795</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">39,404</font></td></tr></table></div> <div><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; font-size-adjust: none; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; text-align: justify; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>11.</b></font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b><u>PREPAID EXPENSES</u></b></font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Prepaid expenses consisted of the following:</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><br class="apple-interchange-newline" /><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2015</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2014</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Prepaid insurance</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">25,517</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">23,114</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Prepaid services</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">24,192</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">15,225</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Prepaid rent and security deposit</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">5,915</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">11,830</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; padding-bottom: 4pt; padding-left: 0pt; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; padding-bottom: 4pt; padding-left: 0pt; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; padding-left: 0pt; word-spacing: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; padding-left: 0pt; word-spacing: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">55,624</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; padding-bottom: 4pt; padding-left: 0pt; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; padding-bottom: 4pt; padding-left: 0pt; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; padding-left: 0pt; word-spacing: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; padding-left: 0pt; word-spacing: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">50,169</font></td></tr></table></div> <div><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; text-align: justify; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>12.</b></font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b><u>INVESTMENT IN SECURITIES HELD FOR RESALE</u></b></font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company owned common stock in DecisionPoint Systems, Inc. (DPSI), MEDL Mobile Holdings, Inc. (MEDL) and Endexx Corporation (EDXC) as a result of certain 2012 and 2013 business transactions of MacroSolve. These securities were revalued at fair market value on June 3, 2014 as part of the reverse merger accounting. During the second quarter, the Company sold 607,284 shares of DPSI and 147,692 shares of MEDL, representing all of its holdings in those securities, with losses of $21,635 and $3,686 recorded respectively. The Company received a total of $168,704 net cash proceeds from the sales. The Company holds 125,000 shares of EDXC, but has been unable to liquidate the shares due to issues with Endexx Corporation not being a fully-reporting company. The Company has determined that the EDXC shares are impaired and has charged off the $17,500 carrying value. A total of $42,821 was recorded as loss on sale of securities for the year ended December 31, 2014.</font></p></div> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; text-align: justify; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>13.</b></font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b><u>OKLAHOMA TECHNOLOGY COMMERCIALIZATION CENTER</u></b></font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; text-align: justify; color: #000000; text-transform: none; text-indent: -13.5pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">At the time of the April 30, 2014 Redomestication, MacroSolve had an $110,000 past-due balance on its refundable award from the State of Oklahoma Technology Business Finance Program which includes accrued interest (imputed at 14.27%) through September 2007 after which interest no longer accrued. The Company has not made any reductions in the award so it is in default. The Company has proposed a settlement to be released from the debt that is unrelated to the current operations and is awaiting a response.</font></p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; text-align: justify; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>14.</b></font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b><u>INCOME TAXES</u></b></font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company uses the liability method, where deferred tax assets and liabilities are determined based on the expected future tax consequences of temporary differences between the carrying amounts of assets and liabilities for financial and income tax reporting purposes.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">During the post-reverse merger period of June 4, 2014 through December 31, 2014, the Company incurred a net loss, and, therefore, had no tax liability. Lighter Than Air Systems paid $5,571 in income taxes during 2014 for two short period returns, including the periods of March 29, 2013 through December 31, 2013 and January 1, 2014 through June 3, 2014 when it was a subsidiary of WSGI. The net deferred asset generated by the loss carry-forward has been fully reserved. The cumulative net operating loss carry-forward is approximately $4,220,577 for 2015 and will begin expiring in 2034. Section 382 of the Internal Revenue Code generally imposes an annual limitation on the amount of net operating loss carryforwards that may be used to offset taxable income when a corporation has undergone significant changes in its stock ownership. The $4,220,577 estimate of net operating loss carry-forward is calculated after we consider the effect of Section 382.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Deferred tax assets consist of the tax effect of NOL carry-forwards. The Company has provided a full valuation allowance on the deferred tax assets because of the uncertainty regarding its realizability. Deferred tax assets consist of the following:</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal;"><td style="background-color: white;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="text-align: center; margin-top: 0px; margin-bottom: 0px;">December&#160;31, 2015</p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="margin: 0px;">December&#160;31, 2014</p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="width: 0.25in; background-color: white;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Net operating loss carry-forwards</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">1,434,996</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">497,501</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Valuation allowance</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">(1,434,996</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">)</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">(497,501</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">)</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">-0-</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">-0-</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr></table> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; text-align: justify; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>15.</b></font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b><u>COMMITMENTS AND CONTINGENCIES</u></b></font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">On November 17, 2014, the Company entered into a 60 month lease for 5,533 square feet of office and manufacturing space at 11651 Central Parkway Suite 118, Jacksonville Florida, with an anticipated lease commencement date of February 1, 2015. The actual commencement date was July 1, 2015 and the lease was amended to 61 months expiring July 31, 2020. The monthly rent, including operating expenses and sales tax, for each year of the initial lease term is estimated to be $5,915. Anticipated total rent during the term of the lease is as follows:</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><table align="center" style="width: 1096px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top; background-color: #cceeff;"><td style="font: 10pt/15.33px calibri, helvetica, sans-serif; padding: 0px; text-align: center; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif;">Year 2016 - $ 71,854</font></td></tr><tr style="vertical-align: top; background-color: white;"><td style="font: 10pt/15.33px calibri, helvetica, sans-serif; padding: 0px; text-align: center; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif;">Year 2017 - $ 73,619</font></td></tr><tr style="vertical-align: top; background-color: #cceeff;"><td style="font: 10pt/15.33px calibri, helvetica, sans-serif; padding: 0px; text-align: center; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif;">Year 2018 - $ 75,437</font></td></tr><tr style="vertical-align: top; background-color: white;"><td style="font: 10pt/15.33px calibri, helvetica, sans-serif; padding: 0px; text-align: center; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif;">Year 2019 - $ 77,309</font></td></tr><tr style="vertical-align: top; background-color: #cceeff;"><td style="font: 10pt/15.33px calibri, helvetica, sans-serif; padding: 0px; text-align: center; font-stretch: normal;"><font style="font-family: 'times new roman', times, serif;">Year 2020 - $ 45,651</font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">On January 1, 2015, the Company entered into an agreement to lease executive office space for its President in Aventura, Florida. The monthly cost is expected to be $1,437 per month on a month-to-month basis with a sixty-day notice to cancel the agreement.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 18pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Rent expense in 2015 and 2014 were $76,492, and $37,557, respectively, and consisted of reimbursements for home offices and reimbursements made in 2014 to a related party which leased the Company&#8217;s former shared office and manufacturing space.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; background-color: white; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">As of December 31, 2015, the Company is a party in a pending motion by Newegg Inc. for recovery of defendant legal fees of approximately $400,000 from the Company in the matter of MacroSolve, Inc. v Newegg Inc. (U.S.D.C.E.D. TX) case No 6:12-cv-46-MSS-KNM. Should the company not prevail in that matter, the judgment would be borne by the former MacroSolve directors who sold their loans on April 17, 2014. Other than that matter, there are no material claims, actions, suits, proceedings inquiries, labor disputes or investigations pending.</font></p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; text-align: justify; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>16.</b></font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b><u>CONCENTRATIONS</u></b></font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of trade receivables.&#160;&#160;The Company performs ongoing credit evaluations of its customers and generally does not require collateral related to its receivables. At December 31, 2015, accounts receivable from two customers comprised 100% of the company&#8217;s total accounts receivable-trade. Revenues from two customers approximated 71% of total revenues for 2015. At December 31, 2014, accounts receivable from one customer comprised approximately 100% of the Company&#8217;s total accounts receivable-trade. Revenues from four customers approximated 92% of total revenues for 2014.</font></p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; text-align: justify; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>17.</b></font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b><u>SUBSEQUENT EVENTS</u></b></font></td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company issued a total of 335,968 shares of common stock between January 1- March 4, 2016, described further as follows:</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company issued 2,500 shares of common stock between January 1- March 4, 2016 pursuant to conversions of an aggregate of 1,000 shares of Series A preferred stock.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company issued 183,468 shares of common stock between January 1- March 4, 2016 pursuant to conversions of an aggregate of 73,387 shares of Series C preferred stock.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company issued 50,000 shares of common stock between January 1- March 4, 2016 pursuant to conversions of an aggregate of 2,000,000 shares of Series D preferred stock.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company issued 50,000 shares of common stock between January 1- March 4, 2016 pursuant to conversions of an aggregate of 1,999,998 shares of Series F preferred stock.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 18pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">The Company issued 50,000 shares of common stock between January 1- March 4, 2016 pursuant to conversions of an aggregate of 2,000,000 shares of Series F preferred stock.</font></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt;"><u>Description of Business:</u></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;">Drone Aviation Holding Corp. (&#8220;Drone&#8221; or &#8220;Company&#8221;) develops and manufactures cost-effective, compact and rapidly deployable aerial platforms including lighter-than-air aerostats and electric-powered drones designed to provide government and commercial customers with enhanced surveillance and communication capabilities. Utilizing a proprietary tether system, the Company's products are designed to provide prolonged operational duration capabilities combined with improved reliability, uniquely fulfilling critical requirements in military, law enforcement and commercial and industrial applications.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 9pt; text-align: justify; text-indent: 4.5pt;"><u>Basis of Presentation:</u></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 9pt; text-align: justify; text-indent: 4.5pt;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;">The accompanying financial statements of the Company were prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;).</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 9pt; text-align: justify; text-indent: 4.5pt;"><u>Principal of Consolidation:</u></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;">Our consolidated financial statements as of December 31, 2015 include the accounts of Drone Aviation Holding Corp. and its subsidiaries: Drone AFS Corp. and Lighter Than Air Systems Corp. Our consolidated financial statements as of December 31, 2014 include the accounts of Drone Aviation Holding Corp. and its subsidiaries: Drone Aviation Corp. and Lighter Than Air Systems Corp.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;"><u>Reclassifications:</u></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;">Certain prior year amounts have been combined and reclassified to conform to the current year presentation.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt;"><u>Use of Estimates:</u></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Actual results could differ from those estimates.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;"><u>Concentration of Credit Risk:</u></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;">Financial instruments which potentially subject the Company to concentrations of credit risk consist of cash and trade receivables. The Company places its cash with high credit quality financial institutions. At times such cash may be in excess of the FDIC limit. With respect to trade receivables, the Company routinely assesses the financial strength of its customers and, as a consequence, believes that the receivable credit risk exposure is limited.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;"><u>Cash Equivalents:</u></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;">Cash equivalents are represented by operating accounts or money market accounts maintained with insured financial institutions, including all highly-liquid investments with maturities of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2015 and 2014.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;"><u>Accounts Receivable and Credit Policies:</u></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;">Trade accounts receivable consist of amounts due from the sale of tethered aerostats, accessories, spare parts and delivery and installation of aerostats.&#160;&#160;Accounts receivable are uncollateralized customer obligations due under normal trade terms requiring payment within 30 days of receipt of the invoice.&#160;&#160;The Company provides an allowance for doubtful accounts equal to the estimated uncollectible amounts based on historical collection experience and a review of the current status of trade accounts receivable.&#160;&#160;At December 31, 2015 and 2014, the Company characterized $0 and $0 as uncollectible, respectively.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt;"><font style="letter-spacing: -0.1pt;">&#160;</font></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;"><u>Marketable Securities:</u></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;">All marketable securities are classified as available-for-sale securities. Available-for-sale securities are carried at fair value with resulting unrealized gains and losses, reported as a component of accumulated other comprehensive loss. The Company did not have any available-for-sale securities at December 31, 2015.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt;"><u>Inventories</u></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;">Inventories are stated at the lower of cost or market, using the first-in first-out method. Cost includes materials, labor and manufacturing overhead related to the purchase and production of inventories. We regularly review inventory quantities on hand, future purchase commitments with our supplies, and the estimated utility of our inventory. If the review indicates a reduction in utility below carrying value, we reduce our inventory to a new cost basis through a charge to cost of goods sold.</p> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Property and Equipment:</u></font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Property and equipment is recorded at cost when acquired.&#160;&#160;Depreciation is provided principally on the straight-line method over the estimated useful lives of the related assets, which is 3-7 years for equipment, furniture and fixtures, hardware and software.&#160;&#160;&#160;Property and equipment consists of the following at December 31, 2015 and 2014:</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><p style="font: 10pt/normal 'times new roman', times, serif; margin-top: 0px; margin-bottom: 0px; font-stretch: normal;"></p><p style="font: 10pt/normal 'times new roman', times, serif; margin-top: 0px; margin-bottom: 0px; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2015</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2014</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Shop Machinery and equipment</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">80,889</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">19,954</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Computers and electronics</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">28,911</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">12,075</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Office furniture and fixtures</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">33,977</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2,035</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Leasehold improvements</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">19,514</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">-</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">163,291</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">34,064</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Less - accumulated depreciation</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">(26,995</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">)</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">(7,040</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">)</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">136,296</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">27,024</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 13.5pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Expenditures for maintenance and repairs are charged to expense as incurred, whereas expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">During the year ended December 31, 2015 and 2014, the Company purchased $129,227 and $27,863 of furniture and equipment, respectively.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company recognized $19,955 and $2,477 of depreciation expense for the year ended December 31, 2015 and 2014, respectively,</font></p></div> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Long-Lived Assets &amp; Goodwill:</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company accounts for long-lived assets in accordance with the provisions of ASC 360-10-35, &#8220;Impairment or Disposal of Long-lived Assets&#8221;.&#160;&#160;This Statement requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.&#160;&#160;Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset.&#160;&#160;If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.&#160;&#160;The Company acquired the LTAS customer list in 2014. The fair value of the customer list was determined by using a discounted cash flow model and $135,550 was recorded on the date of business combination. The Company recorded $31,941 of amortization expense for the year ended December 31, 2014 leaving a remaining carrying amount of $103,609. The Company recorded another $37,935 amortization expense for the year ended December 31, 2015. After comparing the acquired customer list to the actual customers who placed orders following the acquisition of LTAS, the Company determined that the customer list was impaired at December 31, 2015 and amortized the remaining balance of $65,674 in 2015.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0px 0px 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company accounts for goodwill and intangible assets in accordance with ASC 350 "Intangibles Goodwill and Other". ASC 350 requires that goodwill and other intangibles with indefinite lives be tested for impairment annually or on an interim basis if events or circumstances indicate that the fair value of an asset has decreased below its carrying value. The Company performed impairment analysis using the qualitative analysis under ASC 350-20 and noted no impairment issues for 2015.</font></p> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Derivative Financial Instruments:</u></font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes option pricing model, in accordance with ASC 815-15 &#8220;Derivative and Hedging&#8221; to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.</font></p></div> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Beneficial Conversion Features:</u></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company evaluates the embedded conversion feature within its convertible debt instruments under ASC 815-15 and ASC 815-40 to determine if the conversion feature meets the definition of a liability and therefore need to bifurcate the conversion feature and account for it as a separate derivative liability.&#160;<font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The intrinsic value of a beneficial conversion feature inherent to a convertible note payable, which is not bifurcated and accounted for separately from the convertible note payable and may not be settled in cash upon conversion, is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual term, the unamortized discount is expensed in the period of retirement to interest expense. In general, the beneficial conversion feature is measured by comparing the effective conversion price, after considering the relative fair value of detachable instruments included in the financing transaction, if any, to the fair value of the common shares at the commitment date to be received upon conversion.</font></p> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Fair Value of Financial Instruments:</u></font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The Company measures its financial assets and liabilities in accordance with the requirements of FASB ASC 820, &#8220;Fair Value Measurements and Disclosures&#8221;. ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Level 1&#8211; Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Level 2 &#8211; Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Level 3 &#8211; Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management&#8217;s best estimate of fair value.</font></p></div> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 9pt; text-align: justify; text-indent: 4.5pt;"><u>Revenue Recognition and Unearned Revenue:</u></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify; text-decoration: none; vertical-align: baseline;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none; vertical-align: baseline;">The Company recognizes revenue when all four of the following criteria are met: 1) persuasive evidence of an arrangement exists; 2) delivery has occurred and title has transferred or services have been rendered; 3) our price to the buyer is fixed or determinable; and 4) collectability is reasonably assured. We record unearned revenue as a liability and their associated costs of sales as work in process inventory. In 2015, the Company deferred recognizing $7,896 in revenue from a 2015 sale that was delivered in January 2016. There is a balance of $83,288 in accounts receivable at December 31, 2015 for sales on account.</font></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;"><u>Income Taxes:</u></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;">The Company accounts for income taxes utilizing ASC 740, &#8220;Income Taxes&#8221; (SFAS No. 109).&#160;&#160;ASC 740 requires the measurement of deferred tax assets for deductible temporary differences and operating loss carry forwards, and of deferred tax liabilities for taxable temporary differences.&#160;&#160;Measurement of current and deferred tax liabilities and assets is based on provisions of enacted tax law.&#160;&#160;The effects of future changes in tax laws or rates are not included in the measurement.&#160;&#160;The Company recognizes the amount of taxes payable or refundable for the current year and recognizes deferred tax liabilities and assets for the expected future tax consequences of events and transactions that have been recognized in the Company&#8217;s financial statements or tax returns.&#160;&#160;The Company has recorded a 100% valuation allowance against net deferred tax assets due to uncertainty of their ultimate realization.&#160;&#160;Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt;"><font style="letter-spacing: -0.1pt;"><u>Employee Stock-Based Compensation:</u></font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;"><font style="letter-spacing: -0.1pt;">The Company accounts for stock-based compensation in accordance with ASC 718, &#8220;Compensation-Stock Compensation&#8221;. ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period.</font></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;"><font style="letter-spacing: -0.1pt;"><u>Non-Employee Stock-Based Compensation:</u></font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;"><font style="letter-spacing: -0.1pt;">The Company accounts for stock-based compensation in accordance with the provision of ASC 505, &#8220;Equity Based Payments to Non-Employees&#8221; (&#8220;ASC 505&#8221;), which requires that such equity instruments are recorded at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instruments vest.</font></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;"><u>Related Parties:</u></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;">A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;">The accounts payable due to related party at December 31, 2015 was comprised of $6,000 director fees which were paid in January 2016. The accounts payable due to related party at December 31, 2014, includes allocated rent and utility charges, aerostat envelopes, truck expenses and labor charges due Aerial Products Corp (&#8220;APC&#8221;) was $2,181. APC is a related party, controlled by a current employee of the Company. APC shared the manufacturing facilities with LTAS and provided aerostat envelopes and manufacturing labor to LTAS until June 30, 2014 when the APC labor pool transitioned to the Company. Total charges from APC to LTAS during the years ended December 31, 2015 and 2014 were $7,549 and $19,242 respectively. Additionally, the Company purchased used fixed assets from APC for $6,500 during the year ended December 31, 2015.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;"><u>Earnings or Loss per Share:</u></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;">The Company accounts for earnings per share pursuant to ASC 260, Earnings per Share, which requires disclosure on the financial statements of "basic" and "diluted" earnings (loss) per share. Basic earnings (loss) per share are computed by dividing net income (loss) by the weighted average number of common shares outstanding for the year. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding plus common stock equivalents (if dilutive) related to stock options and warrants for each year. As there was a net loss for the years ended December 31, 2015 and 2014, basic and diluted losses per share are the same for both years.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;"><u>Recent Accounting Pronouncements</u></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px 0px 0px 13.5pt; text-align: justify;">Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company's financial statements.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><p style="font: 10pt/normal 'times new roman', times, serif; margin-top: 0px; margin-bottom: 0px; font-stretch: normal;"></p><p style="font: 10pt/normal 'times new roman', times, serif; margin-top: 0px; margin-bottom: 0px; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2015</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2014</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Shop Machinery and equipment</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">80,889</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">19,954</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Computers and electronics</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">28,911</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">12,075</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Office furniture and fixtures</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">33,977</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2,035</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Leasehold improvements</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">19,514</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">-</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">163,291</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">34,064</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Less - accumulated depreciation</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">(26,995</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">)</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">(7,040</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">)</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">136,296</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">27,024</font></td></tr></table> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Property and equipment</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">1,638</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Accounts receivable</font></td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">135,050</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Cash in bank</font></td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">30,361</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Due from related party</font></td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">20,650</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Prepaid expenses</font></td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">1,381</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Inventory</font></td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">109,581</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Intangible asset</font></td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">135,550</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Current liabilities</font></td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">(120,010</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">)</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Goodwill</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">99,799</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Total purchase price</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">414,000</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"></font></td></tr></table> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; padding-left: 0pt; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Cash in bank</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">1,692,896</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Available-for-sale securities</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">211,525</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Prepaid expenses</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">37,403</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Current liabilities</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; font-stretch: normal;">(<font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">39,622</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;">)<font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Derivative liabilities</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; font-stretch: normal;">(<font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2,159,824</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; font-stretch: normal;">)</td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Note payable</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">(<font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">110,000</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;">)<font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Total</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">367,622</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr></table> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2015</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; font-stretch: normal;" colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: -10pt; padding-left: 10pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Expected dividend yield</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 188px; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: -10pt; padding-left: 10pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Expected volatility</font></td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">116% &#8211; 131</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: -10pt; padding-left: 10pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Risk-free interest rate</font></td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0.79% &#8211; 1.25</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: -10pt; padding-left: 10pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Expected life of options</font></td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2.43&#160;&#8211;&#160;3.00&#160;years</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr></table> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; text-decoration: none; vertical-align: bottom; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; text-decoration: none; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-bottom: 1.5pt; padding-left: 0pt; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"></font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-left: 0pt; text-decoration: none; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Number of Options</font></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-left: 0pt; text-decoration: none; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; text-decoration: none; font-stretch: normal;"></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Weighted</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Average</font></p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: center; text-decoration: none; margin-top: 0px; margin-bottom: 0px; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Exercise Price</font></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-left: 0pt; text-decoration: none; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Contractual Life in Years</font></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-left: 0pt; text-decoration: none; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Intrinsic</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Value</font></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; text-decoration: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Outstanding &#8211; December 31, 2014</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">-</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0.00</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Exercisable &#8211; December 31, 2014</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">-</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0.00</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0.00</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Granted</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">842,500</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">7.04</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Exercised or Vested</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">-</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0.00</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Cancelled or Expired</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">450,000</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">7.78</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Outstanding &#8211; December 31, 2015</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">392,500</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">6.19</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2.62</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Exercisable &#8211; December 31, 2015</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">355,000</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">5.70</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2.55</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0.00</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr></table> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: -10pt; padding-bottom: 1.5pt; padding-left: 10pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2015</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: -10pt; padding-left: 10pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: -10pt; padding-left: 10pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Expected dividend yield</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 188px; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: -10pt; padding-left: 10pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Expected volatility</font></td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">116% &#8211; 121</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: -10pt; padding-left: 10pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Risk-free interest rate</font></td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">.87% &#8211; 1.70</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; text-indent: -10pt; padding-left: 10pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Expected life of warrants</font></td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2.4 &#8211; 5 years</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr></table> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Number of Warrants</font></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Weighted</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Average</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Exercise Price</font></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Contractual Life in Years</font></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Intrinsic</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Value</font></p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Outstanding &#8211; December 31, 2014</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">12,129</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">206.86</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2.04</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Exercisable &#8211; December 31, 2014</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">12,129</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">206.86</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2.04</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0.00</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Granted</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">122,500</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">6.53</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Forfeited or Expired</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">(420</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">)</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">250.35</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Outstanding &#8211; December 31, 2015</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">134,209</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">23.87</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">3.66</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Exercisable &#8211; December 31, 2015</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">104,209</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">27.87</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">4.01</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0.00</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr></table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0.25in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2015</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2013</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Raw Materials</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">26,358</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">18,944</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Work in progress</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">3,817</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">1,369</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Finished Goods</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">107,209</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">19,091</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Less valuation allowance</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">(18,589</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">)</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">-</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">118,795</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">39,404</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr></table> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2015</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">2014</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Prepaid insurance</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">25,517</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">23,114</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Prepaid services</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">24,192</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">15,225</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Prepaid rent and security deposit</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">5,915</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">11,830</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal; background-color: white;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">55,624</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; text-indent: 0pt; padding-left: 0pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">50,169</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0pt; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr></table></div> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal;"><td style="background-color: white;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="text-align: center; margin-top: 0px; margin-bottom: 0px;">December&#160;31, 2015</p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2"><p style="margin: 0px;">December&#160;31, 2014</p></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="width: 0.25in; background-color: white;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Net operating loss carry-forwards</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">1,434,996</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 125px; text-align: right; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">497,501</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 15px; text-align: left; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: white;"><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Valuation allowance</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">(1,434,996</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">)</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">(497,501</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">)</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: bottom; font-stretch: normal; background-color: #cceeff;"><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">-0-</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">$</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">-0-</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="text-align: left; vertical-align: top; background-color: #cceeff;"><td style="width: 518px; text-align: center; background-color: white;">&#160;</td><td style="width: 532px; text-align: center;">Year 2016 - $ 71,854</td><td style="width: 517px; text-align: center; background-color: white;">&#160;</td></tr><tr style="text-align: left; vertical-align: top; background-color: white;"><td style="text-align: center;">&#160;</td><td style="text-align: center;">Year 2017 - $ 73,619</td><td style="text-align: center;">&#160;</td></tr><tr style="text-align: left; vertical-align: top; background-color: #cceeff;"><td style="text-align: center; background-color: white;">&#160;</td><td style="text-align: center;"><p style="font: 10pt/normal 'times new roman', times, serif; text-align: center; margin-top: 0px; margin-bottom: 0px; font-size-adjust: none; font-stretch: normal;">Year 2018 - $ 75,437</p></td><td style="text-align: center; background-color: white;">&#160;</td></tr><tr style="text-align: left; vertical-align: top; background-color: white;"><td style="text-align: center;">&#160;</td><td style="text-align: center;">Year 2019 - $ 77,309</td><td style="text-align: center;">&#160;</td></tr><tr style="text-align: left; vertical-align: top; background-color: #cceeff;"><td style="text-align: center; background-color: white;">&#160;</td><td style="text-align: center;">Year 2020 - $ 45,651</td><td style="background-color: white;">&#160;</td></tr></table> 19954 80889 12075 28911 2035 33977 19514 P3Y P7Y P3Y P7Y P3Y P7Y 0 0 83288 1.00 P30D 19242 7549 135550 6500 Pursuant to the Redomestication, each of MacroSolve's shareholders received one share of common stock, par value $0.0001 per share of Drone Aviation Holding Corp. for every 50.56186 shares of MacroSolve's common stock 1638 135050 30361 1692896 30361 20650 37403 1381 109581 135550 39622 120010 99799 367622 414000 1.00 79000 414000 P5Y 211525 2159824 110000 8050000 36050000 201250 2700000 2700000 2700000 182525 0.50 40.00 0.75 0.25 1350000 Each unit consists of one share of the Company's Series E Convertible Preferred Stock, par value $0.0001 per share, each of which is convertible into one-fortieth share, on a post-reverse split basis, of Common Stock, with such rights and designations as set forth in the Certificate of Designation; and a three year warrant to purchase one share of Common Stock at an exercise price of $40.00 per share. 0.0333 1.00 100000 100000 484500 150000 150000 8.40 3.23 3.23 The terms of the Escrow Agreement, if the escrow share value is less than $1,400,000, the Company must issue an additional number of unregistered shares, not to exceed 50,000 shares. 161500 50000 0.40 40.00 5.00 10.00 10.00 5.00 5.00 1:40 the Company effected a 1-for-40 reverse split of its common stock. 1:40 reverse split 1:40 the Company effected a 1-for-40 reverse split of its common stock. 1:40 38100 9600 98650 61500 86300 80229 20000 8400000 10200 10000 2000000 5600000 20 2000000 118921 242013 3400000 20050000 324651 1301000 2000000 324671 5400000 295650 1000 73387 2000000 1999998 2000000 95250 24000 246625 153750 215750 55017 67500 200573 50000 210000 25500 25000 50000 140000 1 297302 605033 85000 501250 8116 32525 50000 6250 70000 70000 70000 2 9310 7 7 5 6 13 3 8 1.00 1.00 9310 50000 50000 150000 450000 57 182525 182525 182525 182525 8117 680033 851250 135000 32525 55000 739126 182525 182525 1260000 4000000 Shares of restricted common stock, on a post-reverse split basis, with monthly vesting provisions to two members of its newly-formed Strategic Advisory Board for twelve months of service. The advisors can earn a pro rata portion of the shares, calculated based on the twelve-month vesting period, in the event the service agreements are terminated prior to the expiration date as described in the agreements. The Company issued 50,000 shares of restricted common stock, on a post-reverse split basis, with monthly vesting provisions to two members of its newly-formed Strategic Advisory Board for twelve months of service. The Company issued 50,000 shares of restricted common stock with monthly vesting provisions to the Chairman of the Board for twenty-four months services pursuant to a Director Agreement. 340000 126667 157500 324263 213333 2500 14275 240250 240250 5 5 3484750 3484750 Series A and Series C stock conversion ratio is 1 to 2.5 common shares on a post-split basis. The Series B, B-1, D, E, F and G stock conversion ratio is 1 to 0.025 350000 <div>The shareholder has the option to receive a preferential amount of cash equal to 400% of the stated value per share.</div> 87500 985725 0.025 0.00 0.00 1.16 1.31 1.21 1.16 0.0079 0.0125 0.0170 0.0087 P2Y5M5D P3Y P5Y P2Y4M24D 12129 392500 134209 12129 355000 104209 842500 122500 842500 250000 450000 420 0.00 206.86 6.19 23.87 0.00 206.86 5.70 27.87 7.04 6.53 10.00 10.00 10.80 6.00 5.00 6.00 0.00 7.78 250.35 P2Y7M13D P2Y6M18D P2Y15D 0.00 0.00 0.00 0.00 920 75000 125000 37500 250000 105000 250000 618 2018-06-01 2018-06-01 2019-05-04 2018-05-18 2018-12-10 2018-06-01 P2Y P3Y P2Y 3013531 2822132 450000 191399 202.4 662.8 101.2 66.80 5056 P2Y15D P3Y7M28D P4Y4D 16842 70000 12125 P3Y 2017-06-03 2020-11-20 2018-06-25 2018-06-16 2018-12-10 2018-12-10 4717 0 0 42500 67500 52500 12500 25000 5000 5000 347201 18944 26358 1369 3817 19091 107209 18589 23114 25517 15225 24192 11830 5915 50169 55624 607284 147692 17500 125000 110000 0.1427 Through September 2007 497501 1434996 497501 1434996 0 0 4220577 2034-12-31 71854 73619 75437 77309 45651 37557 76492 P60M 5533 400000 5915 The actual commencement date was July 1, 2015 and the lease was amended to 61 months expiring July 31, 2020. 1437 1 4 2 2 1.00 0.92 1.00 0.71 65674 EX-101.SCH 8 drne-20151231.xsd XBRL SCHEMA FILE 001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Consolidated Statements of Operations link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Merger between Macrosolve, inc. and Drone Aviation Holding Corp link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Drone Aviation Corp Aquisition of Lighter than Air Systems link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Drone Aviation Holding Corp and Drone Aviation Corp Securities Exchange, Reverse Merger and Recapitalization link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Drone Aviation Holding Corp Asset Acquisition of Adaptive, Flight, Inc. link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Shareholders' Equity link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Preferred Stock link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Employee Stock Options link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Warrants link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Inventories link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Prepaid Expenses link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Investment in Securities Held for Resale link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Oklahoma Technology Commercialization Center link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Concentrations link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Drone Aviation Corp Aquisition of Lighter than Air Systems (Tables) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Drone Aviation Holding Corp and Drone Aviation Corp Securities Exchange, Reverse Merger and Recapitalization (Tables) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Employee Stock Options (Tables) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Warrants (Tables) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Inventories (Tables) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Prepaid Expenses (Tables) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Income Taxes (Tables) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Summary of Significant Accounting Policies (Details Textual) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Merger between Macrosolve, inc. and Drone Aviation Holding Corp (Details) link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Drone Aviation Corp Aquisition of Lighter than Air Systems (Details) link:presentationLink link:definitionLink link:calculationLink 038 - Disclosure - Drone Aviation Corp Aquisition of Lighter than Air Systems (Details Textual) link:presentationLink link:definitionLink link:calculationLink 039 - Disclosure - Drone Aviation Holding Corp and Drone Aviation Corp Securities Exchange, Reverse Merger and Recapitalization (Details) link:presentationLink link:definitionLink link:calculationLink 040 - Disclosure - Drone Aviation Holding Corp and Drone Aviation Corp Securities Exchange, Reverse Merger and Recapitalization (Details Textual) link:presentationLink link:definitionLink link:calculationLink 041 - Disclosure - Drone Aviation Holding Corp Asset Acquisition of Adaptive, Flight, Inc. (Details) link:presentationLink link:definitionLink link:calculationLink 042 - Disclosure - Shareholders' Equity (Details) link:presentationLink link:definitionLink link:calculationLink 043 - Disclosure - Preferred Stock (Details) link:presentationLink link:definitionLink link:calculationLink 044 - Disclosure - Employee Stock Options (Details) link:presentationLink link:definitionLink link:calculationLink 045 - Disclosure - Employee Stock Options (Details 1) link:presentationLink link:definitionLink link:calculationLink 046 - Disclosure - Employee Stock Options (Details Textual) link:presentationLink link:definitionLink link:calculationLink 047 - Disclosure - Warrants (Details) link:presentationLink link:definitionLink link:calculationLink 048 - Disclosure - Warrants (Details 1) link:presentationLink link:definitionLink link:calculationLink 049 - Disclosure - Warrants (Details Textual) link:presentationLink link:definitionLink link:calculationLink 050 - Disclosure - Inventories (Details) link:presentationLink link:definitionLink link:calculationLink 051 - Disclosure - Prepaid Expenses (Details) link:presentationLink link:definitionLink link:calculationLink 052 - Disclosure - Investment in Securities Held for Resale (Details) link:presentationLink link:definitionLink link:calculationLink 053 - Disclosure - Oklahoma Technology Commercialization Center (Details) link:presentationLink link:definitionLink link:calculationLink 054 - Disclosure - Income Taxes (Details) link:presentationLink link:definitionLink link:calculationLink 055 - Disclosure - Income Taxes (Details Textual) link:presentationLink link:definitionLink link:calculationLink 056 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 057 - Disclosure - Commitments and Contingencies (Details Textual) link:presentationLink link:definitionLink link:calculationLink 058 - Disclosure - Concentrations (Details) link:presentationLink link:definitionLink link:calculationLink 059 - Disclosure - Subsequent Events (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 9 drne-20151231_cal.xml XBRL CALCULATION FILE EX-101.DEF 10 drne-20151231_def.xml XBRL DEFINITION FILE EX-101.LAB 11 drne-20151231_lab.xml XBRL LABEL FILE EX-101.PRE 12 drne-20151231_pre.xml XBRL PRESENTATION FILE XML 13 R1.htm IDEA: XBRL DOCUMENT v3.3.1.900
Document and Entity Information - USD ($)
 12 Months Ended
Dec. 31, 2015
Mar. 04, 2016
Jun. 30, 2015
Document and Entity Information [Abstract]      
Entity Registrant Name DRONE AVIATION HOLDING CORP.    
Entity Central Index Key 0001178727    
Trading Symbol drne    
Amendment Flag false    
Current Fiscal Year End Date --12-31    
Document Type 10-K    
Document Period End Date Dec. 31, 2015    
Document Fiscal Year Focus 2015    
Document Fiscal Period Focus FY    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers Yes    
Entity Current Reporting Status No    
Entity Filer Category Smaller Reporting Company    
Entity Public Float     $ 18,981.074
Entity Common Stock, Shares Outstanding   5,461,553  
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Balance Sheets - USD ($)
Dec. 31, 2015
Dec. 31, 2014
CURRENT ASSETS:    
Cash $ 2,659,734 $ 1,369,896
Accounts receivable - trade 83,288 30,170
Inventory 118,795 39,404
Prepaid expenses and deposits 55,624 50,169
Total current assets 2,917,441 1,489,639
PROPERTY AND EQUIPMENT, at cost: 163,291 34,064
Less - accumulated depreciation (26,995) (7,040)
Net property and equipment 136,296 27,024
OTHER ASSETS:    
Goodwill 99,799 99,799
Intangible assets, net 1,460,000 103,609
Total other assets 1,559,799 203,408
TOTAL ASSETS 4,613,536 1,720,071
CURRENT LIABILITIES:    
Accounts payable - trade and accrued liabilities 242,257 64,383
Accounts payable due to related party 6,000 $ 2,181
Deferred revenue 7,896
Note Payable - Oklahoma Technology Commercialization Center- Current 110,000 $ 110,000
Total current liabilities 366,153 176,564
TOTAL LIABILITIES $ 366,153 $ 176,564
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY (DEFICIT):    
Common stock, $.0001 par value; authorized 300,000,000 shares; 5,125,585 and 926,953 shares issued and outstanding, at December 31, 2015 and December 31, 2014, respectively $ 513 $ 93
Additional paid-in capital 15,385,523 3,702,233
Retained Earnings (Deficit) (11,139,270) (2,163,408)
Total stockholders' equity 4,247,383 1,543,507
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 4,613,536 1,720,071
Preferred stock, Series A    
STOCKHOLDERS' EQUITY (DEFICIT):    
Preferred stock value $ 10 40
Total stockholders' equity   40
Preferred stock, Series B    
STOCKHOLDERS' EQUITY (DEFICIT):    
Preferred stock value 32
Total stockholders' equity   32
Preferred stock, Series B-1    
STOCKHOLDERS' EQUITY (DEFICIT):    
Preferred stock value 7
Preferred stock, Series C    
STOCKHOLDERS' EQUITY (DEFICIT):    
Preferred stock value $ 7 35
Total stockholders' equity   35
Preferred stock, Series D    
STOCKHOLDERS' EQUITY (DEFICIT):    
Preferred stock value $ 200 3,605
Total stockholders' equity   3,605
Preferred stock, Series E    
STOCKHOLDERS' EQUITY (DEFICIT):    
Preferred stock value 540
Total stockholders' equity   270
Preferred stock, Series F    
STOCKHOLDERS' EQUITY (DEFICIT):    
Preferred stock value $ 200 330
Total stockholders' equity   $ 330
Preferred stock, Series G    
STOCKHOLDERS' EQUITY (DEFICIT):    
Preferred stock value $ 200
Total stockholders' equity  
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Balance Sheets (Parenthetical) - $ / shares
Dec. 31, 2015
Dec. 31, 2014
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 300,000,000 300,000,000
Common stock, shares issued 5,125,585 926,953
Common stock, shares outstanding 5,125,585 926,953
Preferred stock, Series A    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, authorized 595,000 595,000
Preferred stock, shares issued 101,100 396,750
Preferred stock, shares outstanding 101,100 396,750
Preferred stock, Series B    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, authorized 324,671 324,671
Preferred stock, shares issued 0 324,671
Preferred stock, shares outstanding 0 324,671
Preferred stock, Series B-1    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, authorized 156,231 156,231
Preferred stock, shares issued 0 68,731
Preferred stock, shares outstanding 0 68,731
Preferred stock, Series C    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, authorized 355,000 355,000
Preferred stock, shares issued 73,387 345,400
Preferred stock, shares outstanding 73,387 345,400
Preferred stock, Series D    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, authorized 36,050,000 36,050,000
Preferred stock, shares issued 2,000,000 36,050,000
Preferred stock, shares outstanding 2,000,000 36,050,000
Preferred stock, Series E    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, authorized 5,400,000 5,400,000
Preferred stock, shares issued 0 5,400,000
Preferred stock, shares outstanding 0 5,400,000
Preferred stock, Series F    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, authorized 3,300,999 3,300,999
Preferred stock, shares issued 1,999,998 3,300,999
Preferred stock, shares outstanding 1,999,998 3,300,999
Preferred stock, Series G    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, authorized 8,000,000 8,000,000
Preferred stock, shares issued 2,000,000 0
Preferred stock, shares outstanding 2,000,000 0
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Income Statement [Abstract]    
Revenues $ 472,159 $ 858,054
Cost of good sold 282,753 675,253
Gross profit 189,406 182,801
General and administrative expense 9,163,556 1,904,793
Loss from operations $ (8,974,150) (1,721,992)
Other income (expense)    
Loss on sale and impairment of securities held for resale   (42,821)
Loss on derivative liability (350,969)
Income tax expense (5,571)
Interest income $ 192 235
Interest expense (1,904) (2,372)
Total other expense (1,712) (401,498)
NET LOSS (8,975,862) $ (2,123,490)
Deemed dividend on Series G convertible preferred stock $ 80,000
Deemed dividend on Series F convertible preferred stock $ 192,558
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS $ (9,055,862) $ (2,316,048)
Weighted average number of common shares outstanding - basic and diluted 2,034,421 394,683
Basic and diluted net loss per share $ (4.45) $ (5.87)
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Stockholders' Equity - USD ($)
Total
Series A Preferred Stock [Member]
Series B Preferred Stock [Member]
Series B-1 Preferred Stock [Member]
Series C Preferred Stock [Member]
Series D Preferred Stock [Member]
Series E Preferred Stock [Member]
Series F Preferred Stock [Member]
Series G Preferred Stock [Member]
Common Stock [Member]
Paid-in Capital [Member]
Accumulated Deficit [Member]
Beginning balance (Predecessor [Member]) at Dec. 31, 2013  
Beginning balance at Dec. 31, 2013      
Beginning balance, Shares (Predecessor [Member]) at Dec. 31, 2013      
Beginning balance, Shares at Dec. 31, 2013      
Net Loss | Predecessor [Member]                   $ (2,123,490)
Net Loss $ (2,123,490)      
Net loss from LTAS from 1/1/14 to 5/5/14 | Predecessor [Member]                     (39,918)
Net loss from LTAS from 1/1/14 to 5/5/14 (39,918)        
Common stock of Drone Aviation Corp issued for cash | Predecessor [Member]                   $ 20 $ 650,702  
Common stock of Drone Aviation Corp issued for cash 653,327 $ 2,605      
Common stock of Drone Aviation Corp issued for cash, Shares | Predecessor [Member]                   201,250    
Common stock of Drone Aviation Corp issued for cash, Shares   26,050,000            
Drone Aviation Corp stock issued to LTAS upon business combination | Predecessor [Member]                   $ 78,000
Drone Aviation Corp stock issued to LTAS upon business combination 79,000 $ 1,000      
Drone Aviation Corp stock issued to LTAS upon business combination, Shares | Predecessor [Member]                      
Drone Aviation Corp stock issued to LTAS upon business combination, Shares   10,000,000            
Reverse merger adjustment | Predecessor [Member]                   $ 10 $ (368,316)
Reverse merger adjustment (367,622) $ 60 $ 32 $ 16 $ 36 $ 540      
Common stock issued due to reverse split rounding | Predecessor [Member]                   98,018    
Common stock issued due to reverse split rounding   595,000 324,671 156,231 355,000 5,400,000      
Common stock issued for warrant exercises | Predecessor [Member]                   $ 4 16,996
Common stock issued for warrant exercises 17,000      
Common stock issued for warrant exercises, Shares | Predecessor [Member]                   42,500    
Proceeds from Series F preferred stock issued for cash | Predecessor [Member]                   822,420
Proceeds from Series F preferred stock issued for cash 822,750 $ 330        
Proceeds from Series F preferred stock issued for cash, Shares | Predecessor [Member]                      
Proceeds from Series F preferred stock issued for cash, Shares   3,300,999        
Redemption of Series B-1 preferred stock | Predecessor [Member]                   (349,991)
Redemption of Series B-1 preferred stock (350,000) $ (9)      
Redemption of Series B-1 preferred stock, shares | Predecessor [Member]                      
Redemption of Series B-1 preferred stock, shares   (87,500)      
Shares issued for service - third party | Predecessor [Member]                   $ 6 341,661
Shares issued for service - third party $ 341,667      
Shares issued for service - third party, Shares | Predecessor [Member]                   56,250    
Shares issued for service - third party, Shares        
Cashless exercise of Series E preferred stock attached warrants | Predecessor [Member]                   $ 1 (1)
Cashless exercise of Series E preferred stock attached warrants      
Cashless exercise of Series E preferred stock attached warrants, Shares | Predecessor [Member]                   9,310    
Cashless exercise of Series E preferred stock attached warrants, Shares        
Derivative liability written off to APIC due to warrant exercise | Predecessor [Member]                   2,510,793
Derivative liability written off to APIC due to warrant exercise $ 2,510,793      
Derivative liability written off to APIC due to warrant exercise, Shares | Predecessor [Member]                      
Derivative liability written off to APIC due to warrant exercise, Shares        
Beneficial conversion feature of Series F preferred stock | Predecessor [Member]                   192,558
Beneficial conversion feature of Series F preferred stock 192,558      
Deemed dividend on Series F preferred stock | Predecessor [Member]                   (192,558)
Deemed dividend on Series F preferred stock $ (192,558)      
Conversion of Series A preferred stock to common stock | Predecessor [Member]                   $ 50 (30)
Conversion of Series A preferred stock to common stock $ (20)      
Conversion of Series A preferred stock to common stock, Shares | Predecessor [Member]                   495,625    
Conversion of Series A preferred stock to common stock, Shares   (198,250)                    
Conversion of Series C preferred stock to common stock | Predecessor [Member]                   $ 2 (1)
Conversion of Series C preferred stock to common stock $ (1)      
Conversion of Series C preferred stock to common stock,Shares | Predecessor [Member]                   24,000    
Conversion of Series C preferred stock to common stock,Shares   (9,600)              
Proceeds from Series G preferred stock issued for cash                      
Ending balance (Predecessor [Member]) at Dec. 31, 2014   $ 40 $ 32 $ 7 $ 35 $ 3,605 $ 540 $ 330 $ 93 3,702,233 $ (2,163,408)
Ending balance at Dec. 31, 2014 $ 1,543,507 $ 40 $ 32   $ 35 $ 3,605 $ 270 $ 330 $ 3,708    
Ending balance, Shares (Predecessor [Member]) at Dec. 31, 2014   396,750 324,671 68,731 345,400 36,050,000 5,400,000 3,300,999 926,953    
Ending balance, Shares at Dec. 31, 2014 68,731 396,750 324,671   345,400 36,050,000 2,700,000 3,300,999 37,078,114    
Net Loss | Predecessor [Member]                       (8,975,862)
Net Loss $ (8,975,862)                      
Shares issued for service - third party | Predecessor [Member]                   $ 25 (25)  
Shares issued for service - third party, Shares | Predecessor [Member]                   252,525    
Conversion of Series A preferred stock to common stock | Predecessor [Member]                   $ 74 (44)  
Conversion of Series A preferred stock to common stock $ (30)                    
Conversion of Series A preferred stock to common stock, Shares | Predecessor [Member]                   739,125    
Conversion of Series A preferred stock to common stock, Shares   (295,650)                    
Conversion of Series C preferred stock to common stock | Predecessor [Member]                   $ 68 (40)  
Conversion of Series C preferred stock to common stock       $ (28)              
Conversion of Series C preferred stock to common stock,Shares | Predecessor [Member]                   680,033    
Conversion of Series C preferred stock to common stock,Shares         (272,013)              
Conversion of Series B preferred stock to common stock | Predecessor [Member]                     31  
Conversion of Series B preferred stock to common stock   $ (32)             $ 1    
Conversion of Series B preferred stock to common stock, Shares     (324,671)             8,117    
Conversion of Series B1 preferred stock to common stock | Predecessor [Member]                   $ 5 2  
Conversion of Series B1 preferred stock to common stock     $ (7)                
Conversion of Series B1 preferred stock to common stock, Shares | Predecessor [Member]                   55,000    
Conversion of Series B1 preferred stock to common stock, Shares       (68,731)                
Conversion of Series D preferred stock to common stock | Predecessor [Member]                   $ 85 3,320  
Conversion of Series D preferred stock to common stock         $ (3,405)            
Conversion of Series D preferred stock to common stock, Shares | Predecessor [Member]                   851,250    
Conversion of Series D preferred stock to common stock, Shares           (34,050,000)            
Conversion of Series E preferred stock to common stock | Predecessor [Member]                   $ 14 526  
Conversion of Series E preferred stock to common stock           $ (540)          
Conversion of Series E preferred stock to common stock, Shares | Predecessor [Member]                   135,000    
Conversion of Series E preferred stock to common stock, Shares             (5,400,000)          
Conversion of Series F preferred stock to common stock | Predecessor [Member]                   $ 3 127  
Conversion of Series F preferred stock to common stock             $ (130)        
Conversion of Series F preferred stock to common stock, Shares | Predecessor [Member]                   32,525    
Conversion of Series F preferred stock to common stock, Shares               (1,301,001)        
Conversion of Series G preferred stock to common stock | Predecessor [Member]                   $ 5 195  
Conversion of Series G preferred stock to common stock               $ (200)      
Conversion of Series G preferred stock to common stock, Shares | Predecessor [Member]                   50,000    
Conversion of Series G preferred stock to common stock, Shares                 (2,000,000)      
Proceeds from Series G preferred stock issued for cash | Predecessor [Member]                     999,600  
Proceeds from Series G preferred stock issued for cash $ 1,000,000               $ 400      
Proceeds from Series G preferred stock issued for cash, Shares                 4,000,000      
Beneficial conversion feature on preferred stock Series G | Predecessor [Member]                     80,000  
Beneficial conversion feature on preferred stock Series G 80,000                      
Deemed dividend on Series G preferred stock | Predecessor [Member]                     (80,000)  
Deemed dividend on Series G preferred stock (80,000)                      
Proceeds from common stock issued for cash, Value | Predecessor [Member]                   $ 75 3,484,675  
Proceeds from common stock issued for cash, Value $ 3,484,750                      
Proceeds from common stock issued for cash, Shares | Predecessor [Member]                   745,000    
Common stock issued to Series E, F and G holders, Value | Predecessor [Member]                   $ 25 (25)  
Common stock issued to Series E, F and G holders, Value                      
Common stock issued to Series E, F and G holders, Shares | Predecessor [Member]                   252,525    
Stock Based Compensation - ASC 505 Adj for 2014 share issuance | Predecessor [Member]                     213,333  
Stock Based Compensation - ASC 505 Adj for 2014 share issuance $ 213,333                      
Stock Based Compensation - Shares Issuance to Employee | Predecessor [Member]                   $ 50 2,575,210  
Stock Based Compensation - Shares Issuance to Employee 2,575,260                      
Stock Based Compensation - Shares Issuance to Employee, Shares | Predecessor [Member]                   500,000    
Stock Based Compensation - options and warrants | Predecessor [Member]                     3,146,395  
Stock Based Compensation - options and warrants 3,146,395                      
Common stock issued for asset acquisition | Predecessor [Member]                   $ 15 1,259,985  
Common stock issued for asset acquisition 1,260,000                      
Common stock issued for asset acquisition, Shares | Predecessor [Member]                   150,000    
Ending balance (Predecessor [Member]) at Dec. 31, 2015   $ 40 $ 35 $ 3,605 $ 330 $ 200 $ 513 $ 15,385,523 $ (11,139,270)
Ending balance at Dec. 31, 2015 $ 4,247,383                      
Ending balance, Shares (Predecessor [Member]) at Dec. 31, 2015   396,750 345,400 36,050,000 3,300,999 2,000,000 5,125,585    
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
OPERATING ACTIVITIES:    
Net loss $ (8,975,862) $ (2,123,490)
Adjustments to reconcile net loss to net cash used in operating activities:    
Loss on disposal and impairment of available-for-sale securities   42,821
Loss on derivative liability $ 350,969
Allowance for inventory obsolescence $ 18,589
Depreciation 19,955 $ 2,477
Amortization 37,935 31,941
Impairment of intangible assets 65,674  
Stock based compensation 5,934,988 341,667
Changes in current assets and liabilities:    
Accounts receivable (53,118) 104,880
Inventory (97,980) 70,177
Prepaid expenses and other current assets (5,455) (11,385)
Accounts payable and accrued expense 177,874 (132,363)
Due from related party 3,819 $ 20,027
Deferred revenue 7,896
Net cash used in operating activities $ (2,865,685) $ (1,302,279)
INVESTING ACTIVITIES:    
Cash paid on business combination, net   (304,639)
Cash from reverse merger 1,692,896
Cash from sales of available-for-sale securities   $ 168,704
Cash paid on intangible asset acquisition $ (200,000)
Cash paid on furniture and equipment (129,227) $ (27,863)
Net cash (used in) provided by investing activities (329,227) 1,529,098
FINANCING ACTIVITIES:    
Proceeds from common stock issued for cash 3,484,750 $ 653,327
Proceeds from Series G preferred stock issued for cash $ 1,000,000
Proceeds from warrant exercises $ 17,000
Proceeds from Series F preferred stock issued for cash   822,750
Redemption of Series B-1 preferred stock (350,000)
Net cash provided by financing activities $ 4,484,750 1,143,077
NET (DECREASE) INCREASE IN CASH 1,289,838 $ 1,369,896
CASH, beginning of period 1,369,896
CASH, end of period 2,659,734 $ 1,369,896
Cash paid during the years ended December 31:    
Interest 1,904 2,371
Income taxes 159 $ 5,571
Noncash investing and financing activities for the years ended December 31:    
Common stock issued for asset acquisition 1,260,000
Conversion of Series A preferred stock to common stock 74 $ 50
Conversion of Series B preferred stock to common stock 1
Conversion of Series B-1 preferred stock to common stock 5
Conversion of Series C preferred stock to common stock 68 $ 2
Conversion of Series D preferred stock to common stock 85
Conversion of Series E preferred stock to common stock 14
Conversion of Series F preferred stock to common stock 3
Conversion of Series G preferred stock to common stock 5
Common stock issued to Series E, F and G holders $ 25
Cashless exercise of Series E preferred stock attached warrants $ 1
Derivative liability written off to APIC due to warrant exercise 2,510,793
Reverse merger adjustment (2,060,518)
Deemed dividend beneficial conversion feature on convertible preferred stock $ 80,000 192,558
Business combination adjustment $ 79,000
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900
Summary of Significant Accounting Policies
 12 Months Ended
Dec. 31, 2015
Summary of Significant Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Description of Business:

 

Drone Aviation Holding Corp. (“Drone” or “Company”) develops and manufactures cost-effective, compact and rapidly deployable aerial platforms including lighter-than-air aerostats and electric-powered drones designed to provide government and commercial customers with enhanced surveillance and communication capabilities. Utilizing a proprietary tether system, the Company's products are designed to provide prolonged operational duration capabilities combined with improved reliability, uniquely fulfilling critical requirements in military, law enforcement and commercial and industrial applications.

 

Basis of Presentation:

 

The accompanying financial statements of the Company were prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

 

Principal of Consolidation:

 

Our consolidated financial statements as of December 31, 2015 include the accounts of Drone Aviation Holding Corp. and its subsidiaries: Drone AFS Corp. and Lighter Than Air Systems Corp. Our consolidated financial statements as of December 31, 2014 include the accounts of Drone Aviation Holding Corp. and its subsidiaries: Drone Aviation Corp. and Lighter Than Air Systems Corp.

 

Reclassifications:

 

Certain prior year amounts have been combined and reclassified to conform to the current year presentation.

 

Use of Estimates:

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.

 

Concentration of Credit Risk:

 

Financial instruments which potentially subject the Company to concentrations of credit risk consist of cash and trade receivables. The Company places its cash with high credit quality financial institutions. At times such cash may be in excess of the FDIC limit. With respect to trade receivables, the Company routinely assesses the financial strength of its customers and, as a consequence, believes that the receivable credit risk exposure is limited.

 

Cash Equivalents:

 

Cash equivalents are represented by operating accounts or money market accounts maintained with insured financial institutions, including all highly-liquid investments with maturities of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2015 and 2014.

 

Accounts Receivable and Credit Policies:

 

Trade accounts receivable consist of amounts due from the sale of tethered aerostats, accessories, spare parts and delivery and installation of aerostats.  Accounts receivable are uncollateralized customer obligations due under normal trade terms requiring payment within 30 days of receipt of the invoice.  The Company provides an allowance for doubtful accounts equal to the estimated uncollectible amounts based on historical collection experience and a review of the current status of trade accounts receivable.  At December 31, 2015 and 2014, the Company characterized $0 and $0 as uncollectible, respectively.

 

Marketable Securities:

 

All marketable securities are classified as available-for-sale securities. Available-for-sale securities are carried at fair value with resulting unrealized gains and losses, reported as a component of accumulated other comprehensive loss. The Company did not have any available-for-sale securities at December 31, 2015.

 

Inventories

 

Inventories are stated at the lower of cost or market, using the first-in first-out method. Cost includes materials, labor and manufacturing overhead related to the purchase and production of inventories. We regularly review inventory quantities on hand, future purchase commitments with our supplies, and the estimated utility of our inventory. If the review indicates a reduction in utility below carrying value, we reduce our inventory to a new cost basis through a charge to cost of goods sold.

 

Property and Equipment:

 

Property and equipment is recorded at cost when acquired.  Depreciation is provided principally on the straight-line method over the estimated useful lives of the related assets, which is 3-7 years for equipment, furniture and fixtures, hardware and software.   Property and equipment consists of the following at December 31, 2015 and 2014:

 

 

 

   2015     2014  
  Shop Machinery and equipment   $ 80,889     $ 19,954  
  Computers and electronics     28,911       12,075  
  Office furniture and fixtures     33,977       2,035  
  Leasehold improvements     19,514       -  
        163,291       34,064  
  Less - accumulated depreciation     (26,995 )     (7,040 )
      $ 136,296     $ 27,024  

 

Expenditures for maintenance and repairs are charged to expense as incurred, whereas expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized.

 

During the year ended December 31, 2015 and 2014, the Company purchased $129,227 and $27,863 of furniture and equipment, respectively.

 

The Company recognized $19,955 and $2,477 of depreciation expense for the year ended December 31, 2015 and 2014, respectively,

 

Long-Lived Assets & Goodwill:

 

The Company accounts for long-lived assets in accordance with the provisions of ASC 360-10-35, “Impairment or Disposal of Long-lived Assets”.  This Statement requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.  Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset.  If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.  The Company acquired the LTAS customer list in 2014. The fair value of the customer list was determined by using a discounted cash flow model and $135,550 was recorded on the date of business combination. The Company recorded $31,941 of amortization expense for the year ended December 31, 2014 leaving a remaining carrying amount of $103,609. The Company recorded another $37,935 amortization expense for the year ended December 31, 2015. After comparing the acquired customer list to the actual customers who placed orders following the acquisition of LTAS, the Company determined that the customer list was impaired at December 31, 2015 and amortized the remaining balance of $65,674 in 2015.

 

The Company accounts for goodwill and intangible assets in accordance with ASC 350 "Intangibles Goodwill and Other". ASC 350 requires that goodwill and other intangibles with indefinite lives be tested for impairment annually or on an interim basis if events or circumstances indicate that the fair value of an asset has decreased below its carrying value. The Company performed impairment analysis using the qualitative analysis under ASC 350-20 and noted no impairment issues for 2015.

 

Derivative Financial Instruments:

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes option pricing model, in accordance with ASC 815-15 “Derivative and Hedging” to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

 

Beneficial Conversion Features:

 

The Company evaluates the embedded conversion feature within its convertible debt instruments under ASC 815-15 and ASC 815-40 to determine if the conversion feature meets the definition of a liability and therefore need to bifurcate the conversion feature and account for it as a separate derivative liability. The intrinsic value of a beneficial conversion feature inherent to a convertible note payable, which is not bifurcated and accounted for separately from the convertible note payable and may not be settled in cash upon conversion, is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual term, the unamortized discount is expensed in the period of retirement to interest expense. In general, the beneficial conversion feature is measured by comparing the effective conversion price, after considering the relative fair value of detachable instruments included in the financing transaction, if any, to the fair value of the common shares at the commitment date to be received upon conversion.

 

Fair Value of Financial Instruments:

 

The Company measures its financial assets and liabilities in accordance with the requirements of FASB ASC 820, “Fair Value Measurements and Disclosures”. ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

 

Level 1– Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.

 

Level 2 – Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.

 

Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.

  

Revenue Recognition and Unearned Revenue:

 

The Company recognizes revenue when all four of the following criteria are met: 1) persuasive evidence of an arrangement exists; 2) delivery has occurred and title has transferred or services have been rendered; 3) our price to the buyer is fixed or determinable; and 4) collectability is reasonably assured. We record unearned revenue as a liability and their associated costs of sales as work in process inventory. In 2015, the Company deferred recognizing $7,896 in revenue from a 2015 sale that was delivered in January 2016. There is a balance of $83,288 in accounts receivable at December 31, 2015 for sales on account.

 

Income Taxes:

 

The Company accounts for income taxes utilizing ASC 740, “Income Taxes” (SFAS No. 109).  ASC 740 requires the measurement of deferred tax assets for deductible temporary differences and operating loss carry forwards, and of deferred tax liabilities for taxable temporary differences.  Measurement of current and deferred tax liabilities and assets is based on provisions of enacted tax law.  The effects of future changes in tax laws or rates are not included in the measurement.  The Company recognizes the amount of taxes payable or refundable for the current year and recognizes deferred tax liabilities and assets for the expected future tax consequences of events and transactions that have been recognized in the Company’s financial statements or tax returns.  The Company has recorded a 100% valuation allowance against net deferred tax assets due to uncertainty of their ultimate realization.  Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.

 

Employee Stock-Based Compensation:

 

The Company accounts for stock-based compensation in accordance with ASC 718, “Compensation-Stock Compensation”. ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period.

 

Non-Employee Stock-Based Compensation:

 

The Company accounts for stock-based compensation in accordance with the provision of ASC 505, “Equity Based Payments to Non-Employees” (“ASC 505”), which requires that such equity instruments are recorded at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instruments vest.

 

Related Parties:

 

A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party.

 

The accounts payable due to related party at December 31, 2015 was comprised of $6,000 director fees which were paid in January 2016. The accounts payable due to related party at December 31, 2014, includes allocated rent and utility charges, aerostat envelopes, truck expenses and labor charges due Aerial Products Corp (“APC”) was $2,181. APC is a related party, controlled by a current employee of the Company. APC shared the manufacturing facilities with LTAS and provided aerostat envelopes and manufacturing labor to LTAS until June 30, 2014 when the APC labor pool transitioned to the Company. Total charges from APC to LTAS during the years ended December 31, 2015 and 2014 were $7,549 and $19,242 respectively. Additionally, the Company purchased used fixed assets from APC for $6,500 during the year ended December 31, 2015.

 

Earnings or Loss per Share:

 

The Company accounts for earnings per share pursuant to ASC 260, Earnings per Share, which requires disclosure on the financial statements of "basic" and "diluted" earnings (loss) per share. Basic earnings (loss) per share are computed by dividing net income (loss) by the weighted average number of common shares outstanding for the year. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding plus common stock equivalents (if dilutive) related to stock options and warrants for each year. As there was a net loss for the years ended December 31, 2015 and 2014, basic and diluted losses per share are the same for both years.

 

Recent Accounting Pronouncements

 

Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company's financial statements.
XML 20 R8.htm IDEA: XBRL DOCUMENT v3.3.1.900
Merger between Macrosolve, inc. and Drone Aviation Holding Corp
 12 Months Ended
Dec. 31, 2015
Merger between Macrosolve, inc. and Drone Aviation Holding Corp / Drone Aviation Corp Aquisition of Lighter than Air Systems / Drone Aviation Holding Corp Asset Acquisition of Adaptive, Flight, Inc. [Abstract]  
MERGER BETWEEN MACROSOLVE, INC. AND DRONE AVIATION HOLDING CORP
2.MERGER BETWEEN MACROSOLVE, INC. AND DRONE AVIATION HOLDING CORP

 

On April 14, 2014, holders of the majority of MacroSolve, Inc. (“MacroSolve) common stock approved a plan of merger whereby MacroSolve would merge with Drone Aviation Holding Corp., its newly created wholly-owned Nevada subsidiary, for the purpose of changing the Company’s state of domicile from Oklahoma to Nevada (the “Redomestication”). Pursuant to the Redomestication, each of MacroSolve’s shareholders received one share of common stock, par value $0.0001 per share of Drone Aviation Holding Corp. for every 50.56186 shares of MacroSolve’s common stock held by them (the Merger Exchange Rate). The Redomestication was effective on April 30, 2014. All per share amounts referenced herein give effect to the Merger Exchange Rate.

 

Prior to the Redomestication, MacroSolve had 198,219,132 shares of common stock issued and outstanding. Subsequent to the Redomestication, as a result of the Merger Exchange Ratio described above, the Company had approximately 3,920,700 [98,017 on a post-reverse basis] shares of common stock issued and outstanding on April 30, 2014.

 

On April 30, 2014 as a result of the Redomestication, MacroSolve’s outstanding shares of Series C, D and D-1 preferred stock were exchanged for shares of the post-Redomestication Company’s shares of Series A, B and B-1 preferred stock, with 595,000 shares, 324,671 shares and 156,231 shares issued respectively.
XML 21 R9.htm IDEA: XBRL DOCUMENT v3.3.1.900
Drone Aviation Corp Aquisition of Lighter than Air Systems
 12 Months Ended
Dec. 31, 2015
Merger between Macrosolve, inc. and Drone Aviation Holding Corp / Drone Aviation Corp Aquisition of Lighter than Air Systems / Drone Aviation Holding Corp Asset Acquisition of Adaptive, Flight, Inc. [Abstract]  
DRONE AVIATION CORP AQUISITION OF LIGHTER THAN AIR SYSTEMS
3. DRONE AVIATION CORP AQUISITION OF LIGHTER THAN AIR SYSTEMS

 

On March 31, 2014, DAC was incorporated in the state of Nevada. During April and May 2014, investors purchased 34,100,000 shares of DAC common stock for an aggregate purchase price of $653,327. On May 5, 2014, DAC entered into a securities exchange agreement with World Surveillance Group, Inc. (WSGI) to acquire 100% of WSGI’s interest in its subsidiary, Lighter Than Air Systems (LTAS). LTAS provides critical aerial and land-based surveillance and communications solutions to government and commercial customers. DAC paid $335,000 and issued 10,000,000 shares of its common stock valued at the market price on the date of issuance, and the fair value of the shares was determined to be $79,000, or a total of $414,000, to WSGI as consideration for LTAS. Since DAC acquired cash of $30,361 from LTAS, as shown in the following table, the net cash amount DAC paid is $304,639.

 

In accordance with ASC 805-10 Business Combination and purchase acquisition accounting, DAC initially allocated the consideration to the net tangible and identifiable intangible assets, based on their estimated fair values as of the date of acquisition. Goodwill represents the excess of the purchase price over the fair value of the underlying net tangible and intangible assets. The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date.

 

  Property and equipment   $ 1,638  
  Accounts receivable     135,050  
  Cash in bank     30,361  
  Due from related party     20,650  
  Prepaid expenses     1,381  
  Inventory     109,581  
  Intangible asset     135,550  
  Current liabilities     (120,010 )
  Goodwill     99,799  
  Total purchase price   $ 414,000  

 

Intangible asset is in relation to the acquired customer list with a useful life of five years. The fair value of the customer list was determined by using a discounted cash flow model and $135,550 was recorded on the date of business combination. The Company recorded $31,941 of amortization expense for the year ended December 31, 2014. The Company recorded another $37,935 amortization expense for the year ended December 31, 2015. After comparing the acquired customer list to the actual customers who placed orders following the acquisition of LTAS, the Company determined that the customer list was impaired at December 31, 2015 and amortized the remaining balance of $65,674 in 2015.

 

The consolidated financial statements included herein are presented for the period from January 1, 2014 to May 5, 2014 since LTAS is considered Drone’s predecessor. LTAS has a net loss of $39,918 during the period from January 1, 2014 to May 5, 2014.
XML 22 R10.htm IDEA: XBRL DOCUMENT v3.3.1.900
Drone Aviation Holding Corp and Drone Aviation Corp Securities Exchange, Reverse Merger and Recapitalization
 12 Months Ended
Dec. 31, 2015
Drone Aviation Holding Corp and Drone Aviation Corp Securities Exchange, Reverse Merger and Recapitalization [Abstract]  
DRONE AVIATION HOLDING CORP. AND DRONE AVIATION CORP. SECURITIES EXCHANGE, REVERSE MERGER AND RECAPITALIZATION
4.DRONE AVIATION HOLDING CORP. AND DRONE AVIATION CORP. SECURITIES EXCHANGE, REVERSE MERGER AND RECAPITALIZATION

 

On June 3, 2014, the Company entered into a Securities Exchange Agreement with Drone Aviation Corp. (DAC).  Upon closing of the transaction, the holders of 100% of DAC’s outstanding common stock transferred such 44,100,000 outstanding shares to the Company in exchange for an aggregate of 8,050,000 [201,250 post-reverse] shares of the Company’s common stock and 36,050,000 shares of the Company’s Series D Preferred Stock, or a total of 44,100,000 [1,102,500 post-reverse] shares of common stock and common stock equivalents of the Company. Pursuant to the terms of the Securities Exchange Agreement, certain shareholders of DAC who, as a result of receiving the shares of common stock would hold in excess of 3.33% of the Company’s issued and outstanding common stock on a post-closing basis, elected to receive shares of the Company’s Series D Preferred Stock. At the closing of the transaction, the Company had 3,920,700 [98,017 post-reverse] shares of common stock outstanding, 595,000 shares of Series A Preferred Stock outstanding, 324,671 shares of Series B Preferred Stock outstanding, 156,231 shares of Series B-1 Preferred Stock outstanding and 355,000 shares of Series C Preferred Stock outstanding.

 

As a result of the Securities Exchange described above, DAC and its subsidiary, LTAS, became our wholly owned subsidiaries.

 

For accounting purposes, this transaction is being accounted for as a reverse merger and has been treated as a recapitalization of Drone Aviation Holding Corp. with Drone Aviation Corp. considered the accounting acquirer, and the financial statements of the accounting acquirer became the financial statements of the registrant. The 44,100,000 [1,102,500 post-reverse] shares issued to shareholders of DAC and its designees in conjunction with the securities exchange transaction have been presented as outstanding for all periods. The historical consolidated financial statements include the operations of the accounting acquirer for all periods presented.

 

On June 3, 2014, the assets and liabilities of Drone Aviation Holding Corp. carried onto the books were:

 

 Cash in bank $1,692,896 
 Available-for-sale securities  211,525 
 Prepaid expenses  37,403 
 Current liabilities  (39,622) 
 Derivative liabilities  (2,159,824)
 Note payable  (110,000) 
 Total $367,622 

 

On March 26, 2015 Drone Aviation Corp. merged into Drone Aviation Holding Corp.

 

Series E Preferred Private Placement

 

On June 3, 2014, prior to the reverse merger, the Company sold an aggregate of 2,700,000 units in a private placement of its securities to certain investors at a purchase price of $0.50 per unit pursuant to subscription for an aggregate purchase price of $1,350,000. Each unit consists of one share of the Company’s Series E Convertible Preferred Stock, par value $0.0001 per share, each of which is convertible into one-fortieth share, on a post-reverse split basis, of Common Stock, with such rights and designations as set forth in the Certificate of Designation; and a three year warrant to purchase one share of Common Stock at an exercise price of $40.00 per share. All the warrants were exercised on August 26, 2014. On June 2, 2015, the holders of Series E received an additional 2,700,000 units due to the Most Favored Nations provision associated with their initial investment.
XML 23 R11.htm IDEA: XBRL DOCUMENT v3.3.1.900
Drone Aviation Holding Corp Asset Acquisition of Adaptive, Flight, Inc.
 12 Months Ended
Dec. 31, 2015
Merger between Macrosolve, inc. and Drone Aviation Holding Corp / Drone Aviation Corp Aquisition of Lighter than Air Systems / Drone Aviation Holding Corp Asset Acquisition of Adaptive, Flight, Inc. [Abstract]  
DRONE AVIATION HOLDING CORP ASSET ACQUISITION OF ADAPTIVE, FLIGHT, INC.
5.DRONE AVIATION HOLDING CORP ASSET ACQUISITION OF ADAPTIVE, FLIGHT, INC.

 

On July 20, 2015, the Company, through its wholly-owned subsidiary Drone AFS Corp., purchased substantially all the assets of Adaptive Flight, Inc. (AFI), a Georgia corporation. The Company purchased assets including but not limited to intellectual property and licenses and permits, including commercial software licenses for the “GUST” (Georgia Tech UAV Simulation Tool) autopilot system, and other transferable licenses which include flight simulation and fault tolerant flight control algorithms. The Company paid $100,000 in immediately available funds and $100,000 to be held in escrow. In addition, the Company issued 150,000 shares of unregistered common stock valued at $8.40 per share, on a post-reverse split basis, on the date of agreement, to be held in escrow.

 

The Company has a milestone of twelve months to complete a technology Integration Plan, the non-completion of which may result in the return of the purchased assets and termination of the Company’s obligations to release the escrow cash and shares. Additional milestones include exclusive, no-cost and perpetual licenses to all contributing intellectual property included or related to the purchased assets. As such time as all milestones are met, one-half of the escrow shares will be released to AFI. Upon termination of the escrow agreement, anticipated to be twelve months from the closing of the asset purchase, if all milestones have been met, the remaining escrow shares will be released to AFI; but if all milestones have not been met, the escrow cash and escrow shares will be released to the Company and the purchased assets will be returned to AFI. According to the terms of the Escrow Agreement, if the escrow share value is less than $1,400,000, the Company must issue an additional number of unregistered shares, not to exceed 50,000 shares. At December 31, 2015, the value of the 150,000 shares was $3.23 per share, or $484,500. The Company recorded $161,500 as an additional liability and expense at December 31, 2015 for the cost of 50,000 shares at $3.23 per share. The liability will be reevaluated at the end of each quarter and adjusted through the profit and loss statement as necessary.

 

The asset acquisition did not qualify as a business combination under ASC 805-10 and has been accounted for as a regular asset purchase.
XML 24 R12.htm IDEA: XBRL DOCUMENT v3.3.1.900
Shareholders' Equity
 12 Months Ended
Dec. 31, 2015
Shareholders' Equity [Abstract]  
SHAREHOLDERS' EQUITY
6. SHAREHOLDERS’ EQUITY

 

On October 29, 2015 a 1:40 the Company effected a 1-for-40 reverse split of its common stock. The reverse split has been applied retroactively for disclosure purposes.

 

For the year ended December 31, 2015

 

The Company issued a total of 4,198,632 common shares during the 2015, adjusted for the October 29, 2015 1:40 reverse split, described further as follows:

 

The Company issued 215,750 shares of common stock between January 1 and March 31, 2015 pursuant to conversions of an aggregate of 86,300 shares of Series A preferred stock.

 

The Company issued 200,573 shares of common stock between April 1 and June 30, 2015 pursuant to conversions of an aggregate of 80,229 shares of Series A preferred stock.

 

The Company issued 25,500 shares of common stock between July 1 and September 30, 2015 pursuant to conversions of an aggregate of 10,200 shares of Series A preferred stock.

 

The Company issued 297,302 shares of common stock between October 1 and December 31, 2015 pursuant to conversions of an aggregate of 118,921 shares of Series A preferred stock.

 

The Company issued 1 share of common stock between July 1 and September 30, 2015 pursuant to conversions of an aggregate of 20 shares of Series B preferred stock.

 

The Company issued 8,116 shares of common stock between October 1 and December 31, 2015 pursuant to conversions of an aggregate of 324,651 shares of Series B preferred stock.

 

The Company issued 50,000 shares of common stock between April 1 and June 30, 2015 pursuant to conversions of an aggregate of 20,000 shares of Series C preferred stock.

 

The Company issued 25,000 shares of common stock between July 1 and September 30, 2015 pursuant to conversions of an aggregate of 10,000 shares of Series C preferred stock.

 

The Company issued 605,033 shares of common stock between October 1 and December 31, 2015 pursuant to conversions of an aggregate of 242,013 shares of Series C preferred stock.

 

The Company issued 210,000 shares of common stock between April 1 and June 30, 2015 pursuant to conversions of an aggregate of 8,400,000 shares of Series D preferred stock.

 

The Company issued 140,000 shares of common stock between July 1 and September 30, 2015 pursuant to conversions of an aggregate of 5,600,000 shares of Series D preferred stock.

 

The Company issued 501,250 shares of common stock between October 1 and December 31, 2015 pursuant to conversions of an aggregate of 20,050,000 shares of Series D preferred stock.

 

The Company issued 50,000 shares of common stock between July 1 and September 30, 2015 pursuant to conversions of an aggregate of 2,000,000 shares of Series E preferred stock.

 

The Company issued 85,000 shares of common stock between October 1 and December 31, 2015 pursuant to conversions of an aggregate of 3,400,000 shares of Series E preferred stock.

 

The Company issued 32,525 shares of common stock between October 1 and December 31, 2015 pursuant to conversions of an aggregate of 1,301,000 shares of Series F preferred stock

 

The Company issued 50,000 shares of common stock between October 1 and December 31, 2015 pursuant to conversions of an aggregate of 2,000,000 shares of Series G preferred stock

 

On June 1, 2015, the Company issued 50,000 shares of restricted common stock with monthly vesting provisions to the Chairman of the Board for twenty-four months services pursuant to a Director Agreement. The Chairman can earn a pro rata portion of the shares, calculated on a twenty-four month vesting period, in the event the Chairman relinquishes his position and board seat prior to the expiration date of the Director Agreement. The Company recognized a total of $157,500 expense for the pro rata portion of shares earned by the Chairman during 2015.

 

On August 27, 2014, the Company issued 50,000 shares of restricted common stock with monthly vesting provisions to two members of its Strategic Advisory Board for twelve months services. The advisors can earn a pro rata portion of the shares, calculated based on the twelve-month vesting period, in the event the service agreements are terminated prior to the expiration date as described in the agreements. The Company recognized a total of $213,333 expense for the pro rata portion of shares earned by the two advisors during 2015 and has recognized a total of $340,000 since August 27, 2014. The shares became fully vested on August 27, 2015.

 

On July 20, 2015, the Company issued 150,000 shares of restricted common stock valued at $1,260,000 to acquire assets from Adaptive Flight, Inc. as described above.

 

On September 4, 2015, the Company issued 450,000 shares of restricted common stock to four management employees and one director pursuant to stock award agreements. The shares will vest upon consummation of a $4,000,000 equity or debt financing provided that the holder remains engaged by the Company through the vesting date. Stock based compensation of $2,417,760 was recognized in 2015 based on management’s estimate that the shares will be fully vested by February 4, 2016 when the Board deemed vesting occurred with the issuance of $4,000,000 in common stock on November 20, 2015.

 

On November 17 and 19, 2015, the Company sold an aggregate of 745,000 shares of restricted common stock for a purchase price of $5.00 per share in a Private Placement for cash proceeds of $3,484,750 net of $240,250 financing fees. In connection with this sale, the Company issued an aggregate of 70,000 additional shares of common stock to holders of Series E preferred stock pursuant to the ‘most favored nations’ provisions governing the Series E preferred stock. Additionally, pursuant to the terms of the Series F preferred stock and Series G preferred stock, the Company was required to obtain consent to issue securities at a per share purchase price less than the purchase price of the Series F and Series G. In consideration for the consents, the company issued an aggregate of 182,525 shares of restricted common stock to the holders of Series F and Series G preferred stock.

 

On November 20, 2015, the Company entered into an Exchange Agreement with the holder of its outstanding shares of Series B-1 preferred stock pursuant to which the holder exchanged 68,731 shares of Series B-1 preferred stock for 55,000 shares of restricted common stock.

 

On October 29, 2015, the Company issued an aggregate of 57 restricted shares to various investors due to round factors associated with implementing the 1:40 reverse split.

 

For the year ended December 31, 2014

 

The Company issued 95,250 shares of common stock between June 3 and June 30, 2014, on a post-reverse split basis, pursuant to conversions of 38,100 shares of Series A Preferred Stock.

 

The Company issued 246,625 shares of common stock between July 1 and September 30, 2014, on a post-reverse split basis, pursuant to conversions of 98,650 shares of Series A Preferred Stock.

 

The Company issued 153,750 shares of common stock between October 1 and December 31, 2014, on a post-reverse split basis, pursuant to conversions of 61,500 shares of Series A Preferred Stock.

 

On July 1, 2014, the Company entered into a twelve-month consulting agreement for investor relations, marketing and public relations services. Pursuant to such agreement, the Company is obligated to pay the consultant for his services stock compensation of 6,250 shares of common stock, on a post-reverse split basis, immediately deliverable and an additional 6,250 shares of common stock deliverable after six months if the agreement is still in force. The 6,250 shares delivered in July were valued at $215,000. The agreement was terminated in December 2014 prior to the six month anniversary and, as a result, the Company is not obligated to deliver the remaining 6,250 shares of common stock.

 

On July 21, 2014, the Company issued a total of 42,500 shares of common stock, on a post-reverse split basis, to two consulting firms which held warrants issued on May 19, 2014 for services which were exercised at a $.40 strike price, on a post-reverse split basis, or a total of $17,000.

 

The Company issued 24,000 shares of common stock, on a post-reverse split basis, on August 25, 2014 pursuant to the conversion of 9,600 shares of Series C Preferred Stock.

 

On August 26, 2014, the Company issued an aggregate of 9,310 shares of restricted common stock, on a post-reverse split basis, to seven investors pursuant to the exercise of 100% of the warrants associated with Series E Preferred Stock.

 

On August 27, 2014, the Company issued 50,000 shares of restricted common stock, on a post-reverse split basis, with monthly vesting provisions to two members of its newly-formed Strategic Advisory Board for twelve months of service. The advisors can earn a pro rata portion of the shares, calculated based on the twelve-month vesting period, in the event the service agreements are terminated prior to the expiration date as described in the agreements. The Company recognized a total of $126,667 expense for the pro rata portion of shares earned by the two advisors during the year ended December 31, 2014.
XML 25 R13.htm IDEA: XBRL DOCUMENT v3.3.1.900
Preferred Stock
 12 Months Ended
Dec. 31, 2015
Preferred Stock [Abstract]  
PREFERRED STOCK
7.PREFERRED STOCK

 

For the year ended December 31, 2015

 

All of the preferred stock of the Company is convertible into common shares. The Series A and Series C stock conversion ratio is 1 to 2.5 common shares on a post-split basis. The Series B, B-1, D, E, F and G stock conversion ratio is 1 to 0.025 common shares on a post-split basis. The conversion price of Series B stock may be adjusted if a ‘dilutive triggering event’ occurs which could happen if the Company were to sell or issue common stock, warrants or convertible securities without consideration or for a consideration per share less than the conversion price in effect immediately prior to such sale or issue (dilutive triggering price). In such case, the Series B conversion price would be reduced to a price equal to the dilutive triggering price. All preferred stock has voting rights equal to the number of shares it would have on an ‘as if converted’ basis subject to any ownership limitations governing such preferred shares. All preferred stock is entitled to dividends rights equal to the number of shares it would have on an ‘as if converted’ basis. None of the preferred stock is redeemable, participating nor callable.

 

The Company analyzed the embedded conversion option for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the conversion option should be classified as equity.

 

The Company analyzed the conversion option for beneficial conversion features consideration under ASC 470-20 “Convertible Securities with Beneficial Conversion Features” and noted Series F stock contained a beneficial conversion feature. The intrinsic value of the beneficial conversion feature was determined to be $192,558. The beneficial conversion feature was fully amortized and recorded as a deemed dividend during the year ended December 31, 2014. The Series G stock issued during current quarter also contained a beneficial conversion feature. The intrinsic value of the beneficial conversion feature was determined to be $80,000. The beneficial conversion feature was fully amortized and recorded as a deemed dividend during the year ended December 31, 2015.

 

On October 29, 2015 a 1:40 reverse split of the Company stock occurred and the effect has been applied retroactively for disclosure purposes.

 

During 2015, eight investors in Series A preferred stock converted a total of 295,650 shares of Series A for an aggregate of 739,126 shares of restricted common stock in accordance with their conversion rights which includes a blocker with respect to individual ownership percentages. During the same period, both investors in Series B preferred stock converted a total of 324,671 shares of Series B for 8,117 shares of restricted common stock, six investors in Series C preferred stock converted a total of 272,013 shares of Series C for an aggregate of 680,033 shares of restricted common stock, thirteen investors in Series D preferred stock converted a total of 34,050,000 shares of Series D for an aggregate of 851,250 shares of restricted common stock, seven investors in Series E preferred stock converted a total of 5,400,000 shares of Series E for an aggregate of 135,000 shares of restricted common stock, three investors in Series F preferred stock converted a total of 1,301,001 shares of Series F for an aggregate of 32,525 shares of restricted common stock, and six investors in Series G preferred stock converted a total of 2,000,000 shares of Series G for an aggregate of 50,000 shares of restricted common stock, all in accordance with their conversion rights which includes a blocker with respect to individual ownership percentages.

 

On November 20, 2015, the Company entered into an Exchange Agreement with the holder of its outstanding shares of Series B-1 preferred stock pursuant to which the holder exchanged 68,731 shares of Series B-1 preferred stock for 55,000 shares of restricted common stock.

 

Series G Preferred Private Placement

 

On June 2, 2015, the Company sold an aggregate of 4,000,000 units in a private placement of its securities to certain investors at a purchase price of $0.25 per unit pursuant to subscription for an aggregate purchase price of $985,725, net of $14,275 financing fees. Each unit consists of one share of the Company’s Series G Convertible Preferred Stock, par value $0.0001 per share, each of which is convertible into 0.025 shares of Common Stock on a post-split basis.

 

On June 2, 2015, as a result of the sale of the Series G Preferred Stock, the Company issued 2,700,000 shares of Series E Convertible Preferred Stock, which are convertible into an aggregate of 67,500 shares of Common Stock on a post-split basis, to existing holders of Series E Preferred Stock, in connection with certain anti-dilution rights associated with their purchase of such shares. The additional share issuance was treated as a ‘stock split’ and was retrospectively reflected as of December 31, 2014.

 

On June 2, 2015, the Company received the consent of the holders of a majority of its Series F Convertible Preferred Stock to consummate the Series G Private Placement, as required under the terms of that investment. In consideration for the foregoing consent, the Company issued all holders of its Series F Preferred Stock an aggregate of an additional 2,200,666 shares of Series F Preferred Stock, which are convertible into an aggregate of 55,017 shares of common stock on a post-split basis. The additional share issuance was treated as a ‘stock split’ and was retrospectively reflected as of December 31, 2014.

 

Common Stock Private Placement

 

On November 17 and 19, 2015, the Company sold an aggregate of 745,000 shares of restricted common stock for a purchase price of $5.00 per share in a Private Placement. In connection with this sale, the Company issued an aggregate of 70,000 additional shares of common stock to holders of Series E preferred stock pursuant to the ‘most favored nations’ provisions governing the Series E preferred stock. Additionally, pursuant to the terms of the Series F preferred stock and Series G preferred stock, the Company was required to obtain consent to issue securities at a per share purchase price less than the purchase price of the Series F and Series G. In consideration for the consents, the company issued an aggregate of 182,525 shares of restricted common stock to the holders of Series F and Series G preferred stock.

 

For the year ended December 31, 2014

 

Between June 4 and June 30, 2014, seven holders of Series A Preferred Stock converted a total of 38,100 shares of Series A Preferred Stock for 95,250 shares of common stock, on a post-reverse split basis, in accordance with their conversion rights which includes a blocker with respect to individual ownership percentages.

 

Between July 1 and September 30, 2014, seven holders of Series A Preferred Stock converted a total of 98,650 shares for 246,625 shares of common stock, on a post-reverse split basis, in accordance with their conversion rights which includes a blocker with respect to individual ownership percentages.

 

Between October 1 and December 31, 2014, five holders of Series A Preferred Stock converted a total of 61,500 shares for 153,750 shares of common stock, on a post-reverse split basis, in accordance with their conversion rights which includes a blocker with respect to individual ownership percentages.

 

The Series B-1 Preferred Stock contains a liquidation provision whereas in the event of a fundamental transaction (such as the merger which occurred on June 3, 2014), the shareholder has the option to receive a preferential amount of cash equal to 400% of the stated value per share. On June 6, 2014, the sole holder of Series B-1 stock liquidated 87,500 shares for $350,000 leaving a remaining balance of 68,731 shares of Series B-1 preferred outstanding.

 

The Company issued 24,000 shares of common stock, on a post-reverse split basis, on August 25, 2014 pursuant to the conversion of 9,600 shares of Series C Preferred Stock.

 

Series F Preferred Private Placement

 

On August 27, 2014, the Company sold an aggregate of 1,100,333 units in a private placement of its securities to certain investors at a purchase price of $0.75 per unit pursuant to subscription for an aggregate purchase price of $822,750, net of $2,500 financing fees. Each unit consists of one share of the Company’s Series F Convertible Preferred Stock, par value $0.0001 per share, each of which is convertible into one-fortieth share of Common Stock, on a post-reverse split basis, with such rights and designations as set forth in the Certificate of Designation. The Company evaluated the convertible preferred stock under FASB ASC 470-20-30 and determined it contained a beneficial conversion feature. The intrinsic value of the beneficial conversion feature was determined to be $192,558. The beneficial conversion feature was fully amortized and recorded as a deemed dividend.
XML 26 R14.htm IDEA: XBRL DOCUMENT v3.3.1.900
Employee Stock Options
 12 Months Ended
Dec. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
EMPLOYEE STOCK OPTIONS
8.EMPLOYEE STOCK OPTIONS

 

For the year ended December 31, 2015

 

On October 29, 2015 a 1:40 reverse split of the Company stock occurred and the effect has been applied retroactively for disclosure purposes.

 

During 2015, the Company granted 842,500 common stock options to employees and a director for service provided. Of these, 250,000 options were immediately vested and were granted with an exercise price of $6.00 and the expiration date is May 18, 2018. Another 105,000 options were immediately vested and were granted with an exercise price of $5.00 and the expiration date of December 10, 2018. Another 250,000 options vest over two years or upon the up listing of the Company’s common stock and were granted with an exercise price of $6.00 and the expiration date is June 1, 2018. These 250,000 options were surrendered and cancelled on September 4, 2015. A director received two options. The first was for 75,000 shares vesting over two years and was granted with an exercise price of $10.00 and the expiration date is June 1, 2018. The second was for 125,000 shares with vesting tied to performance and was granted with an exercise price of $10.00 and the expiration date is June 1, 2018. These two director options were surrendered and cancelled on September 4, 2015. Stock based compensation was reversed for costs previously recognized on the total 450,000 surrendered and cancelled unvested options. Another option for 37,500 shares vesting over three years was granted with an exercise price of $10.80 and the expiration date is May 4, 2019.

 

The Company uses the Black-Scholes option pricing model to estimate the fair value of stock-based awards on the date of grant.

 

The following table summarizes the assumptions used to estimate the fair value of stock options granted during 2015:

 

   2015 
     
 Expected dividend yield  0%
 Expected volatility  116% – 131%
 Risk-free interest rate  0.79% – 1.25%
 Expected life of options  2.43 – 3.00 years 

 

Under the Black-Scholes option price model, fair value of the options granted is estimated at $3,013,531. During 2015, $2,822,132 compensation expense was recognized and the remaining $191,399 will be recognized over the next three years.

 

The following table represents stock option activity as of and for the period ended December 31, 2015:

 

   

 

 

Number of Options

  

Weighted

Average

Exercise Price

  

 

Contractual Life in Years

  

 

 

Intrinsic

Value

 
 Outstanding – December 31, 2014  -  $0.00         
 Exercisable – December 31, 2014  -  $0.00      $0.00 
 Granted  842,500  $7.04         
 Exercised or Vested  -  $0.00         
 Cancelled or Expired  450,000  $7.78         
 Outstanding – December 31, 2015  392,500  $6.19   2.62     
 Exercisable – December 31, 2015  355,000  $5.70   2.55  $0.00 

 

For the year ended December 31, 2014

 

On April 30, 2014, the effective date of the Redomestication and effective date of the Merger Exchange Ratio, there were a total of 920 vested and 618 unvested options, on a post-reverse split basis, carried over to the reverse merger with DAC on June 3, 2014 with strike prices ranging from $66.80 to $5,056. During September 2014, the holders of these options voluntarily agreed to terminate their options. At December 31, 2014 there are no outstanding options.
XML 27 R15.htm IDEA: XBRL DOCUMENT v3.3.1.900
Warrants
 12 Months Ended
Dec. 31, 2015
Warrants [Abstract]  
WARRANTS
9.WARRANTS

 

For the year ended December 31, 2015

 

On October 29, 2015 a 1:40 reverse split of the Company stock occurred and the effect has been applied retroactively for disclosure purposes.

 

For the year 2015, 52,500 common stock purchase warrants were granted to two consultants and a vendor for service provided. One consultant was granted 25,000 warrants with exercise price of $10.00, vesting over two years and the expiration date is June 16, 2018. The other consultant was granted 12,500 warrants with exercise price of $10.00, vesting over one year and the expiration date is June 25, 2018. These same two consultants and the vendor each received 5,000 warrants with exercise price of $5.00, immediately vested and an expiration date of December 10, 2018.

 

On November 20, 2015, the Company issued 70,000 warrants with exercise price of $5.00, immediately vested and the expiration date of November 20, 2020 to the placement agent in the common stock private placement.

 

The Company uses the Black-Scholes warrant pricing model to estimate the fair value of warrants as of December 31, 2015.

 

The following table summarizes the assumptions used to estimate the fair value of warrants granted during 2015:

 

    2015 
      
 Expected dividend yield  0%
 Expected volatility  116% – 121%
 Risk-free interest rate  .87% – 1.70%
 Expected life of warrants  2.4 – 5 years 

 

Under the Black-Scholes warrant price model, fair value of the warrants granted is estimated at $347,201. During 2015, $324,263 compensation expense was recognized.

 

For the year ended December 31, 2014

 

On April 30, 2014, the effective date of the Redomestication and effective date of the Merger Exchange Ratio, there were a total of 16,842 warrants, on a post-reverse split basis, carried over to the reverse merger with DAC on June 3, 2014 with strike prices ranging from $101.2 to $662.8. A total of 4,717 of these warrants with strike prices of $202.4 expired between July and September 2014 leaving a total of 12,125 outstanding warrants.

 

During May 2014, the Company issued a total of 42,500 warrants on a post-reverse split basis for services. The warrants have a term of three years, and exercise price of $0.40. The 42,500 warrants were exercised in July 2014 for a total of $17,000. As further described above in Note 4, on June 3, 2014, the Company issued 67,500 warrants on a post-reverse split basis to purchase one share of common stock at an exercise price of $40.00 per warrant share to investors who purchased Series E Preferred Stock. The exercise price of $40.00 per warrant may be adjusted any time during the first twenty-four months from issuance under the terms of a Favored Nations Provision contained in the warrant. If at any time during that twenty-four month period the Company should issue common stock or convertible securities at a price lower than $40.00 per share, unless the warrant holder consents to such lower price issuance, then the exercise price of the warrant shall be automatically reduced to reflect such other lower price and the number of warrant securities shall be adjusted to reflect such lower price. The warrants expire on June 3, 2017. In August 2014, all seven investors holding the warrants attached to Series E Preferred Stock executed cashless exercises of their warrants resulting in the issuance of 9,310 shares of restricted common stock on a post-reverse split basis.

 

Because the 42,500 warrants issued on June 3, 2014 have full reset adjustments tied to future issuances of equity securities by the Company, they are subject to derivative liability treatment under ASC 815-40-15 “Determining whether an Instrument (or Embedded feature) is Indexed to an Entity’s Own Stock.” ASC 815-40-15 requires as of the date the warrant is issued, the derivative liability to be measured at fair value and re-evaluated at the end of each reporting period.

 

As of June 3, 2014, the fair value of the warrants derivative liability was $2,159,824 – see Note #4. On August 26, 2014, when the warrants were exercised, the Company determined the fair value of the derivative liability to be $2,510,793, and upon warrant exercise, the derivative liability was written off to additional paid in capital.

 

As a result of the warrant exercises, as of December 31, 2014, the fair value of the warrants derivative liability is $0, and the Company recognized a loss on derivative liability of $350,969 for the year ended December 31, 2014. The fair value of the derivative liability was estimated at the date of grant and the date of warrant exercised using a Black-Scholes option pricing model.

 

The following table represents warrant activity as of and for the period ended December 31, 2015 and 2014:

 

   

Number of Warrants

  

Weighted

Average

Exercise Price

  

Contractual Life in Years

  

Intrinsic

Value

 
 Outstanding – December 31, 2014  12,129  $206.86   2.04     
 Exercisable – December 31, 2014  12,129  $206.86   2.04  $0.00 
 Granted  122,500  $6.53         
                 
 Forfeited or Expired  (420) $250.35         
 Outstanding – December 31, 2015  134,209  $23.87   3.66     
 Exercisable – December 31, 2015  104,209  $27.87   4.01  $0.00
XML 28 R16.htm IDEA: XBRL DOCUMENT v3.3.1.900
Inventories
 12 Months Ended
Dec. 31, 2015
Inventories [Abstract]  
INVENTORIES
10.INVENTORIES

 

Inventories consisted of the following:

 

   2015  2013 
 Raw Materials $26,358  $18,944 
 Work in progress  3,817   1,369 
 Finished Goods  107,209   19,091 
 Less valuation allowance  (18,589)  - 
   $118,795  $39,404
XML 29 R17.htm IDEA: XBRL DOCUMENT v3.3.1.900
Prepaid Expenses
 12 Months Ended
Dec. 31, 2015
Prepaid Expenses [Abstract]  
PREPAID EXPENSES
11.PREPAID EXPENSES

 

Prepaid expenses consisted of the following:

 


   2015  2014 
 Prepaid insurance $25,517  $23,114 
 Prepaid services  24,192   15,225 
 Prepaid rent and security deposit  5,915   11,830 
   $55,624  $50,169
XML 30 R18.htm IDEA: XBRL DOCUMENT v3.3.1.900
Investment in Securities Held for Resale
 12 Months Ended
Dec. 31, 2015
Investment in Securities Held for Resale [Abstract]  
INVESTMENT IN SECURITIES HELD FOR RESALE
12.INVESTMENT IN SECURITIES HELD FOR RESALE

 

The Company owned common stock in DecisionPoint Systems, Inc. (DPSI), MEDL Mobile Holdings, Inc. (MEDL) and Endexx Corporation (EDXC) as a result of certain 2012 and 2013 business transactions of MacroSolve. These securities were revalued at fair market value on June 3, 2014 as part of the reverse merger accounting. During the second quarter, the Company sold 607,284 shares of DPSI and 147,692 shares of MEDL, representing all of its holdings in those securities, with losses of $21,635 and $3,686 recorded respectively. The Company received a total of $168,704 net cash proceeds from the sales. The Company holds 125,000 shares of EDXC, but has been unable to liquidate the shares due to issues with Endexx Corporation not being a fully-reporting company. The Company has determined that the EDXC shares are impaired and has charged off the $17,500 carrying value. A total of $42,821 was recorded as loss on sale of securities for the year ended December 31, 2014.
XML 31 R19.htm IDEA: XBRL DOCUMENT v3.3.1.900
Oklahoma Technology Commercialization Center
 12 Months Ended
Dec. 31, 2015
Oklahoma Technology Commercialization Center [Abstract]  
OKLAHOMA TECHNOLOGY COMMERCIALIZATION CENTER
13.OKLAHOMA TECHNOLOGY COMMERCIALIZATION CENTER

 

At the time of the April 30, 2014 Redomestication, MacroSolve had an $110,000 past-due balance on its refundable award from the State of Oklahoma Technology Business Finance Program which includes accrued interest (imputed at 14.27%) through September 2007 after which interest no longer accrued. The Company has not made any reductions in the award so it is in default. The Company has proposed a settlement to be released from the debt that is unrelated to the current operations and is awaiting a response.
XML 32 R20.htm IDEA: XBRL DOCUMENT v3.3.1.900
Income Taxes
 12 Months Ended
Dec. 31, 2015
Income Taxes [Abstract]  
INCOME TAXES
14.INCOME TAXES

 

The Company uses the liability method, where deferred tax assets and liabilities are determined based on the expected future tax consequences of temporary differences between the carrying amounts of assets and liabilities for financial and income tax reporting purposes.

 

During the post-reverse merger period of June 4, 2014 through December 31, 2014, the Company incurred a net loss, and, therefore, had no tax liability. Lighter Than Air Systems paid $5,571 in income taxes during 2014 for two short period returns, including the periods of March 29, 2013 through December 31, 2013 and January 1, 2014 through June 3, 2014 when it was a subsidiary of WSGI. The net deferred asset generated by the loss carry-forward has been fully reserved. The cumulative net operating loss carry-forward is approximately $4,220,577 for 2015 and will begin expiring in 2034. Section 382 of the Internal Revenue Code generally imposes an annual limitation on the amount of net operating loss carryforwards that may be used to offset taxable income when a corporation has undergone significant changes in its stock ownership. The $4,220,577 estimate of net operating loss carry-forward is calculated after we consider the effect of Section 382.

 

Deferred tax assets consist of the tax effect of NOL carry-forwards. The Company has provided a full valuation allowance on the deferred tax assets because of the uncertainty regarding its realizability. Deferred tax assets consist of the following:

 

   

December 31, 2015

  

December 31, 2014

 
 Net operating loss carry-forwards $1,434,996  $497,501 
 Valuation allowance  (1,434,996)  (497,501)
   $-0-  $-0- 
XML 33 R21.htm IDEA: XBRL DOCUMENT v3.3.1.900
Commitments and Contingencies
 12 Months Ended
Dec. 31, 2015
Commitments and Contingencies [Abstract]  
COMMITMENTS AND CONTINGENCIES
15.COMMITMENTS AND CONTINGENCIES

 

On November 17, 2014, the Company entered into a 60 month lease for 5,533 square feet of office and manufacturing space at 11651 Central Parkway Suite 118, Jacksonville Florida, with an anticipated lease commencement date of February 1, 2015. The actual commencement date was July 1, 2015 and the lease was amended to 61 months expiring July 31, 2020. The monthly rent, including operating expenses and sales tax, for each year of the initial lease term is estimated to be $5,915. Anticipated total rent during the term of the lease is as follows:

 

Year 2016 - $ 71,854
Year 2017 - $ 73,619
Year 2018 - $ 75,437
Year 2019 - $ 77,309
Year 2020 - $ 45,651

  

On January 1, 2015, the Company entered into an agreement to lease executive office space for its President in Aventura, Florida. The monthly cost is expected to be $1,437 per month on a month-to-month basis with a sixty-day notice to cancel the agreement.

 

Rent expense in 2015 and 2014 were $76,492, and $37,557, respectively, and consisted of reimbursements for home offices and reimbursements made in 2014 to a related party which leased the Company’s former shared office and manufacturing space.

 

As of December 31, 2015, the Company is a party in a pending motion by Newegg Inc. for recovery of defendant legal fees of approximately $400,000 from the Company in the matter of MacroSolve, Inc. v Newegg Inc. (U.S.D.C.E.D. TX) case No 6:12-cv-46-MSS-KNM. Should the company not prevail in that matter, the judgment would be borne by the former MacroSolve directors who sold their loans on April 17, 2014. Other than that matter, there are no material claims, actions, suits, proceedings inquiries, labor disputes or investigations pending.
XML 34 R22.htm IDEA: XBRL DOCUMENT v3.3.1.900
Concentrations
 12 Months Ended
Dec. 31, 2015
Concentrations [Abstract]  
CONCENTRATIONS
16.CONCENTRATIONS

 

Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of trade receivables.  The Company performs ongoing credit evaluations of its customers and generally does not require collateral related to its receivables. At December 31, 2015, accounts receivable from two customers comprised 100% of the company’s total accounts receivable-trade. Revenues from two customers approximated 71% of total revenues for 2015. At December 31, 2014, accounts receivable from one customer comprised approximately 100% of the Company’s total accounts receivable-trade. Revenues from four customers approximated 92% of total revenues for 2014.
XML 35 R23.htm IDEA: XBRL DOCUMENT v3.3.1.900
Subsequent Events
 12 Months Ended
Dec. 31, 2015
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS
17. SUBSEQUENT EVENTS

 

The Company issued a total of 335,968 shares of common stock between January 1- March 4, 2016, described further as follows:

 

The Company issued 2,500 shares of common stock between January 1- March 4, 2016 pursuant to conversions of an aggregate of 1,000 shares of Series A preferred stock.

 

The Company issued 183,468 shares of common stock between January 1- March 4, 2016 pursuant to conversions of an aggregate of 73,387 shares of Series C preferred stock.

 

The Company issued 50,000 shares of common stock between January 1- March 4, 2016 pursuant to conversions of an aggregate of 2,000,000 shares of Series D preferred stock.

 

The Company issued 50,000 shares of common stock between January 1- March 4, 2016 pursuant to conversions of an aggregate of 1,999,998 shares of Series F preferred stock.

 

The Company issued 50,000 shares of common stock between January 1- March 4, 2016 pursuant to conversions of an aggregate of 2,000,000 shares of Series F preferred stock.
XML 36 R24.htm IDEA: XBRL DOCUMENT v3.3.1.900
Summary of Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2015
Summary of Significant Accounting Policies [Abstract]  
Description of Business:

Description of Business:

 

Drone Aviation Holding Corp. (“Drone” or “Company”) develops and manufactures cost-effective, compact and rapidly deployable aerial platforms including lighter-than-air aerostats and electric-powered drones designed to provide government and commercial customers with enhanced surveillance and communication capabilities. Utilizing a proprietary tether system, the Company's products are designed to provide prolonged operational duration capabilities combined with improved reliability, uniquely fulfilling critical requirements in military, law enforcement and commercial and industrial applications.
Basis of Presentation:

Basis of Presentation:

 

The accompanying financial statements of the Company were prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
Principal of Consolidation:

Principal of Consolidation:

 

Our consolidated financial statements as of December 31, 2015 include the accounts of Drone Aviation Holding Corp. and its subsidiaries: Drone AFS Corp. and Lighter Than Air Systems Corp. Our consolidated financial statements as of December 31, 2014 include the accounts of Drone Aviation Holding Corp. and its subsidiaries: Drone Aviation Corp. and Lighter Than Air Systems Corp.
Reclassifications:

Reclassifications:

 

Certain prior year amounts have been combined and reclassified to conform to the current year presentation.
Use of Estimates:

Use of Estimates:

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.
Concentration of Credit Risk:

Concentration of Credit Risk:

 

Financial instruments which potentially subject the Company to concentrations of credit risk consist of cash and trade receivables. The Company places its cash with high credit quality financial institutions. At times such cash may be in excess of the FDIC limit. With respect to trade receivables, the Company routinely assesses the financial strength of its customers and, as a consequence, believes that the receivable credit risk exposure is limited.
Cash Equivalents:

Cash Equivalents:

 

Cash equivalents are represented by operating accounts or money market accounts maintained with insured financial institutions, including all highly-liquid investments with maturities of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2015 and 2014.
Accounts Receivable and Credit Policies:

Accounts Receivable and Credit Policies:

 

Trade accounts receivable consist of amounts due from the sale of tethered aerostats, accessories, spare parts and delivery and installation of aerostats.  Accounts receivable are uncollateralized customer obligations due under normal trade terms requiring payment within 30 days of receipt of the invoice.  The Company provides an allowance for doubtful accounts equal to the estimated uncollectible amounts based on historical collection experience and a review of the current status of trade accounts receivable.  At December 31, 2015 and 2014, the Company characterized $0 and $0 as uncollectible, respectively.

 
Marketable Securities:

Marketable Securities:

 

All marketable securities are classified as available-for-sale securities. Available-for-sale securities are carried at fair value with resulting unrealized gains and losses, reported as a component of accumulated other comprehensive loss. The Company did not have any available-for-sale securities at December 31, 2015.
Inventories

Inventories

 

Inventories are stated at the lower of cost or market, using the first-in first-out method. Cost includes materials, labor and manufacturing overhead related to the purchase and production of inventories. We regularly review inventory quantities on hand, future purchase commitments with our supplies, and the estimated utility of our inventory. If the review indicates a reduction in utility below carrying value, we reduce our inventory to a new cost basis through a charge to cost of goods sold.
Property and Equipment:

Property and Equipment:

 

Property and equipment is recorded at cost when acquired.  Depreciation is provided principally on the straight-line method over the estimated useful lives of the related assets, which is 3-7 years for equipment, furniture and fixtures, hardware and software.   Property and equipment consists of the following at December 31, 2015 and 2014:

 

 

 

 2015  2014 
 Shop Machinery and equipment $80,889  $19,954 
 Computers and electronics  28,911   12,075 
 Office furniture and fixtures  33,977   2,035 
 Leasehold improvements  19,514   - 
    163,291   34,064 
 Less - accumulated depreciation  (26,995)  (7,040)
   $136,296  $27,024 

 

Expenditures for maintenance and repairs are charged to expense as incurred, whereas expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized.

 

During the year ended December 31, 2015 and 2014, the Company purchased $129,227 and $27,863 of furniture and equipment, respectively.

 

The Company recognized $19,955 and $2,477 of depreciation expense for the year ended December 31, 2015 and 2014, respectively,
Long-Lived Assets & Goodwill:

Long-Lived Assets & Goodwill:

 

The Company accounts for long-lived assets in accordance with the provisions of ASC 360-10-35, “Impairment or Disposal of Long-lived Assets”.  This Statement requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.  Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset.  If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.  The Company acquired the LTAS customer list in 2014. The fair value of the customer list was determined by using a discounted cash flow model and $135,550 was recorded on the date of business combination. The Company recorded $31,941 of amortization expense for the year ended December 31, 2014 leaving a remaining carrying amount of $103,609. The Company recorded another $37,935 amortization expense for the year ended December 31, 2015. After comparing the acquired customer list to the actual customers who placed orders following the acquisition of LTAS, the Company determined that the customer list was impaired at December 31, 2015 and amortized the remaining balance of $65,674 in 2015.

 

The Company accounts for goodwill and intangible assets in accordance with ASC 350 "Intangibles Goodwill and Other". ASC 350 requires that goodwill and other intangibles with indefinite lives be tested for impairment annually or on an interim basis if events or circumstances indicate that the fair value of an asset has decreased below its carrying value. The Company performed impairment analysis using the qualitative analysis under ASC 350-20 and noted no impairment issues for 2015.
Derivative Financial Instruments:

Derivative Financial Instruments:

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes option pricing model, in accordance with ASC 815-15 “Derivative and Hedging” to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
Beneficial Conversion Features:

Beneficial Conversion Features:

 

The Company evaluates the embedded conversion feature within its convertible debt instruments under ASC 815-15 and ASC 815-40 to determine if the conversion feature meets the definition of a liability and therefore need to bifurcate the conversion feature and account for it as a separate derivative liability. The intrinsic value of a beneficial conversion feature inherent to a convertible note payable, which is not bifurcated and accounted for separately from the convertible note payable and may not be settled in cash upon conversion, is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual term, the unamortized discount is expensed in the period of retirement to interest expense. In general, the beneficial conversion feature is measured by comparing the effective conversion price, after considering the relative fair value of detachable instruments included in the financing transaction, if any, to the fair value of the common shares at the commitment date to be received upon conversion.
Fair Value of Financial Instruments:

Fair Value of Financial Instruments:

 

The Company measures its financial assets and liabilities in accordance with the requirements of FASB ASC 820, “Fair Value Measurements and Disclosures”. ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

 

Level 1– Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.

 

Level 2 – Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.

 

Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.
Revenue Recognition and Unearned Revenue:

Revenue Recognition and Unearned Revenue:

 

The Company recognizes revenue when all four of the following criteria are met: 1) persuasive evidence of an arrangement exists; 2) delivery has occurred and title has transferred or services have been rendered; 3) our price to the buyer is fixed or determinable; and 4) collectability is reasonably assured. We record unearned revenue as a liability and their associated costs of sales as work in process inventory. In 2015, the Company deferred recognizing $7,896 in revenue from a 2015 sale that was delivered in January 2016. There is a balance of $83,288 in accounts receivable at December 31, 2015 for sales on account.
Income Taxes:

Income Taxes:

 

The Company accounts for income taxes utilizing ASC 740, “Income Taxes” (SFAS No. 109).  ASC 740 requires the measurement of deferred tax assets for deductible temporary differences and operating loss carry forwards, and of deferred tax liabilities for taxable temporary differences.  Measurement of current and deferred tax liabilities and assets is based on provisions of enacted tax law.  The effects of future changes in tax laws or rates are not included in the measurement.  The Company recognizes the amount of taxes payable or refundable for the current year and recognizes deferred tax liabilities and assets for the expected future tax consequences of events and transactions that have been recognized in the Company’s financial statements or tax returns.  The Company has recorded a 100% valuation allowance against net deferred tax assets due to uncertainty of their ultimate realization.  Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.
Employee Stock-Based Compensation:

Employee Stock-Based Compensation:

 

The Company accounts for stock-based compensation in accordance with ASC 718, “Compensation-Stock Compensation”. ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period.
Non-Employee Stock-Based Compensation:

Non-Employee Stock-Based Compensation:

 

The Company accounts for stock-based compensation in accordance with the provision of ASC 505, “Equity Based Payments to Non-Employees” (“ASC 505”), which requires that such equity instruments are recorded at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instruments vest.
Related Parties:

Related Parties:

 

A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party.

 

The accounts payable due to related party at December 31, 2015 was comprised of $6,000 director fees which were paid in January 2016. The accounts payable due to related party at December 31, 2014, includes allocated rent and utility charges, aerostat envelopes, truck expenses and labor charges due Aerial Products Corp (“APC”) was $2,181. APC is a related party, controlled by a current employee of the Company. APC shared the manufacturing facilities with LTAS and provided aerostat envelopes and manufacturing labor to LTAS until June 30, 2014 when the APC labor pool transitioned to the Company. Total charges from APC to LTAS during the years ended December 31, 2015 and 2014 were $7,549 and $19,242 respectively. Additionally, the Company purchased used fixed assets from APC for $6,500 during the year ended December 31, 2015.
Earnings or Loss per Share:

Earnings or Loss per Share:

 

The Company accounts for earnings per share pursuant to ASC 260, Earnings per Share, which requires disclosure on the financial statements of "basic" and "diluted" earnings (loss) per share. Basic earnings (loss) per share are computed by dividing net income (loss) by the weighted average number of common shares outstanding for the year. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding plus common stock equivalents (if dilutive) related to stock options and warrants for each year. As there was a net loss for the years ended December 31, 2015 and 2014, basic and diluted losses per share are the same for both years.
Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company's financial statements.
XML 37 R25.htm IDEA: XBRL DOCUMENT v3.3.1.900
Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2015
Summary of Significant Accounting Policies [Abstract]  
Schedule of property and equipment

 

 

 2015  2014 
 Shop Machinery and equipment $80,889  $19,954 
 Computers and electronics  28,911   12,075 
 Office furniture and fixtures  33,977   2,035 
 Leasehold improvements  19,514   - 
    163,291   34,064 
 Less - accumulated depreciation  (26,995)  (7,040)
   $136,296  $27,024
XML 38 R26.htm IDEA: XBRL DOCUMENT v3.3.1.900
Drone Aviation Corp Aquisition of Lighter than Air Systems (Tables)
 12 Months Ended
Dec. 31, 2015
Merger between Macrosolve, inc. and Drone Aviation Holding Corp / Drone Aviation Corp Aquisition of Lighter than Air Systems / Drone Aviation Holding Corp Asset Acquisition of Adaptive, Flight, Inc. [Abstract]  
DRONE AVIATION CORP AQUISITION OF LIGHTER THAN AIR SYSTEMS
 Property and equipment $1,638 
 Accounts receivable  135,050 
 Cash in bank  30,361 
 Due from related party  20,650 
 Prepaid expenses  1,381 
 Inventory  109,581 
 Intangible asset  135,550 
 Current liabilities  (120,010)
 Goodwill  99,799 
 Total purchase price $414,000
XML 39 R27.htm IDEA: XBRL DOCUMENT v3.3.1.900
Drone Aviation Holding Corp and Drone Aviation Corp Securities Exchange, Reverse Merger and Recapitalization (Tables)
 12 Months Ended
Dec. 31, 2015
Drone Aviation Holding Corp and Drone Aviation Corp Securities Exchange, Reverse Merger and Recapitalization [Abstract]  
DRONE AVIATION HOLDING CORP. AND DRONE AVIATION CORP. SECURITIES EXCHANGE, REVERSE MERGER AND RECAPITALIZATION
 Cash in bank $1,692,896 
 Available-for-sale securities  211,525 
 Prepaid expenses  37,403 
 Current liabilities  (39,622) 
 Derivative liabilities  (2,159,824)
 Note payable  (110,000) 
 Total $367,622 
XML 40 R28.htm IDEA: XBRL DOCUMENT v3.3.1.900
Employee Stock Options (Tables) - Employee Stock Option [Member]
 12 Months Ended
Dec. 31, 2015
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]  
Summarizes the assumptions of estimate the fair value stock options granted
   2015 
     
 Expected dividend yield  0%
 Expected volatility  116% – 131%
 Risk-free interest rate  0.79% – 1.25%
 Expected life of options  2.43 – 3.00 years 
Summarizes the assumptions of stock option activity
  

 

 

Number of Options

  

Weighted

Average

Exercise Price

  

 

Contractual Life in Years

  

 

 

Intrinsic

Value

 
 Outstanding – December 31, 2014  -  $0.00         
 Exercisable – December 31, 2014  -  $0.00      $0.00 
 Granted  842,500  $7.04         
 Exercised or Vested  -  $0.00         
 Cancelled or Expired  450,000  $7.78         
 Outstanding – December 31, 2015  392,500  $6.19   2.62     
 Exercisable – December 31, 2015  355,000  $5.70   2.55  $0.00 
XML 41 R29.htm IDEA: XBRL DOCUMENT v3.3.1.900
Warrants (Tables) - Warrant [Member]
 12 Months Ended
Dec. 31, 2015
Class of Warrant or Right [Line Items]  
Summarizes of the assumptions of estimate the fair value warrants granted
    2015 
      
 Expected dividend yield  0%
 Expected volatility  116% – 121%
 Risk-free interest rate  .87% – 1.70%
 Expected life of warrants  2.4 – 5 years 
Schedule of warrant activity
   

Number of Warrants

  

Weighted

Average

Exercise Price

  

Contractual Life in Years

  

Intrinsic

Value

 
 Outstanding – December 31, 2014  12,129  $206.86   2.04     
 Exercisable – December 31, 2014  12,129  $206.86   2.04  $0.00 
 Granted  122,500  $6.53         
                 
 Forfeited or Expired  (420) $250.35         
 Outstanding – December 31, 2015  134,209  $23.87   3.66     
 Exercisable – December 31, 2015  104,209  $27.87   4.01  $0.00 
XML 42 R30.htm IDEA: XBRL DOCUMENT v3.3.1.900
Inventories (Tables)
 12 Months Ended
Dec. 31, 2015
Inventories [Abstract]  
Schedule of Inventory

   2015  2013 
 Raw Materials $26,358  $18,944 
 Work in progress  3,817   1,369 
 Finished Goods  107,209   19,091 
 Less valuation allowance  (18,589)  - 
   $118,795  $39,404 
XML 43 R31.htm IDEA: XBRL DOCUMENT v3.3.1.900
Prepaid Expenses (Tables)
 12 Months Ended
Dec. 31, 2015
Prepaid Expenses [Abstract]  
Schedule of prepaid expenses

   2015  2014 
 Prepaid insurance $25,517  $23,114 
 Prepaid services  24,192   15,225 
 Prepaid rent and security deposit  5,915   11,830 
   $55,624  $50,169 
XML 44 R32.htm IDEA: XBRL DOCUMENT v3.3.1.900
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2015
Income Taxes [Abstract]  
Schedule of deferred tax assets
   

December 31, 2015

  

December 31, 2014

 
 Net operating loss carry-forwards $1,434,996  $497,501 
 Valuation allowance  (1,434,996)  (497,501)
   $-0-  $-0- 

 
XML 45 R33.htm IDEA: XBRL DOCUMENT v3.3.1.900
Commitments and Contingencies (Tables)
 12 Months Ended
Dec. 31, 2015
Commitments and Contingencies [Abstract]  
Schedule of operating lease
 Year 2016 - $ 71,854 
 Year 2017 - $ 73,619 
 

Year 2018 - $ 75,437

 
 Year 2019 - $ 77,309 
 Year 2020 - $ 45,651 
XML 46 R34.htm IDEA: XBRL DOCUMENT v3.3.1.900
Summary of Significant Accounting Policies (Details) - USD ($)
Dec. 31, 2015
Dec. 31, 2014
Summary of Significant Accounting Policies [Abstract]    
Shop Machinery and equipment $ 80,889 $ 19,954
Computers and electronics 28,911 12,075
Office furniture and fixtures 33,977 $ 2,035
Leasehold improvements 19,514
Property and equipment,gross 163,291 $ 34,064
Less - accumulated depreciation (26,995) (7,040)
Net property and equipment $ 136,296 $ 27,024
XML 47 R35.htm IDEA: XBRL DOCUMENT v3.3.1.900
Summary of Significant Accounting Policies (Details Textual) - USD ($)
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Property, Plant and Equipment [Line Items]    
Uncollectible receivables $ 0 $ 0
Deferred revenue 7,896
Accounts receivable prepayment $ 83,288  
Valuation allowance against net deferred tax assets 100.00%  
Accounts receivable, payment period 30 days  
Accounts payable due to related party $ 6,000 $ 2,181
Total charges 7,549 19,242
Depreciation expense 19,955 2,477
Cash paid on furniture and equipment 129,227 27,863
Amortization expenses 37,935 $ 31,941
Purchase of fixed asstes 6,500  
Impairment of intangible assets 65,674  
Customer Lists [Member]    
Property, Plant and Equipment [Line Items]    
Amortization of discounted cash flow model 135,550  
Amortization expenses $ 103,609  
Equipment [Member] | Maximum [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life 7 years  
Equipment [Member] | Minimum [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life 3 years  
Furniture and fixtures [Member] | Maximum [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life 7 years  
Furniture and fixtures [Member] | Minimum [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life 3 years  
Hardware and software [Member] | Maximum [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life 7 years  
Hardware and software [Member] | Minimum [Member]    
Property, Plant and Equipment [Line Items]    
Estimated useful life 3 years  
XML 48 R36.htm IDEA: XBRL DOCUMENT v3.3.1.900
Merger between Macrosolve, inc. and Drone Aviation Holding Corp (Details) - shares
Apr. 14, 2014
Dec. 31, 2015
Dec. 31, 2014
Apr. 30, 2014
Merger between macrosolve inc and drone aviation holding corp (Textual)        
Common stock, shares issued   5,125,585 926,953 3,920,700
Common stock, shares outstanding   5,125,585 926,953 3,920,700
Series A Preferred Stock [Member]        
Merger between macrosolve inc and drone aviation holding corp (Textual)        
Preferred stock, shares issued   101,100 396,750 595,000
Series B Preferred Stock [Member]        
Merger between macrosolve inc and drone aviation holding corp (Textual)        
Preferred stock, shares issued   0 324,671 324,671
Series B-1 Preferred Stock [Member]        
Merger between macrosolve inc and drone aviation holding corp (Textual)        
Preferred stock, shares issued   0 68,731 156,231
Macrosolve, Inc [Member]        
Merger between macrosolve inc and drone aviation holding corp (Textual)        
Common stock, shares issued   98,017   198,219,132
Common stock, shares outstanding   98,017   198,219,132
Description of share consolidation Pursuant to the Redomestication, each of MacroSolve's shareholders received one share of common stock, par value $0.0001 per share of Drone Aviation Holding Corp. for every 50.56186 shares of MacroSolve's common stock      
XML 49 R37.htm IDEA: XBRL DOCUMENT v3.3.1.900
Drone Aviation Corp Aquisition of Lighter than Air Systems (Details) - Lighter Than Air Systems [Member] - USD ($)
Dec. 31, 2015
May. 05, 2014
Business Acquisition [Line Items]    
Property and equipment $ 1,638  
Accounts receivable 135,050  
Cash in bank 30,361 $ 30,361
Due from related party 20,650  
Prepaid expenses 1,381  
Inventory 109,581  
Intangible asset 135,550  
Current liabilities (120,010)  
Goodwill 99,799  
Total purchase price $ 414,000  
XML 50 R38.htm IDEA: XBRL DOCUMENT v3.3.1.900
Drone Aviation Corp Aquisition of Lighter than Air Systems (Details Textual) - USD ($)
 1 Months Ended 4 Months Ended 12 Months Ended
Mar. 31, 2014
May. 05, 2014
Dec. 31, 2015
Dec. 31, 2014
Business Acquisition [Line Items]        
Stock issued during period for investors       $ 653,327
Stock issued during period acquisition       79,000
Cash paid on business combination, net       304,639
Amortization     $ 37,935 31,941
Net loss     (8,975,862) $ (2,123,490)
Impairment of intangible assets     $ 65,674  
Customer Lists [Member]        
Business Acquisition [Line Items]        
Cash paid on business combination, net      
Intangible assets useful life     5 years  
Amortization     $ 103,609  
Amortization of discounted cash flow model     135,550  
Lighter Than Air Systems [Member]        
Business Acquisition [Line Items]        
Percentage of shares acquired while acquisition   100.00%    
Acquired cash from LTAS   $ 30,361 $ 30,361  
Net loss   $ 39,918    
Common Stock [Member]        
Business Acquisition [Line Items]        
Stock issued during period acquisition, shares   34,100,000    
Common Stock [Member] | Lighter Than Air Systems [Member]        
Business Acquisition [Line Items]        
Stock issued during period acquisition $ 335,000      
Stock issued during period acquisition, shares 10,000,000      
Fair value of shares at the date of issuance $ 79,000      
Shares issued for acquisition, total consideration transferred $ 414,000      
XML 51 R39.htm IDEA: XBRL DOCUMENT v3.3.1.900
Drone Aviation Holding Corp and Drone Aviation Corp Securities Exchange, Reverse Merger and Recapitalization (Details) - Drone Aviation Holding Corp [Member]
Jun. 03, 2014
USD ($)
Business Acquisition [Line Items]  
Cash in bank $ 1,692,896
Available-for-sale securities 211,525
Prepaid expenses 37,403
Current liabilities (39,622)
Derivative liabilities (2,159,824)
Note payable (110,000)
Total $ 367,622
XML 52 R40.htm IDEA: XBRL DOCUMENT v3.3.1.900
Drone Aviation Holding Corp and Drone Aviation Corp Securities Exchange, Reverse Merger and Recapitalization (Details Textual) - USD ($)
 12 Months Ended
Jun. 02, 2015
Jun. 03, 2014
Dec. 31, 2015
Dec. 31, 2014
Apr. 30, 2014
Drone Aviation Holding Corp And Drone Aviation Corp Securities Exchange Reverse Merger And Recapitalization (Textual)          
Common stock, shares issued     5,125,585 926,953 3,920,700
Common stock, shares outstanding     5,125,585 926,953 3,920,700
Series D Preferred Stock [Member]          
Drone Aviation Holding Corp And Drone Aviation Corp Securities Exchange Reverse Merger And Recapitalization (Textual)          
Preferred stock, shares issued     2,000,000 36,050,000  
Preferred stock, shares outstanding     2,000,000 36,050,000  
Preferred stock, par value (in dollars per share)     $ 0.0001 $ 0.0001  
Series A Preferred Stock [Member]          
Drone Aviation Holding Corp And Drone Aviation Corp Securities Exchange Reverse Merger And Recapitalization (Textual)          
Preferred stock, shares issued     101,100 396,750 595,000
Preferred stock, shares outstanding     101,100 396,750  
Preferred stock, par value (in dollars per share)     $ 0.0001 $ 0.0001  
Series B Preferred Stock [Member]          
Drone Aviation Holding Corp And Drone Aviation Corp Securities Exchange Reverse Merger And Recapitalization (Textual)          
Preferred stock, shares issued     0 324,671 324,671
Preferred stock, shares outstanding     0 324,671  
Preferred stock, par value (in dollars per share)     $ 0.0001 $ 0.0001  
Series C Preferred Stock [Member]          
Drone Aviation Holding Corp And Drone Aviation Corp Securities Exchange Reverse Merger And Recapitalization (Textual)          
Preferred stock, shares issued     73,387 345,400  
Preferred stock, shares outstanding     73,387 345,400  
Preferred stock, par value (in dollars per share)     $ 0.0001 $ 0.0001  
Series E Preferred Stock [Member]          
Drone Aviation Holding Corp And Drone Aviation Corp Securities Exchange Reverse Merger And Recapitalization (Textual)          
Preferred stock, shares issued     0 5,400,000  
Preferred stock, shares outstanding     0 5,400,000  
Preferred stock, par value (in dollars per share)     $ 0.0001 $ 0.0001  
Series B One Preferred Stock [Member]          
Drone Aviation Holding Corp And Drone Aviation Corp Securities Exchange Reverse Merger And Recapitalization (Textual)          
Preferred stock, shares issued     0 68,731 156,231
Preferred stock, shares outstanding     0 68,731  
Preferred stock, par value (in dollars per share)     $ 0.0001 $ 0.0001  
Private Placement [Member]          
Drone Aviation Holding Corp And Drone Aviation Corp Securities Exchange Reverse Merger And Recapitalization (Textual)          
Securities sold to investors, shares   2,700,000      
Securities sold to investors price per share   $ 0.50      
Securities sold to investors   $ 1,350,000      
Securities sold to investors description   Each unit consists of one share of the Company's Series E Convertible Preferred Stock, par value $0.0001 per share, each of which is convertible into one-fortieth share, on a post-reverse split basis, of Common Stock, with such rights and designations as set forth in the Certificate of Designation; and a three year warrant to purchase one share of Common Stock at an exercise price of $40.00 per share.      
Private Placement [Member] | Series E Preferred Stock [Member]          
Drone Aviation Holding Corp And Drone Aviation Corp Securities Exchange Reverse Merger And Recapitalization (Textual)          
Securities sold to investors, shares 2,700,000        
Preferred stock, par value (in dollars per share)   $ 0.0001      
Warrant [Member]          
Drone Aviation Holding Corp And Drone Aviation Corp Securities Exchange Reverse Merger And Recapitalization (Textual)          
Securities sold to investors price per share   $ 40.00      
Common Stock [Member]          
Drone Aviation Holding Corp And Drone Aviation Corp Securities Exchange Reverse Merger And Recapitalization (Textual)          
Common stock, shares outstanding   3,920,700 98,017    
Preferred Stock [Member] | Series A Preferred Stock [Member]          
Drone Aviation Holding Corp And Drone Aviation Corp Securities Exchange Reverse Merger And Recapitalization (Textual)          
Preferred stock, shares outstanding   595,000      
Preferred Stock [Member] | Series B Preferred Stock [Member]          
Drone Aviation Holding Corp And Drone Aviation Corp Securities Exchange Reverse Merger And Recapitalization (Textual)          
Preferred stock, shares outstanding   324,671      
Preferred Stock [Member] | Series C Preferred Stock [Member]          
Drone Aviation Holding Corp And Drone Aviation Corp Securities Exchange Reverse Merger And Recapitalization (Textual)          
Preferred stock, shares outstanding   355,000      
Preferred Stock [Member] | Series B One Preferred Stock [Member]          
Drone Aviation Holding Corp And Drone Aviation Corp Securities Exchange Reverse Merger And Recapitalization (Textual)          
Preferred stock, shares outstanding   156,231      
Drone Aviation Corp [Member]          
Drone Aviation Holding Corp And Drone Aviation Corp Securities Exchange Reverse Merger And Recapitalization (Textual)          
Common stock, shares issued   44,100,000 1,102,500    
Common stock, shares outstanding   44,100,000 1,102,500    
Percentage of excess stocks held   3.33%      
Percentage of common stock outstanding   100.00%      
Drone Aviation Corp [Member] | Series D Preferred Stock [Member]          
Drone Aviation Holding Corp And Drone Aviation Corp Securities Exchange Reverse Merger And Recapitalization (Textual)          
Shares issued under share exchange agreement, shares   36,050,000      
Drone Aviation Corp [Member] | Common Stock [Member]          
Drone Aviation Holding Corp And Drone Aviation Corp Securities Exchange Reverse Merger And Recapitalization (Textual)          
Shares issued under share exchange agreement, shares   8,050,000 201,250    
XML 53 R41.htm IDEA: XBRL DOCUMENT v3.3.1.900
Drone Aviation Holding Corp Asset Acquisition of Adaptive, Flight, Inc. (Details) - USD ($)
 1 Months Ended 12 Months Ended
Jul. 20, 2015
Dec. 31, 2015
Drone Aviation Holding Corp Asset Acquisition of Adaptive Flight Inc (Textual)    
Share price per share   $ 3.23
Georgia Tech UAV Simulation Tool [Member]    
Drone Aviation Holding Corp Asset Acquisition of Adaptive Flight Inc (Textual)    
Payments made to AFI $ 100,000  
Escrow deposit $ 100,000  
Unregistered common stock, Value   $ 484,500
Unregistered common stock, Shares 150,000 150,000
Share price per share $ 8.40 $ 3.23
Terms of escrow agreement, Description The terms of the Escrow Agreement, if the escrow share value is less than $1,400,000, the Company must issue an additional number of unregistered shares, not to exceed 50,000 shares.  
Additional liability and expense, Value   $ 161,500
Additional liability and expense, Shares   50,000
XML 54 R42.htm IDEA: XBRL DOCUMENT v3.3.1.900
Shareholders' Equity (Details)
 1 Months Ended 3 Months Ended 12 Months Ended
Nov. 19, 2015
USD ($)
$ / shares
shares
Nov. 17, 2015
USD ($)
$ / shares
shares
Oct. 29, 2015
shares
Oct. 29, 2015
Sep. 04, 2015
USD ($)
shares
Jul. 20, 2015
USD ($)
shares
Jun. 01, 2015
USD ($)
shares
Aug. 26, 2014
Firms
shares
Jul. 21, 2014
USD ($)
Firms
shares
Jul. 01, 2014
USD ($)
shares
Aug. 27, 2014
USD ($)
shares
Aug. 25, 2014
shares
Jun. 30, 2014
shares
Dec. 31, 2015
shares
Sep. 30, 2015
shares
Jun. 30, 2015
shares
Mar. 31, 2015
shares
Dec. 31, 2014
Firms
shares
Sep. 30, 2014
shares
Dec. 31, 2015
USD ($)
Firms
shares
Dec. 31, 2014
USD ($)
shares
Apr. 30, 2014
shares
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                                            
Common stock, shares issued                           5,125,585       926,953   5,125,585 926,953 3,920,700
Common stock reverse stock split       1:40 reverse split                                    
Common stock issued, value | $                                       $ 3,484,750 $ 653,327  
Shares of series preferred stock converted                           2,000,000                
Shares issued to services, Shares                 42,500                          
Shares issued for service | $                 $ 17,000                       341,667  
Number of consulting firms | Firms                 2                          
Shares of restricted common stock issued     57                                      
Restricted common stock vesting description                     Shares of restricted common stock, on a post-reverse split basis, with monthly vesting provisions to two members of its newly-formed Strategic Advisory Board for twelve months of service. The advisors can earn a pro rata portion of the shares, calculated based on the twelve-month vesting period, in the event the service agreements are terminated prior to the expiration date as described in the agreements.                      
Stock based compensation | $                                       $ 5,934,988 $ 341,667  
Series B-1 Preferred Stock [Member]                                            
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                                            
Shares issued to services, Shares                                          
Shares issued for service | $                                          
Shares of restricted common stock issued                                       55,000    
Common stock of Drone Aviation Corp issued for cash, Shares                                          
Preferred stock, shares outstanding                           0       68,731   0 68,731  
Private Placement [Member]                                            
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                                            
Common stock of Drone Aviation Corp issued for cash, Shares 745,000 745,000                                        
Financing fees | $ $ 240,250 $ 240,250                                        
Purchase price of restricted common stock | $ / shares $ 5 $ 5                                        
Proceeds from issuance of private placement | $ $ 3,484,750 $ 3,484,750                                        
Adaptive Flight, Inc [Member]                                            
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                                            
Shares of restricted common stock issued           150,000                                
Shares of restricted common stock issued, value | $           $ 1,260,000                                
Members of advisory board [Member]                                            
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                                            
Shares of restricted common stock issued                     50,000                      
Restricted common stock vesting description                     The Company issued 50,000 shares of restricted common stock, on a post-reverse split basis, with monthly vesting provisions to two members of its newly-formed Strategic Advisory Board for twelve months of service.                      
Expense for the pro rata portion of shares | $                     $ 340,000                 $ 213,333 $ 126,667  
Consulting Agreement [Member]                                            
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                                            
Shares issued to services, Shares                   6,250                        
Shares issued for service | $                   $ 215,000                        
Additional shares issued                   6,250                        
Director Agreement [Member]                                            
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                                            
Shares of restricted common stock issued             50,000                              
Restricted common stock vesting description             The Company issued 50,000 shares of restricted common stock with monthly vesting provisions to the Chairman of the Board for twenty-four months services pursuant to a Director Agreement.                              
Expense for the pro rata portion of shares | $             $ 157,500                              
Stock Award Agreements [Member]                                            
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                                            
Shares of restricted common stock issued         450,000                                  
Shares of restricted common stock issued, value | $         $ 4,000,000                                  
Stock based compensation | $                                       $ 2,417,760    
Common Stock [Member]                                            
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                                            
Common stock, shares issued                           4,198,632           4,198,632    
Common stock reverse stock split       1:40 the Company effected a 1-for-40 reverse split of its common stock.                                    
Series A Preferred Stock [Member]                                            
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                                            
Shares of series preferred stock converted                         38,100 118,921 10,200 80,229 86,300 61,500 98,650 295,650    
Number of common stock shares issued upon conversion                         95,250 297,302 25,500 200,573 215,750 153,750 246,625 297,302 153,750  
Number of investors | Firms                                   5   8    
Shares of restricted common stock issued                                       739,126    
Series B Preferred Stock [Member]                                            
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                                            
Shares of series preferred stock converted                           324,651 20              
Number of common stock shares issued upon conversion                           8,116 1         8,116    
Series C Preferred Stock [Member]                                            
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                                            
Shares of series preferred stock converted                       9,600   242,013 10,000 20,000            
Number of common stock shares issued upon conversion                       24,000   605,033 25,000 50,000       605,033    
Series D Preferred Stock [Member]                                            
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                                            
Shares of series preferred stock converted                           20,050,000 5,600,000 8,400,000            
Number of common stock shares issued upon conversion                           501,250 140,000 210,000       501,250    
Series E Preferred Stock [Member]                                            
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                                            
Shares of series preferred stock converted                           3,400,000 2,000,000              
Number of common stock shares issued upon conversion                           85,000 50,000         85,000    
Restricted common stock issued pursuant to exercise of warrants               9,310                            
Number of investors | Firms               7                            
Exercise of warrants, percentage               100.00%                            
Series E Preferred Stock [Member] | Private Placement [Member]                                            
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                                            
Additional shares issued                                       70,000    
Series F Preferred Stock [Member]                                            
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                                            
Shares of series preferred stock converted                           1,301,000                
Number of common stock shares issued upon conversion                           32,525           32,525    
Series F Preferred Stock [Member] | Private Placement [Member]                                            
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                                            
Shares of restricted common stock issued                                       182,525    
Series G Preferred Stock [Member]                                            
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                                            
Shares of series preferred stock converted                           2,000,000                
Number of common stock shares issued upon conversion                           50,000           50,000    
Series G Preferred Stock [Member] | Private Placement [Member]                                            
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                                            
Shares of restricted common stock issued                                       182,525    
XML 55 R43.htm IDEA: XBRL DOCUMENT v3.3.1.900
Preferred Stock (Details)
 1 Months Ended 3 Months Ended 12 Months Ended
Nov. 19, 2015
USD ($)
$ / shares
shares
Nov. 17, 2015
USD ($)
$ / shares
shares
Oct. 29, 2015
shares
Oct. 29, 2015
Jun. 02, 2015
USD ($)
$ / shares
shares
Aug. 26, 2014
Firms
shares
Jun. 03, 2014
$ / shares
shares
Aug. 27, 2014
USD ($)
$ / shares
shares
Jun. 30, 2014
shares
Dec. 31, 2015
$ / shares
shares
Sep. 30, 2015
shares
Jun. 30, 2015
shares
Mar. 31, 2015
shares
Dec. 31, 2014
Firms
$ / shares
shares
Sep. 30, 2014
shares
Dec. 31, 2015
USD ($)
Firms
$ / shares
shares
Dec. 31, 2014
USD ($)
$ / shares
shares
Jun. 06, 2014
USD ($)
shares
Apr. 30, 2014
shares
Preferred Stock (Textual)                                      
Shares of series preferred stock converted                   2,000,000                  
Shares of restricted common stock issued     57                                
Deemed dividend beneficial conversion feature on convertible preferred stock | $                               $ (80,000)    
Common stock reverse stock split       1:40 reverse split                              
Proceeds from Series F preferred stock issued for cash | $                                 $ 822,750    
Restricted common stock vesting description               Shares of restricted common stock, on a post-reverse split basis, with monthly vesting provisions to two members of its newly-formed Strategic Advisory Board for twelve months of service. The advisors can earn a pro rata portion of the shares, calculated based on the twelve-month vesting period, in the event the service agreements are terminated prior to the expiration date as described in the agreements.                      
Common Stock [Member] | Predecessor [Member]                                      
Preferred Stock (Textual)                                      
Proceeds from Series F preferred stock issued for cash | $                                    
Proceeds from common stock issued for cash, Shares                               745,000      
Conversion of Series C preferred stock to common stock,Shares                               680,033 24,000    
Conversion of Series G preferred stock to common stock, Shares                               50,000      
Conversion of Series B1 preferred stock to common stock, Shares                               55,000      
Common stock of Drone Aviation Corp issued for cash, Shares                                 201,250    
Series A Preferred Stock [Member]                                      
Preferred Stock (Textual)                                      
Shares of series preferred stock converted                 38,100 118,921 10,200 80,229 86,300 61,500 98,650 295,650      
Shares of restricted common stock issued                               739,126      
Number of restricted common stock shares issued upon conversion                 95,250 297,302 25,500 200,573 215,750 153,750 246,625 297,302 153,750    
Number Of Investors | Firms                           5   8      
Note Warrant [Member]                                      
Preferred Stock (Textual)                                      
Securities sold to investors price per share | $ / shares             $ 40.00                        
Private Placement [Member]                                      
Preferred Stock (Textual)                                      
Stock conversion description                               Series A and Series C stock conversion ratio is 1 to 2.5 common shares on a post-split basis. The Series B, B-1, D, E, F and G stock conversion ratio is 1 to 0.025      
Securities sold to investors price per share | $ / shares             $ 0.50                        
Financing fees | $ $ 240,250 $ 240,250                                  
Securities sold to investors, shares             2,700,000                        
Common stock of Drone Aviation Corp issued for cash, Shares 745,000 745,000                                  
Purchase price of restricted common stock | $ / shares $ 5 $ 5                                  
Series B One Preferred Stock [Member]                                      
Preferred Stock (Textual)                                      
Shares of restricted common stock issued                               55,000      
Sole holder of Series B-1 stock liquidated, Value | $                                   $ 350,000  
Preferred stock, shares outstanding                   0       68,731   0 68,731    
Preferred stock liquidation                                
The shareholder has the option to receive a preferential amount of cash equal to 400% of the stated value per share.
    
Sole holder of Series B-1 stock liquidated                                   87,500  
Preferred stock, shares issued                   0       68,731   0 68,731   156,231
Preferred stock, par value (in dollars per share) | $ / shares                   $ 0.0001       $ 0.0001   $ 0.0001 $ 0.0001    
Proceeds from Series F preferred stock issued for cash | $                                    
Conversion of Series C preferred stock to common stock,Shares                                    
Conversion of Series B1 preferred stock to common stock, Shares                               (68,731)      
Common stock of Drone Aviation Corp issued for cash, Shares                                    
Series B Preferred Stock [Member]                                      
Preferred Stock (Textual)                                      
Shares of series preferred stock converted                               324,671      
Shares of restricted common stock issued                               8,117      
Preferred stock, shares outstanding                   0       324,671   0 324,671    
Preferred stock, shares issued                   0       324,671   0 324,671   324,671
Preferred stock, par value (in dollars per share) | $ / shares                   $ 0.0001       $ 0.0001   $ 0.0001 $ 0.0001    
Proceeds from Series F preferred stock issued for cash | $                                    
Conversion of Series C preferred stock to common stock,Shares                                    
Common stock of Drone Aviation Corp issued for cash, Shares                                    
Series C Preferred Stock [Member]                                      
Preferred Stock (Textual)                                      
Shares of restricted common stock issued                               680,033      
Preferred stock, shares outstanding                   73,387       345,400   73,387 345,400    
Number Of Investors | Firms                               6      
Preferred stock, shares issued                   73,387       345,400   73,387 345,400    
Preferred stock, par value (in dollars per share) | $ / shares                   $ 0.0001       $ 0.0001   $ 0.0001 $ 0.0001    
Proceeds from Series F preferred stock issued for cash | $                                    
Conversion of Series C preferred stock to common stock,Shares                               (272,013) (9,600)    
Common stock of Drone Aviation Corp issued for cash, Shares                                    
Series D Preferred Stock [Member]                                      
Preferred Stock (Textual)                                      
Shares of restricted common stock issued                               851,250      
Preferred stock, shares outstanding                   2,000,000       36,050,000   2,000,000 36,050,000    
Number Of Investors | Firms                               13      
Preferred stock, shares issued                   2,000,000       36,050,000   2,000,000 36,050,000    
Preferred stock, par value (in dollars per share) | $ / shares                   $ 0.0001       $ 0.0001   $ 0.0001 $ 0.0001    
Proceeds from Series F preferred stock issued for cash | $                                    
Common stock of Drone Aviation Corp issued for cash, Shares                                 26,050,000    
Series E Preferred Stock [Member]                                      
Preferred Stock (Textual)                                      
Shares of series preferred stock converted                               5,400,000      
Shares of restricted common stock issued           9,310                   135,000      
Preferred stock, shares outstanding                   0       5,400,000   0 5,400,000    
Number Of Investors | Firms           7                          
Preferred stock, shares issued                   0       5,400,000   0 5,400,000    
Preferred stock, par value (in dollars per share) | $ / shares                   $ 0.0001       $ 0.0001   $ 0.0001 $ 0.0001    
Proceeds from Series F preferred stock issued for cash | $                                    
Exercise of warrants, percentage           100.00%                          
Series E Preferred Stock [Member] | Private Placement [Member]                                      
Preferred Stock (Textual)                                      
Preferred stock, par value (in dollars per share) | $ / shares             $ 0.0001                        
Securities sold to investors, shares         2,700,000                            
Additional shares issued 70,000 70,000                                  
Series E Preferred Stock [Member] | Private Placement [Member] | Restricted Stock [Member]                                      
Preferred Stock (Textual)                                      
Securities sold to investors, shares 182,525                                    
Preferred stock, Series F                                      
Preferred Stock (Textual)                                      
Shares of restricted common stock issued                               32,525      
Deemed dividend beneficial conversion feature on convertible preferred stock | $                               $ 192,558      
Number of restricted common stock shares issued upon conversion         55,017                            
Preferred stock, shares outstanding                   1,999,998       3,300,999   1,999,998 3,300,999    
Number Of Investors | Firms                               3      
Preferred stock, shares issued         2,200,666         1,999,998       3,300,999   1,999,998 3,300,999    
Preferred stock, par value (in dollars per share) | $ / shares                   $ 0.0001       $ 0.0001   $ 0.0001 $ 0.0001    
Proceeds from Series F preferred stock issued for cash | $                                 $ 330    
Preferred stock, Series F | Private Placement [Member]                                      
Preferred Stock (Textual)                                      
Shares of restricted common stock issued 182,525 182,525                                  
Deemed dividend beneficial conversion feature on convertible preferred stock | $               $ 192,558                      
Preferred stock, shares issued               1,100,333                      
Securities sold to investors price per share | $ / shares               $ 0.75                      
Preferred stock, par value (in dollars per share) | $ / shares               $ 0.0001                      
Proceeds from Series F preferred stock issued for cash | $               $ 822,750                      
Financing fees | $               $ 2,500                      
Series G Preferred Stock [Member]                                      
Preferred Stock (Textual)                                      
Deemed dividend beneficial conversion feature on convertible preferred stock | $                               $ 80,000      
Preferred stock, shares outstanding                   2,000,000       0   2,000,000 0    
Preferred stock, shares issued                   2,000,000       0   2,000,000 0    
Preferred stock, par value (in dollars per share) | $ / shares                   $ 0.0001       $ 0.0001   $ 0.0001 $ 0.0001    
Proceeds from Series G preferred stock issued for cash, Shares                               4,000,000      
Conversion of Series G preferred stock to common stock, Shares                               (2,000,000)      
Series G Preferred Stock [Member] | Private Placement [Member]                                      
Preferred Stock (Textual)                                      
Shares of restricted common stock issued 182,525 182,525                                  
Securities sold to investors price per share | $ / shares         $ 0.25                            
Preferred stock, par value (in dollars per share) | $ / shares         $ 0.0001                            
Financing fees | $         $ 14,275                            
Purchase price of stock | $         $ 985,725                            
Common stock conversion price | $ / shares         $ 0.025                            
Series E Convertible Preferred Stock [Member]                                      
Preferred Stock (Textual)                                      
Number of restricted common stock shares issued upon conversion         67,500                            
Securities sold to investors, shares         2,700,000                            
Members of advisory board [Member]                                      
Preferred Stock (Textual)                                      
Shares of restricted common stock issued               50,000                      
Restricted common stock vesting description               The Company issued 50,000 shares of restricted common stock, on a post-reverse split basis, with monthly vesting provisions to two members of its newly-formed Strategic Advisory Board for twelve months of service.                      
Expense for the pro rata portion of shares | $               $ 340,000               $ 213,333 $ 126,667    
XML 56 R44.htm IDEA: XBRL DOCUMENT v3.3.1.900
Employee Stock Options (Details) - Employee Stock Option [Member]
 12 Months Ended
Dec. 31, 2015
Summary of assumptions used to estimate the fair value of stock options granted  
Expected dividend yield 0.00%
Minimum [Member]  
Summary of assumptions used to estimate the fair value of stock options granted  
Expected volatility 116.00%
Risk-free interest rate 0.79%
Expected life of options 2 years 5 months 5 days
Maximum [Member]  
Summary of assumptions used to estimate the fair value of stock options granted  
Expected volatility 131.00%
Risk-free interest rate 1.25%
Expected life of options 3 years
XML 57 R45.htm IDEA: XBRL DOCUMENT v3.3.1.900
Employee Stock Options (Details 1) - Employee Stock Option [Member]
 12 Months Ended
Dec. 31, 2015
USD ($)
$ / shares
shares
Number of Options  
Outstanding - December 31, 2014 | shares
Exercisable - December 31, 2014 | shares
Granted | shares 842,500
Exercised or Vested | shares
Cancelled or Expired | shares 450,000
Outstanding - December 31, 2015 | shares 392,500
Exercisable - December 31, 2015 | shares 355,000
Weighted Average Exercise Price  
Weighted Average Exercise Price, Outstanding - December 31, 2014 | $ / shares $ 0.00
Weighted Average Exercise Price, Exercisable - December 31, 2014 | $ / shares 0.00
Weighted Average Exercise Price, Granted | $ / shares 7.04
Weighted Average Exercise Price, Exercised or Vested | $ / shares 0.00
Weighted Average Exercise Price, Cancelled or Expired | $ / shares 7.78
Weighted Average Exercise Price, Outstanding - December 31, 2015 | $ / shares 6.19
Weighted Average Exercise Price, Exercisable - December 31, 2015 | $ / shares $ 5.70
Contractual Life in Years, Outstanding - December 31, 2015 2 years 7 months 13 days
Contractual Life in Years, Exercisable - December 31, 2015 2 years 6 months 18 days
Intrinsic Value Exercisable - December 31, 2014 | $ $ 0.00
Intrinsic Value Exercisable - December 31, 2015 | $ $ 0.00
XML 58 R46.htm IDEA: XBRL DOCUMENT v3.3.1.900
Employee Stock Options (Details Textual)
 12 Months Ended
Oct. 29, 2015
Sep. 04, 2015
shares
Apr. 30, 2014
shares
Dec. 31, 2015
USD ($)
$ / shares
shares
Jun. 03, 2014
$ / pure
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Reverse stock split 1:40 reverse split        
Employee Stock Option [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock options granted       842,500  
Number of options vested     920    
Unvested options     618    
Exercise price, granted | $ / shares       $ 7.04  
Stock option, surrendered and cancelled       450,000  
Fair value adjustment of stock option | $       $ 3,013,531  
Compensation expense | $       $ 2,822,132  
Stock option unvested, surrendered and cancelled       450,000  
Share based compensation recognized next three years | $       $ 191,399  
Reverse stock split       1:40  
Employee Stock Option [Member] | Minimum [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Strike prices         66.80
Employee Stock Option [Member] | Maximum [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Strike prices         5,056
Employees and Director [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock options granted       842,500  
Stock option, surrendered and cancelled   250,000      
Employees and Director [Member] | Vesting One [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of options vested       250,000  
Exercise price, granted | $ / shares       $ 6.00  
Expiration date       May 18, 2018  
Employees and Director [Member] | Vesting Two [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of options vested       105,000  
Exercise price, granted | $ / shares       $ 5.00  
Expiration date       Dec. 10, 2018  
Employees and Director [Member] | Vesting Three [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of options vested       250,000  
Exercise price, granted | $ / shares       $ 6.00  
Expiration date       Jun. 01, 2018  
Vesting period       2 years  
Director [Member] | Vesting One [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of options vested       75,000  
Exercise price, granted | $ / shares       $ 10.00  
Expiration date       Jun. 01, 2018  
Vesting period       2 years  
Director [Member] | Vesting Two [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of options vested       125,000  
Exercise price, granted | $ / shares       $ 10.00  
Expiration date       Jun. 01, 2018  
Director [Member] | Vesting Three [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of options vested       37,500  
Exercise price, granted | $ / shares       $ 10.80  
Expiration date       May 04, 2019  
Vesting period       3 years  
XML 59 R47.htm IDEA: XBRL DOCUMENT v3.3.1.900
Warrants (Details) - Warrant [Member]
 12 Months Ended
Dec. 31, 2015
Class of Warrant or Right [Line Items]  
Expected dividend yield 0.00%
Maximum [Member]  
Class of Warrant or Right [Line Items]  
Expected volatility 121.00%
Risk-free interest rate 1.70%
Expected life of warrants 5 years
Minimum [Member]  
Class of Warrant or Right [Line Items]  
Expected volatility 116.00%
Risk-free interest rate 0.87%
Expected life of warrants 2 years 4 months 24 days
XML 60 R48.htm IDEA: XBRL DOCUMENT v3.3.1.900
Warrants (Details 1) - Warrant [Member]
 12 Months Ended
Dec. 31, 2015
USD ($)
$ / shares
shares
Number of Warrants  
Outstanding - December 31, 2014 | shares 12,129
Exercisable - December 31, 2014 | shares 12,129
Granted | shares 122,500
Forfeited or Expired | shares (420)
Outstanding - December 31, 2015 | shares 134,209
Exercisable - December 31, 2015 | shares 104,209
Weighted Average Exercise Price  
Weighted Average Exercise Price, Outstanding - December 31, 2014 | $ / shares $ 206.86
Weighted Average Exercise Price, Exercisable - December 31, 2014 | $ / shares 206.86
Weighted Average Exercise Price, Granted | $ / shares 6.53
Weighted Average Exercise Price, Forfeited or Expired | $ / shares 250.35
Weighted Average Exercise Price, Outstanding - December 31, 2015 | $ / shares 23.87
Weighted Average Exercise Price, Exercisable - December 31, 2015 | $ / shares $ 27.87
Contractual Life in Years, Outstanding - December 31, 2014 2 years 15 days
Contractual Life in Years, Exercisable - December 31, 2015 2 years 15 days
Contractual Life in Years, Outstanding - December 31, 2015 3 years 7 months 28 days
Contractual Life in Years, Exercisable - December 31, 2015 4 years 4 days
Intrinsic Value Exercisable - December 31, 2014 | $ $ 0.00
Intrinsic Value Exercisable - December 31, 2015 | $ $ 0.00
XML 61 R49.htm IDEA: XBRL DOCUMENT v3.3.1.900
Warrants (Details Textual)
 1 Months Ended 12 Months Ended
Oct. 29, 2015
shares
Oct. 29, 2015
Aug. 26, 2014
USD ($)
Firms
shares
Jul. 21, 2014
USD ($)
shares
Jun. 03, 2014
USD ($)
$ / shares
$ / pure
shares
Nov. 20, 2015
$ / shares
shares
Oct. 29, 2015
May. 31, 2014
USD ($)
$ / shares
shares
Dec. 31, 2015
USD ($)
$ / shares
shares
Dec. 31, 2014
USD ($)
shares
Apr. 30, 2014
$ / pure
shares
Options And Warrants [Line Items]                      
Total warrants carried over reverse merger                 12,125    
Loss on derivative liability | $                 $ 350,969  
Derivative liabilities | $                 $ 0 0  
Number of shares of restricted common stock granted 57                    
Warrants issued for services, shares       42,500              
Warrants issued for services, value | $       $ 17,000           341,667  
Derivative liability written off to APIC due to warrant exercise | $                 $ 2,510,793  
Common stock reverse stock split   1:40 reverse split                  
Drone Aviation Holding Corp [Member]                      
Options And Warrants [Line Items]                      
Fair value of warrants derivative liability | $         $ 2,159,824            
Series E Preferred Stock [Member]                      
Options And Warrants [Line Items]                      
Number of shares of restricted common stock granted     9,310           135,000    
Warrants issued for services, shares                    
Warrants issued for services, value | $                    
Number of investors | Firms     7                
Warrant [Member]                      
Options And Warrants [Line Items]                      
Strike prices                     202.4
Total warrants carried over reverse merger           70,000         16,842
Warrants, Term               3 years      
Exercise price of warrants | $ / shares           $ 5.00   $ 0.40      
Warrants expiration date           Nov. 20, 2020   Jun. 03, 2017      
Number of warrants expired                   4,717  
Warrants issued to purchase common stock         42,500       52,500    
Warrants issued for services, shares               42,500      
Warrants issued for services, value | $               $ 17,000      
Derivative liability written off to APIC due to warrant exercise | $     $ 2,510,793                
Common stock reverse stock split             1:40 the Company effected a 1-for-40 reverse split of its common stock.        
Fair value of warrants granted | $                 $ 347,201    
Compensation expense | $                 $ 324,263    
Warrant [Member] | Consultant [Member]                      
Options And Warrants [Line Items]                      
Exercise price of warrants | $ / shares                 $ 10.00    
Warrants expiration date                 Jun. 16, 2018    
Warrants issued to purchase common stock                 25,000    
Warrant [Member] | Consultant one [Member]                      
Options And Warrants [Line Items]                      
Exercise price of warrants | $ / shares                 $ 10.00    
Warrants expiration date                 Jun. 25, 2018    
Warrants issued to purchase common stock                 12,500    
Warrant [Member] | Consultant two [Member]                      
Options And Warrants [Line Items]                      
Exercise price of warrants | $ / shares                 $ 5.00    
Warrants expiration date                 Dec. 10, 2018    
Warrants issued to purchase common stock                 5,000    
Warrant [Member] | Vendor [Member]                      
Options And Warrants [Line Items]                      
Exercise price of warrants | $ / shares                 $ 5.00    
Warrants expiration date                 Dec. 10, 2018    
Warrants issued to purchase common stock                 5,000    
Warrant [Member] | Series E Preferred Stock [Member]                      
Options And Warrants [Line Items]                      
Exercise price of warrants | $ / shares         $ 40.00            
Warrants issued to purchase common stock         67,500            
Maximum [Member] | Warrant [Member]                      
Options And Warrants [Line Items]                      
Strike prices         662.8            
Minimum [Member] | Warrant [Member]                      
Options And Warrants [Line Items]                      
Strike prices         101.2            
XML 62 R50.htm IDEA: XBRL DOCUMENT v3.3.1.900
Inventories (Details) - USD ($)
Dec. 31, 2015
Dec. 31, 2014
Inventories [Abstract]    
Raw Materials $ 26,358 $ 18,944
Work in progress 3,817 1,369
Finished Goods 107,209 $ 19,091
Less valuation allowance (18,589)
Inventory, Net $ 118,795 $ 39,404
XML 63 R51.htm IDEA: XBRL DOCUMENT v3.3.1.900
Prepaid Expenses (Details) - USD ($)
Dec. 31, 2015
Dec. 31, 2014
Prepaid Expenses [Abstract]    
Prepaid insurance $ 25,517 $ 23,114
Prepaid services 24,192 15,225
Prepaid rent and security deposit 5,915 11,830
Prepaid expenses, Net $ 55,624 $ 50,169
XML 64 R52.htm IDEA: XBRL DOCUMENT v3.3.1.900
Investment in Securities Held for Resale (Details) - USD ($)
 3 Months Ended 12 Months Ended
Jun. 30, 2014
Dec. 31, 2015
Dec. 31, 2014
Investment [Line Items]      
Loss on disposal and impairment of available-for-sale securities     $ 42,821
Net cash proceeds     $ 168,704
Decision Point Systems [Member]      
Investment [Line Items]      
Investment owned, shares sold 607,284    
Loss on disposal and impairment of available-for-sale securities $ (21,635)    
Medl Mobile Holdings Inc [Member]      
Investment [Line Items]      
Investment owned, shares sold 147,692    
Loss on disposal and impairment of available-for-sale securities $ 3,686    
Endexx Corporation [Member]      
Investment [Line Items]      
Impairment charge on sale of shares   $ 17,500  
Number of shares, contingently issuable   125,000  
XML 65 R53.htm IDEA: XBRL DOCUMENT v3.3.1.900
Oklahoma Technology Commercialization Center (Details) - USD ($)
 12 Months Ended
Dec. 31, 2015
Apr. 30, 2014
Oklahoma Technology Commercialization Center [Abstract]    
Refundable award   $ 110,000
Accrued interest, perecentage   14.27%
Period of imputed accrued interest Through September 2007  
XML 66 R54.htm IDEA: XBRL DOCUMENT v3.3.1.900
Income Taxes (Details) - USD ($)
Dec. 31, 2015
Dec. 31, 2014
Income Taxes [Abstract]    
Net operating loss carry-forwards $ 1,434,996 $ 497,501
Valuation allowance (1,434,996) (497,501)
Deferred tax assets, Net $ 0 $ 0
XML 67 R55.htm IDEA: XBRL DOCUMENT v3.3.1.900
Income Taxes (Details Textual) - USD ($)
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Income Taxes [Abstract]    
Net operating loss carry-forward $ 4,220,577  
Expiration date of net operating loss carry-forward Dec. 31, 2034  
Income taxes $ 159 $ 5,571
XML 68 R56.htm IDEA: XBRL DOCUMENT v3.3.1.900
Commitments and Contingencies (Details)
Dec. 31, 2015
USD ($)
Commitments and Contingencies [Abstract]  
Year 2016 $ 71,854
Year 2017 73,619
Year 2018 75,437
Year 2019 77,309
Year 2020 $ 45,651
XML 69 R57.htm IDEA: XBRL DOCUMENT v3.3.1.900
Commitments and Contingencies (Details Textual)
 1 Months Ended 12 Months Ended
Nov. 17, 2014
USD ($)
ft²
Dec. 31, 2015
USD ($)
Dec. 31, 2014
USD ($)
Commitments and Contingencies [Abstract]      
Rent expense   $ 76,492 $ 37,557
Term of lease 60 months    
Area of office and manufacturing | ft² 5,533    
Recovery of defendant legal fees   $ 400,000  
Operating expenses and sales tax $ 5,915    
Operating lease description   The actual commencement date was July 1, 2015 and the lease was amended to 61 months expiring July 31, 2020.  
Lease Monthly Cost   $ 1,437  
XML 70 R58.htm IDEA: XBRL DOCUMENT v3.3.1.900
Concentrations (Details) - Firms
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Accounts Receivable [Member]    
Concentration Risk [Line Items]    
Number of customers 2 1
Percentage of concentrations of credit risk 100.00% 100.00%
Revenues [Member]    
Concentration Risk [Line Items]    
Number of customers 2 4
Percentage of concentrations of credit risk 71.00% 92.00%
XML 71 R59.htm IDEA: XBRL DOCUMENT v3.3.1.900
Subsequent Events (Details) - shares
 2 Months Ended 3 Months Ended 12 Months Ended
Mar. 04, 2016
Dec. 31, 2015
Dec. 31, 2015
Dec. 31, 2014
Subsequent Event [Line Items]        
Shares of series preferred stock converted   2,000,000    
Subsequent Event [Member] | Common Stock [Member]        
Subsequent Event [Line Items]        
Common stock of Drone Aviation Corp issued for cash, Shares 335,968      
Series A Preferred Stock [Member]        
Subsequent Event [Line Items]        
Common stock of Drone Aviation Corp issued for cash, Shares      
Series A Preferred Stock [Member] | Subsequent Event [Member] | Common Stock [Member]        
Subsequent Event [Line Items]        
Common stock of Drone Aviation Corp issued for cash, Shares 2,500      
Shares of series preferred stock converted 1,000      
Series C Preferred Stock [Member]        
Subsequent Event [Line Items]        
Common stock of Drone Aviation Corp issued for cash, Shares      
Series C Preferred Stock [Member] | Subsequent Event [Member] | Common Stock [Member]        
Subsequent Event [Line Items]        
Common stock of Drone Aviation Corp issued for cash, Shares 183,468      
Shares of series preferred stock converted 73,387      
Series D Preferred Stock [Member]        
Subsequent Event [Line Items]        
Common stock of Drone Aviation Corp issued for cash, Shares       26,050,000
Series D Preferred Stock [Member] | Subsequent Event [Member] | Common Stock [Member]        
Subsequent Event [Line Items]        
Common stock of Drone Aviation Corp issued for cash, Shares 50,000      
Shares of series preferred stock converted 2,000,000      
Series E Preferred Stock [Member]        
Subsequent Event [Line Items]        
Shares of series preferred stock converted     5,400,000  
Series F Preferred Stock [Member] | Subsequent Event [Member] | Common Stock [Member]        
Subsequent Event [Line Items]        
Common stock of Drone Aviation Corp issued for cash, Shares 50,000      
Shares of series preferred stock converted 1,999,998      
Series F Preferred Stock [Member] | Subsequent Event [Member] | Common Stock [Member]        
Subsequent Event [Line Items]        
Common stock of Drone Aviation Corp issued for cash, Shares 50,000      
Shares of series preferred stock converted 2,000,000      
EXCEL 72 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 73 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 74 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 76 FilingSummary.xml IDEA: XBRL DOCUMENT 3.3.1.900 html 264 342 1 false 58 0 false 7 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.macrosolve.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 002 - Statement - Consolidated Balance Sheets Sheet http://www.macrosolve.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.macrosolve.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 004 - Statement - Consolidated Statements of Operations Sheet http://www.macrosolve.com/role/ConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 005 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://www.macrosolve.com/role/ConsolidatedStatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 5 false false R6.htm 006 - Statement - Consolidated Statements of Cash Flows Sheet http://www.macrosolve.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 007 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.macrosolve.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 7 false false R8.htm 008 - Disclosure - Merger between Macrosolve, inc. and Drone Aviation Holding Corp Sheet http://www.macrosolve.com/role/MergerBetweenMacrosolveIncAndDroneAviationHoldingCorp Merger between Macrosolve, inc. and Drone Aviation Holding Corp Notes 8 false false R9.htm 009 - Disclosure - Drone Aviation Corp Aquisition of Lighter than Air Systems Sheet http://www.macrosolve.com/role/DroneAviationCorpAquisitionOfLighterThanAirSystems Drone Aviation Corp Aquisition of Lighter than Air Systems Notes 9 false false R10.htm 010 - Disclosure - Drone Aviation Holding Corp and Drone Aviation Corp Securities Exchange, Reverse Merger and Recapitalization Sheet http://www.macrosolve.com/role/DroneAviationHoldingCorpAndDroneAviationCorpSecuritiesExchangeReverseMergerAndRecapitalization Drone Aviation Holding Corp and Drone Aviation Corp Securities Exchange, Reverse Merger and Recapitalization Notes 10 false false R11.htm 011 - Disclosure - Drone Aviation Holding Corp Asset Acquisition of Adaptive, Flight, Inc. Sheet http://www.macrosolve.com/role/DroneAviationHoldingCorpAssetAcquisitionOfAdaptiveFlightInc Drone Aviation Holding Corp Asset Acquisition of Adaptive, Flight, Inc. Notes 11 false false R12.htm 012 - Disclosure - Shareholders' Equity Sheet http://www.macrosolve.com/role/ShareholdersEquity Shareholders' Equity Notes 12 false false R13.htm 013 - Disclosure - Preferred Stock Sheet http://www.macrosolve.com/role/PreferredStock Preferred Stock Notes 13 false false R14.htm 014 - Disclosure - Employee Stock Options Sheet http://www.macrosolve.com/role/EmployeeStockOptions Employee Stock Options Notes 14 false false R15.htm 015 - Disclosure - Warrants Sheet http://www.macrosolve.com/role/Warrants Warrants Notes 15 false false R16.htm 016 - Disclosure - Inventories Sheet http://www.macrosolve.com/role/Inventories Inventories Notes 16 false false R17.htm 017 - Disclosure - Prepaid Expenses Sheet http://www.macrosolve.com/role/PrepaidExpenses Prepaid Expenses Notes 17 false false R18.htm 018 - Disclosure - Investment in Securities Held for Resale Sheet http://www.macrosolve.com/role/InvestmentInSecuritiesHeldForResale Investment in Securities Held for Resale Notes 18 false false R19.htm 019 - Disclosure - Oklahoma Technology Commercialization Center Sheet http://www.macrosolve.com/role/OklahomaTechnologyCommercializationCenter Oklahoma Technology Commercialization Center Notes 19 false false R20.htm 020 - Disclosure - Income Taxes Sheet http://www.macrosolve.com/role/IncomeTaxes Income Taxes Notes 20 false false R21.htm 021 - Disclosure - Commitments and Contingencies Sheet http://www.macrosolve.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 21 false false R22.htm 022 - Disclosure - Concentrations Sheet http://www.macrosolve.com/role/Concentrations Concentrations Notes 22 false false R23.htm 023 - Disclosure - Subsequent Events Sheet http://www.macrosolve.com/role/SubsequentEvents Subsequent Events Notes 23 false false R24.htm 024 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.macrosolve.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.macrosolve.com/role/SummaryOfSignificantAccountingPolicies 24 false false R25.htm 025 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.macrosolve.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.macrosolve.com/role/SummaryOfSignificantAccountingPolicies 25 false false R26.htm 026 - Disclosure - Drone Aviation Corp Aquisition of Lighter than Air Systems (Tables) Sheet http://www.macrosolve.com/role/DroneAviationCorpAquisitionOfLighterThanAirSystemsTables Drone Aviation Corp Aquisition of Lighter than Air Systems (Tables) Tables http://www.macrosolve.com/role/DroneAviationCorpAquisitionOfLighterThanAirSystems 26 false false R27.htm 027 - Disclosure - Drone Aviation Holding Corp and Drone Aviation Corp Securities Exchange, Reverse Merger and Recapitalization (Tables) Sheet http://www.macrosolve.com/role/DroneAviationHoldingCorpAndDroneAviationCorpSecuritiesExchangeReverseMergerAndRecapitalizationTables Drone Aviation Holding Corp and Drone Aviation Corp Securities Exchange, Reverse Merger and Recapitalization (Tables) Tables http://www.macrosolve.com/role/DroneAviationHoldingCorpAndDroneAviationCorpSecuritiesExchangeReverseMergerAndRecapitalization 27 false false R28.htm 028 - Disclosure - Employee Stock Options (Tables) Sheet http://www.macrosolve.com/role/EmployeeStockOptionsTables Employee Stock Options (Tables) Tables http://www.macrosolve.com/role/EmployeeStockOptions 28 false false R29.htm 029 - Disclosure - Warrants (Tables) Sheet http://www.macrosolve.com/role/WarrantsTables Warrants (Tables) Tables http://www.macrosolve.com/role/Warrants 29 false false R30.htm 030 - Disclosure - Inventories (Tables) Sheet http://www.macrosolve.com/role/InventoriesTables Inventories (Tables) Tables http://www.macrosolve.com/role/Inventories 30 false false R31.htm 031 - Disclosure - Prepaid Expenses (Tables) Sheet http://www.macrosolve.com/role/PrepaidExpensesTables Prepaid Expenses (Tables) Tables http://www.macrosolve.com/role/PrepaidExpenses 31 false false R32.htm 032 - Disclosure - Income Taxes (Tables) Sheet http://www.macrosolve.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.macrosolve.com/role/IncomeTaxes 32 false false R33.htm 033 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.macrosolve.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.macrosolve.com/role/CommitmentsAndContingencies 33 false false R34.htm 034 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.macrosolve.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://www.macrosolve.com/role/SummaryOfSignificantAccountingPoliciesTables 34 false false R35.htm 035 - Disclosure - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.macrosolve.com/role/SummaryOfSignificantAccountingPoliciesDetailsTextual Summary of Significant Accounting Policies (Details Textual) Details http://www.macrosolve.com/role/SummaryOfSignificantAccountingPoliciesTables 35 false false R36.htm 036 - Disclosure - Merger between Macrosolve, inc. and Drone Aviation Holding Corp (Details) Sheet http://www.macrosolve.com/role/MergerBetweenMacrosolveIncAndDroneAviationHoldingCorpDetails Merger between Macrosolve, inc. and Drone Aviation Holding Corp (Details) Details http://www.macrosolve.com/role/MergerBetweenMacrosolveIncAndDroneAviationHoldingCorp 36 false false R37.htm 037 - Disclosure - Drone Aviation Corp Aquisition of Lighter than Air Systems (Details) Sheet http://www.macrosolve.com/role/DroneAviationCorpAquisitionOfLighterThanAirSystemsDetails Drone Aviation Corp Aquisition of Lighter than Air Systems (Details) Details http://www.macrosolve.com/role/DroneAviationCorpAquisitionOfLighterThanAirSystemsTables 37 false false R38.htm 038 - Disclosure - Drone Aviation Corp Aquisition of Lighter than Air Systems (Details Textual) Sheet http://www.macrosolve.com/role/DroneAviationCorpAquisitionOfLighterThanAirSystemsDetailsTextual Drone Aviation Corp Aquisition of Lighter than Air Systems (Details Textual) Details http://www.macrosolve.com/role/DroneAviationCorpAquisitionOfLighterThanAirSystemsTables 38 false false R39.htm 039 - Disclosure - Drone Aviation Holding Corp and Drone Aviation Corp Securities Exchange, Reverse Merger and Recapitalization (Details) Sheet http://www.macrosolve.com/role/DroneAviationHoldingCorpAndDroneAviationCorpSecuritiesExchangeReverseMergerAndRecapitalizationDetails Drone Aviation Holding Corp and Drone Aviation Corp Securities Exchange, Reverse Merger and Recapitalization (Details) Details http://www.macrosolve.com/role/DroneAviationHoldingCorpAndDroneAviationCorpSecuritiesExchangeReverseMergerAndRecapitalizationTables 39 false false R40.htm 040 - Disclosure - Drone Aviation Holding Corp and Drone Aviation Corp Securities Exchange, Reverse Merger and Recapitalization (Details Textual) Sheet http://www.macrosolve.com/role/DroneAviationHoldingCorpAndDroneAviationCorpSecuritiesExchangeReverseMergerAndRecapitalizationDetailsTextual Drone Aviation Holding Corp and Drone Aviation Corp Securities Exchange, Reverse Merger and Recapitalization (Details Textual) Details http://www.macrosolve.com/role/DroneAviationHoldingCorpAndDroneAviationCorpSecuritiesExchangeReverseMergerAndRecapitalizationTables 40 false false R41.htm 041 - Disclosure - Drone Aviation Holding Corp Asset Acquisition of Adaptive, Flight, Inc. (Details) Sheet http://www.macrosolve.com/role/DroneAviationHoldingCorpAssetAcquisitionofAdaptiveFlightIncDetails Drone Aviation Holding Corp Asset Acquisition of Adaptive, Flight, Inc. (Details) Details http://www.macrosolve.com/role/DroneAviationHoldingCorpAssetAcquisitionOfAdaptiveFlightInc 41 false false R42.htm 042 - Disclosure - Shareholders' Equity (Details) Sheet http://www.macrosolve.com/role/ShareholdersEquityDetails Shareholders' Equity (Details) Details http://www.macrosolve.com/role/ShareholdersEquity 42 false false R43.htm 043 - Disclosure - Preferred Stock (Details) Sheet http://www.macrosolve.com/role/PreferredStockDetails Preferred Stock (Details) Details http://www.macrosolve.com/role/PreferredStock 43 false false R44.htm 044 - Disclosure - Employee Stock Options (Details) Sheet http://www.macrosolve.com/role/EmployeeStockOptionsDetails Employee Stock Options (Details) Details http://www.macrosolve.com/role/EmployeeStockOptionsTables 44 false false R45.htm 045 - Disclosure - Employee Stock Options (Details 1) Sheet http://www.macrosolve.com/role/EmployeeStockOptionsDetails1 Employee Stock Options (Details 1) Details http://www.macrosolve.com/role/EmployeeStockOptionsTables 45 false false R46.htm 046 - Disclosure - Employee Stock Options (Details Textual) Sheet http://www.macrosolve.com/role/EmployeeStockOptionsDetails2 Employee Stock Options (Details Textual) Details http://www.macrosolve.com/role/EmployeeStockOptionsTables 46 false false R47.htm 047 - Disclosure - Warrants (Details) Sheet http://www.macrosolve.com/role/WarrantsDetails Warrants (Details) Details http://www.macrosolve.com/role/WarrantsTables 47 false false R48.htm 048 - Disclosure - Warrants (Details 1) Sheet http://www.macrosolve.com/role/WarrantsDetails1 Warrants (Details 1) Details http://www.macrosolve.com/role/WarrantsTables 48 false false R49.htm 049 - Disclosure - Warrants (Details Textual) Sheet http://www.macrosolve.com/role/WarrantsDetailsTextual Warrants (Details Textual) Details http://www.macrosolve.com/role/WarrantsTables 49 false false R50.htm 050 - Disclosure - Inventories (Details) Sheet http://www.macrosolve.com/role/InventoriesDetails Inventories (Details) Details http://www.macrosolve.com/role/InventoriesTables 50 false false R51.htm 051 - Disclosure - Prepaid Expenses (Details) Sheet http://www.macrosolve.com/role/PrepaidExpensesDetails Prepaid Expenses (Details) Details http://www.macrosolve.com/role/PrepaidExpensesTables 51 false false R52.htm 052 - Disclosure - Investment in Securities Held for Resale (Details) Sheet http://www.macrosolve.com/role/InvestmentinSecuritiesHeldforResaleDetails Investment in Securities Held for Resale (Details) Details http://www.macrosolve.com/role/InvestmentInSecuritiesHeldForResale 52 false false R53.htm 053 - Disclosure - Oklahoma Technology Commercialization Center (Details) Sheet http://www.macrosolve.com/role/OklahomaTechnologyCommercializationCenterDetails Oklahoma Technology Commercialization Center (Details) Details http://www.macrosolve.com/role/OklahomaTechnologyCommercializationCenter 53 false false R54.htm 054 - Disclosure - Income Taxes (Details) Sheet http://www.macrosolve.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.macrosolve.com/role/IncomeTaxesTables 54 false false R55.htm 055 - Disclosure - Income Taxes (Details Textual) Sheet http://www.macrosolve.com/role/IncomeTaxesDetailsTextual Income Taxes (Details Textual) Details http://www.macrosolve.com/role/IncomeTaxesTables 55 false false R56.htm 056 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.macrosolve.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://www.macrosolve.com/role/CommitmentsAndContingenciesTables 56 false false R57.htm 057 - Disclosure - Commitments and Contingencies (Details Textual) Sheet http://www.macrosolve.com/role/CommitmentsAndContingenciesDetailsTextual Commitments and Contingencies (Details Textual) Details http://www.macrosolve.com/role/CommitmentsAndContingenciesTables 57 false false R58.htm 058 - Disclosure - Concentrations (Details) Sheet http://www.macrosolve.com/role/ConcentrationsDetails Concentrations (Details) Details http://www.macrosolve.com/role/Concentrations 58 false false R59.htm 059 - Disclosure - Subsequent Events (Details) Sheet http://www.macrosolve.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.macrosolve.com/role/SubsequentEvents 59 false false All Reports Book All Reports drne-20151231.xml drne-20151231.xsd drne-20151231_cal.xml drne-20151231_def.xml drne-20151231_lab.xml drne-20151231_pre.xml true true ZIP 78 0001013762-16-001358-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001013762-16-001358-xbrl.zip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

MF_BLHS/?8G=D_2$YZ4Y.F%FQ4RK%DR+8<)^T>,GE+KX13E0LX6>T5W[ M][!GE+7V9D+TJ[3VIT\:!M3!:,3QFZRZ,^=BWV@3(#GJ3IA7,:]B7G4L$&T# MT^IW1_LS@YAI,=-J/=-B!8OK]=3"$?MCC!ZQ]*_E-RQJ88?7TL?M?\[^M4X0 M%I7NPM07VZ/_Z8?BT/:C&4R(N_*%_E;ZKO )L)]_!C3$,=!@M+0= 'GN<+T% MVLR_I4?)XTK?B<)ST@UN(]C;-L]MYU9,/TE8"TX-OP:?1'H(<-3#XG#YL)B* M\W^[_9'T&5=?BBL8?(H?7@>A$<^%L1)V: @ @KNE,_PTP^4^$F,91#%G5#96QG/C MU=E+'.J?B2^,@=JQ^@&@(S\) V#A "B!-*XQ"V &\#2>C\?=DQZ.^GQD]D;C MKO$J"?'72[&,%9/*(3_O1*1HX71$DH M+F8O@\52^!'A\H/P8!'N2P!P=#F'&5[8D7#?VZL%G(;H"LCSA1-O%7^",^4C%'\3LUV>/K_\Z_]BS/O[3]C_BY>!5K_=1_7-U M\7%@?80-EK]_]G=2.NF:\>NI71\@:S2>X,G2S! '"SO$]C?9!*D>[V+6:]AIEX60JJQG';O MTD?V&2G0"/#@AP0__'GVXA>N.W;R'HX1:$S[(X0Y,>O*^38 M+2MXCZ.4LZKWB-;6Z##6UD =)48LVUM'BBNPMRZ<."";X50=-;!KK)^&/:-L MUVA#"G5TVU_!6E#'#APG"4-M)^5VFC&W(V,J!)A(2W@9?H>9P\ FNPS,#0"Z MX6:*O[%,0C"DQ%9K@8]V;?P&V UG24>#']CH?=!E/-=V$&/,NPE!OIH+,BN)$@OKO& MA2\*K\#0439@GR+^"K.AMT/H%E#*WX',YKF%=T$F.6+(HT".%%@);B?*&0X6 M:57>'_+WR$CY4JPQ,;.3KG$%3P7HJ-BV($L!Y:L6!,2EX'O?>F#7^7J0J=H+ M40E8'$2#5MC.'#BG(X!KNL:.8!O1(N5B(5P)"P!N6W!EV?[& N&=3-FR>GJ1 M?+CK?K@W,,0LGZD"M;EWP)>T"]C47+^HM\DH2H 93'H/P$VJ^!V\M+:"?B_U M?R\] "?Z;PW[&O\K??JZ+(U">8/C9,^R4EA[JF,.T1Q<715X00(V%YW %Q@J MU+ETYH$'WVBF0%P %9U%X H/SS J/@M]-63,;!D:-[:7T)G/&(D=E32*U'WS M"*>828&/[='B"H_M+/"\X!9/I+Z03!8 8?E??8AMD.P+?;>;1,IRV^7$IF:0 MJ^Z0\;3^M#-!/'WR<%*7L?]-)[7^M]0ZX!3P[-G+"#"0?MKG!?8A;JVYM.>7 MQK#N^5JZ8Y4NIM-P7TLQGO)]M57_B-\'S4[00#C>#=\?]MTJ$#AP(D3X%4D# M&DJ5:0-1X$GW_.-KE/._:JD]W:L=D& M(+8N\N-AJWVMA?^R0&F$0#G_O!0.N:PDAAOXKK&2PMM?H];,,X).C%J?TH?; M9L/8TX-L_.1D?>>'E4+[RX2N)ZJ_:X( 8@.FO?+F)O#L6'HR7K$E<^P*[Y%8 M,I8U_JY4(=7J6\>/XD9($BY3-8DRN,6Q621PL8)&R>;QHDG9Z7 +A8HS64VK1(H_>ZP)$]& M*L6+L;PA6[B\7S-#,SF(NA:X^A=L-[PGX4&H= =S+5H:7]J(F)91%F#M&G9L M/!\,)V:_9V7UN%3ZU?-!?VCVQP-,=,KJ6V'B%'P6E(D:"B>X]N5_A?LXV4ZQ M^G^F(C[Q1XXKK[X%/?D0\B%L!:[J4-+3&ILGPWXFP@];OM,"%:%/Y3O'XW[W MI&NJTMS) ML(I5>")5\B9[<6[?$"L4X4+Q%;QZ(@^+J;CK9M6'7G?84Z.LKX+X:OJ&BQ4< MB-<0=\$U%#;PW)I@C0G@;K"\)*0*/*Z(G%!.<:=38*WX_KL 6/K07.>BE> 9 M3[X$)L!@L]I&6*!^*F:#":)$E>W#!$EF[B+N25[83Y\8K^V; %?VSE:Y MPN^Q:%.$LA8K)MO25W@M6+Q=X\U,P6E]+7;%,G [,G#+U>+F0>*Y"HUE\ =4 MEHGN/2A]53@P=HQ0Q DUJ+S@EG8"B"J C-!APC;!AH^*Z]4UKZFT$E:+1I1% MB3/7XZ@Q4S 1H?FZELDZ@HJ#PG2>1[A)8CCZ=$\#I ^@3!R5;0U(][#Z'3<55_<=3Y+2@'K Q>&7#OI2@U8.TD3P!XH8,DUC*9/%LX0 MP8'Q"X2,($OI*R_F$,>V,U=KV$;;"#4GP84Z=C0G5*1P3(N.RS ?,A18[0IG MTC26D2L67C<'5D_AE=[%RW'8)PU>(IJ[SCVK+;47A:RV- =7+X1C)Y&J(+&N M#6BQO&X D<8Q2X#+P $6L69E"\6*I6(GLR3&TI_IZ:?C+OZ3R'A5Y(;355&, M$*M>4;N!*)G^&SDBC 2<'DM&H7GH27M*X9D&[,2F&;44/+M\:9Q8H\ZPU[%& MV6U3O_?S*Z$Z'I#A,Q?$M$',O/$!& D-\#V(J'/@V"XZC68P+*S[!_3]OH&1 M/ZO=P!OG?HQQH>D]UN3GR+BX];7\SR8$/)>7$N*FD=W9*;=41FY1\L@4TDHI MJMYP@$)C(6RLJ$K>Z((#&R5/*#H"_TJ=U23PX'N$NZHSN Q"8LQ*?C,;K?W1 M9#;:'%R=T?'>M'#NN&:J/.=X7?2\;UJC4_.D7[XWC\"N(VOJ;T,LP)KI?.-T MOMM4T=UBSI5M+E=S1N%N6>@=? A6.+)ZYN1TH&S,9 DR(F5GZ7QW<#/2C VN5II[:E_ T/,$YDJD"?:VB!<-[8S M$]+<4E'P*]DGJ%+/>V9FBJ>\+K^ AQ5Y042NI4 MBS-6X:9^Q1D?)G7B2PJ$'7=&Q4X5%P^9/L$P>/1L@[0 804 OK0F(>:+?FU5 M0F1PP'O\7Y_UGSVP]*S>[X&P^RZ[;OQS:V;0DFF>SWV#SOW1G/H]=T$X,.OY M4V!BF:BHS'74VSX#E=.^KLCH/^I=GZ?1,^\Q-(5E#,L8EC&UD#%[P^U+^"6T MG3B!8=YB]KGTC;^J4W?Y\//AY\-_3(?_#9Q]Z4?2:9F:\P?>XC&#V_5P'V-E M'*X:77DSN$ZQPWK1ZT4AQ:T8-E6=![P/J)6J[M8<6H>O-_T04GRX58:[03+U MMEU<'15X^QOPU>5^CAK E-=Z>FC:Y-6>_;),K=B;M5Z;L5*5K.#R=,GS$"8 M5)B!,%6P_L&$PNR#J:)V,&'V<=R$4A=G&0?KU=55MC>PO ["F9#8?A+;GG]> MRI C]S@"IJ$0;4,HS/?#/H?M98/_P+R*>15'Z]4+DOU1KSL8,9-B'T(MN!7# MA'T(3"C,/I@JF'WL@5">/CD.J-3%"RUT0^[:K&=_5D7- <3V?L,AV@;# MWQH,S7Z/BS>RZLY\B_V4M8=D?] ]F3"S8F;%S.I((-H&KC7HCKG@+#.M>C M MA@D[1X^?4.KB&N7XS-8Y1G=M:L..4=;9FPG1-NCL5H\=HVU4VP_=L+AEG(M= MHP_F&IVP:[1][(J9U?%"M U<:]CM6UQ]C M=(3A7[_\Z(:^^.E/.\1N(]$5;/B%%SB?_O[TR2])U+FV[>5/;_P;X<=!N'HE M(\<+HB04V7.& Y/!'Q_$[-=G+]7GCZ__.O_8LS[^T_8_HDOMJM?[J/ZYNO@X ML#Z^$D[Y^V=_QT6Y\B9#&OGIOAY 68_X\23K$A_#!J,9#( 0\X7^5OJN\ EI M\)PGXACH.UK:#J S]^;> MWGW]*C,$-P&\$4*3;D?T7'=M$=FHY?[1GNW(KI M)PG+P=GAU^"32,\8#OQ,'[)?G_6>&8[P/#UM]K>F-?Q[+[[T.%C>1V#?=*32 MO7;[(^EO\26O8:9V)VRJ?%%=.DK3^\[=P_O:&P$?_)#@AS?O_CA_=W7QX-H._1__;#/_ ZB+X3A>?6F7#XBM^0'QI_G/\*$NEMX3W05A',J(J)3,CG@MXS?."6]SC MWI''A^TAS:YEZH+'^Q/T1#M](C$@6>=+=! KD?,";_UV?]1[A^VF= M"Y,@0X4/YE<3:JN*5W.QU]G!]L&^-WVU@8=+V MHKW!)+/+,JNLIN!X!/K8A$5CB&5_%WTI4/H;4-'7?G4&2W]L#D8G3# U.4X, MBP922J-8R],GCQ@E?F*>#H=,,DU7LSE-JT5:]9]!^,F0OK$,@^M01/M3K.L, M!*:*6@3WUADB _/$>LR,@CK#XJ#NW/9LG^FAL=S",@?CQTR7K#,LFJ7\L,C&;IOP_I_-T2_L)*\9T46]M@H;95'=*K(P3 XM./8IG6M;%^E1*TRU#+86V".3T\?L MS,Y'G-D>LSUF>X?MF'1J#GMWQM5OK=?THR[N]LN/NQ25P^)S5);N?2B6MG3/ M/R^%'XF\.ETCJLXI0.Y8T83KOC6EKIEE<=VWN^"#'ZC$V_L/Y^_/WKPRSO_W M_?F[R\84?SLX_ Y262W_]ZX#>B#8:#%@""T':EG'K(9*9;;S:6@XGAU%OSZS METM/ ^)1>C,;?]:=&!23_KBF?'CGN3@'?6_OE!$'FE1+PY/X)LFALJW:$AI M2:%6%1#BREY\#&L"E38?P_T5&CA:@CO.VUBNX]6L>.C4JI1^E(1[C1_E@CM' M43VE405W'@\L_9$YVF-)@@83#-?R8M;"K.5;6,O M/:H8#>88)JE:#>^DE?] M&E#7F3A3S1H>O)&.X'(&3!6/#Y FB+>A:9WVF3P.[\%MS_:9'AK++JR1V>_7 M(^KX\,!HE@+,>3^4> M-56/^GD.U'^5\,UMFV=DN)+'LK!O267*V"-FCGFG=W4-JAZHO M=U9SR_G[ZZ,-^^,R_.7__KPYNK-^:7QC_.WKXS7 M%Q^,#^>79V_/"6PU*DJ3_6L-E'>Z$A>U=9<>7%KM5 [E46OF,*ZVX>IJ+HR7 MP6)I^RLCN/6%"[!:+ (?)D,A+WT#A+:,9."_#R2LX7(5Q6(!([_QG:[Q_:OW MEV]^,(W?SU^]-7X/IA*$]S\"#SE2]@C^]@-%VIP#:#]_ANG"91"JOB'?G[_Z MWY?P:V381BBBQ(NQFI #HLF&J4%7Z-.;\&%@3)-(^MAVA!!G.SA A(__;CMA M@BD#6.E_$GA3 MA"9]EP(V I 88^R;=C(THKD-.\7!$7BT/6LX,<>G_<)/"#039E["WX(FPQ8K M^(N,(V.N08SHB>=!:<,F$%T\-T!;B]10S_N6.1Z,:*+G W-\,H9Q'=0U, @J M6@H Y(WP5@2[;,GPB("O 6*@&,0V3?W<&I^8D]X0""TV'#N:8Z-P1P@W,F9 M=PH,H"U&Y:%PM1$F/YEP]@I[1-2;@-78F /$IT+X1N*3_A<'AB?_DTC7CH4: M5;WD)O2;C*($,8O[K* I/XAA- *9,4L\;]4!. 8A =%1:UI;($SO"L#:0N(! MB.= )3@K+C"=&OYC2'AS0$#Z^ &=2+*9 C -+ MT6SW#DZ[9@'LJN!G%L'%)\^> UNY$L[OCE[ M^^;_G5V]N7AGO 2CX?Q#:PR#3CK@\2N<.474N,8FVPO;T'>F5"-\/-6/SY:A M](Q!3VO/'X0;P%@H1E U, OJ.2A-J#R!GF3U2!E2Y^&>Q\&UZ&]0& [<]"6 M'2]Q49ESG!"M 2K!"4LUO@?5+HF5?0#*5'_RW0\P6Q@DUW/C4BQCI6SU>[V) M8<_@G6Q _;X/"FO@:^L A]Y4,%$K7=@N;(BT:S?1]@NI\.DV(U!N8]!O\5M7 MS&RPAS9' J5["3H_JN81T)LG4)=#O7B*MHHG;/PM Y@KIK%2:6'8Q(<';-PH M/(Z_@I))B1#!4BCM.2+E%AZ%!4EE=Y"5 +^(;4JF5BR_3D]$-3.O1P[ZN;BR M/[,^R?IDR_7)(>N3.SJ907L\-Z[._K"&FY(>$RCU"*O. M.ZBWS)(8M (:!@O0B_\D A0]\B>"EH8^P'!EN'(&TZD?IB*^1= MH N7WMJR&'2ZS4B+!.U%Z42DG-#,N3]QF82HBT5W^=_J;GS>&:EQ//3*O*4Y MN"K<5 M=&M!FZ$EDB__-C"B.3"0=!\ @"3T81'*0,UV3K_J&ZX0S,W^J:ENPK9M=$", M"JRA!+F@M0:6TAT7L&4TM>D> NS(9!I)5^);,-N?E[^]468GPB=CW<0IC6OA MHZF(#'JE6#[>7!!G[<#NR(S-[G/H^@7M1Q'>I$:QDRP2L$'EC1I>6YZPYXJ! MT Y=@KW[62Y@2ACJ^=#L]WL Y@F!$HT[VO.M]#R8$LX?B@I) *<+Q,&P"Q8\ MV=K&X*2?^BS>H.7N Y%^ ,KR$R0.,,W5WG#)1J3L[X6]0A,]B93Y'[#8G M4>X"[?40JNL+K$5)91"S#D&@ &(6A;5GKRP*FX.K5Q6:LVZ]E#(S_"4_BN\N MWI:/\OIUO'(AWDBZ>2863??4BMG8V,,I=<4J_^'F_%/AV,#&TOD37P=LQ,CK MKV%*8K_DQR777RH^=]C+(S:18M)\##92?V?K';VQ]N>';4(;K;O3S$B,TV;TARV TTF-JJ6IN1")PZ6FBWH+U)\92PU-;IR M$&KK:[06=L6$PQMNZDEY^B3=3_$ZXV[Z'S+]5UPLU;7DY=I-Z0%D?:6V?2"T MOKO'';*_\NFE_@>U)NI]MGDXT,8/V/+C0#NVS.%@:)Z>CEN&Z<:38^]U?9Y8@*GAZFK.P1 M ?#[_>N+FP18KS/X _,:YC7U@]\1\II]:[2-YC1U46GO<"FR4ELO=M&Z#1^U M?'G4@G]'!+=.K]-:B<),AIE,;9G,TR?'!#EF,U_@E,VS+7_Y<9?D[V*2.":5 M2ZI?%)WY+F:" R"$[T@1<=HXIXVW/&U\Q&GC.Z6-8\FA-U2;]-(X>_?*>'GQ M[NK-N]_.W[U\4\<\<@Y"YUR6YN/JPC?>!35F+E3%1P#'V%+ B/(41WI9A5_V>VHR>H22+OVXF%&:1[<)7?M==3_&>IV8 MCV,2=(7MS%6A29V/(WT98P:\6A$FYV-F8)I)Z.JR0\^INVK7."N 296\I.I" M;I[.2R/HL=68F.,9Z;R?:/]9/X7DP1.N[;S/G!\"ZJ_/5$3SL[6X4ZMW.GX( M+9A6.K,7TEO]M.N^0"M6\/B&=*"'3_"IU'F_MHL]',;! &@0>R M(]QVZ939+*A-%-0&YMC:M34(4QO [43!;60.!Q.FMEVA=JJ@-C$'/::VW>'6 M[Q'6B_*, M[K)ZP=J\#D56U5592>*SAP++LL ;TC?.;N!#$@([ MU'9LV3)T@HB*P68UU;0-AZ%^$ZPZI&UNC+=5'P%['?7=U(ZD[KQ@&Y'\'*\Z M+MC1?A#CFF @!Z-S/54?)]W%HU:$8>[&G*:]G.8#L@#MX%$%L+17217]PE*, MSR=C!GN9@F843G655'G >+E!DI5]+: M,U3L6BUA:) W+ZT]C"&BAA/^M;D9YIH 0R)FK"X][CY'H'- M-(VS;#-,ZM#ZFYG.L3"=,]7-:JT8X9J.@VY>??(E*A; HL@OO0@HLV>Z,MZ) M6W%]K;J&(8/!]DA@.%))0JQ"Y;M8\\X3U[#:F5 U7]>K _947X&L^GU>\Y'^ MA.>PCEVI9YCN4W93FO_[?W4ONZ^Z+[OG\%_CZG]_P'Y7PG@7&..?K'['N>D, MQYW?+R\[__/N]ZYQ.0\23S$QW6 *-2)CB6W'I*TT:WBV] M"OK7- A]D195U'ROT#K!E0"/. A!^YH'JJ,8/"A#PPMLGUI'J3X,Z;U*U[C M+;$OFZZKQJ@/0'%TDQ;?.EV8_])9$A-QCP; MU@N+BK!O DP/:BCUE9+7NHV QN_VG@%?%\]1C@3Q';K0P1D_R.@3QW]P_$?+ MXS_&'/^Q8_S'.^PQ]8':3=4PX*-9>N;!59 HVH2D157C=+^K0Y0"UC/ MH;*;\ZK3;H 0 LTQ%*AH"77U'..O1J%QDZJLFJ_,.(NKM&_=J+;XK%:,;X/" M$E!C!4# T%:O]UT:F^%4&.,JHJ-BV Y!JYL6TXZJIBEHZJXQL=1$.D0D?4M7 M]*[#)#AKP P"LN1#*=.#+?[VX M//^__P(UV#C_ R.AOT0-5B#4BG#Z1ZH*J[]9&:[I=#HK\16U03OC[9E^J@1??!I;A*V*DYSWQSU>E][@+'#7)38*A0$M'GL@Y6:DA0I M3^DH,_&9B#D\GFR7_))[^!M,0GOTG8JCCYH]Z:(-[;P>_C1-52_Q6?_092 M$Y_])F'KH&??,D]/3^'?D\VS__JXSKZ*Z3Y^2D:#W$$*,30](XM0WP6!K=C-:OP8(I0.IUE<$MI MD2YN(\*;+("%"H'2#:R-:\P0\"F07N4L+18BI%"Q/#2'LA6%/\?,1!".27@C MI.=1C^OTG<27C@*F8R]5NVJ)@57_BN'C?W'--DZY!%$;HQ"/!=VD1:LH%HM2 MGL/_H>;:;N+@9D)1N6CX?R_PKS&A217E"7Q8L)N$FTO U4TEOD^[D L<0V"N ME2=U6VW3@-6#& ?PSQ)O!EM3P6>2(DC24#*5DR5]8X$OP1XPA/\6P +(T26) MU@"(?\)1 3 2(NWETM- BKI5ZL07:PHE-0/S2B]F:T^OU']9M]B=N=6+E9UN M3<8M<>)AA7)!%(%J!:8VPU-$>:U3+1J/3M8M:H7!>W4+5:].1_^B()EEP=Q8'_ MY4O\ZQ)GI-G.0"J!]"EI-YBB9_QV=O:^J,!4BZ:=I,M::AF5DR:NPU*H=6PK ME4+O%;6J6*P24;1.%#6>M;$L:AC"+C##(CMS&,%8)8OLZNQS;6\*58HFS>K M)^^RGLGH@>>B9!I)5]KH6_TI?>7U9>&IM\J(-:XPO_H,C-A+,@8C_BC"VP;1:(F-6Y;WMA1(J<_M&&%.\H,P\C:J6 M4WI*E>L2.#1N%S]2=F@24F%O&FI9<-!4RHTOE0=%6?*O2%S,SG6Y\8@EQ=%? M1J5R A"/&D^&>A83]<0:BXFC01CZ_I07ST[O]"NM%NFG\D!B';\'=?#IZRHL M'^C;UUD1U(7]261=)]0U(8B19+%4=16HOI5-=Y,T/&PB"'&"5,QA,$T4"7W# MF-Z=424K-\NM5[$[NOY4O/6%M$E'U219LC]=9*:--@K]+]1+!"<2B)5E)9*V%^8EC8+H@(\*J5N67+>63?K)56JP$\L8(__F./0RN*V60BK+&OT0%6-LJ)&^+4=S970VJAI9)0*&'DVEO*E M D7X"@GV.2 B'?@_()10XL]*"Y=QHH)"L&J/HJ(H@2W0& M[A;4M0>J+SS!X M=G/X^M6;EX!J4""ZQI\XCZX_3 ;F^C++A43# .;S,=P%!33^HRIF%C05L$VO ML8!Y1;4E$WVN-H&'8E\=8<("/0ER6ZL12DIG!8:*0 6!KA0%&:G%"W>;HW2; M@"W)88 0EKR$_SL'K>?&]I "^+:Q=9P@E\AX9@JTT#HIW!S$K9%>%U,H6 XW M#(G/LD,G\D-'<9M@IRFW)MAWTU6A>V)^'4=],L0*)_TDXOR'A2U]=+=F09L^ MR@QWB]@L]F@$<4\"UUMU/ D++3:8>EG+ EQ^ @@+-ZK'*SR0B+*]\3" M;!0XB^5BW2"9QK.D4)96H!&>7L/F;9C5!C$UA[:L\3$E!0 -P=$!2'E@Z3/ M!3[YIP$%:2(,.M]O))RMM 2PON1%<"=17A2Y@ABJD5%1E3C3',HV/:@JH>U@ M)PI$SO.>ZDW40_VCM+-RGZ)N.WC($=SHXILI=M;AT>EUK2WI OC:MNSEG93& MHI;Y.ZGI^-NE<+0.S:IE6^18IEKF9&#D=,"*9./PR8IDLQ!VYGG:4Z(*R6=G MCQ2T0K09^N>Q;1:5WH?]=4B1S)_O&F=W_:R&L\.0QHJ-&2888PL&G8JD+M51 MCTO\4&AU\-H&/5/=] =XHV 6+O?5=<%B"3#VE;;K.,DB4=T8 LH#II8#8BY M(;X1-$39O>)*=*_$*M@.O[AS@[CJ#<6ITM.R7:05!=\;'\M[!"%GT[91]2*A MEI( T$?;)%T%"FN),+Y/:-8!VR[I"H>-A!%%SI$L0I/7PZ(6*M(,G2>A%HJF M@>43KO55=A@A'/2'((F-A8CG@=L%B8*]NU5V4)0U;\SZ,6YVQL7Z&'-AN\7^ M03A'>C] K^B*%=K%(O/U=XT_\2KD&J1=Z*U2_T#ZP HC OQ8WT;X(-[P?GV6 M8+V0? (G[^^H)# VSHD2+"=1C*8K^#)BJFN!2\%'L]FZQIN9OIW7RW QBARA M#%^E&P"PI0-,!0";= '*9"8EP#1NA7I:E$=7+8KQG!!B5*/S>!X&R37V.D*LE,W;I&XY40KOE>+5>P_ "+8L7INFC$\3E\6G6NLJ(&.1$8*ZZ;IID^D$;@D>=8&;.Z[JS6?O ?#5>G MB?3 87 7MIX.726TB=_3G;KM4&QZ=6?]H",GT7E"U2]9>AD(:[+@&V M]9]YN#.R8RP/GY%OXF?U[PVH.OAUZ!9P&0$&TD\5.'BPMH&'Z)2M^L+>IV]\ M4^>[:FA,;>?3-6C+OMO1IXDH_L D^D -K],N?FG774OQDB]N[O?M3"WM!/RY MHA/P-C/VV3ZXZS23412G&/,NPDH :/ZK()4RB*D'/&/]MU06 M*%B6?]->*2I"LFW?R-F!Z?J_/NOO'\"HS=2>Z329O!@&?,2L(9/7W>2EN_ ^ MKC)9H?']S7&$F,T>2,]<:TG=0K6S>/*1%NM$F9?S8&G\;CMSZ:>QFID_8&\ MR0Q%5#'K XM'((72SNM,%\_W#H+^!@Q"=*;5"0@G/?/DY)2)X;$/1GMW7F3J9,.KYF#.NC_B8@ZHY8%6S_JHF.S3W M1(BU#2)Y*^Q(S //3?M'4S+>WB52;>%1%T'U>!%;QP;2[<+OB&!JG9JC/<:^ M-9"1<<#I89C7TR='?M28?3T\3#O,N9IJ(K WFITRO-DC]4,^!"&\>&WWBP]DEW-;;-SWF(#FDZI1*I;*(S#;IM#BZPC M$4R_[X_-T]-#7./6]N3^P$R+F5930=H.IC4Q>\,>\ZP=>59=K /V M,K/\8!@:@\?N#K_O!2^2[F;JKK^PI9^+'P[;9T;BJ4M M0]U[CCK%4*,=;+#K8X^="'OV8#M=%POVBU# -V)ST'_#?T,!*[0]59-D2J!5 MO7/BN1W#2S"M:IBSWAQ@65V:7[7#6\I8M;KK,K75G=J8,S0'5Z]4ERT\C]A[ MPX##"4=_U[;7:8\LUWAN]4_-?G^B&E^#>G,R'N"A+N>,%YIZ;/;!9CJI,9WP MF6X.KHJ=6[$1T+6ONM)3!;^1/J'F<#+! UJ,;LCD/4KS+V )Q;-LWD$?/^KF M;7F3N5T;R)7:P2Y05\&'+L)7,EH&D>U=S-X&_O5;6(%[1GV%'J%5+!-Y+;K. M(>([A'E#H=X@7H7_&K\%@7LK/>_^'G1/GS0"M]R%KEGXJM59?'C(Y?Z2XX5< M49K:CA,D:,NB@/20\7C$>%0O.VS=BD^$+MG5U"N66M5B)[T(Y"N9N6>7+XW! MN->Q>IW!R%3,ZF\G_7[OYURP85O=5+3A.V_SJ12/R]ZR?JYL>']:>X& ])9&=A(GB9TL&,@.O$JM_ A_3UKIJL7&P?X^EQX M+JD@"9H?L-N%L".P,UQCNM(-[^U01JHC<-52<$!?C8E#ZJZ_"6PA(B3#2#[\ MY-C1W)AY0$>D'3FZ!3&LX!H $U*$*,R(,]!8E7MY<_\2Q&='"!=@"#O,&RCJ M5>6+P'[#1?3HMKZZY:/6]-+UJ%G@+]5C<F8+M16/ MB.HQ2:^\O3J[-!Q@ \$"*,B3U/N9E,:N<54Y2?GA6SL"!14]2-)7^U)-IFVC M@*4,.,8B<(6G]%L+SM9HU*,1LF:8NGNEBR0*\TUQ,(SW!6*92I]48+6NHO9, M;SX'K?=T:!'&%D$8R_]^L<(\!'9FWZC5AP(=L9=8VS&8 V/2K:"Y#AKXP)W74;VW(#2TI_BX"R F/I =<% MZ.(M"[+&M'5F-EPDT];<2!!E%T(!O3G7V" "1?&JGVFU):+!H DO!_#4]H@; M(V#'(W,\&6H2''59)GZU-E%6SU@CJYO^O%5IN=86$9T9Z8/@OI;8^W2[!D/Z M"G#29V^RIZ/,L*)A+I ?/>MF3Y:UC=*,BG7)PD@T!V)G!N<5^+*Z#@#Q&H,4 MW%1';-]/5"?B$-DY"D-L*"87NN&]G!45E7NTD[+XR43QG*2.@Y<<*'0$BA84 MRQFOIE?*['DI0J0YX987:WLK7)626CCE?V#U$O0RV&7A9]A^F(*OT^\1J(#- MHPH2% >4493HRY:<@VT:1[E_Y6M\)45?RRL [0VM=H\>%>T58O91&_:1.5=R M_!NO)5X72ACXC0\O)72I=[]CA;%:'ZRR#[\QN"K*%H'R!@27,@YGV3F4^3E$ M_3S3I%$(1HDS+SV U^ANSLU)/,+LH"4;,V&K2WP2C"2A9BN\\T&Q#GU)SPD;(!"*)9H%('S1Z#.5ME'P7ZQI >IQ%.+JIRCUH)#G M!J\JR,S20 CQ?G4F9*6J Y5/P'A58-<+D'\*%LWA=G#>F M#B*%]!+1&(J,4,>,5R;B/CT?A';<&T:8P"K6* "P)P.W:[RJI+?B#!1RHC>5 M$T-J249S 4HB+($"8I2S#AA5)_U3$00 (MTC_1ZC-ZE#O@K0N6)/.>:TUZ/Z M"#@Y)+1-CNB'U5A]H X_GD?I^^6E(6KNNE+?O(;;KN:A,NB&OOCIA?!!14>R M!F7O!@Q]0/5KQ3B:=]?&S2_'MY$CW- 8WT'OVZ\[@!'(-V<'N/_)-3$2 M,ZEZY.0'1.M2*:F?P]Z&7D?NTJ)DL_#@&DTBFXQ-0,>C.*H646X2)5FQ3:("R.H--%("Y.2Z]7K@)4_H Z1FD'R1+6&J^ M:M)Q8/-JYJAP^9%ZY;=-A.H9O)L]#I]S-SE>KJGK2=*+\F6GUR/H;"*M0L_B MID1"4^"XB2AXML1LIF* E$=.1#%093Q'C4M??Y5@0#=6,6DUH/'B=450U-WT MP0$FH6X<\ @H'3KQ\ST4=Z:O/C)U36\+QE+S+#2^L]7I%V!YOK[+\]0,]]!. M^:JQ?'N2 Z'P)FKT0$RVOFT!4L4CH]\(A:?-AI(S$@X]:*\*4@5VH13H?)/: MUL"QD)T"L!3!H#<3E&,-TXIKMF"Q0,U^;J/=EUZ[P)Q\;@ZNBSJN%W;KS45\8HBI3=)UL"8'2'HS,E?;Z[/*%4G/[O5(,5.'4_ZXF MUGXIF.<52'LOH,44XY_2<=!E$Z+'IDH1SD6@"?)81$XHIR+2&HI.7Z+Y4)86 M'Z:TA0AS#64T)Z]=09K.)6@-H3-?H:S4'B,5>R/]98+JO59(JL9&74X%2VA& MQD>BQD>"V5=S9]+5\R #\J#X:3 9>):"(=B9(B4" M_SI0(5&1C+J&AA*^ $N5WDK9)I'BT-77.N2NI]Q/=8F"]+9V063JC1-H(P$; MT/ B24$Q'>2[A^\X[ZOV1XG97G-PI0YTWRCRO?<9-R!]!'F1BL&*X?P:_REQ MQ4T^6'0W>(I=I$XQ'$E(&LH%S5VHBM28LQJ3_GMI-+K@%*NI;ZEA*'UXSA,SO-@P4!9X:J# M86*N';KI8S1EZJV!H4,9),CUHV1!MZ.EZTP-2*# 6QQ" W1&E^P+&#"][@9, MIHHE<&Y8*['Y&8 ]"".E;*;7B H'ZJN"(ZPPM/*&P>J\E4)QX:85('XK,.@N MTK )!2#0AG$%C!8LI),I]EWC,IGB[O5E._Q'8XLR_[/]*N+)D:I=4&J=% ,, M?X=!C#IJM>F#1*EIIJIB6R M(I(D]U6%6"4"_0SRIW"?7UAKM^A(4+]+#/&+Q740KE*'(!$(T2==\=XA]C+1 MF")\942W]I*H1#LZC.=:_M<,_"I+0R86-'@>O>:9"^0%TJ#/ W:B MD_X#1E@GXH-*.$(^]@@1(.N$3HB?V0N0X3_M2B;ROT*15T8W5 HL)5GZ#@6] MC618^O968%6R_,MMQ\>3ONC,UQX.PB5(#3@L=A('VX[H?:>LXF#><\2V',RJ M3)53!$DE?REQCB'5Q"J[Z34Q& 5J(*'V+U_8(6;UZ ?6??6;[/+(,*PA"8I5 M&%=QX!J2@2YZ5LF;U^'1Z76M[-DO$HM'AN>&(/6.X^UBH"793>F"-RICVY% M@&P7V]^*P'6T[([5:I#?O8/*"BD8D*!X&>8\DQDT YF>VBYY7J,32DPYLDD_ M -$-&_D!PPVBQ(Y0$Q#HA],YAYA4%(9H,]"]NOB,_K6?C?X/(/TQU0E,#4PW M(D=?J"-+8AF#>H%?JVT)^H6"3,(;LO[F]@V&*5#(,QJ POW9&/Q@X&K)/DPO M_J?)"M.M\-[FLQHB#29"#>9GFFWX QD@H,6D7D<*S;"C !]:D04($W2-/].0 M7# Z-6]/ 491*1N11A(#=:, B\M0D)3V+$:VI]RG0/:?4,%9AH&#NI7T,7,+ MK"\*R4!E8#U55(,B11DBX_G$/#D=XS#I8D@OLU5F*,ZE]"F52DP@5_8@*"*) M#>"'Y\:DM*G8#KN4,7HR,/LG)^FM%F71J7@(Y=:H2D:E:"#:8I"]=7^BUKTZ M5:D"C@]&IKBR/[/>U29N75:\%!$80 6;X;A'+W2;@[2J CY;+U(>;YI)D$A+6DEY;SDCJNXFCXD-CL5B"M@>"SY6S&4;!.OIR3J21]K^;&^=I')7OY';JE8+OFS?;JU;HB(VU96G+K922 ]3+],50TAQWZCR8=CN>B!F 1'WED@I M:)R%,BVH9A(%I1&R5$MWEOBN\C9IAW\*(:KLH4KW9J/M K%TG*R8C=XUOH*W M'>IR657DU9GTI,X57>ND4!5UT*SRC(:&WFG)7Y5?[!2SZHAF,$(W"?UJ"BE" M;EZLYF+#6>E]5[CTL5%!5R6-KVV\:J "/E5G B.7045.X-D04R!5?2&ELB:> M=JF!#NSINBJ5"_MC_Q:-L*@U(A %(!&7_$%0;\N7J).S$LFNG>VNG53=/%\LO6 EA'%) M6:\OB.L62>H+@W&9)!I+$NSMJSU2[[8?=\7T5HVWF/GN%'C MFSUB7524H.+ M?*-##*7$2C:B>^']7.^EC!N?+LJ"5._2^2L1J5$B9569ORS+89%^%KJFZA' M>BEB U^CC/)M">NTY?3:WLRU3ISX&D@@[E!$2T79/!J?=*@@5Y5T&ET)>&GQ MMO7,+)5KJ/=$SKFTQ%X>]:>WNK'!; 6FD42J791.X"0.JQZ,&&P\M$V3#^(\E$JOYQ67Q[URG67 MSY7@5WSEO;W**BH5F4_975=X6X]8^/F'-$:V7 B1 @0WE0QR&10+'"DW1%&1 MV' QZ42#JTT/X';@8(0B!2N1VD!R7SJ&[2*"5+7":#VBM&*QJ#C3"BYSWJ#S!YJS!YT4!%1@J%)H7776\W')%]N-0MA9\;2#E7L1YKS M4/ \J].HW=.I4-;5:-1[VW) PC0G *0876DL@E!7"%D(5P)V$*V4X!!XD:GG MQS\\"O-5SZ^4R3]&0_GT[IH2- M>Q9Y)S#U$=@G4"F."2G?SLXNP;C+S+@1S)BE9\,0=C47N8V:WM_K2^;2":P. M&;S5GN!0DE,9.U68@%Y!O"5UDLF-X8)F"H:3>VSOBVIZIC$+Y%BSG#T%G/ M>!\&&),2@:P+EV6#^OW+HC%-T'G>-ZT3"X3%^YCO>UNQ>YU4;?B,&KO 'QZ'[ B M/>.?"7P:@V!#Y4Q3HAMH%: YBK$RF04J2 5]/YW'+ M'5VC>_LW*I)Z/C%'PU/=/.?4[ _[Y1:MQIGKTHKP#F%;%UA*B_ 2D^2$\EGD82Q,JPL5613G2J]\<@)L^+S]&I MW7"NNUE9L-137AUJ.#.>8>4;YQD)N6>N]+ TP+-\*=]CW.L/^8JZ>"4@G>T/ MJ$+QL+U$UR9P):@'*-LP\%"'!>N7=$\^12(H'[&WX;4P_(2$'L:^EFIR!DE, M%2E('RET<^L:K]3"[UB6C!YC54LOB;*?*3H",7)C>P3N[\'4)A"#^O!#T854 M"J0@5-Q2AE1&&(!;M=&S2-4K)@W0IM539'(1'/>K-Q2K@3<=&%*L08?#B&@- MD=3PP5ZHN(DIV/!J@LIXRWL4C*(N\D[N\!U9SY+@9%+/'5O0HF1"27R*FF\F>; M;%\75?QJV.G1K=%XLOV\?A,DIM0%N$,EK9810"/]5 $/8&,=%7^23OUU<#(< MX7EZ&;\^ZZF_E[;KZK\SZ(7? +J-@@)!' >++4O.IW0?NK81:+/.I^L03K;; MT91-U%<=8/50L]X;>Q>[#[)EC;6.@BZ\K+AW^K4G9D23\7UP_W8&TXF#I:9I M_46ZINT2J.+$'G@A!Z&%95VIHLDGHRC:4!D1824 -/]5D$H9Q!3[#*[_ELH" M!GB^=Y!T-^ 08@.P3H!X:1GGIR<,C$\]L%H M[\[K3 7,$F!PZ]0\'>U/DVT,,31+HUU3)MEO>CP*[$L5BA*J8 ^!E6;#P)=. MM'=K\_![;SGJ'WG[M9-%_1/SU+(8];MN_^D3/NCMP?81'72K;_8F^[NA:#[J MZZ)G/JSGE#7-6I'B!39)Q;9SH2^IJ"TJG#/Y.::6T:QM'CGZVRZ$!@/S=#)A MU/,Q9UP?\3$'57/ JF;]54UV:>Z)$&L;1/)6V)&8!YYKR 66"BCD\.Q3(M46 M'G415(\7L75L(-TN_(X(IM:I.=IC[%L#&1D'G#+S:CY(6\&\.LRWFFH@L"^: M73*\V7UZ(9X^.08 U,X#98T'9O^4XQKXI#.NC_F<#X9F;WP(P_CP6V^6)LFN MYK99.F]%%!D=+#J3+!)56\T5RU X4G708[<-NVT:"M)6N&V^[X_-T]-#7./6 M]N3^P$R+F5930=H.IC4Q>\,>\ZP=>59=K /V,[/\8!BP#*U1/GGK1*&O?12EYN+*^&O]BRMS/;Q'E1E9'?7Z2,V4K1RB M&-[Q*@KW5#8Z.G%^;TVK0YD*YGAPTC(L\W4[2Y>Z2)>SM$\==GV1-Z35[@L4 MM3YN#VQVMF.O!Y8=@Y'9&SWF%4VML5H7@<$W,,F3]@H,RQRJ3EB,5$W,<%FQ;$+BMCVKR4&/=I1 M)/87/U7KT]8FSG(L\F(P,D?LAJJ;O&"SXIBEQNM%16US'7\+ O=6>M[>P+(% NW@L(KM'%'RX6$D MU!$!\/34G)R>/B+Q-?'\U44F/J3QM(Z'X58LL)A4P*F/D+P*8AA@F83.W(Z$ ML0RE\X#9)T^??#6I'!U%?*7 '&[E]FZ03+UM>=9-3I1\"#%96[ -K:'9ZQVR MJ-E!S]QNHK&JML/75&O :@]NZ(O"RQ_$-=:O#<+5&5Y"1&>^^S9W,5WAO%SL M@8L]/%:QAUTU@19K3H=7DAXEW:J4*%^?O1^^$$1]8'' VA#U 8)ECD_[YLD> M:\LUAA[8Y&>Q56.Q=79C2P_US@XHB9W(1@54.$FXW\O4^NR_+L4.V[']V@FJ MOF69HSYWKJ^_9'I8"XME4P-DTZ/EF-5GRRR.6BV.!A-SV!LPZFLOC=A.:IDL M>LQ0T_KLFL51W<71]_N51Z?FN-^O*^Y_J 'RZR*0V#QJ@TA:*]OP"AZYL6-Y M(U@NU8PW'=/VZR>7^J8U.C5/[NX#ZXO7'@IUD2Y'%/=?&XGUN##=KQ2TK-Z!PT2_YNBRU;9OJ^VKT@A8'-+1I'#--M]8&5S;I(+&]:"L+20'X\F!W**-/JQ;^(?>BNE'GY=P.Q0L[ M$NY[>X5-^,YN[="]C.&%BR4E@OQA>XF-GV"*9*&^VT-6!WPS$V$HW)?! B,8 MU)1A:/O7 M?UIXSG;WQ7WD@WL;V-94K)6RH%CVO7(HX!]^+\^ZS]"?"K( M$R:<0UONS* ?DD'7FKZX1MRW(O)1^6/;D7J/F&9PM8)2Y2MUHDG9\((9D:@XDQ8I+!(:81(Z7>'@\*&<]&2?SGH]GKY M7RMAA_LC[X81P^/5SL&TWN"B<( M"5OIB@\0<;$EP&7+ ENN6*615+OG^'P)'!\!7/L"4F,!"U]SN5;N&KQ6$.">3H/R4FWM[^K4^95S*N8*MC=R832 M<^! ME\>OG-<) BWC6.R'Y%B$AIY4A@!3!;L1F%"8?3!5,/M@0FFL%Y(C(5OHAWQI M^]AI4_DASS\O91M5MN9;[&'LA&0''>M4^95S*N85QT)1(^4::W= _>[X_[=X(07F'$Q MXV)QQKY1)I3C\HURN&8+O:.[=O%A[RAK[LV$Z)%J[F7OZ&C$\9NLN#/?8N]H M$R YZDZ85S&O8EYU+!!M ]/J=T?[,X*8:3'3:CW38@6+:_;4P@W[8XS^,/SK MEQ^3J'-MV\N?+IVY'6%PUP!N%YX\./?GS[YY>%&,QS8!OSQ00I_'HLZ9-CC<:3Y6=-2S%,$LU@ $2;+_2WTG>%3Y0#SWDB MCN&014O; 9K*_*K0*! R="A%^A4VDH56I5 M4>!)]W &X#YOP8Z#?.IRE([%D M+&O\72E\W.I;QX_B1D@2SNIHH2SY(*-/G5DHA"'1#2^BV CM6-11GCQ]TB#\ MLT1YK,UV3R9K$N5Q8X99I+!QP@)ETSCQY$P8P\_VSR\OWK^2D>,% M40(*+,<]]\$PJ([M>X@4BJ\.]T/V!IS' M__59/P/P\ALVN+##:^EK7EJUVP/A]EU"93A Y?YSJ\J]9(KG4\^G_O%/?7[R MCI'U_"G08JMJWWC4VSX#A=.^KG"6'_6N=2$H8;P/I7/7YIF_,@Q8QAS!B4?G M26@[<0+#O$6WKO2-OZI]8GSX^?#SX3^FP_\&SK[T(^FT3,WYP_82UFZ^YEK@ M:*Z<.1VCB85J=VWC-=P;U$KA[#6'UN$3.8ZZOLXC@K>_ =\V%#"R^J;5WU\' MG;MI]^D3/M[,[9C;I8/OKRY;NYEW;D M'JG@9;;%;*L._MFV<:L]>V296S&W:CVW:H*2]?1)PX"Z5_;^1XX$K:\'\GBES=,GS$;J M1;HL;YA0&L1 F"KJ!1-F'TPHS#Z8*IA],*$P^V"J8/9Q<* <$:'4Q5G&P7IU M=97M#2RO@W F)#9J#$+C_/-2AARYQQ$P#85H&T)AOA_V.6PO&_P'YE7,JSA: MKUZ0[(]ZW<&(F13[$&K!K8X))D^?L!>!2849"%/%H8TK!LJ1$4I=G) \_VSR\OWK^2D>,%41**Z H ]<*#A_[^],DOF^.\\6^$'P?A MZF42_O_VKJVY<1M9OZ?CWZ[/_YZ?+;Q9,H/?UNV$\D+/M')X2=Z0ZH M3@ST"NU ?LP8Y[*R5J3_!#=YR+#=%_P-(@D;!%>A/0:$ K$O:]#^!6N/Y^&A MXTX-$VM*&"A^QT,JO"J2,^UII)A> Y'[X-AY=S%'21'GXW?P_!UBTF\-UAB'ZN+%%NB9;$--NGIOO LW!C9AT+#< MTC!9K6]UD$#JM:$11 M4),147I#J=O=CF#/>4097;+)J,1;O\;[#):'3N;V0\$^X>H?P?:=C3ALUP^AL[WLL[^JV%8'3&;_] /E#C=]P(#6[Y M2&_*FJ:+Z>_&\H\_9-#15N[E+GF&/E!,*IB?&]M1H=+>% >&K817)/JHRC-= MNR'>F;W.['5FK]ZS%D8]52ROLOY@K%[FQCWI#7=(DYXQLD'D@3L$I@8<7WQ, M@>T"M[0&/6,X7W+ J5=/^/]@&RRWUCTYN]5T?7NZOCW\^_9T&<@NG-RALHM' ML.P:[Q0K3+D>[:]=S M@'XUOG$.3=#M5^ZTHGI VC"YJ3UI)+=IZP+//;7'U]!XAA;T8(D; MF;M=N*W=A9N^JJB]D:CP8%)NFH5/Q V&R/?PQO)ZDCO:6)Y!R\U4\[M M\K\2<_L)3FU3O+!F^=Q_5G@,4;,XKR5#M$?54O74I.T1@/\IWU_<5,!FC<'R M3OUI%I^=K6D5?GMH:\KV:%MM:9KBTJ:$%"MV:DFFO@;+S(L3O>)$O!8*U2I%4=K.-S#($;:,/);'*/$3>L.V,QP7]P+QUTN\S*7P.CS.-VNBI5/E6JF[9J?<7I M.=-BM2J:-%S/1:V*I79<8RZ_H,@)7Z O^@8,1"J=!L*Q\).@2[VAIFY]I:3S M)9H9""B,>F*&*@F##&!N@T_WX5-Z VF4^R45X9*BC67H7R*W.TZ/1>M<\YF1 MF'2'OG2UGJKHX=R1A_.#'1@C'SJ]IXC=P,@$F2Q2R%2M-]"DQ)?LK$_I1PCN MX,!$/:(;PWR#-D +[$)=_#V#4_*&+XC6(C+/U(F-G0 M?\D?#^='PAB8$ ]?ETSD)])HI*DA=\G$<"0Y@V^61O)0' Y'64FF^Z<^.Y/I M#.L0\5(O+&!BA\>&9C7XRJ*N!=NX$LC@0N:.F,K#D21M)W.)^>4,X7=A[<>W M7,(/\B>W,I65144+Q9]("C]Z=\1644:ZGI-@:C3>'&M\-9DB9PZH52D3X0\7 M_FQ#"UM>- -'GSC2LB-ZTDB3(@8JF9@HR7>(5'5[BSO+L+VH7?C#!2\SZQJ^ M "YKR*?$#YTM'A=3\-^]7\/9A#_^M')G?(M9#<# M(^WEV_B(\:WO"=^L 7XP0L_&_)Y*_C<#C=\-RON#\^*1/QZ,X#/QSD_NI\N2 M4.QJGSNS9P_?0<0664:KWA9MRH[7G%\^FI V_6^ F\C[,TG M$AVR,<7V,LJ'C!V@OB@&;!0F<\7H(S+&8!,(_&+HC#F%U>\4\3P@./5S472BOU>S+)95.53^/.25RM:.8T+7U-'N M7)U.'.3!?ZCVD530LW<.72KC.P0F<#;A,^MDKCJ'29PMM8;+(UT,0(4T7I7%F+<^":"$Y]4,YF+K2!ZWYV)L_0 MID@]O.%9'E^P:0[>WZO!XM&7SI,D/9U.T>;HE%3&]>7G3DWL"+B06CK?AS#Q M:L^QYN#*-E>>Q RY,^PW")XC>&] N =CK TN"6R2!WL",,PWP7D1Z-,/Y.E_ MNX)+R"=K28!< 5'K!,:"8P/_%W*_Z4PFF"E,OOF])TP-),RQW07"3R*VRJ(D M8)\-]"V2,34"B.?=1%S5LIQ:;EHYYG3?JBJ@,I)) WP"A&7 K3[_/ M; ;Q&9GLBTC>3@:'!38M5J4RG6;3K\\/Q-XUR5X_MS!EL6! MMEQZE@Q!)3-FO'DBOO\6^XHH92%?LW51=%54*I@]TW!ILF!J]FV&91FBNF5S M9<_Q_0YJK&&2Q)%6%OHKYLM#=PQ>DE?FC<5\+6)2(20EVZ#(#XVJY+(I2N6M6OGA_<9SQ.[0LYA=)@[N& CT:Z:/1SCAOX[XLA4X' MMCYC,=!+LQ:UH5FKFJJ2*HHEV8,$1".DQS)^#HG37Y%B6."&;VY&&"HQ<;D; M9 M]P?3#$,]$81L^4'>A3F[IDA/[K1O6?*%[!JDMTOFH]^?A": AV=DVY?*$P4C <\Y(![?H>" MNK52 50&C4 P]UQ?N^9AM^X",-G[XZ\TU\I!'C>B&ER:^;I^2DCM4^A'N\ MND70]'(B+0WEF"O/ 6A,KDE*G>ESO/RX'2P9=N2>I@1@0L]:K$;L:VPMBS'1 M#$:_.A[XRT 8_WP\JF(_82CQ9%+6GTYGKYM,,J]O&R&77$9(9AW0V0. JPZP M#&E1 _NE6G@2[$,6>&)QH_N@U!@_TS!GAUW"F30#96 J 8Y8/7,C,#BY(!7B M! A"@TMB9*0P.U8,3BK+B=MMV(M_NX*O@L*%$)GEA95""@];2\;#JO3W-XC_ M .E"8?4J:'L.^3XYBPHO@KVWY5/D0 1AZKC>,2(%Y2ZF<(K7R<*S@^0/#O#7Z#M]US!L,=8R"Y\]=?J^((KX(4Y*5''=T+;9Y30\4(*Z/W: M]O#^7^@+#'P7=O*%!>G(\>Z;8U)^/PUV%L2ABU(D&!Y^@P ^ #(AOG%*Q@^Y MZ2=JH4. ^DRM2](=YF8NO"#!2R#ZG/L;L%*3)=6$4]83)2JQ+**B*(P]7NO4 M,UF\G7FNAR4"[=?((K!YC"9O96-S$-OI&O9566XNW9)U^'UF;4XRLLBXGL3A M%^"@5V@\ O/M#V/^ " 7/A>#4/D2O4X6O:&$WT6X=]->J^K1C(S5;Q7:B)M"E]6:F< MMO(A3V/+WQ<-T 2O9WS#N0J6-L%2G#QBW\\CY"T]7I](845E3X#^#\#_P??Q M?!\7N[ 6_B[^&3MX/TD]511[>)3UHJZS,,$G=VB 76%*%ZM$\M#JHMD#U)[#'#NJ& M7U:%>GQW2@5KY8*3>2#H].'S"WTB_:R* M,><8O+P DKP4#$$BD=]C_'L\S(O=8^C%NX1$ Z7;.>4(C*QG!R9@-L9,&^A^ M6JN_$GA:K&%&&4C0TNY4]?EA("7EOC7$])Q:? MBV$Q&E0,A7)SX:]Z+*9./(!I+3HQ&@ZT&H!839K;>_%5!$00+*D>B"0[&NR! M*3+9[ 3$<*#4 T30YTU+,)?5 R'*\FBO@"AH*^5X2F\/@&"6DV?0"%6L"PIF M@#^<-RH?')(H[QD0!0>'M'<:4;1>6]R_P5'03FB#_8/BK*A6U.AX=%0;.OR.I MVR]3P=QOD<%H*J*T;TK!W%O1S*FT>%XKH8!@AP&A5SL@N+-><(K0:I@B MC0J)-M MRWJVA7CKD67ZHW4CJRO*4&\]M.P6$C5#6\>46 :XR9M1Z[0((_+/<-_ 7=6E MU8TO#^5E-$#P'PK:ATQI7[7@K6E%_JRT>KWI]I$F;\[UN?@M#RYFYKW>C+RL M,G2I(7 Q$_3U)N[Q>F(0W73>++QRG+575?!24_3&#D=FNK_>,@!9TIJ+%]=. M$04#.YHF2AM>\3[BLWNKHH'.J*UI"%3,-%V[ ?(EX% M\TX;*:>F0)6G*4-5R1E=$>4#Q*N@H2>]DI7&NJDEXE70T@^;/#&6"%?1(LJ@ MI?3!X570T@\E:7" :!6,WBCQEKX' U?!TAT^7JK?'9[*_X[43M.CA.XA$F-_W26T#=N$AG5ENQZ:D4!7=*]AZ=9=>+VY=E M'XQ4#I+V:0]VSPH7' ,C15J*,#>K&\+TNX(XB!\(NXY\MO#U->&OZ*Z (\YB M+9?!NO>2L[G3.'''O8!WVT*?SQL6UBRV9&4IO*S;2G#YJ&/L?'K#\S06JN63L_7?C>U8VYY-W\WWV-:\ GK@SQ?DN,V9XU,] MF]UX+!>EQ+8]K.-J_ 0OO *S=/Q'+H.6IPYF!P?M\VS>+-%))J(GR(F M'!@F,7+_26&*[B!%"P#"J_+LC:NOP:MA7=@>#+3H=&Q,R4FLEQ8Y MN>3*-O-V=V\R,J+,SB2**N-ZDNJ$WULI3^;AI;8 )%G-T6%P^WC1F\UMOK!? MU8>')8VU]:/S]AU8[L>.M1E8G@="=AI;$K"=QC9HF_A0DIHZ#54>C4I*O@W% M6-G)?H-4M%.=%B^>V&^0"J[ _?,K#P4D/H42^XW1V:U=<(N+MD^J5$V]I:Z, M)'EPH)AU[FP%(.^=:TM/Y6*]X"OP;E\N'?0"H#?;7@M39M2-<1"9/,@43,K, M755(51>%8YPTNMY<@2MH1!/I(0L)9S*<+<);@G,8?!;(O_[$7\/?O_=/C.:4 M0#@Z"2J2G!IHUOMU[LQ;"W*=2F")G#DD%HDM."/3>'6'B M9QJ6IVG8X-U:D/,V)O1H[B W(2R3$P+-3I #L/'#P)H#_POT<1>@.31!7R G M(QK^ Q@1!LN.?+;1/ 9WQF\/'Q5]( 1?FK3<&WDG_V9 -#%6YB4F.]LC8IZAI0 #Z;G"-*B=(V\QA"7]X6FN MYF^0XY)@!C]Q(Y$QIOM$U,TCHAS1R/BCI48[W0H\:Y>1KY>7XQ)^3A%/!L/'ZW?_+YV#9:(;;C&F@!Z\[!8DL\^2^ MMEI@!HO/56PA$E/P UK!2\]ZPMFQU!/.>\)%3[BDW_NR[4-B7]S<7\T&,*YG MT1GV&F+'\&"9N#6=(3C$XKU J^9 )P#&AKU>?'P MTDHP)L[,IN<;FX;[)H"_9_@BOAVOHO]W%3/U:"AS3N6/K;O_I3[Y_*?@^TO3 MG@N_/+"G[)JM1_N2ZC_TT(7.S%9L( :'+P=$+@A_8]X0@"NX-M.%D-@GL3T-'C]2/]DJJ .6V"]7X:(-0 M%:D3:E&A?O'GO-,CX\ M33B=3MJ\B>KD3OZFW6CG:P(K!<.62JHA\\_)G?*MDQ+_*>7D3NMP+6&6()9% MO9'5>DQ+D1G''V[N[+4F),*6CC&2-2ZR^U>+AJ>Z**HMMT?>@ MG2#9"=K9WR;AUUS[N\%R_7BVVOZN=T$X2/'P5'>1K_TM%= OM(7KE>WO2]Z? MZ@NF9(8J7U[2LMM9HU3R[0>%Y'AM+0Y M8 \M0HG.6*1QPZD]OECMV$_7OR)]*WBKH+S>.;9L).J'O=5*'.\ZT@FORLD/ M>W]D,&+9F$TB0ZZ$OEA![W5)XEC"FESZ4DHSX11 (>W33%>YK*"&Z+ MY=G\::KE,MB#:4KKT MJ;%>$0YNI"&/K9#%4=P+(>;=@2IQV=K>.-"O\%>@[4*3[HI-:T[9QKSW=A>S M%!3;):O"/D.';J,GBTY6E66B]P!=$KUWGX=#I%#!,C,JXW M81"XE*7U;L\;]=:<(:Q%1$W(E;!B[$P1Z(PMHIT0RDLU,H4@R9T4*DX;,N6@ MZ)N[]3HQ5),!9 J$N7FMDT@UZ3RVJ1([4U5C;FXO1LE7<@Q%1K$$ZPB66]LZ M=W<@K>==^(/():,2Y@7.N74L+=7)/<'?&AZ+@V.11Z_S./N'A&@X#72(\O<^ M"::C8U$[SE5,O9>8EN!*!AJK'6]8V0Y=7O9 DH\E'KMK.G19MJ%,>TMSSB25 M=?L2$-E8DQD9TG?RMR!='B.]90S%Y$S;/S>!I7+4>)O$2 M@>F2D,?Z_F>L1 MC75>Z.&EP:&4+:\12#V(5)04C1R*E D)+BNNZ.WDT,36UV"D'A$^E&5)D3FL ML39@VZGTB;[RCV"YMEF(=6"]C,J&<8NH[H'IO-KP'[QPQOA2V_4-&(A34*@) MZ&\.#&DD*:-1*O1)L,0/6:6'E,)Y<$@[= ,2'CP$OV_?EIPGB+,Z7_7B[QGT M%H14QZ8E< 2&;:64ZP>:2,2_DON195<67CCR+BH)YQ"SKN?@/>GHA&R8# 9R M?]@.3")\QH\RX*TGDBCUY79CTA CQ$28["$9Q';EM03AAAP?LQUA;.\U41L4 M!WC7R'3^NF1Y#XI*"W"]NU-9=SE]/L25;_J-/-RE )Y#_3NGXOO\-<1U(*Y^ M4_GM-\C/'IWH\31R1?SFJ1'=S@,YD4(KQD,X3_JAJZ4RI[9VEK!GL&"6 M>F]>SR.L^#%Q2:01\B%=$?]\1?]#O0__16Z&B'CI7.!'=1K55O[[*2.A_'@J M9QB1E:1X+$G'I'BU(I[R3Q-YEI# PC=CFX^\!0GINEBQB+T_6T1_H0]B>MR9 MY9&AM)E[)^/N8/%8!X.<]GU@8/P)[/&J*WTL7WA@0(1:D9 _S8$']=V6)3ZQ MVS*=X)!E Q)/%T+5)3UP.!.(9L^XU]!X)D?70^!^GN$EL=?/OKTJ-BS*C M$)ND<"4YEY.S$\E,*?A'A#PZ=S-DOF%7'XM[0B(!>!6QY0B+4N*7&33*/T$E M+S-M 2"\-W!5PP7= Y8O<"_N4! EHK]DK#34ZP6M3$N\766TFE6F>?-0MH+[ M8 '5@<=T[;8B%VSB.7CD8G[@]L':@9;D,Y:(W=*'"$_D7A6AA.^HT[0SJF=4 M78X6QZ62'N61N-FVYZ#%O?%^@VE!$+^R"O=2&H[42,J920:1;(T62(F9SG82=R=O56&I:=&2SR*,S&1#6L"]N#P6H!V6;&5/WJCX8R078G&!A M(W\M<>W8K]=P#L:GK@L\]]$Y ^?0Q2,*C&]?^*R-UCF^L,?@X^.S@Z:.GP;( M4MP;;UJ1F8,HVVOU'/$MQ80[##Y^H[4@RTI2 %(7^YG:I^3F)E;)0..] .'/ MS>PQ^?42<-N;OF4&6JN_8%(2I?5LYD(;KR/PFOH9VH9?TP>FIR9>:6.[C__J MK[FO,+V8=>_*IC\A .X ,C$$&!W^G*T7)*JD)9>DRA&GB0?A?( X!ZZ)(+^M M1T]JC765B%M MDE4&%Z4+)2<;D43J5U!]"CJ5&MZ$\TQ$9R:\WD&LRK*HZ1%;G&W,)M]50E$* MJ1115%(IHDA9"$W>2A\^ PP7N)-05L8@8 M5T068Q$OTRIC4=4&&M.X9"4RRB)]Z-2FL2>\FO/C)%Q*T]+S*[JF1521204/ M,G?5IH$:C4,DDAEIF4#OR5;:',=0TC>O'YW<#<2;6$L&^OXH-*<(&/BR8;,K M"GWE8[T\\:.1!?O?+]Y&@$V)'&(:?GP% YWCELMT)ZW*N E3%R+;U')0QK4 @\-36SKFDNST\G$A#BIFZLL=@8L,7:/J^\RNV MWKX5*&&U# 1_PQ!^X01_Q*1?$L;$GWHW7.'WF;40I)Y GA.(BGKX"8L.$?*S M@>\> WS5$0:2,,%TO+D"(#X1V75"'U;HT[+83[1X6?@-M9,\4Y%8XJQK5Z*'7N0QD;#V-TF3 :O8C_J5%7$ M:T5CL2FBK6*<,D6K2_EYC6:]KO#/]BO$V/K1*%(;Y &+Y,'*GZL'VD!7V=FX M%+HP*YB9_SD^%BX=Q[,=[/L\ %HK*AP?$SXM:'__^27X[1K_1?B@E[S%%/QZ MA+F@7M!1G]_[W\\(ZOOH-=/LB@JG\C/G\B-1^35GS;> M3:^21^#/Y-_XK_\/4$L#!!0 ( $""9$CE#SZ,DA, $?U 1 9')N M92TR,#$U,3(S,2YXMF 2DG"& C0@:5OSZP\ DN(%S:ND&#+]XI*)[@;ZZT83#8# 3_]^ M7KK6(^8>8?3+T>#X_9&%JB+^PKO[J73G$9]SZ-91E#8X_'+\_/K7$S^DBX)Z#UN^L M6\3MA?7^])UU\G[PR1JJ=.9S6%*?H,Z1/I\>,SP7)^T'_]]N;B6IK+-@E](\,]?,# M=V/ZT[XL?D >CLEEJ>-O&-+$'_MAX8;4+9'[^XT0G!9*2H@)]7Q$[:016J,C M%0>?/W_NJ]*8E.(Y\K%3*/QSGS,7]R.RF"OP>G.$5ANN&?(>%$=4H.#NO1_T M-H#'+#WD^\5LHI"3A\#'7LQFLX#Z?)T%U,/V\9P]]J-"6=MIMC8[X%SX>Q%? M5"H9/V09'4Q@'E$ D.-G>P'3RQ( !D(?L>?#+&$9H U%Q/9@'E4D6099%H_8 M,(,H ,B% ?SU"GN@:50)H(OGKWA!):($J(7C6:&C?>J+TL0**X[M"L<4,4?Y MY@S9?@\_KUQ$D8A4ZY'X?X,E:GU!U!-4F!-[PU?-%#'(Z(8H M93[R17C\^2>T6A$Z8_*Q[&=GLHE3P6#)']_OK\N"E%(GCL1#ZEQ1G_CK:R&. M+Y7X(XL(1$HI-A4[>$8H48T2@=,?U9 M_18F\H0,Q2&C5<05D4 ,BB?$D0YWCEP92B<+ MC'TOQ+NX& ;[1" \$;C@".TTOQ4)L$();TA'4-XA$9']!?:):$H%[%E:V :G M]6U@_2,C\)]=MLD&,F\\&Z\P5[4#W:" #K;%AS);))(L-K,266]6"-&=^,S^ M8\%<1XR_K_X,1*0NMP9 #UOE8WVKI&7^MQ5*?;-/B/<%\A8CESU5=)*$#+;& MI_K6D*(L):MK-I@$RR7B:^'D9$Y%^F?GV'_"F-YN"*ZI+8:GEYQ1 M/'PDJAF_B BD+I@?!6:J!TK;+%_Y2T6"K<>0NE6(OZ=1:A]K$:^J@XKKL2* M:K%D-5TS8P9N"Y%\-L%VP(4.V+MZM@5N*^,@E?Z5SSOW6 ?K$X'V%3Z0[+-2AU?.D-5; M?)O>O"BRL.=A\>9,=>NA@U8^><0C5W9 $:XK7*2& -C^@R;V5]58J7IDB(AK M>F>%=;VS1&W'73/M9"$27""' )[#ACC1QD,ISJYF!'<5YAZ M,83YAS",6N8=L5DQ7]>PO%:+@G+RYYHF0]E?L.N,&+_''G)QXJ)5A##F6NZ< MB!*YR)!OV!J5A/39$*UC #&5TO?4B)4RIT1TCW J2TTR2^QI9_!L&K)6):K M:SA.@@/YN=7. IR: M*\HZ;?XQ#*R6D:PS53OI]SQG]Q9']FCRXIBS[QI!7_OPHCOTWR):W2WW3-]R7R]< MU9<#^\>^=O!W-\SH>_:SN7MA,6R@6CO[NXMV=C]_!FFX"$:Y:L=_=P&&EK(R M,)<1P_!+@#7, TD$EZ(,"U+5IHPK4K<$;[@FJ)Y6XGQ3@KDWN5.'>U;%2 MO#*;B2[YAS#&VCQ+LLK;U1B2 VX PED4*[19#0W/#D:''':93*^@#$:W9$]" MUV- :C-!)@P ST%L/Y9O3^AJ,,AM0L@/DZ$R&-X:.Q2ZBG'R31;)?=XUBS_O MTERZ)CUL"V!30[VOPKIKH]H??&4LU9@+MI>68S;Y6JR[-DOM\6.IW_3!XQ_N7((\N5/-XA?+90QZ?+BPYZ\6T&_Q$J'3\OW9A$ M2BZY)T"9*(]"5'$L(CI5O?SV "&$K3"7H_]^W/BC_@[T$8 WU2=K(Z.T<=%# M4VT$"W:-4T3X=5-%,-(T:49X>4D-\Q6 M8DI8Y'^]F*\G'_4&)[W3P?&SYX0-:U#_1J.&]<=\S>J'+R*I67/,(*O\6*.R MTNM "NI4]8&,?>SZ7ORDEXBJJW7)]1IE;0'8HM^]1$33-D WEM1I1)HO_F>; M9D 7H-1J1YIQ\U\O$=.T)=HU*75:L6%2O[9P"?WVE#K5)USASUXBH&D#\K>Q MU*D^YI$_MJDZ?T=+K;IC)O6K6>U55PO5"48NYQDN&9$^RR X^+1-"VJ&PE3M M_K8UE]]>4[S6%!^MTXM&/)<6Q@&OA&H62,8 M_=:F'>7W+;5_9RI98(2,KE53;2F_4VCXX(G,5KJES.+DR/ _]Q, M/"-T?NWCI4Q]CBP447TY\GD@!Y^*2@SW"'.FBL\)PG3ZR*+$=>77>S&M)S)! M46D@2[]R%JSB2H@0+[2S-/4F6*[0G8\ISF[;NL7+A_BX-J58%6&H4GBMU)G# MEHC0E]+I$HO_G$OR2!Q,18)YP<3H1(R6A5#H:-K0;O5YTL9;,A'Q$%]#JLZ0 MZU7H&I8]A+?NB +\0/P?BH P9QL0%-L!X* :>^UY@= JD-WL3E7_*W*#>)NW M(IFL7!(?D!5Z>T/&_6%A"\QW"(:(2_&N!UT]M<4U:^D4?1Z>K41E(J"D]5K" MM3TN=YS9&#O>B+.E5$3B/IYI;0\?8'G95N(<*4RV$V,0'F6^'SZ^QPY>JNUS MXUGX7BB,J[L0=C"=JZ ;[ JT1L(,UZLFS*JIP6*8E#:"C#((2Z%W$B!B%?H^C=.?!\+;YY-V7!% M[,L 3UG4^%C3S$BEI81#<)&6RBE'V!ZC2(Q![G*.*9X1N3 7L@9K;*9Y6[%'HRC%8SA=@]D2[&OT?&F3VP?CJ?$=LKQ:@'94NRK=+P% MQWN)>9'@;CE?/3!;"WZ-#CAB =^'_X5R.^5^]:!L*_=5.I_(,_?B?$INMYRO M%I1MY;Y&YYN0YWWXGA+;*=>K!61+L:_2\? CIGMQO5!PMYRO'IBM!1OD@.T6 M"[-3 5O(.("E^VV64W>!4TJ207Y38S;[ZS93X1KS 7A*O%\E%P%R6UM*B Y MQX)0.%W@U$KZB'&Y.%@=00O8#OUETQ %B,>@KMXN;&4G[;:0<0C.L$UDWP50 M*4D&.8[TY#M$,KX.[%0M)S-GAVKA)L1PD2VTP?<5H\E+306WM*JM11S JT$? M"9_76[MLRGB86&@;EAO 4<5[D(ABSQ^),:"7W\)SX+.8%"/X1!TS^TRW6*# M:K.MJ8;B4;&9LO5.U1^X075G6&0O2'#^+P@/OTLI74AQ -IE/X(JFS-K\6%9 M6W$'@-MYX!$JNKT(@@^$AA\\0KY107< FJJLL>YM(4#FW9+?G)2\D0+R1*US M-]LIV@H((8@^,O7CYR\VTY*_!20YE0E2NA:U81KFWMRZ+Q<1F..L2:#5/I*! MK%2/W# SQ4,IP$!ZD3FFV=PD#M@!*#,,]-P!SG#G@"G,,4&NB9 EBDD,,TAR M#K,\>'G$^ 2Y&#!+!9TYQ@$;6OZ2J<]BF/%J'/8,F+(1ESF&K='L3#5'5+G M%A8K6D%GF%83.9,5N'@\N\=S>:PCXVLUT)?'%L=)Y.:B MY1,V\^5/[22H$IJ,J5[V$"CP:FE-EU(J@[3YBAF?$_6Z_XX>)V09G2 [9*=WCVU,'J7 =*@HHC"_0]V),9D\5'HNXIS<4Q(.25V7 M/!4*>;&P.>7(P;H-PWU'*64K MZ-(6CYOW8CK=;@YZOZ:VU@W!4H/Z7='=QIHB580&Z11.(I]C_PECFC% _N[O ME![1G0] >KD;<>;DG9?8LSF)SHT"%F(VYU8(-8D359M:RFK!74_Y'Y-MZDT6 M 8;-*?D+.]>.O!%L1F05T?A;3M6+<)H=AXNR0"[H!5CN%4TE*^OR-:[=UF3^ MBR_3.ZK#BJ'Q9*>&U'8"B+)].0U'7Q5$U7S E<^2J_::K"7"H?X' MUVO..R&S!YHZF&<69X=SCA5U2)9?PZW/EU'XA;^L2(VG17M%EU,S:NH.R()A MMTZVWA77IUB(W1K+!+YA;2Q[.A@U8RV(U$X\'W,U*1P;,_\A1#G9_K;>[.[U4*"!%ITJZ R*1E/,EYZ( M,&)LS9XV83.=$1<0F#VR'CJ.ZD?(W>Q[E-.AX1QOWB];\A_ 7K&FFFF.W%: M01XN,\+ E;Q] (=P&7WT3[ M4Y9\U %\^=&"UT #AENH&(=,ERHSR6@ZLDFB!YZG#Y&9LU8T$@,=:LO^@3-A M(??\ (9_POGM!?+PG>@6..D>!*,D<(3+%XH.X^^;"O\:*7@!JEJ!H/> M7/K^;WA2H8+.G'F";$-OR)]!M%"3G&R16N4IU+":T:#DM$;3M0%( YXMWV"[ MG E,QP\1V4OC2U*^94C9^5RTMK-Q*-]5(^I)Y2(@ #I#9= M3O6X[VHDCIVHXXT8GV$B]X![UU3;5+376@Q*86 ]DU7D;V)DH@Y _U^,N+:8 MUX#Q-7O6B[U*7M>;9/N7:92NRF:\Q+N\3?5&62#2(W7OYC2WL;:0X@=G+(Y_ MMEC+68?@00T^RY814/'J 3)RNCUIW)CJN^G!4B-;/WUB):U/E1K4^E\Q=8 ! M;/:Q0>W5.^0-H:I+>*7=-D5ESF1#/&D:-_+J>24WK '3JAJ%06.J?!OCDYWB M;!J>RVO$99"VT;=8$\P?B9V?$LF6;#T&W/_'%V&3[^78BCK1KKWU)5XQCP#? MZ1?1F:_H)18#%3D[Q0CUB[YU*B,R* 3>8L>]90_$Q='N+ _\N**,RB!MKJB# MGY_E!C,6"M4G4XHH#-(BG#&YP2ASM%GFJ5$CWQLF-\Q0.;^#J;V6>:P8N:_' M,_F)%'5$7[S!<^3FEI<:<1U !JPL= #Z;-;/ \]G2PPN MT*;*3%J@!4\'A=*!*L(7#0I]SUZ(U/?GO__M_P%02P,$% @ 0()D2-@@ MM"IE"P \:8 !4 !D;M!LX762K8%D'=C9MF\%(XUC=F72)24[WE]_2%F^R*(HRA>) M,H("3:+ED#/S# M72[+MII_/]P/G!&,40,3[B/BK*ED-2JZUOOW[YOAOXJB'%_QD/Z>.L@/%97) M5RVUA/RKL2S6D)\:K8O&9>OLE;MUJ0-&/>C#L!8V?^7/)W!=YW@\\23;X;<1 M@^%UW65$TK=^;ETLJ'_L4,*IAUWD@_L1>5+2P0C Y_6:K/1+OQOC?(P<1@7! M%,X<.F[*(LWT*IJ2-P=Y3N"%2K@7G,1XA%9 G5@3G@2 MLK@>HA9"+0\1?PY5'?#&"T*3IM1/$SR?+[^$&FN>P0N;_4==KEDPEQW$1VWBRA^W_P5XBCS!!6_['<387/39/Y$7@(9[ M,_IMJ-LL+J#HQ_ 9? .[TY'9 M#YA>Z@BG"YMPZI*IX(VRN6!4@TNLF/TXQ*6*]'YID]X?&4P0=F]?)T XB$[> M\T? 3(=G$VK[43+2003>.[O HQ-@_OQ1S.2^X%L.SA/I+^H[D9:L^<$*"3X) MWX7O(L."4$A1ELF9@)*T0+T:S&;6@N?58"S5"^X-3!@X.-2-^-V#4.7$;8\I M\_&W\'NJ@/HY^#!-5,P8#J?:[(F^4;3=; RM&N@W2Q7+WR=*W1GV/ USJR(E MVI5"C=MFM);$OM&C2WQ$7K#P2Q6HIT:[294I;)3%2BWV3Z!;[?0A=QD?$=H)3 M35Y%'%,48=]<>@-#$,RY?9@"T2XD;Y>L!"P)\>P;QL-9YC/U86D[V=TFE:02 MF*0+;+:^5=(<:S:Y6@)!FNZK,:L,?.I\'5%/\,6E/^G/-4V($1:)H)7!("FB?5]%V7;S@X1%AMTLZ M:()]I%M.2:.H!"2IXMKG;?3!1YB >XL8P>2%QQ9ZA]C!.K_#@+@2>)DHP6I? M1(2)N>;(3%([O!:M6!I7QM9Y"/OC\) *<3N4^,+2@#AZ3U)'54&,M$JP?&UP M5YE5)0WG@>;68;L/WW\7_^] )P4'OOA_B$IOV)L "QO<\#G;=;XEE>%^?K&:C_H_>>D2,5; O?[B969"MVV?N^G+OG'F M!AB>ACU+I1%7"4">[A+DR45 QG-B25_FXEA]+-!),8X.&RX^I:W)'6(N3EQOO/#H[P%+< MNJIB5^+6[1:\!" O%XJV17 \Q4*8C_,O'-PN65EVVQ$^4M9!CAR5%+W$L>O M4^+B4GY($MTW+K2-BWYVQ*"51GFOL-2NA82*TY8FQW]4-JH8U5!Q78T5%*/_/ M)I0'(\3@(Q(R=^A81M-9W3.%H.(8IJDA@NQ7FR 3410#P>H-+'YV23(]CWY- M/IN\XG":J2@"][U544>2]:4GIU_NT-.=')XQI:S6$BQ',IX8B(>7IW)!JJS@ MY+!5JVD)LF;%R J036X![S0\:RL\.2,P4^/2*"S+/;-L? ,[F_;TL$VYO]VR:CTJ1?+%"8,]]YY4E11\OQ7- MP\V])]IV_@NPB'D"C@F(6)5G9LC+(BUW_S@G:(D;L9F*R=ZP*OP @Y#7 7"Y M'#*7 MQ1MMYU>0R8,Y)1[1'$J+:]/IEGO$_05AO:;-5D M;Y<5/^)O3%C>0A1ODEA8MXJAC1A18? M0#[U(;_TB"K,W;/"2J*YKQ+M]A?_0HPAXM^^ G,P-_8/$V25A-9,(1;Z?SM9 M8^Z!.+/"DP$]CQ+MNWJR$#O(J[B(+OQVKCE]VZ.J YEQ&9YFJ CJD,YO.R;2FB/:TL#J1(V M[PT'^(7@(79DQO?%EJM@\I%Z6"9VNI')U;P<5YCR57N#B))Y8*?P.O M0F_UE+B+:L5K/7:=ESG> UT5P]GPB:[L@RV*V6&/>>&&40+MZ<+H.I1-VH(O M'F9$[0WO9-GX4Y(!OO@ M4#')?1,NABML1\QV:+6!$2U_N\*X-O,?B@AV#*Y^NCET2T6/,H?D?Y?IJYCV M2QWSCF2,V\-D04C:>!OYD*)'#P0L2J[/P.LFW$*:?S/A0^%HXR/,!Y5\$9MO MQ.5%V6ZRX3>KW1^[PUX93]G2/*00R:/)JBSMA31[RO97#&XVWH0_VCRA>X^\ M# = R\\IVW;)2-N8(>"0JEBEO"C(J-?MO1GMSDC9F/K@L**Z, RS -S++ Y M#N 6R<6; 1\851MS/1QAVC&[TWKDAM^,=W_LLA-=E+!9M*/0R_?NBUOXSFSQ MS43W0"L[3\=1ML(V4DSDWN-2T!YG\TK14%EY]O0]*U:LM%R ?31[0#XPC#S] M_7M5^5([L4K-J3G_XF+:N+FQ3D](V5>9\H,ZH-W_3R&H#B9;@MJX7K_B5:8M MXZ/%V&P$2IR@.J!L"6IU'E/Y0G TJW)@TXP$(JE$U0%'(;#AE\5.6+/Y\6D\M93:/PV!2^8PSZ$E&P/6A K[[3M M>726X2N84)\$K"JMF+_NH1J*F[+A9\1!_/%_4$L#!!0 ( $""9$B)'^X> M2#\ %G"! 5 9')N92TR,#$U,3(S,5]D968N>&UL[7U;<]NXLN[[J=K_ M(2?K=2<9R79FS=2>LTN^95SEQ"[;F=G["463D,TU%.E%4K[,KS\ *5&4A!M) M@-U4]#+CV 307W^X-AK=__7?K[/HW3--LS")?WL_^OC3^W__] M[OS#/]__]__[C__S7__WPX?_.;ZY?'>:^/,9C?-W7]DWTY &[U["_/'=V=\? MSH(P3])W?Y1UO1M]//SXT\>#=^S'N\=YF@7>VW^^^^JE_N.[GP[^\]WXI]'G M=Z/QKX>C7P]_>C?Y^N[#!]Y,%,9_W7L9?L*'^9^%Y>*$HKUSOI%_Q?'Y:??>"_^C :?S@8 M?7S-@DHN]DV05\W4*SCZ5/[Q/5<74V>:1/2&3M\M?OQ^<[%=+(SS3T$X^[3X MYI,71:PE+L.O^=L3_>U]%LZ>(KK\W6-*IU*(R_:YY$= M9SX$=.K-H]RB;-MU6Y(TF7EA[$;0LNI.AH-"XGBW^<)'&61&'@ MY30X]B(^L=T^4IIG[]]M0N,BS3R&AA5XIA_]9/:I0":OPI5LUU[*EH]'FH>^ M%UD0=+T^BU+?YNR_?*G+KJ:W>>+_]9A$ 5O3>9RS+<\U(\H/:79*\>O7@2IK=O&1M@66-X[9N PM:X;W9NR2;26B?9[#_\=[?4GZ=, M-)J=O?I,I@?6)C^DT+(;LB(WU/>>PMR+PK^+4MT8=R;.$'36K2>YELJ5!K., MLJFY&@+)=!)X;+E[IN<1'PML8K/7IHC$(>14=9;MFOZ=I MRC=!;&O16"YQ<0<[IL:2J2IQ)]_(BH CAQ*.K4@XMK7O;,SK9D&[1!M3V*#.[B='GS63>NWF M$''QSF>=^XS^>\[J/7NF;4: K()"KH!.P[A8SRZ9$&OBL0Y!XX &2P%Y91U, M$85A./'7FHBX*39)A?:7PO8R];+[P@ SSSX\>-[3)ZZ:3S3*L^5O"F5]^&FT ML+W^8_%K4AW2&2YZP3?"RU8B[YY&1=M$_C'YJ=0/A,3%&=E$VN)#,MIDT]*S'/F"1)L5#PF:NTK_WJ M)W'.^MY95!1CPX0^\!]6?X^2C :_O<_3.84CZ23RLJ7]9_(:&O6NS3)D[((Z MA556065%CX9& 08IHWV34Y?M=,VV+V!E^V-RX((.V76#@@N1CL6T"$'L#A_D MM'[?XXR7]0LK9\14:- 0=$M3MI.:K)_*OJY=.(GF,WDI-#;)-Y9_,4^[A90D2$PUII#0D+AP1LMNJ$^9O/<1_4;S!6#5R%(4(R-(PT!3 MRG1(\,Q^_.XR9G6_,0$5U-0_(R-(:T%3*C8EQV,C8/N2)R\,SEZ?:)Q1-L*O M\D>:KN%3,&)0FHP@C09-B3($A,>"8,K4!@1(,T'C>6Q3=#S6@>LT>:)I_G8= M<>_G..!+XQ/?CGY)DTQUVZDN2$:01@+CC9P>!)XEABV&\]D\XAX7I_0II7ZX M\,!\BFBAWSB8S)(T7WAF2J&I=PY6FB!C2/N#^3;>(EQ,ZZ%$3/761%6,C"%M M%=U'\P("GC6OMB8;')4%7Y,QI,W"F!&)Y'B6OR])$KR$*R/#N0 M&CZSV8J,(:T-S>C8$!O/>JY5^%)H>'."L>F4"XOG_NTR].[#J/ V9[N&[:>^ M!DNT:15D#&E+:'+7T 01GL%2D]K\*D)>B(PAS0R-*-"R*("&9FNP-/1>>V_< MRLL/7KZ?SFFP+;^!X=N@%C*&M$]H6%$;PPW18>7VAA8'[FLO;46JL#@Y@+0W MV&!3"@O/[N]TFR\^@'D:P( M.8 T([2B1@4%CX>HEF, /(&T-K7@1@\!CZ:G)9T8%.8"T)=C=^W$L>%:2 MDV0V"XN'OAS;25+$VZ&QKZ9&48H<0-H9+%"EP89G[6EU.%:HY #2:&&!.#4T M/.O1NO.FSOM+\#4Y@#5<*-4LNPX2HD!S,.*#/HF-"-G\E!Q VB5:L2&"@&=) MF@1!6#9][87!17Q21CE2G4O%)<@!I&&A%3,*)'@6GAL>S2*FP9F7QFQMS-;N M[J>A'ZH6('UA<@AI06A%FQDH/$N0*"QG@RT#.82T(K1B2 P"Y9%(N/_I<-]! M#I$8%BPC4>(3-MBDF18=HT<;.XA5EC"YR52VX9H#=M;WX)ZA$@'@G:_A<\51/)" M0LN(LARH.TA#=G1 \)BJ-U]%:#D2%P#U&FE(CA0!'INT7===)Q:8GEUW?T8T M9KKZBKJQNECPW96_MQ:!0+/<=.8#V^:L&S'X=F7V?7>1N>](HWRH,2 CR*;O M+C;O'0U#4A!#\][%YI&SI7=#$(CV8M;]=T%];YJ/#2D(/"X"]CUX05UMFG,D M!8''+<"^#R^HITUSCJ0@\%S_._#B1?:(1\.1% 2>ZW\'7KS(GOQH.)*"P.,* M4)WD;GT:>VF8F-INZM\[0['N=B$88W7!Q,XB*PO8I'+*;8#A1L5P&89L\"A \B M\XRBWTU\ME')"HVW'8GU*F!3F-D:C)N(,%EQ%-VO&Y?;=0PGTUDC2)IW'YWN M3Q6=BB>B23-:OD=YBD)A0L 6M< F.#-AJ26H)4^_X!YU1KRVK DVQYFU$2@& MMCH8XR!X$@=_>FGJQ7DFZ:?K5O[:]SK&.U0-FQBM<1?HB+3J$RZ<6[3R%;VU M"G+7U >E9O_1FTX M:%$A;/JVAD:&EO@JUKN8@"2#NIU4TN?IG>N$3?MF/)B[0JPH[6)D:K&)+G]] M0P,Z*]J[FI87\.N2M]E8F]4,FU'.RF;;'&A%5 MY(9 *Y)QVZG*7Y\G*RP*VD(NB4=Y;. MST)<%;L.[%AGKS3UPXR*IXU)GGO^(]4>C)K5 IT0SW#6;0ZJ(JJ+(4M"U(F7 M/48TRY92+>Z^-W=RAH2UJPTZ7YXA<>W!K7P'[!-XRCK1LY>'SW29KNKMSS3, M<\J6[.E=,GD*_=,YO4L6\BR%ES'8LCKHW'F&%'9 5W'HP+#44BQ9V,'.=4+G MV7/+9@6QHK2+,4E"Z3&-BP2,7G22Q-QXS>H]IUX^3ZN)_]SL.-*\)MC$>\;T MM0-6D0;O#G0:/H[@:(5D&[1L@1=DN>&\Q5+P T_NF%#9_=;PYX(^1HIPR"QIBK M7M"SOY?K7M"N$7(T'&.A3A56!,LK'L6]4>L*R>=!V 4[X:N8=& "[/*PR#J?5;7D\R",?!905MS" M.,5M!$+MX!2W41/Y/ C[7#M@%6D.C' 2ER_%6).7()\'81Y3 ZB4W9^MZ^Z1 MKK_2X;[H#;[ O)Y\ :D+3P5,PZ,0^U6/X7; M0.L*R>=!F'TZX:N8=&#CZ;*/LV\F[^:Y[E15[S MNT22@[*8:NZ]C 8\82*-,X]_=$/+L%UT\>BQG)9NJ)\\E.05:X?"6]]UT^0S M=I-0GYJH^AR2<%U?^)LA@15,C/-+JHX*V[9*\AF[M<@&PE6\4AS8QZ%D2/=./?C+[ M5*CA;/84)6^4UF>3(CE4]K[O)\6+0]K:A,=?KS\4^O\SS!\OXH";)^>+^;%8 M6*^]MV(JK?A1]#M;39"? %(I/=)@'K'NTQ%$0:YJ;%IMB#A9E+THDH]8BR3+ MQKEM%4G3#;WC*@CR7_V$'2U>\[.HJ/:W]QE]X#^L_AXEK-K?WNTVB2:E59I^.[3:/ M([$7DIN&".2%?Y]G!DO*0I0:4P"MKL@ZM(F?,RWF;YTZ6;/*":0_ DS':JP@ M38;/'NQ0RYBA,+:G1=;ZA1!7Z4WX\+BR^"FZI[H@@)U(*)#.YB,O!&"_T:I4 M,A"4((9M8;F=WV=A$'KIVZT7+:]^-+81:1D$5@TU59)Y3H$'S]YK)=HW;\9^ MO&, ,[;I-#FUZ0M#VP*4'$AH,P'UX_"'Y#3MB$A\Y]MO24X7TXSV7+OU+>AY MUFS@B+D2(4%#"?;C N0YM.W>QPILC"?*=8O+2TS3[#%\NHZ\^.SVZOHTS/B^ M;)[2K%GG:%XMZ"FR>[=H!1C^5'@[G\W8(L6Z=?@0A]/09_ GOI_,XYR[5R11 MZ(I&C.G@:E$9Q"FY I[@YF.-'LO.0P6CSJ2$?#57SGUJLIV^S02ECMV57X/>CYU7 XB5F3 MP4'#S_D\91IE&V:&[#Q\Y3]E6I+DA4 /G9V84F*R<:*4/)/]W4N#%Z]H]C:9 MYOQ'J?[5!4!/=JUTK\6C.;CU.$Z.YQG;56?9Q"_?0NI].B4EB)/WQSWO%^78 M\-A>1#+R'U.JWU5HRQ(WKWZ--X@* LP9VT2$9E%R3!V2[: +#FUN "4+UB6W MV='T[M&+)V%Z^Y9Q2X-ZR5(4(9!/HXT&A6#)4N-QI_HOE($-O3OJ/W[WGF_# MV3PJK.)W21*I&="7)"/(A\IMF3##A6=1.N>JI9?A,PTNXMR+'T*VSI;OZ([? MOGK_2M+"1*[96C2HA8R<&"9[WF\T!(QGVZ@0?"4VOQ;5KFL-:R(C-\^(C7)MQ*"93 M @T-43?HA(TB#81=^&\/$8\58 M/OZ[X6E E.%6-[XD8TBC8A>V!$!L[(QE\ M SOFKEZ5+V?4R0/#G>7?:+XJS1X7[<*R1C2#M-ZD'7"NR360;S_N]0+ MZ/;@+P,.RLA3%B)CE-YB.H*TF)8D= G5;VGCY_LI&_]LWO9X+IO%EH6!_9;$ MOGZ[IR]-QBC=R$PV>6;@EEPB",V_Z''7WAOO;CMB'-5^*KR=06)V.4 MCFEF;!JA6]()'_6^)N);_9WEG/),$G=)_>\J,U^#:L@8TB+2A=ZF*%=';W"> M3^E32OVP#/9$GR):J#T.)K.$=*-)O;?Q*&WW.7^=RM>3ZY3.POE,M:SJRI*# MH1I6C*!5-,+?0JZ2')PGJ>'T*BU##H9FH3&"5-$%;Z=1."HL ]>OWEW7$EBT M\[Y15DD.AFKEZ8*XZ@M=K$!V^L+%[,D+4R[9U7031PDQXA 5U!O60 Z&9A-J M ; B5F(%ZB&*PE>:/M#TF.8OE,9?JP\N8I_!/DV3F$Z>RVW?[TD4L+YYDJ1/ MBZ *?4=3$'@T5WPH>IRJ&&@$!8%@V?%;[5_FD13,J@*(J*!1OLPFWAS8L&,J MV'L+AREV@CEYXFX@QXC&X\7MNRK@F D*_9L3MHGH1Z$.B2>?"PY[>!*WMA51 M/\02? H:W_NG#:16;[8S>1#AH$^54I6?$ M?TOYI?_D.ETXT13B:OW+%:42-K;21>39R7U69)B2'F(LU.TH M,$'[W;?"TF<5-*+]73*;+4)JU_UZ59L*<0E7P0;47-IE1;+OD -&LZAMR7@U MS[/N\,1VD43FL=9/5Q.K^'F@"?5 MUN)J*HP8MK^9WM],[V^F]S?3^YOI_& M^LE#'/Y-@XN +;'A-/0JY\P%](!MN"_9K\,HY&_2BCS;_&6VQ"/48"@Z;1_; MC;O!'JHOO> Q/-A$O'P 6WRY>M5LLB-SV3QHJ@3X?JA0"YZ@,U8!>]GC8KP] M>Y'FO8?;AAUY10RFZXD4XC"RCDW9%P^#-6^H^V@6U"^@Q=V9>W7@B13D;**^ M3NF3%P9GKSP;+G_X>I4_TE0:Y@94'FQI'2 76(V>;$1-PM=S+^)G]GV2JJ), M.&D/71Z+GKO>FB)L!&["V+<6W(J?J/;6XY12#,F_!4@]>"):.9C[:W_H=W&N M_0'&+P=/'Q1K!$_PK998OR1)\!)&D1#S-^K RJ=K$38Y1:\=S405>.*!V1Q- M3GJ67(W([AIZGKH6*M"%',/LU[)P^-F[M^S=6_;N+78?5'+S:?[&YIDG-C;C M7)1AD2(A,?GQ='=%7:7 B_(,>)F MSIY#)7!0!@4!YHQM(D(S]SFF#LF&P@6'P_.%1>:"L3TH!'X8:CQHAE&#M-&* M =4D^;03=P6@-:X9;CP.?X#YTMVX#!@OB@T9:TR[#/00!KQSZI$LJD!] -]Q M7I @7G6"%*63A_2\:#,,)>=+,30T1!4GW_*A_>D\#>.',E<9SRY'O]&7XB]J MJ[1!^2&Z,!@#PW/FE(ATZ MR&AX+^0:@4/M=7^;TZ>:P.6]Q'+.N:A,/>=>F!:==F0PIGHQVXM%:*]RH M7>AY&*20B5?\HTAA65X--NP0TFK(")F5LQWQ2GP[ZH6.Z,7KZ =_#";4"!XO M]*WDFDOP-/N2)EFCM*,;1(^Q3##ATF&AT/SVRF!(,H5[/;Q+[CX5G(C$ ARLS\C;+=OI_,Z*5Z=5O[ MCHR'9\O: H HKW)_R5G'P[-0-8"FR[W<]PNA6L3?S6# _'>WU)^GQ>[X[-5_ M9,#H#7VF:4;+F,*L"-MG>T]A[D6+&64?)7?_C&C_C BG:_ N/1W:1\G%Z1F\ MCY*[CY+KV#-X:Y?2(*MH+?^A<[T;"2JZ-07WU0)\<^+*Y6/_A\O'[L.),[X9C0BY[PN*?M:K2UG?"5 ML*L0&^YS?41VIBG;A>3A,U5WI'X:'E#PW-X4@MI?KWV4KR3VMX;-91(_W-%T MQB_2>IK,M'+\Z%%UC12$VE5P*&'_AN=KXD %&I_$7;G3VT<(W%_M[:_V]E=[ M^ZN]_=7>_FIO?[6WO]K[P:[VW 2T=7*QAC*@+:8;,SM!4]W<0%F*:'LD8TF& M!24F'0AB1D3"HV'!1EQAR"NAAEQ(Y,>SP-S. M[[,P"+WT[=;C2VLAIVZC("NS4Q'_5"CQ."S49./QKZZFQ4MLSR\,@KH%25\8 M/(J?D@4)<4:HT,R([AG$LL%P1"6^K<9U<=U*KR//+W94!LNS) :$CZEN3T3R]EH/3\;'T+&T&O$S5"+(@V),MC2!'3T7!#(BOC*#0>M-E" M!!./)UI=.NT"MOVQJ_AVS(-4=CP63=Q:[#NGKGPRYS<9WG*CNI&SA*NA1A2%#H8[>#9 MUM2N]NUGO8]9JT4OUA"G#RDM+!LE)])E_DFE<"$UT/!=SMEX3D? MK6]_#"=\>2&8>'TH>H*9K'>F?6-M2)D#&%, MP]H/ME2#YTUR3OY%AH]F62%-]CN-1$=,;1ER\,-:%8UT8R4IB@&7M>-, MS=9EPJBX)#GX86V DRZ0"&5R$!TBI7;$DTTG@/?%@4.=1^/#(DUGLLP'L M0X;L0X;L0X:(*=^'#-F'#-F'#-F'#.FT1?U"&>[0NZ/^XW?O^3:.QP%IFT[D+ 7O3&V"=6A[\_W M.*4/89;3E 8UTT%A!99-H*HR(#$PG!-C MN&BTXSDM0.6-]=I?S_W,C<\J+( MM%;<]TCK*#9!6+QE,F@(QQU4 UZ[7U&9:678%UAJC,=O=TP S8V6:17#NN(R M)%]B<3!7"1[#D1HP:]XP\*V^"NC[L2;TM"%X#>F/23"26[0^F<87:JA;*&3( MV[8FXTO,FP@/&F+LQQ>"O#KK3I8:&9ZK,?LAAR##0MGB388,SRM;^U&(X./$ M=^=-A@R12=]ZK#SXF/+=>9,A0_2DU7I *B75LP)2\$&);?%G!0:GD>:YV'LQ7[H11=QEJ=S;AK4&-PD M)1S=N*$TL"E4@.>T4#SR8[TOF\0!ZX[/H1_&#U=3@>P9[]&9^$]:HXS-9ES= MX!F;YE3$BKN";?AHC 3#[#Y(#'_@_:@'7WL>CX"UP,2LW$K4+O;2 JYB\9LM M]M9'L.#Z7@G=H?M]F%*??6Q(D.1SV CO?="C .XR4E^15>#%2X.JW4P3?5=: M C;">Q\![3[K?]'LL>-=\4-]:XG;X4+S7:W.T=(MI[NR.IA3WF;IZS=A]"?!,]AEJ1O MQPF;\,MI7KLV:HO"Y@60# #A4F<$Q?+8R:C_\2%Y_A30D ^;0_X#I^BP-EK8 MK\@E??"BLS@/I:N8X"M'F0%0+5,2V+;OLTQY*J60SF6;G[@*TJ]=961JVU;N MIKA Z"Y8H&7AM8:[F'&W_*'5\_RDL^!D@V(^J1@/E<(C6;_8S=#MYL, *AF M>R,E(+H3=YS_V5$. L9O,?R2SHC6'B&J',*D1QAG'&)ST?65@YOD,0+#<>1 MF#@Y(#0DV4T6[28_ LZU4:4$/'Y'7?,6.TIG8"&5-%>SF!HQ##1#KCLE6-8R M6]ST87USDA(26<+4\9;1TQ %GK%A+T4?I#W4R?M:!5+;GEE+V9H=9M*P,68%81(@.*'1'#">V[VB MLZV%-UC$!"][X5.D#(1F4!HFD8'386J(VH;I'$^:1)#4!4YH; <>CS'L.DU\ M2H/LG*FI@!O[["RD3F1@7!8FE8'3X6J$&=%Y+HGY9!+R>#NUK4#YZYP&(^56 M25.6'""+ VQCTV2 &<]CDX5<(0,GS[;Y_8EG[%CBTA+>J#9R@"Q4L*TNT%@+ M>-ZQ%,*68I[.TS!^N&8'NB2HB\]#YA;.B<(%O5U%Y #2[]+=WJR1 A E%1/+ M7D3 L] )Q/60 \CGV'WV 3E^ARG$)+*LPM]I]NAFQ[<'+;+G&'+ MY+:K!Q#G82H,IZ?ZG!SLC*%*!U.7XJL+&3=,UC3T\\727DI]/4_YACZ_2Y8V MEJOITNHBHZEQ1>1P9TQ4[1504>L@J/BR1Y66LR35CK#J0W*X,]8E.974[91GM(PGXNWJ+:J)H<[9Y6RH9*J\\!;K8JN?NQE M11X+'J.[#.+-9\2'PE!^_+;Z9)'EIWSNR/_S!P/,5'##'8B5_*^1PYZQ< MEK53]2YX\]Q; F 5W1WL6FY7#L:+P/D<&=L7'J@*P<1^T>^1?2"^.&-!U3(6ZEK5( B9)DNI1MV93" M#SN?4=_!GS"%7!6R*>X"C1"B>7?1-400<&S39DK7$X3M M1G.&9!@0/2JVGGH,-!52EX8[:Q,PB)Z[6@W7 MZB;!2P]6&Q4B1)LYQX$['>5^L1![=22U'YC!PG.F=4XA%E.0*R[QQ5[]EN1T M\21)N]O8^M91WAU[$5='TDV'$ L:5FQ%Q'64-*<'?N2 \%B0U&%AC]]XFB_- M=L2T"D=96]SO3IH Q&/5,,U]W)K9516.DL*8;UP:,=2&Y'6L:.;8?CE&LK/I MEVQ\VYWRF#MI9681EG*5,&V- P5]L\&*RK@J\=I<=QOX1*L."Q M+S,YNL)2L?>$.F@.4?Y;,P7L6UZ);L]1^#1C.K=Z$Q(UF'@7H5O$=\(N:-=Q(7? MNTJ59&B5=34#B+N&5 -H.*W\?LO#--=*$G,]F+K_B\HYROC3XQL &2H\(= W M)#2TUFU\[RK]3_/W %*%J\QP C1H!I8M?I LAK:)PK>ZU:(H:%>VK6]A$S#) M1X.8%*'X:(BHNMJM3V,O#1/3I:C^O:.,23TN09MH$'F>+23['F=/U ^G(0WT M1P59&5-;V&3 M3JE'A9@<(01W#P?7+_GNZ&L^]Z+)/3NA>;XH!I&^$&PB*,.@*V8P\/@5.4[= M!1'1UI "V6;- !.:*0Q+_'20I$R=>&X/%/'8/:69GX:%.$V&;:T83&HENR-V M XZ-9PF2->Z49]P,3L/G,*!Q%Q$8)/5PF2?,G")-H8)9Z+_76I+T/648/BMJG\ XU]6B2R4)_Q MC*J 2>#4B=XFT/!9"IB5_*ENLTK4H7 OO=4D+[%X=:L0)J%/1[K; M K62HM5>+B60-#SM-R);PEM):2K=#[8A>?%\,I8F+.Y8+4PNGBY[Q\YP$:4> M77@R+Z^+EX!.DDR92U15#";I3K?I3P/'2C9/DSQ7?&%5W<((/R9' S,_R$!@ MRJ)9B]*R.+;7#QL7<>W5G]F67EL-.1J,.:,M/"MY,Z7I)>37Y.6OSY/TQ,L> M96/+N )R-"QK1R-@+G-C2@29!$%8-J$V1QD6)T>#L6HTA64EDV:+\;/FN%!$ MQMA FM0\QQ5;19MMD*/!6$6<8+>2>]/.8GE*[_.+F,&?%XDB5A>T*US%6J_R MT#.N@QP-SIC2")N5+)VNQ_@M?:;2RS.[K9"CP5A3'*'7)?)$T2/N6#/NY_VB M%?)Y6$8>^^BK'@'OS:+T3OU&7XH_M?;CK2H@GP=C)6H.K*+303!WIVFT/P_& MTM, 4<6& V//V2M-_3!CA^9%E-V,=0J?;0J\!^GDJ2I#/@_+]*/#4ND>@05( M%Q%"&1#B#]:[V)"_"1\>E894BZV0S\.S']E%7_6>+N8E2V&THJ)R&H@AGKWR M'U4WRV85D,^#,44U![9RM@=+8'\V>XJ2-UK>X5P5K6= :>PK46CZ'"[\D[:' M3JG<8CMY0_WD(0[_9B.GV'@4MQF7R_> BJYGN27R$\ CY^4#>SM8BJ?YJEG< M17O$R8[7BZ+M >V.>=G$[TAATN>.[[A"@OQ7/XES-A.<1<7R\MO[C#[P'U9_ MCQ+6]F_O\W1.^X^CQ9<]35"+ZAN"*6ZO91;%G:8.'8SK?;7OB.041 V.K%8ZYOBXM&W]VJF M[_IW!.(PT$S?&^+B>:%^NCC-2 ZB?X;YXT4<\%?"\\6-;/U0FI4Y(JZFPFK4 M*[KCEHF3VW#,^P3W"L73;NH:X3UI5(9I5:G"]#\E^<">Z(;Y-JL!:IT\H(2M#(),$VITN)'U!@1P- MI:UO",Z],"W>*DVR;#XK+;>3./A*\\%(EG M6V85+[\2X??4RQA%-UZN-$:[;IN,(&,:]]25>NC',MWNYN2[1/M'$K%J(AZ< M": ?K[=.1I!I"G>O)V]K=T>GY)LP^^L\I7298[+/KBQJFXP@/+%VKR/+=&LC M,J/%;GROAWO?9-S>T72FRV%RW['5U6#NXQ!Y PWM M0@38%ZF'GN'\'@21@]3@>M\/LX2%\RN]-%T^LX1&YIK0_,B_-? M+0[T31)%YTG*_^C"W.=/BE>(M]$9=>'0X[X7I# MH#Y60^N!6ZI#="FE"G51M_\OW_\KNUCCRD!]J'KO1FW4@RAO64=U,?U,:9C/ M&=A)')R]/H5I44,?DY>V[8%Z1@%-:$;JQ).LS:)Z_Z0\9@4-)L\T]1[H&$@S4M0IC/V^@\0'9!+)&!TY7G=V>%&0$>42-UFYU_<:*_X&,*T [GDYRD=&.7+?![X,Z\V##FB.+9-X"6U: R[2J MOJ&<:_;[I9_'W(NXI[V@RX/)0D8[#G7O7+0-W/M#YSFS^4ZM@'P4LX*J;*1;U$O MPWX>=Q?F7 VKJT_-HS;A]ZB>HEE@5-QI9-#17$QM"<@OM6]H5)ZP'\.GN^0L MSL/\3?M$IV%-T*_ I,P8$JE%MZ<8S5,KUUS;? 4ER^&TV)=E;"-[&J;49P6E M[YHT)4!?-;482 )[BQ(A#H<[\2#'AN:1>Y'#2;%MJ7Z$*9^UL ML[(.&!U=VN5I[3OHH,\;RE1J'%^,Y98J1[+>M]$]OI?,DG%>#&0VUME\,]D&G:MZ M8%]YV&-T'1$>'Z[=C?GDY@D%MLUK#UK$TUF'%G/'T>,'-"&?Y/>%=I6(9C\S MO Z(Y&BR(ST1WVG);MPGT%-S M"[$:)4IU]'R@15+:D31Q_(:\N 9&0VTC60*;JQW?:M,N,RWHFX#-GBQ6_); M>%3>*CDMJ'^ZHFUI7A-^2^+G?'BAID8P'&0^JATZH4!B><]2/%T%A M/,A\>#96:[M*W(&H9:O7O:>.DMNMMT#&@PS+Y'*GN*T@&X],)6ZM_.W>U71Q MNRSS9%W[B(P'&6!(P9@8([+'C"[?[SL\%^JC/8X'&;ZGAZ.BD>HT#Q:[3 T\ MX> S?QGI!?^:9SD7+YEF_+:B;$,V6^C*D?$@H];H)A 3V$NV_HEC3FFSDZ]_ MSO/ .WD0O=4(&0\RFHO+(Y501\L.]@N.2"N%H-\79[[M:4VQ_KANDHP'&3=% M-PDYUMC*5ME7_[JA?O(0AW_3X!M]S0OGQ?^E7BJRZK2HA8QWS4[=4@D5L0BL MT'S)?$PB)D]6.F+<4';>SDI'B=NG*,Q52XZ^-!GOK(W8#'Q%-KS-]Y1-+<], M \^+$"!AMG"%N 2SB-ND 7K@>NNPH3Q0=<)M MQ2!S"+<%F%O'SU/*@W[3E&9YG[U0U#9L8E44?5"F%F2NX&V<,U1#SEGJ#&VC ML#E0._4Y9_K0^&SW?SYV(W#73'NBS#*.!8VK:0W0SV/5-2"V5%D^7=5ZFRW)QCE4V M"'I7V?O95:>*';#<;4,L7VCWT[/*MMSO#]O+9C!^KG MAA+ 7E;O5#]OH/$!'=YV+@P?:,Z#875XNUK?G5V,]J !-.=WDLM16HF='!BN M>4!V2FWC%J;EY8;RCL%^OTSS,OOQ+>C=4*+ IE!!T;4A56\C#K#% M?IVM06H^5FUV[*ZR##1-#(J>;4/W-H('H]N_7#"889R%?O'THZ=MRD:C TU# M@WPW(E"R)J!R_Z]W[E@E;(29O^&1+ T+].R0OFS@4O$B1U>DT5L<8XED+VM4 MG_?XIL9 *:+)6"[XL-_1W PDR)R.!/$T4Y<4 P\RU6V)U:/#PM2&@]O&B M\'OP4'(Z=8M9DF%!,WM9(@?)ZFV7)7QKN^G[43QAX:0#0,P$WBAPRYZU\ @V MBGL@*^/&6[^/Q4: !(^[3ETX[42V_;$K3_/F:XQ(RV)BQ"C0C)KNC&!;6#I2 M@V])N:5I2+.S:U8E35,:%/)J%QA%*12AU#8'A&1:4Z- P]'Q/ MCFF43GZVF M6:E2]=(C*>'(B]OARJ, @L?Y320D_S&E5#OK:BR MR1Z2)II&L+EB&1W'UH\RJ6 M7R/+/H7U8VRCTS71;5S<:/5Z]Y*8ZK7Z%-:-KHU>UT2W8:>4Z/4/&@=)JE9H M_1LRAHQI8:[)39GQG+B[^C'^4:17+X-D74V+3Y66? ?-D3&$G:RY&YYK'>"Y MJ.Z*\%L2/_?;KR0MDC%$L :XKJ50 Y[;J3Z2JX\A8A:TY]T4$YYU1Q@/JN:A MK[_>DA8E8P@#57OR3/#@,66LNAI_;G,U7;Z_,1IQZT7(&,)YS\8HV\9AXYEH M'5A&_8\/R3,#QR=D3L_!XF=.S$&-F/*WY*+X'Y_0EXAT03#,"I(QQ ODYB29 MH['Q\M$Z5\TE.F\M-SEKC5!2U4?4Y&4-8 M25J^ E)@T+PY UEB+A.V,L:K?QLM,IN%R!C"W&)CF1$A6=+T"R::0N^>)UL, M:78R3]/R;9@!45O%R &$/<<*54(LJR.Y^]GK(LOF-+A+KN>I_\C.=^P$..,' M@,3_RW1&4U1!#H9A9&F#JV+)@:5X>5_-FKP/XV)ENZ%^\A"'?]/@(F#]))R& M_-)SDF4TSQ9WV0$#6^M11:(_&@A[FXQ;YPV3@V'81OK31M6/X&TD1=\NN_WI M/&6'R#(,6FG.N6&;+K89SA=^>H4!Z$O*UAJ5@:U5A>1@6':4]B@K[N%-*TH0 MY>_/D_26IL_L0-2:\ZV*R,&PS"[-T54:H5E?E8.&[5I;U,+ZE/MO]\$/J[S0*IDG*#C)> M1!>1OEFZ\ZA4;7+-4>>E]]L962 P\8<]A@!3JDEWU8(I[->2G("&G)E# M_@.GY;!&"_L5N:0/7G3&.K/T]8/@*\!@7W*E;VS0A%);=HDW57(I@]3U??,3 MJ*!>$IUM*W9#V*%H%?@504OU]O%\C;(#"JOK.F&P;M\R/M]I7K!)2X"$Z1)U M2N&!32&U._5^I4'T-6$'1/H[.UZ$\4-V$?MJ_2J*@,3E,E2P6FR'SP;.V#[N M]94_/DQ*)P>U>B6?@R04-U2M7&0\_J.K5?GJ):;!L1=YL4^U+L:J8B#)M9OL M @U!X'$AYT>5N^2KE_.CR]OJ"'/+1NSB7V\WU(OX_=T7IJ5+]?55F^I PCVU M(;4E.$0CC6=/'MAQ 7E=VKL-ZMI2$%PDVI@PB&UX;8I*HWO> _F0M;A?,J= MV0N[:"?+8(P_SKQ4%Z=25Q30(JDGS9#D;4AH(GALR[J45!\R45,4.H.!"0VF!&XA M^S$(1!*=Q263^()B3GP_F<=Y=D-]&C[SJ48;$5-6!#2S@LDH$K.F@(.&);XE MS;@?23RGWZ@^*K;P>]!,#.WYD6%Q: 9>'O9.YEF>S*C>%;#Z$,3TVV:/*!4? MCX5Q"\XUVT6Q7[#3N"J[GJH8B!G8ZA9^'8S&0MC#P?1V?I_1?\]Y(H)GNDI' MU_?1=$,,DX.IK C L71#%-VA5/0YP)%4H4#95"X6?-C'4;OY$N /H#*2))0J MD*#9/G4-S@]\ME3J6+)NB$#L#A](CHJ6B,%W*BS3!4Q:I4H0EH(]&PH'@V0^ M4V) 1M!)*X*$I6 /AXT)DF' 2N&A*5 $\0U9TB&P8:;@<3T)6Q8&YM:70K$H:>)ULTPV(X@ M9\]>P-K3'3C%)1RYX[@\;\J!(%K[MX74'G.D95RYU9@?/Q4J-R9IA07/'MHR M2U@.I5;I0G@V79=6OQT0?>\H/9SAFJ0>'T8DK6#@(<9)MG(W.>'ZL(C*X. Y M =E)B>THW9BEA.7;V<:T:-",*%O\8%F9+!.%;VVJQ2W4KDM;WSK*]M8I?3D? M#1)#MDA\-$0H8X=]HR_%GUJ'5JLJ<)7WK=4VPN0"UA@5GL/4"4]YD?(99G&* MKYY@L%_G--#X@JC+PF8E:TZ@$:#F7B&?>&,\YPC[Q_\'4$L#!!0 ( $"" M9$B)W;\,.8$ -\*" 5 9')N92TR,#$U,3(S,5]L86(N>&UL[+UK<^0V MDBCZ_4;<_X [Y\8=.Z)DN_V8,YY]G"A)I>[:4:NT4K4]OHX3#HI$21RSR%J2 M);7FUQ\\^*HB 0(@B41I-C9VK): )#*1+R02F?_ZOSYO(_2,TRQ,XG_[P[NO MOOD#PK&?!&'\^&]_^+2^.OOS'_[7O__?_]>__C]G9W\[O[M&EXF_W^(X1Q_) MF$V( _02YD]H\8^S11#F28I^XK#0NZ^^_^J;K[Y#Y,?UTS[- N]UACYZJ?^$ MOOENAK[]YMV?T+MO__+]N[]\_PV:?T1G9_0S41C__N!E&)%EQ=F__>$ISW=_ M^?KKEY>7KSX_I-%72?KX];???//=U^7 /_"1?_FC7[XKQ[[[^F\?K^_] M)[SUSL(XR[W8KV=1,%WSWOWXXX]?L[^2H5GXEXS-OTY\+V>$ZET7$HZ@_SHK MAYW17YV]^_;LNW=??YW:A*PI2#4U_?F:?/]@9?ASCN, !^7:Z$R)MF2 MF99ERC_Q#X!%5-TFZ2&>01I3K?GNAW??LRWB3I MEJGK^4.6IYZ?EX#8TAGXWSY<_?G;_WCW']^^__%/W_VF#NCK?R\I<+#@%&?) M/O6Q%O9\$PY7YCW\]A\?OOG^^KOK[Y?O_OR#QLJH82-@J/7&\=FG^S_\>V6Q MO3A ?")JS$2_EG/_][_RQ8R'&_$K'I)*#%Q$<9X>LASQ3\J%DA][<"Q&?.TG MQ*78Y6<'6[E)D^T@'BO7E0PBUM?*@E6@R5#,L/_58_+\=8!#@NJ[[^D/5.B^ M/_OFW5DI=CC\C7_W#C^&]'-Q?N-M<9>4??_#G_[CS]_3__SIQ[_^Q[OO?_SF MS[\)Y]L0KC_]SS]??_,G^I\_O_MX_=V?WGW[C7A!;88K>*P>A^A Z_)C!0LK M(J+%(,>2H44&&P)Q0:0R]:(EL82?_XI?>^V.<*)U.R-!0< ]Q4#$1B(R%-:* M3(" ?1O1QTC=-J&'BZ9B^77JT6C!_>OV(6GMCTRV#R=":OUC%(XYI?@[X@.< M4?/#E@VJUSN9IE>A=W',5&P])ZY50-VKJ\A[5-'@AQ,@-/?QDH_YH?H[H@/ M]?2PY8)HY4ZF$&KC+HZ8BETO]FE*OQ1FOA?]@KUT$0>77J[EC0MA0.IF"6+' M#%,,17PLHH/):3! =+@S2GLB?$"U>1_S]2KV'LZ;2FC*$_2:@%51\0?C(33\ MT8*%<1#Z=W#]/F2Q(-J]BQV$RKV#%Z9FT^I60U>Q=P. U.HBE(1,P@>ZI\[' M1@14CTL9K5>)R[AL:M&H+<<5^4VFH\R/IT+J]38:0CYJ.@5LL#/Z?DPD0.V M@*EZ34(W1]D1 2Y\0B'HD_PV$!>L1!=J?3Q5Z%D8T;"-D!-60\B RI9#Q'W3 M1NM_QE'TUSAYB>^QER4Q#I99ML>IB@V1 X"+WHM1$@3!Z82SW^D,5$Y!?(X3 M&EEIHWJBXO)=FI;%?DJB?9Q[Z>M5&.%42S-W X"_(VVC)&"M:B#B(YW27=+M M4;Q@[-Z;B6\8><#D#N^2-*Z7S ^T810J);NR(V5DU ?(9#ZDJ^ M1WUW>+(-FI:W&!M?D+/;8Y)VWEW+A>EP.KRB.D9'P%!L&"K'.>,QCHB# XJV MD[44U6P77TTK"+?[ARCTKZ+$ZT\=[)P$ITX/ERY@%SX(L5$.ZZ8KCQL@>&\3X[>_2\'97%'[[&49Z5OV&IWPVA M+'[]&_6/,(TAK#978>S%?NA%MTD6ZN1_:\&RK=LU$3WFV&H:6FU0-1&5,UW) M A^(Y?S^?K&^![=E)DS9:>(,.!) Y-;>0Z1\'RF8#67GA,B(!>A7-L2^G$R[ M?##;)&MP04M%V5HRD0JW-7%,4I8S;H**J%FTAQG#OG3R@(G=IAM5?B!I3!*("O M8FSB-:B "E]T8N64&3(%%<4PGA8G;US1Q4,QTJH L[>C8Y-4&0:LB(9$[-> M0EAO=XC;5^#ND(:6$%<>45(1MMVAB_'A:3[98C M'H94Z#0\#)G$V58D5\,]C&X0L!Z&""T!*UZYHCA.$2-S#T,5)Y$2O'+,PY * MDX*'(9,DVXKA_7@>1CQJJN(D4QWM'/0RIT&EX M&#*) TA&O YCO"0_ZFS4A$ZJCV= 6IX5,Z\T &P#Y &+8\N&>/&AP@8XV[60@V]Q?O+_6?3K4 M/1E*C8I0Z1:!6?6HWK''0*IH7'RZNUO7WAI^AK&CS]YT5[[_8\:4&CKH8IZBQ7)!-:-A/W0 MF#I#\QR5LQ&;[I2]&8+P^*>Q1F.J$T9CU^H+9@F9^?V'&7K CV$<4VY+-H@O M92(,ZVYM-O'#1,J$F('[05JZ4^UA@H;BM.@U^7ZR)^NXPSXF:WJ(\ W."\.E M[#S)8(#Y4'+$6JY4,1S5XV>(S*B<*S<\*D.DTFH\.D/$&0G&-UYRG6\7&3B/ M44&:Y(YCORC9TPW+^)E\-DE?R1ITW<2#N=#>X!$BQYQ5_9E)O%-NG>K*'7+A M!A$;W.YW\;R2>>]@>'N2>IOBG1<&B\\['&>8>!FK_ FG!Z=056.N @K*IJNA MV7&O06>A8AH[WK&)Z"A^XH2)'X8CYM,RAF2 =[36"'QM10,VE5I)=1X%"C^: MQ=YMBE=_(%?BB0&+S9"UL\[7R"\"IAX;[9#Q'&/YX#94+M#JZ-NWHLD.I_GK M+2$YZ\Y+CND[>J7W/DTRY>O8'BAPMK,'N;9)X1-FB$WA/9K+23/$ICF0\&6, M%T,(5P@]3H*/F0>@B]'=ZG9QM_X%S6\NT>(_/RUO/RYNUC/DY_W4=>CH-+O$NQ'[(GM>3G"+.JA'$PW]+2Y?]@OQ>N7MO#'>N[X,[Q> 3L MB'"6H%$3]@Q5T)GX-.$3L3H4L-FAA(VG-G[D1(OQ(UV@F7<['>VN<9:A,^0U M2!@T/C$5&=;&>:?NT +^O#"R3E([:HRKD!PXI0BB]%IVS5:T7LM2=@>2>QP+ MB$C^"%B1WZ)=YPG%92\>')?1O7=3GCM!S]TANM(ZYL'E/XVJJMR(FZP^+.] 45UT.T?&FQ!QF3U#>)TGP$D:M_1.I MB6H\E,/36/ QMY1_CK!;<^ JE30-2VX%V'WD,8 MA3FM0Q_S(@-/213@-*.!A?Q5][&J,CPHVZ.!<.ONHIY:A9SR5]=>M@Y!<#D_ M7UXOU\O%/W39%L0^51X/B[3 M21)(T 94BJ1$"IUX73X:8N53\X84NA>,Z^=')6O7RXSV7QG>>J_T31.]6_7] M=(^#]AI5C: .2.@WB&IH"Q^\%=-Y[@<'@+HDU G3.!+.NP+GXH4?P]TK<(]J M2 Z<76$1!G_JJ"'22B\?U>493'W=898V)_FFJ%B M)BJF3J>RS L!#L6U%.!@CU&>H+3 >$< M)YG@KL8.ARMFDZERL[VY/:RJ.MW MAY]QW%WJIDNU'4^#)G7JNCUCF M(.-V!A%TZ!B!TBG1RFE?W]8KK;T,'UY/>&H?&,-7?6_M5N#!,00"O GCD*K! M]_LPH G!D["1B[$0PY"' Y&-QA(&W'6 >UN':$BTIU/>B'S5_/*]<5'A4,; MP)6#^T$=;*][I6*_FB_Q-L-\RXI&QL%%$N=A_(AC7R"Z77I*!@+*_Y&CU;(" M]6A>IK/RS4M;<"S 2Y6-^OES?O%S064V.CRC8JAZ^<[FWTV M=-)OI%U(8!-OI(U-=#)2FH/+?)MYGJ?APSYGI]]U0N/V#J< Z*';D7"#OKA< M7"TOENLOW^PE/"M/=HE]UD$.??=NABAG ML5''O_U^A@B<'?;S\!E'+M5O'L8D,\0BCN[UXAB(E0M5':;$3U[*8;A9##,_ M2K)]BF5F<42!=\Z-%QD3M=XAW9;$8@9<$#"GQHMNO3!8QA?>+B1BKNJVBZ:# M)>8*T6GY6]5(1(>B,$;%8"=<7R-$:.WL,X*(WXT(7$JIG,GDZ:-2#K,G*'?RQ$ M1/]X(GDR#66 T'EI&1'6S.%T&A$%B)O':^^,3'P5%QF0@#TPI_2GC4I[L' MIVKV*2V^.+J-OO+#2K>WH/0'[ 8O,A<]W> %ML*=J@,#\GVZX4%[H0H(JU4; M<,KE-,"JE7^C7&@ ,.QH%4]P/UM5.'6SDF22"77!2US,54H,!S$B+'A%+,D] MC:*;W?D*H;EQ#2Q!MO=FF,Q%28KX;!Z@160^8@ <<-%'P+2XC*EN8= 788R" M)(J\-*.MH/G]BOU#OR5TG;UNMKF9CMQ%]ZDEC>OI'IT$I7C9&K)Y=0<(:4J9XZFO"EC@=2473';!L/<>=+K$">]$P"BI6CJ'Z"2/C;(G@ M_8 +9EC[#"H7&D#9'W#ZE,)RSN#*3V7=?.CJJ=,,.>7SYF#<1GRA,\KFG=2; MG9$P=J AJ['R&.190083EK&?;#$[5VU[>D=T61C1="C72HQ.NTT='8FJH:YU M:9D$$S!/I(?-I)Z(G,=LOHYAY6:U:XU5\Z ]C 8"[6<>_$]..0T&ZP6W$L=, MHOC2Y(!#;#K76;[::%88/YP$=X@^7'K;X+BJBM^3)+ K3H8G6S2 M^F6;9Y!K?Y MHL%-3@>W*UF=-JM;E% <=CC-E4]0'!LHX]:/7 MXC ^@[?).IB#BDD.6+!A:'F':.&)T#(Y;)T$8OI1[3'1A6[00U3.BO$65? ME/#Q26R[UKX=),!]'HG J+4!$4J+/:&_2>+D6BDS)92"ZO*D_;$[0..@G7RT$@_=>&)L88:-O0%MI0\(5O3?O%C8219@EI=?87L1JW0)5';:-*3T[A-N=%Z;L M-HHB7L%%3^2#:).DM("H-V:#M<."'RX0(PBS79(5AZE#@GC/7AC1*D9GA!1G MC&HUC9QSMH9H3B5O;(#:M-F/-0V?V2F1?GX5U_]6]=,D$."ZM$J0:C<1+?\X M0R63U[]S(#ZEAZ#GE0#:V:=-DOI3(8ITKU3(J-HJJUB@U@ ]L^M=#3 MR[9')]A.!5I[GPM/_1S'V. &300&VLT5HR=(J"%#R]@[^J(8[9*7JHU03A : M/3@]@M\U)B+@SE*/%"GY0W(1LJD1GG'&6E_Q%2UI@V#R&U6'1S@?+CU0B%"; MUUM7%CV+'AR[? >O=*_9'N MO9$#P0D=7'AIZH1=%+F4)^,:#OHI,2-CX-XMW;#;.?M*"^?F.2^'DZ$]IV-4 M6@H*YX<9+F[T,QB*4D3^Y)0+J++HZRD6O4NRD$7R3HK4YNYJ[Y(7:W2]NF^U M A^\9+7"L4.IW7U:'K[XP=WD5!;_1<0T#.")7UUQZSC972I?Q5H%:8R9#7KW M;6&!Z&]^N\1XBX/+\#D,=#:T*S[5!K(]N^^Z-S M43D9K6+4F(Z.JN !NMMC81J4F#ZPX*L?$E?09V RHG?0!M/;:DROI_P&'8[: M&8,Z[6^;$D'B[VGTCR6H6B>%'-FO0.]:IT#V'J^>]SA9;/QN9:?3.@Y*1 M.K=AAU:Q"4 MP7)\X\%.2,;60'IZ,C4%0'' >9D>NTX:Q9**ME#G7A;Z73:P,TRJ"1;LHD,; M?87H8@D&K1/4K+]50)HA!LN%JY'AV!,MFU+>9+GE#W042[L.PFB?.U(K?YI/3^_7J#U"EVL/GY(B1YZP.EJPPK[->KZ ML<7-8V)]F3[2O>@R_ KTC9@Q<8[%H02$"DB(@Z*)^^UV&X5=8_K_8X[@0K0N5L9I&7LJ=R% ME]*ZN%G9 4)!MW99JSXP4$>!?O1:/=2+&75K$W@5.#)F54/.65N!N=R&51_E M\Q9Z<7'S7^/FC,>G*(I2#T]-#NVIEZK0+-%\K6[4LM(<,NVM!A3:7U-%_9AG MZ]+#U"%KS/QCT90>NB3Q\*W1L:,ZFPW UWP=Y "U2V+RSVS^.>S,O.L2>#D0 M*)/9AUK+K'"FK,<1_B0CW2F7K;174JVJLE$67;;#15PF6R]L78?T"6HW$&B= M*4*MC^?0KWRH>PI1NEE*"E"V4R"=8SYB>I1157+MB0YTBJI0D'760+_R8>,7 MQS(I=SW2VEUHGW3(0*J-DPZXQQ[CSX. )<=ZT:T7!LOXPMN%N1>)A4"F#>3 MH+5O'ZK'#%>/1W3"&3DY%E.F$YTA\3!=_%21 C7NF24YBTEM MDY2_ (ZB]SZ.O31,1$=0I7/[ 1!H@R1"K14R*?X,>?+4IZY1%*1C?RRR6O'Q M3W&VPWZX"7$@/GUV'L6% ,"B'1*41&PV0XW1L$=//2(KQ3IZML@>M]VF., ^ MSK(D-?.VVP"@%5H72BVOLQ[CIAL]%A+@:EG(8$HJ6<1=%M6Q2@O?3@T!TJ^W M4]LH=#NUT8Y7/R*CLO*B">L#;\(Z@ZI9;+K\QE^K!(\-\HO3\#0Y_BJ]@TWQ MJ;L 5SMR/\V.]'<#'HNENA& \SUZF_FJ(6[?UZ"=NTS*9C1FPGL7#21Z4]II M"3X_VC-VNDU2&O5IU="X(2R0Q#E94L0+ 0'5[!N$=53U8+E>S^_Y3^^^)O_W M/47QAZ]_(#\YZ)L<,Z2B4W+$C3;C$,0>++-L3PX,^Y2PRRU3@C_1HM W^(7] M1>-J7 48W!6Y&JKMU YZ-<,G(CX3\:DSQ";/$)G.!TQ0FT3?QS'$\Z+Q>(*Z M#)=I$F,T?P[9RSUTD:0[%'(JT!$4#=K7 J. [RMW 1A^(:NNF;1? MD "F1&C(:D]JA+J@@NLB[F=(E9$\C*<$%=H-4$9>1SV5AS P_30)Q@:*:K(S MPQ ?:."6]VNNR(,;B^XFJT3V$9JWSKFLO8 MD@Q08:77#:C#ID6[3YF!W9E,A?9P[7::'II4W8U#[,%UXV0:]@[3XE^8#;G? M16'>ZWZ9@ 2I9*J-MKH&XSX8*J 4J>D<#GPUS\%XEVAMQ8@?28L8F M8Z!&JWTR*TIM(M],B0@=T2&B"-B]<"7Z="Y*D_TT63F3.6G#U/MI>F *>F], M>H+HP'D<_.REJ1?GF4!;'Q9G;(S7BJ8-^0YHE&T8@;K5)"VO40Z2A^*.ZP8W M9[H3MAJ71EU:E-XIO/ I"'_&J1]F+N5PC21)_=&LX6(T]+0G70'3;5H*0UB$ M=O#'0*N)CT"J;M4Q[U,=W-*V%,<<4G'8)).R]ICN>M*XZ#8D.6#.H=.)OXJG M-J:BL9IYZV,<9%>$C'2Q] )\M6FMC_\"DS^RWZAZ:X;0H7PT8V*TW]]P0#S; MM01%4QVZ?+ :'GC'H8DI496O/RI9[V0ZHF,T '-(AZD(J1LZ2#\,<#[-OLN5 MN9;C.>A#H$[G0!()9>#J0".NVAIQWJ$1"^?4'5]S*NIH:0@'G4Y(NCCF=(ZA M8_H=SA$4S$17MOS7=SC VQWEH]6&[Y]!+\H1/N/;2O>XL_U:"IEBUD M9^K>EJ/> AN3J(%Z4J%^?O8.OD666_B?P'6QGA8QNT+64B'C:TMFQ,VUI3SJ M,>QS\&'/H>32T)X\UNFR]K1+*E4M,EF2X,#8Y[3TR,BDS V%.J4&T(M\CJ%M MP/-V&C;A*DG)2I]#?YRGTVV@+K[YZ$+=X.''LCZLEH <"&P.1IPGW]79PD0X MLWV44P)LPG3KT$7Z:%C2+XRP\& ML MG-@WU!27R;+PMGA:$AP;Y5ISGUJU@.&V:N)* 3]!8JZHV4\S0[A?U8](V\'! MK$61Z]-]EIOGN><_8>7T7A.0("%];;1;%00+ .*P$BJAN)&<.P[:%U[V%-&G ME&6.6".FM&A=Z'DE!5ZFHH!^I'Z\G:\Q[\7;D0B]F;"+H_%&DCY 697<5WZW MJ'AY?$^JH+2$L3;#3X!&V(W)(I3NBL?+5M8=^1W@VLTB/XWBUV:R3^2[T+_=XG11? M+)>GY.:9P@;Q]\P)T2H]44%"%2A4P")ZTY\+B)5*A7<")Z%% M5-'BI:!%0FA!SO#SV^5%^>#U^(&! ^Z@.\1PQ$<4[ M#OH0J $OK-!43$&T(KZAZP"\G>[A2Z192SI(3O32J MY?PX,+9.&AWLE=R&,;[CW%LC=0)I/S9JN!L=L7YR1"MJ1CCB;4Q#I081:E]C MW@IFLVS1NH*& [['E$Q3)&D*>EIGZ&J M-KSOSB09H&OESQ2&?A#^J=)PDG4*4HCN18^5,L?5KVUZF>EA!Z-B$]'G9D\; M);/72P>)=(6.SI]P50,^0QXB(_913H?3O_BC&#D''D2-I-H4GT2-H],Y= MF3@'2UG%:O>[HW[0:5]:D60#G6I!EN"1BE\K3: MG5<8.!GM#D5!,RT_<].+GXY,XWOSCAH .SI)SZT?5Q.ZX-ZO7Q*[[CW]X&F[ M]YQD=MQ[\BW \@DVZ-:I]L__F9S[;KJ,X]SW$O*M.?<-?6;!N:^5F0O.O4"7 M3V](;>GTZ8VSMFX?X-S;U^U0]#/3\:Y&Z*>CTXB^O=OZWXY*LN_;3VD/#*P3 M^8SEX#W_Y(G[]P79+'GX]&MOQ\<7T*[; K2*2KYI-U] &F-'_T#/]Y+RS3GZ M3>5FP]5O:#8GG'V10L66U_9#W'Y)U'V\!']D=7^F_;\!:2:P/=W MU";84E [O^D-D+?9ET1 ;'K_[,OGK;[7Q#-CO=//_9FG'\!Y3J-P.4_D^LO M(,PX(?Y>2KXUS[^IU2PX_@V5YH+?+]+ITUM5:[I]>D.MK^,'./T .AZ,@F:Z M_BW[^P)"C>_N.VH'+.DE^\[^I';!P$R%SY9C_>R+)^[KO59H3OKY IUNPJ;9TNP4[K:WC MA_CZ]G4\& 7-=/V;]O6["36^K^^H';"DEP!\_2GM@KZ9N@\_VW7UZ0=/V]/G M)+/CZ)-OO1D_OYMNG:J_5>OJ+;OYW709Q\OO)>1;\_(;^LR"DU\K,Q=\?($N MG]Z4VM+ITUMG;=T^P,&WK]NAZ&>FX]^R>]]-I_&]>T?UOQV59-^YG](>&%@G M_(Q;_#VQ^66?/''_OB";)0^??NWM^/@"VG5:@/?_5%Z^@#+C^/F]I'QS?GY3 MM]GP]!N*S0E?7Z3;+9A6:SK>@L'6U_5#/'X 70]'0S.=_Z:]?@&EQO?[';4' MMI03@.<_CGVX31,?XR"[(C2CR_((/5O-&N. _P*3/[+?J!;6-(<.XM$/(<:Q MB)6P$ 6&2FB=[67C -4@)ZR>INFC3T(-*IMBU5RHH4V2(M_+GAQPQZ%RE%Q, ["N=DULHV_: M-?']Y,W)-'W)L;%OG$&KEH%Q2^)+:CC@1]H@0-N/I&:@/* [XCN:JX%!#12[ M=<"05MO=?>-T'4$)&-@VV3+TA$T16^Z:0RZ9'D;"KH@MO\(AUTH+Q?DVV<$_G5OF"6">]$U\>]BL?H\L6^]C&ZJQF@@OA][M3J9X)+VC$UD'-AJ2&( MBZY38171".(WRK7FR"K)+)"EVBO$'/H)W5AV5_ >&(2?HB2\M@\U)CTN.A18 MGE2/16?HBAUNWJ.G) J(MG7'K1J3"F[X4(.%?NP;QU&JI0^)R>LVS!CZK9.] M<9Q$V17>&X3.LT@D?0WHG%LW(>_*VC5G>*<;2.BHHMB,4(M?&R M!T:M?7;VZ'F[KZGJ_1I'>5;^ABGCLV_>G17JN/CU;_/@[_LLIZR6K9-Y$(24 MX;SHU@N#97SA[<+@SP>UM@[;WJI% K<"W?4GJ?:J/XKH5VE0NOANH;[.V*=1\]LS5'T= M%9\O3_.-!8"ZOX $YB;QO$4U=(;F]Q?HAV]^($3_.SL-$['[GA^2J_PW< ?3 MMNQWNJ*6!=^>1F7,\3[UXKSC14PW)N_3),M4G=O!WX%R;$<@4+<@%K"*XZA, MJ3$X#D0>)R-%IT[B/FKM\Q.;L-CNHN2UW=X"S$L;2WJD'MI(HF-9EPBBC!G[ MWW-E7=)E 8SA0WE3 PBB?F%1GNISH[[4=E"F6 .V[3$/6"0YP+#A3?I"]#N7I:?R;#KE M=B@JT6T)G\0(]N*EU"N 46:V94G'8YI.EL&=*>;TW1*&?_+H$N=9AO.A#E0W M3,><)A'B.HY2<>(JH5!%P^&XZQJIHMUU%T C.AZ=@#R?!Q\ZHF"N>3Y2!C?Q M=F3<#2[.W!53D>?>8Z@R<&BO1)<4)D#G+PE]M:+;5592\9/.'+$\]/UWE0GMB=8-SNHC;-*'//(+SUT_$K5_&JQU.B5+N[_XIQQ-9<&)0MK+ I X41ZQ1K[ M883)PI>QGVSQ=9*1WX^@,7JOJH^A"BZH=_"GU!/_8E M*Z%WH(_.2WVT!-!'@S- [- T3U!:T30F-(W(1^AOZ<_L,>B>:W245 3TJH_ M:#AKLJ6=]C&N4-O3BLOXF2"0I*\_IV&.+Y,7Y7JA$@C07DXG4L>R4 U";-19 M0(8YY)LHX3"/B(O-KC/I43^L,$H>,O+US,=0N5J:#*/C:@CYS9[07.(=49TA MNQP@/T>XN"68;Y,T#__1F?$L4E]*L*!,O2*B[4H,];09JB:R^ZGF5 E4T_B,B$T=B!'RPZ8B:UU!HR!G$>N4K2/LVA=K%Z# C:#LM0["AM M J473@(%DR=&0Y$H-9M[=P6]PJ.9$M M.1;=\.W."U,>.EW&.=F0\"'"_$+B M*HR)HQ.%SSA0=2I4P4'Y%>KHMKSV:B:-I]=SBPN]&>+3S]A\!_R+L3 -:TR] MSJM+,"NMR;I20ZW'MQ:OZ#K3(K5OY+NA0%MI(7*MJRQ!HIY#YEH=%W9/SG'Q M);B 6SHYZZE=?\OXSF:HR4\Q6<4EYO]M!,**]#O=L+H&1#!+IX-T.T3%)Z$O MRNE?$I/7"&@7(%R+9@]"^N*)_(O6XXF1OT]3:O^XQ6/A@RCT'L+(L1"T/F?+ MK: N6T/*\-SW:4W*[ [[.'SVB+G6#R KP(0VDHJ(JT@P8>QR+JHG.V1$#7&M MD$JG0VK(*=@0K2_*>5_24JI\-\D6>FULT1DB4AF,B/6/'.L8/WHY#AS;3'#7 M2$<9*5XM*&LB2)5;WH 0&VCN*36!N.,<':*FJ$T;DUPX\6LC5=QG.>JZ65^] MHM*;=/4.N9(=TJ[I/;9%'5)[W::85BQ?%*'E5?Z$TRXUIJ?Y.Z&ZYS0*D%=4 M=,5L5$Z?(0; <2]+$><2N?+.@1WWDG'QF\2?&HS?T3GW!/PLF0P;>EH2 7;A M>'OKO5+OCUX:^WZZ)\Q3!R+,G3 EZ.YX9XK$4 QC54>, AQ/#^$ 40.BHWZ1 M(3$JK'<-K+T"ZZDR2?(D]R(8?.O-#YJFS#LF0W%V/B!')&8"AQPT'16AZ;EI MZ =()7FYQ[18Y!V.J%F]]5*15M2S,MU@W7/J1.@K>G5D.J]+6@! !03'W3I5 MK"OTT@*]'1EJ_[@(B9R#'IQ49 U=.)F\@JJGHG+M'6V_KE[/M1^0.YY9&T55 MY5-6/BYF.NIL]>-7(9)V(^*0PR#@1TW?H)L977Q?J^L):$"&=@:TB##".UK+ M)X-)4>]]8^:<&=5G^9$?S[HBY#2BG U[$FL &[4^=T: MEN >B*J4*OD=BB)J40K,?&A!F M1:=CU/'&TXDHP$#$;Q9KM+RYN%O,[Q?D!W0QO__@P)7$"%A]<;G@:'W9BR"8 M;V(BKE*'Q$!6+59ZW^]V$7:!!RE_ FC5^RE&<(Q=>N)8<#;!YRB M[][!OQI5YL-.>ZC*A#9+IQ ]BK.<+H@<('2-W/%T:&/61J==%(6/8%(THYV% M';),ZLMWSK (&$FQKE 7%UFM'Y1L\=K[C#.)' @JO1S/!*P0U$:BHR00;:+- M1H%)P-#5YW04N"7H9YZ^ZC[=G&,Q_$JP);:H3@2C29U%L&B9XZUYTI4R8&A[ MH4."UFF>SVVD3_)T[S("R>8[FU0U N+A >)=H5=V-^6.[C'_GTRZ)^<",D.XGFF6E:LF&?03*J@TE39LM*U"M MG (.K9 P1.&A&B#ZJ2NE#<3@34.3[##18'Z<9D"?@S73&,=/6TS\/8NX=74E MM46+FSVSXX0.&>>&ANK"GO_$?TW_[CU\YXQN,HG&D M?L(8ZF:P-J4 5QO.T>>'*U@G&AG8)B!A8J^Z:$MTP:I..FJIRG4R;9:VNCLR M.MJ-7"OW5.#4F&<<\X<^S&$TV5"1[(]CFXCXN%IJ%6--1=6CWW6@.^#EZ1%# M47T1.(ZI,%M4D&:.PNLSBV2H5%L2=SAL+JBW$059TT/3UQ&C*KV+\5TS*4A' M7+,>M)5TVX5C>FU2M),&VK95F7[.P!M!? R?U KFSOJD*NI-QR=5T&VCJN?+ MZ1Q2*6C'O-$>,BBIZTOKZGI@@'$< B0- CBGOVQ1H'! S?UV%A".\#S5% & MH^JUQ?ANIQ2D(VYG#]I*>FQQ>FZG.=I) VWGM-?4F!=:R]$C\U"1-/"^%$1\ M5"UU-9WW)07MF/?50P8EK77EF-:R@G[20-\Y[66+ H46V[BIQ<82V0&^EX(J M&%6KO1_?]Y*"=,3WZD%;28N]=TR+38IVTD#;.>TU->:%UGIT4VL-%4D#WTM! MQ =IJ0H8STQ9)X7+=S6/@_(W:8CSP%?!$OY+051 M5?RCSM.QSU3"*RY<_X.O0>PBC,7W].PSS'Q)7=K).C$I9:+J4F M:%#74IL,QXQ< T 5!%2 (%I]0_W-X_JNKOB98R(?58&" M/:8_']>#=.?8C:QP[#_Z^SW+*%$H^ MJ&@NB*LI1J1=BI4WR^5#43T6WF721X)W_$7>=$CH^SPC8.&(]](C'6(G12X: M@WP1O,7!94A+:,;!.8[Q)O1#+ZK#:U?8HWVO5K'PO9:FAS+"!X']EE%(UC9B M%"PJX:(::6'Y-K$U!+/*CY$&F4YZ0 M\]1RSF\:3W^I>%.C*:\!.OM\GX4Q.;%>)-N',.8U!_4\+3D$$'^K#ZECGB[' MH\8$IWPO8X3\!D).^6$C8^2(3Z8D36+/3$64[)6WF?M^LH]IR9W;)"*JR;R1 MH 02=!$K*9+MHKW;K9>^LD!O^!B'1&'3,$ - Y5 )*6KP,LT]>^K4EVFWDVU MQZGG7A9F+-::E4IH'@>-+6JO=8T_Y^>10@[0*-^ *O0TD# M)4S!%4UR*H#L M7K97'"A8Q.#:KF9M@2[WGSY^G-_]0DM9WR_?WRROEA?SFS6:7URL/MVL:>/, MV]7U\F*YN [^X0^>+]<^+ MQ0WZ.+^X6]VOKG]:S&AKG*_0_.827=ZM;A9H_M.2]=- 'U;7E]07N5C=W3KC MAPP3%:D',DA.0'V/>EU2Y:"I6+N@.NB/=".O%+*KIT(>.";!]TB6J0RC^7]^ M6MXOV;_)R>-Z^?[#FJB$]8?Y#9HO[]#]+_?KQ4>8(\<(K#G0^HNY?4"TG%63 M7'SVB8?UB _O4>/@#OO>+LR]*/Q';_.K5N30##)(=-V4"#T>[8%WWW&P8+^_ MQ_X^Y>71RQ7,T%'2!)U[O QH'WBD_>Z-( ]A(UMRH6W3AGP"]';?F"RM !.K M!2SD^'DGQ[ME <?[HC!7-RCQ=\NB)U\3]SEN\5/B[O[ M!2H\:CKY;G$QOUVNY]?+_Y]-=^A6?S0*KI\P(BL("5\%M=NTPVGNA3%K)9:P M[A.\##5NL=ZV5K;IT6<=N]8?IISZ+_('::8!2I=%P!JG&\530\L4J< !<334 M$#QF['9@T-:Q0/M:WPQ!B>Y#\_O[!;UX.#@9S"_GM^LE#0U;),?&77_ET*!C%;W( M=GIMQ80_(CX%^B R@/XZ!W*EK83F4P.#J0\0M,>3(LJ=#:".&9=.=R3"-CJ^ M'^9W"VI'R4& X$N,Y_H7<,MAS+O]K:0T&'> ?WKT]%'3*,A @![JA6@=<]7Q M0W '-;_"/O6??Z2;-$HMI^SX':W> 4<)$'#=)BF*XN(]65?% 4I-7F(MGN<)RQ/;KC6W219'G&G/D'+\/!K?=*6<1)DA4P$0,Z(SW33QC<%$)V$6S.BY?*1VX1F$J!R7NO+E<[6/: MT,] '=Z&DV=L(7/#I9B./HN/M]>K7Q8+[F^@U2T-GKJ3KCV2O$B/AN,(RP"' MOZR*8W14;$T&/21VH'+,<>40%PV8=#OZ3X2"O1B!-?0.?NU9(*>\KL6+N<$- M3:N^\/G=W?QFW5*5]F_35%9;Z'5VRS_9RO4/ESHS7VM:9GN)DH*"/:'(TCQFK'.WXLU6%O5,Z*?5O'"@_:I]QI#"@#C ] MB(E8\-7)7 U3I&Y^6MRL5WV\,%A\IHA(5 YU426K[)72O9%DH\;C(KTS@W RR-%!@DH_X[BB/[4QN5O< MSI>7:/&WV\7-?5M[ CCH&JOO3D_S'I)]3F]VV![A HXCOGR?P(A=^AYI&2#$ MU-#PPCF]%VD[ZPJ00,U"'Y)=?A(?C\*X^1B&3F,TVO5@8&8F T4)4P(V,_,AG1V0XFB0U&E;CR]^N/Q)U'RYOF M,Y(/B^M+=+6Z0W>+^_GUP@%+->V&.F*P= 54;, TI7. 4EG]'GE/R=9;8_\I M3J+D\94V>:&ULI5>C I5J@Y<4&.G1X!6Y+:8C>KIJ#4?79"-Q*FSYL^ !_J- MH3X#3,O%IH;2$#2(V30F@QE;NQ@5&YD.?[V>?UA]G*/UXN+#S>IZ]?X7=+'Z M^'%Q=[&LWF&B"V*!%W<.6%FP_7?$ ]3 V)S/$@'V(S;^\D6K[W/8]PCB4'! MWR/)T&R[CW0T(L/=C%IJ;)[B15+?SH$RI,%%D@0&W$62%#$Q#SII,TVQNB&F M<('6\[\Y=974SW(]5TF]_&9/@*B9"7.>%!L'%PDK3(IC6I9TN([7 PZM]75) MT=7)M9C/RD,<0'#9,!CQ@)*I,&$ QWA?VYQH0H4R,-K(Z[&[RU9H..KD@+9D M85&>47>Q8M6N%S=.E;HV8V^IZ3+B;7L"?1=FO].%?2+$8O5\\@'-&^3 H(U5 M'ZH=3R=]LFTIKQ#LLC52VD0EZZ.R@S:M36,'Z-(&V1@%6'"610E1*86RI="YE/Y_>+__Q$ M\R(6--G9'57>RV7R*CD]+&:_.OPESOPTW!5M=#3[6:E4XU;_ +2:-R&)L'Q\ M P@[O5MO7F72#7=,2C0)D&Q0"?(OSEE!8TG0JB"O*P;6F]P=+>F5_Z^V$56$ M!MRXKA]988NZ>NJ,2_(K^K7XKVMQN.'(-KNLP4CN !Y3,#V5QESW3*<*FRK> M8_7RJ#WA(SN0I+>8_"^MLAYY6<8Z2S+3775-;MAS5=.H#1?*2!H0X)B+C^;199'FZ]'&>Z=O-H-K2E;"%SS'YD #49 MU1"G1&Y4S-PSA-VJJ+:*4M!Y3$[9S#(ZFJ%ZKE,".R;N';AR MC<7-:1G9=\>D:O&SU+CJ,+,]>?WHI;_CG"Z@KF A%E*9AI- @C:H4B1;W=RK MP8VB'DX)Y+2HNF<[^WE4R6#V,BA K4'#&T/A?/ :@_V^6C74*9D:"2G"4LZ8 MKCXF4ZLM".U0WJ8);83[>DOHG1/S27W='8V2#CP**L.%-EX:!&C?B_&I1-+H M9.9I5=.=$K^)"7"(N7L63I?)E>R=)H=;M'[;G1>F="6K]#+,=DGF1:O-=1(_ M7H?/.&#-554B/9U*SP0VF-4T(T3+^%1@4)*B$A"-4E)09PP6XL"<$OH)2=)" M'/U_WG;W+^A]D@0O812Y<\ <(@QR"VXN"19[#^&4'']SLJ"AH5T))&@++D6R MG0-:#79*6"= $%V%L1?3_69@QS>25N)]J$E0]_=$FX($CM3QTI=A<>TN;0&V9_*OB%?RDQ?M\6I3 MZ?^&^C<+/JL!A78$5%$_9G$Z#[&)E,4[K>;)^ H3TL ]ST&+UY6<"!U&MUCD M C_C>(_OL)\\QJ%B G[7::@?$-19707%=G8KFX,:DYR2TPGQ9!&W3S'VB#4* M4#' G5.W,L-*C]BJW I0>W#@:5H(!]J$2A 4UQ]T2NA&Q\[%*]L^/M0KZ@DM M5:(.O(9&3A4<8!DV170[ZJ\)>UD[)(+C(KW8[J+D%6-TGY,!9ZPC\T%7;W?, MGB8C]]5=T^#B ;&MFR0N2FPIF^W$X?&IL29Y5 64SH@DNZ9(PN#XPN?N-3,/&R\418Q0<9HAP&Z+I" MD=YZ:9V=IA>ZET, B=;W(=4^3G+'H9C@A#(:&RD7PNZZ**@HD+1 <\>!.A): M5Q(K<31=1:;LG4867AH3JF>W.+U_\I0N^&1'M3YPT"?^?G1;#GDQ Y$IB,UQ MZO0Q$;)$^*Z3+$.[$FGWH@**G*L4'%!C6WM2>8-?&A5QTB0F/_JX$90W#!9H MPX6*&A@0H.65XY>#HF\'0)R2X8D(0)\#Q;F8!N#6="BW2R,*AJSN0"[Z^%GH M[MA?):2U,L_1KVOVYLA5(VR$\;W_A(-]Q%SC73/M')>SG3/'ZNP\+-\<3F#+ M35EMRIJ2W6%KI?O/ZP7=VC]87Z#YLL[ M=/_+_7KQT:'2S ,$1%ZUV5PZ!H3/ZJ_>X<=]1.>]\D1WHH^N0^\AC-BS3\:4 M9A<&AI\ O38P)HM0_E<;5(,JGU@08*@!S54S/RY)CI3 A]7UY?+F/5,&7[%& M3!U:XJMFV_K%WRZ(=GB_F*&[Q4^+N_L%^KBX>T^4!IU\M[B8WR[75===AVXD M1J,@&4"FIR@X""\&./?"" QSF/^EE1_1' M^X >H/Q]FN+" XV)ABS_R2?Z*6;ARIL#\\> 0?'Z/L"6,ZU,O12[*/ I304@\O84:&8 *=:+R4?(O,\G8[ M3# F&-'Y]&[%BU__F-%ETZ2.C&P'._>P57-8!(+_Y*6/!(#WZ(5QEE>HX<_T M0@*S$%#*4Y((";P,O> HHO\5T*!!,55".';U,TS?]U\ #5+V$&[N)>/1PTNJ M.6':^)'QT\]A_K2,@_ Y#/9>Q.)F[$[KUGMEQVR&A[X#/,I7X5WCD8@GMC<^@E[(5U#]F1F/Y1:WL.6G"M,*TQ[' B_H>9@CLI_-EX^#%GW^NB8K M%.#^.=2NW#KU,2!HDRE#49X#C?AH M]"L?[Y[5ZMT]M12$GJT[&6?R.HSQ,L?;3J^Q2T^,]CTH*S$BP=KU+48ZXM&/ M(/85=PS$V(PF-0\C7?4IU/@6_'4G+"7WVZV7AO_ &8MK>PW"$-KBHF$' M^]N&/N=_9L_YV3,#E!0#'XE\YSAPSF681J;5VD5/(="PVK"ITIO+G_LYT>?Y M:[\&E$0"15S=8$W%)L)71X76:/3K7>(I324%U$^JBZ$FHMD#S4 MJ4G409^F"D=> =,9IW4\!:1X(3%0^UA\V$X[T*TV/W,V7J5WX>-3+KP$E/8W M$4."=B"E2+9>L-/!E*6+X?1.G4T O7(SI+R.D]&[@18=AOU#%@:AE[[>>TR< MJ."(+K4Z!5X( ,R\2U!JJ5JOL-A,J0+>^^B15DE%]FR,11ZKOW_C;N-PYO0%]BG&9/X8X^ M %OA'9@%">P3?@@WA&A.F[5"_!L#>5Z L*Z4O4@.7"@PL+9&E&-4N5 MX'#,R5Q&%*--Q@("H3&JOF(7_!'"6%>=/7"A#;L& 63LWNB=5TR'C]+;1-LY M(Z_+V)KW?4I:;S9GI8P04F8G!"&OPQVV-,PDAA-Q\-$7""TQ]6> MMC3Z&,;A=K^]H^8D*M,_KY)TM<.I1XM)76-/VZD9]V/P(8EAI)*)#X>,"M"( MPZX3F6E9T H\XO!=T#-0Y$HJ6D1T,KC',8E4*<8NAHN4/:WST?.?PABGK\W: M5N_3)-.^A9! @O8\I$@> MCAP09* Y<'NZ=Q1VA/T\3>+0[TWFDGJ@\)&LII(C;& &;3&*# ! MF! %_4C "%@X>[3.*0VG*SC*OS,^JD:V40Q(&B3*$.Q MU:6R',OXK1SMGD'4P6FUV80^1IL#U#;%).<,8B]#JK79[.%&>P+&7-^G) J6 MVUV://,7\D()Z_+K)1"@3J52I([YKQJ,FJ-A9&I$9,+&:'!CI,YMTH-=+ZM! MQ(C$=8E-'CHHPX4V6QH$,*G>[5["E>Z.:X9$E;;;@5KTO(R1SG,)%5!0ED(- M32T&+JKR./:P0F,_I2I8?3,=X%6Z(K/7%BH@H36P&MI&O.OJ*PR-G1[84^!X MF^UQ,S\/52O1>XO1/1E*NXI0$1P!&S[ 5.\R]-UO51SZ%P^F^Z4<)=7V,G:" M#0*954.30(+6YE(DU>) 4&(S$5J;/K3 S5$_8QI'@[1%37 [\L%+@Q>/@;Y/ M-CG]4- +![2]EAS!U@T0'XWH<$3&HV("H,,P,6:.-0U2X,?^SD#]S#A 8MYC M@FWHK;'_],E[O@^WM/40[927))'&X4 !#,@I00F]8^8J)B$Z"Y%IJ)Z'Z$1G M3@XC8#?_R1YV^J>)21!TY(2A+GGBHX:RV%D,T(5QF./K\!D'2[+5\6/X$&'^ ML./\]:/W]R1E)29,SB$ZH*'/)GID: 6_V.PS-AW5\\N75 ^OB(% O%Z)HP<9 M TY0"Y%ILX$3W%^OC%;YTCO^Z(*%.@SIHZ_'^;,#OJ> W#LL&;* ].ADMO\6 M*V?MLSS9XO0ZS'+#ZY@N$-!*O!NM5N)W,0JQ8>[>4$@V2:TTE'"'[#':'>W( MH9-P5$^ THG-)1^S#ON;:^E!+1I+5=,Q@2WS@IFR:4Z%5C*': @XQ-4DG(X] M4-(E[0VP^;CR,WT"JI=,#@96B4>H]+BF>+YOX,Y+D.7#J[1.]E([6%O!P\YD/A[K=MQ4 &2 MK'.^D FW[*\&8?78<;[6="*B"A-;H:VIKY MZ7PNHI,=L@!FJ"Z*MD\!VG.LH@ZLP(V#!O<.R[EOL:X]"9U'4?+B$1I=)>EE MLG_(R4+FOI_LXSR[PSX.G^DCK*)*IJI-T0,*95YT43]FXFH^*\140D E"%3# MJ(K*.E&*:2C>GV(_B6AE!!:J3JL9[CRV-6)JJ6TUX>@AY6,]0LXV?*VL'A$, MT(P>,6)=W7&R+F%RHFRB)C(5&K6T\ JIKUVUCZ9//9@():H',[9OK%LA&^!8 MCE*/9/7G)\G%RN(S?-H*,5MFV1X'MVGHXUN(@"[ MZB"[8ZW')$M-"*\BA%<0(B:$4*A[#&CDQZ3$'29^3,;*T3[K$P4%>XSR!.W) MV#0G0_-76LAU'Q5=H5/L1>$_&%#'_(C!&JC?TQBJ?@;HUW7J!;CMY) 5A4G0 MYV H0 #)CNY#JM7<@([O.H$@/@6^(X4N1AT^^PP5AQ#J?DR!E'X:M 6L8'*@ ME:1*G/ZL(E(6 X>^GQ+'CAR'O#3$61'ZF,?!#2&+.%PHB[>J@(0.[:NAW<&B M=!8JISD4P!^&4"9 "#QVK\&>2K%[==ZTF!*&(WJ'7Q$BK9/F MWU6C EHPP9(,]1!O^ZSLSXC]'34 S! !@2B'H2_RY$MT,-"!F,) O-<);1_A MDR/XHT/!>A,NEN=HZK.P1;.Y3=*\.-+0;C /.>TC24WZ;8JWX7ZK;31[ 8*; M3 646_:E,8=W6'K(43D-?5%,_-*)Z,*8> ;%#*)T?"][0AMRVD/;),"1>Q96 ME9/5[*LB&SOQN.F6L-63EY7.>!@_SH._[[.<5>55M;3&\!U\[M1'$-UW3R4\ M5 -$#8@.F.(1B5$A2^1_$WXF%/&R+'?(0@^5!-/'7BIB %'WNJ.T1W;^VOC7 MP/K7BO"A[;H!063=N[K*Q!!5\/!Z6,;(^1K9>MRA62M;BS4&!( _>H0D61(] MXV7L:U3&Z)H'$NSM1J"CSU8Q:D;,D._.LXR^31!'"<4[,( =+M,DQO/GD+EG M'Y(H(+KX(DEW!L6&>D"!WISVHGG,/VP"*F>@8@JB!T&MPD@D:_D>#"PJ MX*(:,/-$:.U>F74IX*-?RR^XT4[< L$>"H)M:X*%A&#TM4P@-E?HB^(#K9@A MK-T:4Q[[K=N(PCC$F\29GX8['NHKU=U%LGT(8_9MGCAX08XV210&G6Y.I[]L M A?D<&)&@)9S5D.AR7F5B6P 0D6:[ $HZ#I^XV.?;'CB+)'T*?'43V6QA2K1 M@.BAW'^_AN](\;\! B\^Z)I+NWWWO;&L.^PGCW'X#QPL \)+X2;TJH!G42 X M(,KXFOPZC(CWAS/R-\)V@?#UH&Z@T6M:@2MZODVU,%I:MXRV8N- MK!,OM0,PDZX%.I S,:$MJ=EB!=5%])WX=3/ I3,0K3L2K,']2@@Y5PK;61#R M$]6B7O94F(1G+Q)ERMBRG1VK>4L>:R>Q;>E0FKA6NJ?%U]^H@ZI$9D8/>D#W MXM^="-*"4:+B'9[;2/.LK]?S^S?MI(O5GG7O7*CS!L1RQUQ?D:&M\VS!RAI M8L33$U;%'"A;@WFW-6 /*NBWG7E+ 431^+MFYI4:8P6'S> MX3BC/4U7^1-.]6J'P"[R39UB-+8&*$!4K H5RV(3V<*FJG_BR,%GP,Z4),-\ MO'MOAT&UB_U3@:9J.4TMOXR?R?@D57X(/:DCA-W5QXU(T_ &:*-%?Q%KS/3N):/OPW_OC&'%(E MZI9DZ(C#CD>.'SDY8OQ(PXPG1Y WZ;2+%9OMU)BV5G/>5+Q/DN EC*).M&ZP MK33NWF6K)055U3 MGB(4]9;S9D!'_4]MSVVI^ZF=@@G4NTLZ'89\O%KHKBQ.MJ,=/)SH7V8)]?$W MF4)U$=.I-[F(])#5O]^' 6U>X!@!WN1AKG M"1W:B=,FADI]IQEJ=)]*-HA#0Q6XRE=SRBL93(I#I#->P*/*?WUY"NF]5?T1 MYVR7F6#HEL12EPK0$^%]CG>-5=.G%_EKN=)E7"P57WEA2EL\X7*58Z%NM$OX,T2^PQGJ(ZB)7+" *?L'ZQA!O>R.G61XJE%#!/: M55%$7$V7'$! #1!.N22&*!>UPT+6P)7U=O::6C/GW60.*)"+*0#NE^APO.Z! MN8_=7>A:\2G#FWUT'6ZT*],KP83V(101U^I$,4-\+J*3'3+_AK@>)[YE:,_1 MBSK0 [?G.IRL9*\UV'BL4NGR&NGM.GF"N3!%*H6(]%1!G[;ZN6ZQ25,LE&JY M Y53E+.8I&2BE+].\^KTX/G21R_]'>=TYCWV]ZDP]Q+D]5?GXJ#-INVM 'JF M6:\&U*UDQ-*7 G"D33PCYAE:A9 M5^KL<83 4NK./U:-P+BVJEV4WWLNS%M ]Q)EJK847$E MTPC'LNN95K4C@,PM,.(=WEV]V%$_!H^4'!>U-U @2^9=62J1)7&M3C/*J7N!;R// MQ_18HW;%V#,;*C%'B$P[T9T-1-5(=Z[EU#9&FE4BW94)6G?/CQH^TM_5 =/% M9_^)T![?X6=J;'G?2#*%")&W"W,O"O_!.3<2I,I,"'1-F&XEE[@AGQ4%">D"U] MQ@3?-!,I;_ 8D8F,*X5X# 0<1+/=TIH:MX7F58W1".=#16DD"/5H(S:J0*1#T-&#T*Y_!19@F%:2#GW9]A!&@Z0*XZ/H882G25RRZ/AG3K.CWJ MH@VBURYQYJ?ACBYCM>E19CV*7@C* 6=(@F:/FFK,I+^=4C4-="1T<)3Y%$$- MQT5_HH]C55V+'G8=$/5M%KU9?/9QEK$/9A]PU%EA2AB$EP("O2GK05%2+&FU M07P"%[ ,T2E.6,&!B!'E@#EB&4?L:0K$>H.TMC"#"<2:B8KR]9*"P(VD%U;[ M/,N]F-]?47>0?4CI"D@!#,B]CQ)ZG?!G[DR3Y MZ'_6S0P>$_)II870#S3KU5%U5GX#\8\@\I73S+NQ3[VDFWJGEBUC++4#4F%, M1=9B8JSW2NU3=I6D]\DF?]&X<>F:"I82VXE&RTP6HUAIMG*< ]@&F M<8+YU1+P>L>W5P.!GZ9N 8E6,>XG]'Q0 G MS)WFTH/NI8.'L#N92"E"W<5! ]S63W&*'\.,5E -&OXPJYZJ=*B5 @ YSO:@ M=,PIS>$'9U>0JL2C8G.8L#,-.OIG5DV,UO0E?O5R?R_"C[]-=^30JB)5XN.J M@DB-+_'B5&:A\RR'!'J<[$-270F Y"E/@Y>5_#WS.+C)(V?4!XQC?I=&O/Q'6M0"LVLU-NN)_)YLE&,AI^A6BUG"\ZD%W]\O-4-=85@ZB)";T1Y9@T MGN5X3C#ZF=E,\BNE(Q4(H)2&<@:4E77YI4]LBV N7'R'HL$#6RK$FFLY@_F M\]PYF8^%\>&1_:%D ;_! EX/41PYR _2!5K%T)05@47-9A 3,/P$J#=D3)9Q ME)U;$8;1B-&O]IR+0(R&>U=HHD_CT3%=JM(QKVV8#NGWZ@8I$(OA"O\)!WN: MD]S1/#,[?Q5WJ6.O)U6WT*_L:^X4PYJ&!>6AE2GXS^+5O71-YZ]KLH#YYU"[I8TR M7/ +?W4"M"[4CP2$#D6_TL'N=4+7W6>UBW>]37:%J^FR+I.M%RJ_#%.&!V4^ M-!#NX^*VFI\5G,U!N*/M=7=9JLTTO]D,O6L99GC(WWD0AB\! ZU\Q M>AU],_E(5 ]U5=WV;)IJ\TC)CMECP+*Y;$9.&/F7 J\I"YIZ6G8!^I)I^ =P8$&.F;^7V4DR54]S'BVLG"$(,8 M"FB84(;<,;O68QLE#R?KV6H>\3+$J;I>="PXUD8 P\ZHOU+1OKR#U5#VM)6A9+^6I(!5V:2S9_ M\=*@ IT9V ()&%!C($6O%8YDF:1L="T(F8OVP MCZ'EU6A!"H8)'RF;AEY> MM'=,N<,1;;ERZZ7Y:Z,$2G;^VOR+Z.CI <2 M7^50H+V7,(PK/B7+H@T=$*##.IU(]3 @Y,E5D[PZ<1SA[@QR)5("\S'TY\%S MF"7IZWE"=##7O!*?HEW[6P$.3.%])03;YK>8AM& O?W1N$[JF@ATZ.M$X9BLV O$AKMT62#9"[GH+ M=V$J=N$?4HOAM\9;-R#M!;KXK?J9R\UU#;OAO?UNR_U!U^+.7TN?SV>(S3OTP$S_F[M(EBM"@ M[*LRLL<,7\] Y13"[\4DD,?AHZ)78<+?CI.3^DLQTQDKI<>G4GNEQ:06WR+0 M>XFB5 57#T6_3%[/81=UURGKS"E7 7V:D )S*=[:=,/$/H.1P7ECHRH8DZC[TC1$[*:Z,1Y>@B6]U7]I RG MM//(CG :3FF%)2Z7O@A5\,LL93Y6NMM296+;EL;*B+^V.MM4N MEZ[J"9B AO(,S,C0+^8&'?SIZ&#B:8Q-"7/TP5R3 6I!ZJJ8ZX2AB80<].4^#>/'6V*%DJ!^ M%&Y0I4(5)GR*H1+BDM(+!PSK0*3A5# ;F$)IA!P_C!:Z)6!S:34^,KE9/(+C M[=@M@*:0*N9:*DOH /52]K:N\_ZOPK0_I"^="Y)$)$9$8-M6&]1XTL$&PV<* M:6/!+'2%Q682+/2S@L9 PY$?]R*5C@,C>5;YI0TO<[M-L[\7Y.BF# ML:M-&9[5\@WTH8-Z"2;$:(?9*F>?VZ#BF%."0>NDOK,@:N-G08P?RI\8F08' M'G]ACGE 47ODW'($9JJ$W,:#W>&H\F?I41 M=\QPJXA=OXU6D#G+61KMB :/8QQY$^R1Z?LTR913"PVA@^9RF!"C.V96G% ' MW,,91RGTYY68:@1PM<@JGG>M\@;GJ\U5DFYPF.\U[GU&^QYTHLH(!--1H@RN M6(<2Z%3>&O =" I-22I%%3OC_0B=\:K&%C>EA)F19,UR$[)S+V,-T6AY<5Y_ MG/J.CZS>Q_EK/:1H1LP+@M#_^8F@1)"\H^]8U!VW$3\)V@9M-+)UBMS9 YV+ MFO!1XP.TGG=S7/&14DOQTCO%AQ#_D@N.WZ1T$T6TGPLR!.*V5["MWL85P/Y> M<:-*GSUE-8\8Q_!?3 ]P57RM+2D=D X MO"@>&S]>X>ZC5RN,?S@#Y.KI>-&"VL(T"08#",* ]6ZF6*_^15/?@DMOC"B; MS<':';EJZN1J\353%TL/D*E;LD%/7O%XL';:&BV9M2Z:%,"!7C9.A"98%$&/@:4! BWNA6@_R%3$^>M%Y&69L)>@ M-"(L 05]RI>C*>OZQR\I'EX1FP':N\^4^%J1]MY-'/("BSW[70A??^F48%4# M!5.%517-%M_Q9]$+="%^0>I4R5(KB#IRMM-C7DD54QW.M=ROBI?WIOU]3)JE M=8& 5OS=:+7RVNI13O>CE&R2DG87[Q (HQET-SN8"-JB[ @%&4LY4S"U=P_Z M6X1U;(#%#J6?R1$W?L07$2:'^4"OWJH<"+2B$J'6OHCAXU QT*URJ\;8]+=U M E>^4N93Z_PKX3R+U[WTQEEFX[LTQN$D*,5[O/36G2Q+SX"VX/WT4]&V711W M*($IDR8TL'7'P2W9G1MO*^D;+3W33K$&:#T_$6$%_:FY0#C;(V9*+E,+=TS' M8C9;(1UD0*I%4>23X3IS=:/2^] X*DGL&B" \NAT49X1YS,$.-V:B>7KP#="*1Q1C7 M>_)%Q"NM,[W#;S//S]X5Z691 0P' G0!$UKT.+HGI46+G4=S(CN_9& 134## M9KSJDJ'/9^N64>@P/I74,0;=12.4+,D70N;>E4 MC17TBZ;% PR_L"C#>F7>\462J=>R58(%'3?H053PCJP1W*W2[MD4)[P>4]Q: MKV(Z'_N APQ4>%,I9*# F&,]JKO%J? =75O#=,Z$LQY&1$[V'TS>Z MNAAP[FNAFCL,Q1BHFGGC$-M1,@Y(H9E8F'Q&1*9,.>>;S$#_DRSO*4 M[60C([N.0K(%:G>I4P<,;3AU2'#,J'0NJB?/FMG\LT97JXFZTPZQJ4/0/FB3 MV8C/[[JP!#>SVCRN9'-U&1SB0=MBNXN25XS)(>LY+%SP=JH/KW?![AONL)\\ MQN$_<,#+BS$/0O@4KK/JT"0?!ZO&-1$I9<_MRB^AXE/"XCHS5'^/3JR_6%0< MY)X\Z(,]>RRB$JZ?DCDM/@$89>VM%!E5RS[VYZ'M__CDG*#JWL$T^D&W<[$F M8E&U)P:3\*=#>>>B?-PK+TS9;>./@(\Z?DB")DL=7U:0SFTLY MN4*;6F2>0!70[_,[==18 ?+B #76,&5BG<7JG,.(O=]NO?25^D9>@U)[2E3: M="G+PRVMND&K^6TH55F=X3IBGQ03G*MT;D]#3%/Q4UL]G*CVI;4":1;[9?@< M!C@.[@BWZ;I;TR\(V@&S07)K>GB&RA6@<@F(KL&IV \$Q2NR!"597D,C@J6\"?=62&8(M5HO D:QND/MBB3/ MUCRJ5\1-5H7=A]OM5BO&2''%H\5!P'[5S06_*1Q60O/7"EPP[ MVY!Q*"P&TGKS+M72?\M4<<:_'IFIB KA1--ONQ(7MD77"ODHW+ H;Q'?=><$ 4:)LH>Q6\>' M2;58_ZEA2A5V H>%%5_]:I]GN1<'M#E7$D5724K_:.V$(%_%R1X+^H@[@4U8 ME4:@\5'T*_TL*KYK^Z;0"^>S=#1$B^GX@6BS@X,4K\X-818 HE-DB2-^HPDQBCG3$J.H<<46\Y[63(S]5O*U2T1I^MR=9ST1*)J&D_'ZVA<&?V, MP\E-\'TK^V<,3WE^^8L($"6F70YIWH&5R>W*P;M M+::J:9*^AT*':=UN7.Z_*0*^R<0X%6UK*UU.0=6>CD5K9#KH6C1+Z1_@ELU2 MH@F@A3M(PW/1PKFY!;V*^I\VC!.9>4:C;9]B@FOL2>L=7G\,.OJ/KSA,R555"H*FU&N2TC+LZYX_"8V_&I#:L(U74-3/F M]&:H'D'<3E0%T2_CG#ZF4"X.:?:AR3F%1?Z#3(3AMFB#3&, M_&D(\CA?)\T4+[(+?[R-?XD_QI?K^ /YS_T?Z92ME\_85/S9V^[H3?D?;]_] M\L/'=]]=_K'9!9XV:2/_3%*ZF@WY+JO@&V/T2K:60 B?,=J2)3V1;:8^9OX4 MDJ$X1H'WFL&TBG=+6:L<@Z%-R0F42>^]9A2A.'W]] %+.[G"ZH.V 2[IQQDC M[NYF2,RWM7P5B$+NCA+Q]$K #]?0T]2&'ZR>3](Z+@DJ89R%/BN+WVD$>^\* MIEF)$S=[4Q'9FHFK/LW[C;B9QVJ+RD?$.,5,53=)Y6CNY*0J4OW"ZH8<.-EBI;LUT><#N\V.ZBY!7CS(N#RS#%/IGX$>OT M3N@# WK3*D6OE7-?#D;S.$#E+O4S8_\54"\GVK,$ M_?+4I58 Q*=+$_5REAN\I$!!%;T+S"DTVSF,'TW\T^94:*_T$(UCABG^ZJK_ MV;$'2EYG>P.L\XV>)WDX"4J_'"]=R"VNN7V=-)]ZD#TK'W)@*T3469P( 2Y?&1+D58AI1K3P!D;&R2L"_A8:=$EGQN,GO< M!.Z^13XDA;$@4RBG:97E!*B$6HK@"5CF#I8?R3:W^1U-L9 M"QCU#57])<=LN1Z11L\80K]2\(C!=]Y.&C#4-._=CKGI=)+^>+4!7F"]N.?6 M#L1-L@8G;/3XA)TRQ8]_LFP>7:6 V.Z8Z0!5^;"RIZ1[W0*FIT#- V5CS>?. MNB*#::':#GE]@K:'WW6"1=_%/)- MH,GJ;R#Z$==\^$G(UL YZ,#9#?]L/'F;MK1VI[ -R)>DCQI7FR+RVN<,=,>^^FZ7C<6_G$C+[$\WKF(V!*>O0PILQC M$/+Q $&Z\L+TF;[6\H*_[[.<$CS99+1)+_?15,VQ&C#0)&0%5%O=>'NF.& ( MAZ"&V!Q43Z+2D34Z-#M4SL@41?XV=%ZC2!0L;T+-_6?'"ONHRF-_!K:B,)Y M**0Y_"+)\NGKX+2_>'(!CRZB37 R.)A&OW/* 0T5FAT@C#_3GV'.!A,S_*2A M"Y%\6:ZOR=92!J7:94*/N](K^4!3KN/DJF6J$WC$HIA%[D 5;"QK8S9K2"_+ MFM&N>'"6J=OP\="^"DYG^S3%<8!36JXQ#I!?UGYVR ^T2R@R"C4O%6D522]' M?K)]H)DIM&IE&'M%F)\6F(RK^'[&PK"$NH2>%8VK"U &YH50NB8R"O8I/4_7 M=2KKTS7R,N21WV;[B)>M]'VV5SY[5>[5"R$S\#,5@FR'_7 3$K!A?%!ITWM, M<5%N@<#.BV)R><*^VW3^T8Z0@M:J9FO%O&"U8^ZR!:T_3;E+/94_NEV\PW[R M&(?_P,$-_IRS]#Q6W$TIE*8)$B36IHVVL@&J82 *I$C[9&"@(W8C(3)MV#*YH#- OGN6F-7=\*AKD)C M1Q\'/'EUJG@G;1PB])Q$,T).H&+%CD2Z-"ZW57(X% M;=6@36AE5U*^4_9B[,77]2K*'4Z"BDL?+[UE(/C?IRL391*]';IHL&AI)Z-( MXYA=7#) /Q*%2S.6I,PJE-?69%"-V(%*AX=8#'&IS)E+JS>/'RD@X%=#'(N/ MB*2@W^((1& 4B926&VYYC5WS0,[EW0A(F!FP%O#PQ2=3+E[_&*FV?O]@_8X< M>R2,+SZ5B+E^%!&4E@564"=V:P K:"E9[=L&5P/6]!T/B7Q*),8PE$IX4#1< MM9;BO4M8<^"G]F?'3%] M7?PKMGD=S#MJA.Q:5E97(WAS;;5HKD90Z%I2$K<[6G8-7.76B.H#PF;'6V-=M@%M1;F]*/$PBB@:8K)/0SZ,4/U-BHBU.'W$*;G1T MA4T:D524-(@7*+P43WFII&K.>N&X\]*DA:#L=4E97:D<[E2A8PV<2B,UZTQ^ M<.@923?[:3X=Z>0]76'*L/_58_+\=LU)1^J[XF0K1=PTAXK_];,=?54VJ_$+;JXCAX5& 4U19 MVO4 /M8K3"*" 7IZ$B,F\N0V1_(Q07$*$T-CA@TQER\' N)4J8TQT''L*JY' MD/H/LW(I@O!"KT/O(8S"/,39!<^!4SW$2F& -;R6(R;V0%$Y_G6&BO$.G%G- MT8GJ\4Z<68=C\@IN]'6D1]ZHO%]T1C3WRRS;XV"=W))]?O(R?)%LM_29=^+_ M/L@%D,%URBV0$T#!5> T#I!)0C$8?!:H.ZZ$'J85_B&'-\\0;L27Y_CFTV" M[WA.AM%6-QV/'M0==T@41%W?2>F7BYR(%"N2Q]J M:O6)ZT"\&W;?""M>6+HIEH_T/^WC#9@+H,2'4A] A0GMR14-0L0$]NN=]_+1 M(XYJZ$7:S1.[@4 'I$6H=<70V+@9(B-1-72&WJ=)YE;G/56<#A!QQG0I,9U2 M)%K&<0#"\W.2_KZ,;]/$QYFR-1+,AC)#0F0D\D*'TL=QQ>"I)$;__*R,3(G! M+DT>R=+RD5$:BBE\@$@Y%=A'&9/.'B?)(&YB3R$XHR- M/$9.(O3E4,3&.FTE^[ Z1,5=.]G)>GJ&LHOO (2(>KY%:= ,I\_J+4DE$, M M9A=20@%"U6A4#G?+Z*A@)C]R3&+\2-R[ !X3> LJ M%!TU*RJ2&WM*X#;%.R\,EG&V3[M:;/>IP]9\:.O9@= Q>Q5#4#7&*4.I@4 H M0@#<2HK82LD^"GAJP"U, ?&>R!@M*-QGWSKG@#S^:"]F MNK@-TD)"@KQ]M60HTLKWM"J:P;I7O^ ]#35SR;HG0QWH1:B(A+X8.%WBF,DY M7A>)HAGE!%%[^O3(RM)GZ :WB ]V8)<*A/2L+I,&BX\KM(K1"69#^2="9"0O M)UPK.R??$*E]D.[& +?V$OMA1DS];1+&^?UK1E_A:E0VD$P'.>I*T6FGI/+! MB(U&Q7!WRK8I;I#X$-2[.P,8YR,.HH_)0QCA#TE$'UYFR]@WJ%XC@P-Z%I(C M>,Q+=#3BPU$Y'I$)L-QD1'5E=[5_ZP;PUR(.\.?/%TFZ2_AA1$,KB>:"J"0Q M(L<\Q$>BQE#'=%'/GOR?ZJZEMVT<"/\5WG)Q@7:[W<=E 6>38 .X39 $"Q1[ M4F0Z$6)3J22G\;_?&4JR94ND.)(LCD]YB!QIR'E\Y) S9D-DGY 1$=",FFS$ M0H$-$II9$HQ4T=",85J1]AFBP:+#Z1DW$EZ<^ORIY/P\6.*6B4Y238J%&VGX MC(9;&+-(G&X_$46/25Z4@,LILFXLQ3E+13'O%/R>=]-,$<#6B'*+](VH3BM8 M,2?Y(>I9K)YFT9N<3W&[,GV(S^5%E+[&J9S?+*C!9G?"OJ/0E"&HB>RV+^ZO M8N\/NKO(^^-6[Z,4)0EHPR#OXL!\AR"X3U+@19]@J2\?I(WVQWNVDW-!@ZA%82NC2'7A/R;1EU9C?G$S86][[#D-@+)Y2ENS9 M77[+Z4Q$E9(H23'POT.PO^,V+;@-J]Q&!F[])=_O*O7V!/T=17[$%'OK-(M7 M,KF3B[6:XR=LT_+&.T@C_O(3?LLVU C,,\/U: MZ4>)E+<21$=E8!5<_><@[_+E4@<:J$-1+\F*"EU8R0)E42$]$3EQ45+'4Q,E M_8G8O8%%)/E(0S4-PP2OVD=%MPF>\) &QKWYX2$5RNJ:!]2F4S W%S(-D^BU MZ?!2F[4>YJ6^L$X M9TBM&S/1V4(FB9P_!._Y9L9->4AP%@,O09)L%G&B"T&ZPAX*27]IT"ALUT\Z MY+T%="]V "=B2T$@";%'@P5,Z7IN6%_2HZ,&%I&]LX,:VD]KN;IE.A[^<.4AJ[2ZL_LO@RJD7KKP# M#X)&.N82=U5'CU:GDJ41_$1GH'! A@TXJ+'G9%D:SEKW7QN0SXKW8"8#9@(S M,WP$"-0*O?OS)!77XX8 MHBJBICK"*YJ:9/0JK#D)_8U=S9%Y(R ML=)NH5T_V>W7[Z_N7KI\\79R*1K\";CNUA@F#X M,T[P7L1]=N+<)#G2,%'C-8WCM]:[Q81*'4TKT*U!J58)V MDV;CUNIB8O5E-1GIX<#T$9 R\4&XN9-A#&9Y<[/ $Y1J'JAL)I^")24) 9FN M5P=(&X!:V21];&K7793]T6MN*0A-@D\&@P$8W_()^C7?\KG4?"Z.P6=WO]N/ MT0?PG\&V D !B,N\_3K=/WK8(CD_^N-\#,(XQ6KJ*ESKL]:QPF3]CQ(:2-WA M,4\7)M)G*;/\/!K0R )8P<'J(8L%CM'R#;.GP1LQ76B>[1]4/Y,**.)9YJ?B M=BN\9KG6;8+D,;5.YB@=J]/MS\>MOR*90@] M]K#MZ#VT4&'!O!B^/%IN_>[Q *V> &HR"Y;8H?2)&W M/>]K-92A"ZO8+;K[3@L+7M03',9#,UKOFR>FWGEMB%, M$?HN.\($B>^S?,!WZ=/"R\W? 'G:/%ES)R^9QAL^O5X4%86J:".P$8.R>0[? M77YQ#D(K]:JTEC I4F<2'7->=(/N>;;<3L)R&F>UF M0YNG=<2X3!CBCEYZ)T,9O:%!=ZN7T]K?6\S&S%!#WDG=5.S:\BF4WF='J?=F)^#:$)M8.I4VW$T5#G6?$*&Q>0B%4?HHF MGNO>T>6%8JYM$N<16\QLU:B<,-=LU&I43@AN9JE&U;30FGFN2D4NQ/E1G^R_3DM"!VO;?74'43,X8Z#S<+L6W%PLY2&8@7(CP: ]UCR2X4MC]8,S 7!V-(WJ@M"M3"_&Z92K53,6*2]#43:O, M(50GE?+G9.!]IF 6Q0269+BYFAU[K=X&V_J,8749[CY.9W_*O$J@.735A/K, M!'PM'FPL.@ M@$7JO"D0.21@[,_$6-O" 75IXQ@,:)LABJ4^F)Z<1?CGRU_P._QX#%()#_X' M4$L#!!0 ( $""9$@HL(]G65@ -7!!@ 5 9')N92TR,#$U,3(S,5]P M&UL[;U;<^.VUB9\/U7??^@O2/7^X^OO'JX!DLVSUSX\?7U]??WI[2L*?XF3Q?W;V/>R M7%#*?GT0EF#_^G%;[$?VJQ]'XQ\GHY_>TN ')H,D#O$]GG_(/__/['V%__5# M2I:KD'4[_]US@N?_^B%((E9_]&DT+FK_]ZURIE%P%64D>[^)YG&RS/O\PP?6 M[N_W-WN=7WI^$J=Q^()_\N/E1U;DH[25C\UZ>!%']&LD\#(W.2Z@XGG%&?"^TT-']]BSV^B&C_V6J2V?SV0HGN:=B M((N(SM2^1T>T[\=K.J2CQ1W]MD^P08#D'&>O&$=?RV[<1#Z= MC2Z3.,+3%Y*;XF]4L?3#%W&RT@=1K_F&F/;:90U.J3&FA/UK-K\EB^<,)X_/ M7C0ER<-[2BW!0"LUVK:)IB*E0P&RWSU@?YW0SN#TZLVGO5C0;[*]!B[T0*O< M8]];D*N,O.#KD&F+6J(%$6A\I.GL\DS7 ML)KS-:=NP][76;MBC/[TD MH=.T02_*&@V_?!.]T/4L3HR6F&JEYA:Q\DAP];;"46K2A\.*%N209FQMOXEV ML]!O. RNX^0>IQYKPD0^JL8:]G?V5^@]QTOO$?O/41S&B_>+>+G$B4_*J?&" M?A\G^KW6;[*QK.DW\:/W9F9SNTJ-=X?+):[ M5Y^V6^=44*W7>%_ZE.+_K&F#5VRT&^U #VIVLD-N:Z=L:\>L][5'[RFTCV'3 M:N?[8U,TM;_0Z[UR(RFTU9L6]E"F."5M6-I/F?;HH)Z]O95I1XZKVMUGF?:' M7]W>/L!$1OV5K$X]NK=8A/&+& M2FKTE<[7?V-X]3\!A;7M]X3%BB[&K3Y MZUY;1:6/_^M#%SV\PPF)@ZNH7E3'*O\R#YV-_[2LC"TN-$-5NSWR!9X].GE"X0?K9M*&0P\^:1 M=EWT$ M?3#*OGE+S.NPH"C:'*^J:ILF^WWU$G_;(OWQ2&?[X?R;$A]7>5#WC_XS"4MU MSY-X:2Z_;5]B)9(/<1+@Y%\_T#KKE'8RSH_6V[U&RRJXR+<3X0VU[[?_@]^E M.C@HB\;N*N$8RE8+HX[5\)AXS 7Y\+Y\BD.!^/?*H(F+8C^$L!7WN&-Q3VGW M P;A.O06 G'OE4%G+HK[$,)6W)..Q7VQ3AC*:Y+Z7OA?V$OH+O:2[@L$DA<5 M1Y]<5(($S58?9QWK8POFD38KT$&U"/KLHMP/$&QE_0E(UN7Q36+XW++H%Y>E M?PAEJX;/0&K8#<-K^IM4H8B#TN@?+JOB&,Q6&;^ *J,P$7UU5,JC7]U7R#Z< MK4K^ 7(.^!.'X?^)XM?H 7MI'.'@)DW7.!&H15H'C7YV43=*3%L%_0JBH#_B M<$UEF;Q?DQ GHO'"+8M&#A^7.5AV1S68(W.QK;O'JSAA]P3LX:]P I-502.7 M3]!"2*5ZNCY*%QW+[>2"[CD6<2+W9^R51",GS]4")*4.NCY?%_VY6S^%Q+\. M8X_KAN250R,G#]I<'*7TNSYN;X9FO%S&41ZFDP>*I;-UQAA3F -&/DU)*J*1 MDV=P/6"EP@3G\8^']P.'@K!S9R F1:EE-7,O?BIG.IX\XS-+M M;_*KA8H-;7Z-2BZ+V?R:1+0?A.Y6XR(P4G*_8%*]]A6#!53Y2PN=_N<%@2X; M#(5Y8/M"*,+;A@^K;?#F;2$18?_SSH>;VS,@%5Z$7KIEAYF^$=[V2UD'Z )# MK!J%"CG]=UN;54"7\=(CD42-QX6!;D*T],)7)1>#VSI\P"R@<[H?^?T5+Y^X MS@.-6D 7+G(5"4:F%(4MO;[@Y"G>!5% J/>\EGJYM8"ND"(7XFML]_5[6 MTB^W%M#M57W]BE"(K\W=T^]5+?UR:P%=AM77KPB%^*K>4+]9->P40KO7M;3+ MK05UGU9?O4(8XA@ ]\;OEUH:YM:"NJ"KKV$A#'%@@5,:WA[M;TF$;PHR5[5_ MJ2P,=;%7V[.TUW-K!QL8AT3^D#_5\%+O%X2Z_U/H@J^XXZX/PME0P-K<+&MK M\* \U$6B1#2;3XPPO7LCL8 MK?I0EY)J%0K\O[J@!F$"&U*M]![[F&*E2]$WG&V$)1O5DFIH!.N*,E6X"@NT M$]&.HK?,#N\4G$2QU6)H!.MS,E7D8=^'X4G<)\"@,],L>\;)GFPD^M2HC4:P MKB=3-6M"&H:?45?/!_!AG4W&,_!AYZWY$+/J<_&NQVV\PDGV?A=Z15 4W4RL MV.'A2Q*GLK.JO"(:PWJ:M+?.:AC#6%CI]F&]7(43: SKP](_=ED$W'P7(&%+Z,F4(M_3R:JA,:P;K/ET ML@%A;;D'7#(J&QD-SPJG-!K#.LBTM2GH^S#N#K_$#\'[<4(E'"T*/_(4,Z%QR]>:':Q9SKJ%%G>IH#.O^,M.P+J)A;-TJ MLM&;9]$8UK5EILR#CEMSAP"ND$IE;>'VP7.E?;_ NFLOK )..[?$>R)A3GM* M=VC'66$U-C6Z3: QK-/*Z"K0!-0P9M8*8OVK0G$E-(9U:!DI4&D#''"#V$UM M+U+NO'=VB\(.Z;Z?K&G7C[!K7"UIM((FL+XPA4[EUTV:^(9H&?4DM MD^!61Q-8WY8-6Q "L[8H ,9<7F[ZR=*61-*P@H.2: +KHJJE60Z&85Q'YH>* M;W&&MT:K'KZB*F@"ZZVJI5@9F&%<.1JMUKQ%"]:E54NK?!A#N(:L(--3(YK M.JSL[K49&GNK)YP:I2FOA6J5U$(36%>6!34KT UCO:WE19&(]<5]9."@+(;9F!="$C7>YE)]Q1GP*YL3>:!/5B;W16:ZX$WOCB;WQQ-[8 M(QV>V!M/[(T"]9[8&]O4[XF]L:JS$WOCB;UQ*- MV!M/[(TG]L83>V,?/!/?(WOCOF7>>]2' M- BGQ3[<(E_7=)T]QPGY>W<_HU3]845H7L@&*N=!@79@M*?K/..JJ9Z+2M!\ MD(UUO(,Q#&<'#Z,\&Z%F36@BR,::/L R#-]')3"OQM*M41N:-M)([9IXAN$6 M.4JQJ;5D2VI!4T?6534/AS7/2+]4K%RI!36@.22;J7:'81@.$<-TP3K5H(DD MFRGX $B+3A& ,+52-.EL/EOA)/],YPF&;R+:.5SV12,J35 #(!!M\^Q:YE3: M%@$./A/+3# 4*OT>A"OA(DZSV5S-"K!7#CBPS%AIAYT? J%#SN-[E\1SZ8N( M2BG@:#)CI>UW?0CT:5]P1%>3D''.!$L2$2:!C+S@#9>Z3(WRFL A9>:J5<(9 MQF%_LWN(%H6$;N7,XYS2P,%DQHKE0QC"2Y9O<13O@]MF0%!OS)1U@>//C-6L M V@8!_K?"12#/$ZS0$' MKVGIFF\F-=$.8E]]B1/RDB]J#-4LVOU;8A[B2L 1;@V,0(JI^49\/SL C*X+ MB3QZ;QNAG-/MC7Q;+J@!'.?60,MB0+830$"I^ 6G.=E-@?0FHD<_^ANICOE5 MH,/=&FE9#&D8._8M(O61[* D=(A;(ZT>(6F^8^_#H!7*I,Y>'3KFK8&"I9B& MP'S^#6=:)^R]6[MC)K #I<35N!YK":7Z@UFW^;ZG86\>98XS:@@]5:TO &V5;)_W![ MD:W.2M,7CX0L)OLQKMP9;TA-SKV4^+JSL[HEZ/BV9O.W'KZMB?S:=(9?Y80: M+T"[ZC\Q63Q3"YW2\> M\+TTQF^>Q!)50@ASV-*)#*%QGTJB9>@U"A\89 M6TQ]F#O'BL-7G%N^LVTHH+Y]*&I"!\X9&X(&GE+C+82[ P?A<'C#X/BB:C(" M:]0_,4:9,T9)I2D83$.EC"KPT]W$*H[8P-&EC>+5@%(R2''+ M]X5$2J0AP8(G@.*V0BL[?>5SZJ.RP$$^0HWP%(D.E(4MO0*3A)EDU:S?R11"NT*8<"^/NF2 M5K-_M$]'.M.$8>_Y"?28M$FK"1P28SXFA3"L1:^!Z]0E)-;U,%7+0T>I&+N7#CMO;:\,Y)?8P/D]2E?8)W." Z6+ M25@'.M)$K"2!4F5 W/8WT8DGP#Y.TSA13KE'9<'YF*1ZX>N2"V(0CRN;TA?W MA7O)G+ZX0K;4^*@*%:[2+,'GN">Q1_LZ$2F0UWU;0W!%-U0Q"Y1+,J!A:,"% MQN$-ZTF(D98B>;VWYL<%5V2]]U/CGD06Z2CPJ.?#N-8NZ)$46ML50N/>$7R+ M5;;?[6$\+\X7A((=\W*=T'GD+A_Z.>'M-_R:_T6^E]&HC\:]H_A6+)$ZB ;A MP>6#+5:7!OH_: "->\?\;6P '$B#2)XD,?>I3[>(1=[CNG- M0DT[HD?J>DT M< AJ&)S"4KMO9@K';; D]*[; A\5=#XF43B%Q)X9#RF=@ HZY55(,IZ*:[2" MQKWC##]6K\;CGX_-VCMIZ*W!- K^])+$B[)4 M,#[V[\\JY576TJ!I-''-Z=80K+WGTRTL*U)L^2@QL1$K[:*) \X\:TC;?&K= MK?/(QSA(KZDXF1B\R,>S^1'RXA>8_E%$V].L031QR(]8'V)I-% >1\&44@^1 M,*]-XS;1Q $?I164I45 ^31KG%V*7]_C "_SOL[F15C//NHZYQF]EM'$ =^F M1:REC4"E/C.SD7SM;,5&#%I&$P?/"KI!=,0-(0F0W&:)SEQQ9S9%65H$E"M38!%%_A"?>&'!HIS2 M/EUCEDFH7/&N]$69H\7NXY#4;-I=#8$CZ(!V-),^NA2) _\$ZP-.VG8-CISRJUH 6UI M*5".Q883"N]DO =2DJ;"YC?0F0-.QE90EQ8$Y8"L<7W1L@75^@8Z<\ 5V0KJ MTH(<"O TPOGX&K<^!]%OH#-7/)NV49<6U-CO:95OS=8X,;>?6M] GUSQD-I& M7=H/3'!IZ_,/_4S[NZ#\*^B3*SY6^[AW[Q<=L*(:8Z6&%=7\"OKDBG/6/N[2 MBGKFKK4V7J[CM9ALU.9'T"=7G+S689=&!$-FVO945,.$ZGT$?7+ ;]P.[-*$ M8/A26Y^%R$O[6R+V$?1I:,YG;=BE"<$\Z&]]%C(WH7H?09^<Z6D+7T&?OCOO=(F[M*)A^J?K6%'-KZ#/WYV/NL1=6E&OO-3UGDA* M+E5K-X@^N^)[;@1QQY+FOAD4X\.Z,93-HL^N.)(M "T-HU=9IS0"6 \2!C0( M\SUH"7UVQ0-<#UNI\5ZY>07QJY)1+JZ!/KOB@)5C*#7E@C?U\1GO/SAE+Y(, M]W?<-M!GQWVA0E2E?OL8<2M]?EY/O<<-H,]#<%(>02H5VRL'9+W=@B2.J':# MZ+,KKL5&$$LSZ%F4:Y-MHW5S*)M%GUWQ%UH 6IH&5/BJG;=6T^#?ZS1C0DL? MXVD0D +#G4>"F^C"6Y',"_,I\LE+<<"2SN,HS15[CPN^5KRA'BBFTWOLQXLH M;R5?,B6/MMK^-/KL@.NQ2V&4)CL KM4O[-$KQU/+E]&71)Y(H6Z3Z!<'_)(V M0):FXSP/JXA))?_O>2W#J=$D^L4!IZ4-D#MJ?X<-I_[D3#<1%3Z7W#.P4G&_ MM_ U](L##M&6\9>6".,G;9]*[6Z=^,\>@SY-4UR'9)S;#/K% 6]J76"E4<"X M4CM8UYI;!;\=](L#+MK:R$J[@''<]B,AXR\.N&WEW2_5V-@_6V3RNXH"(%4V M2LCXBP,^6FGO2STV=L?R]/BQ*A?:Q[\.9<5^MRD+NA&)0Q)0802E2-+9G/FZA\0ZV,P;0STYR/&5 M(1ADM6#:RFX+N"+63(<*JN%ZNA+J?0^7M83%&Y[8'AS/F>,S\DF(][ ^QO;F MB#8^AV#/6#9MK"7Q6,O)#.J[_@V'P6/\E47XT"WJ _;9_RG0![ISW?SK_1Y[ M(?D;!U\\$BGFJ3K-(=AS6UOFP3?&F@)J/"_^6MA:A!=LMP=$H[AC$*6H9M'N MWQ*+$E="L*?!;NU&*H9A3$4WT0L59ISDM++X,G[EQ?*+"R/8,V6WYL"%;RW1 M/."&^!+3KOHDUQ[].<0;-_IT&2<9^3O_O72V4%='L)%"7<\;6@(91L[[G6BO MXT338H1U$&SL4+=F(I/"[J&'N]/*S7+ED:1P2]Q0948+\A3BPKU^32(ZAX9T M*>5EF3-L <&&^'2\"FG+9'?K[JX-\0,+5'[OHPIH!!NBTZV)B&6P-0F8%_&V MMJQ^@BFX2US\OR*D35R AOM&OQ$T@O7M=KW'-9'+UISF)C\ZO1J9T7!V-8-W'AFK5M0T^T$'X38[!;H]_1)J#3EH/C6 ]O"V9P0'" MYIZ1?AK 78+IUBNX>F-+*DYGV3/F,=&9-8!&L)[8EDQ"!+6YNZ2?MK&=">^\ M=S8-LL.^[R=KVL%-WB;364.G032"]<:VO*JHH _#?W*,_W*-V9.D>QPR"[_S M$F/CX;: 1K#.VI:L18BUN0NEGU/-Y:;O]XP;1OJV2ED7C6#=LFV9Q#%*:[X0 MT+E"_X;>2G03&L&Z8RT'O1B@MG>K$U,C[I6QL,UZ:BLD3M(8&O7DX:6-F#@% MSF'"%[$'.BT="=A)D$J&_V4E%T[Y4S:!Q+X-[FYN2#G!K6YU^K5V'5Z,FB]=A M733N96"NI=6+A[:Y:Z47Z]-@FORQGXR,@Q>?32&=>"V:QPB MQ,-PKNC+SLK1"(UA_;563<4,MKU8E-X=J*])Y$6^I0.UI#$T[LD#3AL':@7. M@6Q*N 1C\GSFVG71&-9W6U.QZDVK$*VM=VI]8.%KA0-]W$MWK9E%-!>!M6,P M8(Q;50!_>@FCZ]IRVN@>>@^KH3&L/[:U^8('= BO,NH- N,E1=4@FO32=6MS MG=$1@;5@ TB+VGD6[_&J)+QI8E+U6D237OIN:]I4?1D,^A3-D::5\Q":]-); M6\]XS& /X13-X-+1P/['*)I>O) -GH**ZS"40V(O)LV@24_(ZXQ.SJ8([:U0 M?3..*1TC2?).AX.*35JK/IKTA+3.@CEPH%E[.EBP9-'>)MF@K:$G!'=M6(-% MQRLT]]UZM0IS.7GA5DXWT3Q.EH7"-!C+]%I $Q?=K ;@8-\ "KQH^2;((WO$ MG!*=*NN@"7!J$@-]HC]X;3G6T>%@836!\DLT4R4,Q!*?SMSCRJ4QV-[CLRG]S#LT) M6W6N-77;0&<]29IA=IMI F\8KZ,KK-DCV>ZJ4@R= ;OWC+0DV% =X &=K$6; MICQ=:,9"M_:]C05]#"B@7(6D%GP &.]M6O@@M+U*:M^TLKNI>U@LY@_68MZ%X%%_I1L;;VKZQH M7]8*.@..1K2O?17/\N79U7_9QDZ ZWLQBUU0D7WXK;< [MTZ_-G>5 MG 0;-JR?''?327"5>H-Z.28$Y\XH6[[<:*"R=6CG "DE= GQYUU M2G2E+AL[YXYUV5&ZT(?UA_+W,$V:!13X5PF<01GKX428#8R9)Q6L;)JNNARIDD=0:KK!K M<"U$G>:D)"S)*.L-E3%)BYRC])_T9S^,4\9/HC-0ZS4(/$052A$,TMI0VPLR M[6B [HU!-OBFI0AF\UNR>*83Q^.S%TU)\O">LBW':71:0K$S*:UE4ZL!)T>? M-C3'%T/1>G>X%++?[0CHKMY\.OX6>/]$'P7WV"_XG[>YY)H>G_) +MVOJ1X> MU&K,:%S:0"$;> U: QJ%C03/.SW61C_4@U MW]OJ*!B%AY+26^MTJSJURAF #[[%&=9Y M^BBM"+!CY'?(;-.HW0;PB%(*7[!S-,'G^)IT<,_1G))M[W97L9OCE[:Q4.SN M'M+#*V?E2J%3%W(K)I2:/,A&"L9Q*[Y:KL+X'6_(Z/*^=^Y0V$T/.7UBF?QU MDQ[I(DZS-%_(GAB9_):Z2&,):=8PP!*CW>'S:H=U%IZ&+0,O1XT5*5BNFDO% M\>%?AETU73:V#:D6KL-R-I:L;9O*]>FH(.1BQ)$$;QGB]=EQHZLFI>W\[7_Q MZ??=R-=*O"VL!;!(<'JCLP+(J@%/[W+Y"N9N!1[GC^YW^]EH;1PPJNUIG#!X MQ6W,UP=-*Z=M47G@HX1 /+Q)7(+ >3LM8J'8QN@FVEV2_(;#("<73;T0-[;= MW3 1I?4HT'@R9LC Z-SQF,E7JM08X<,W'SQE%M MS -84TJ^JNY/")M/&YX0A+5 3@A'O=$[(8BK@9\09/(5GA"D>)P?)6PV(%GA MZHJ"BSB/6<411'"UI"M&X\BH'8"1I=4_G;%FUA#PZ#/5BF \&F,>P B-?-IB MXH'O\Z'T>'WM6B[^54@HE8.NJ(5I2*J QV5(A:K8(3(D#@_ M+'1>V9U>VS4-Y+S$J9^0U>:=6,TG=J9MN?BNK@;&05#";QX4'B!]+_YK\ !3 MT0""Y;-H\-12#0R:C];:/I7.T23(5:.O?EDU!,MZ44?I"CC#R'))XJ0@W[_' M?NBE:;[^YLHI'_-7YD&)\DV;0K"4%W4,H@9$:^2TH//![XRUZ2K-R-++I'D$ M]PLB6(J+.BH^ F"-819Z0M\_7U_0;I.,_63B;]C50K!TLS6G-Z0DV M7D3$[*Y&61>-W'/Q:8$JE>^VJZ^,"38Y^?&KH)%['CT9EE+#;KOQ1._X32YD MM5I (_=\>0;02G. \N<)=G;?XFB/M"2G9JCBTMS?F;:#1NZX\FH#+)4.Y=\3 M)A');?7.2W;>2*6&I970V!V_G1Z:4G=NN^ZNO"2B4DGO<))3K^C/VXJ::.R> MHTX#TBZ@QFFU?\.O%0$E<41_]''E!*)O!Z9-H;%[?KDZ&$M+:<$GUZN@YT=V M>74*>;9W:]+HOL3EH&8M4,X_4S//.0 SPJ"YE2V]R&%I&]:GC&%SD1^>_B39\TT4 ML(R<:R_D4+\R16HMQC8^-%#67>M"LC5GA$ Q)HV$PGW%RR>EDYE)IY&&U\ M"/@-K$W[41UO+(FK+0\FL*U6-5"5R=3/J/BS]T;V:=8X\-M<&)LT%E&++"T= MI[NQY/;N).F-I:A(QKLQFV]Z,DONV:V>RILEKM3OQ#E:_7=[8\J([4A O.2= MD>O389UGM).[>X1U@!TU& M5&\"5>M@B8K%I=X]3"[VUW5ZA$\-V@6 M^*STXE 19)45^)7$22HNQD#RD!L&/TNKN9/#4!^1\ &,E^1K40N%^"K;C MZU#:LUK!Q U;!%]&:B1NJP_5^<$GR9$%,QB_E\QN.YN[7C,BI*\D(LOU\IZI M-]S>M%W'R6R%&1=RM+C%GLYR:+7]8>2!LR4*YP>[WFO62YQY)#P]9S5&\-6C M]DR/]^_5AYM?J!9D#EAQ)0>?KTK!@+K'!,<.YN-;LP99AT/L9TD<$9^G+UEQ MAU+E*&!8,'ZT[/9Y1N6F9"LFH/)=A1PK.78R6)ZRN[Y69>=\M<4VNG(6]N+)68NTG[" M+F_"P>.P 32WXPF%\(KGH8HX88W:O7G:K5:DX6R[AW&@5L 0*D.)-6H#'\8U M=6AH 'OPW#: V9RNL[A$I@PMYI8'/H]KZHFO9!&@ 40&\KQ*2@6+*P$?Q1MI M68H*UH,J<'/_YB7!JY=W^"&>9^Q'H>[D%8#/O[7TID0T!*\HAZ-0L>T2U ^ MRC;?:HEQ.1[ZSP/&?DRP>G>EK N<*%:B-'TM'P*"VDT)9F$NLZU\'I94 <[T MJB5_SCPL1]0SC7W!M%GB/6+_^7?OY8'D;E3:H<$3N1:5X%ZR 9Q MD4SH-@_G>2=OJ'ZB!:'K3A$6>/[^U?MWG.2/0Q3+K$$KT*E=FZ^]AF"M;;Q@ M%F0)VAU6]DA5N3P;M@2=V=54S<;&(@+MMG_D8IUF\1(GMR3-U(=G3FGH?*YU M-,;7O0"V5@TZ/>J@!OIZ.NNRXIHKX>K6FJN6@LYMJ:NJPRXZ[E(13 M_ZT&=XBZ,G3*TA;O;?A0N,86#DM Y41LIFX,%]N90Q*7@A3@]MD*1JUI0'#I+:2U5 MJ0!9.Z6"#K^T$WICHU[NXQ,%QZ)4A:"?<1$(!J^M1M$XYY&6BD'>"/(S=\PM))Q_C'Q M GP\:5&H) Y$NI=60N.>QE@I]:N$9>UQ N@T3A$F=-ZBRY7'6-(VNT0JJ6]Q MY*LWV>K::-S3:"VMK;4>OJTI_.+RN6MCZG?>.[/S3;Z[.R_)=L#EEJ"LCL:P M[K6FIJ %<&L+_W#8%BK@WJO,QFM\387Z&%?_+KNI,&@&C6&]=(ULPQ3HUD9^ M==A&=)YQ2L_DZNIH[+#'3A?@SAGCL#&4>:SB3?@6+SQ=YK[5J8\F#COIM!&6 M]N!RU%K5R!FAW5/&N++8^GF7X"59+V4["55=-''8?Z>%KK2!QBX]V+-%\.]U MFE.G7<>)YKH@K(,F#KH"M5"5VG;;(2B)R[I;)_ZSE^+=^^6=0&J&K4J;1!.' MW8E-0)>FY#(3R\URY9&$86*4VOL2*(03,N%([$:S!31QT/E8 V-I%8W=C4#$ MXU]QLL#).,8Z^E@5N(I]*[3*)(SQ]*7;:O\5A0(?%19RL@"@DMT\:+N+E M$XGR3NDP:LBJ@7)J<)YHI.?OE7_IINV]^(3=J$ETIJ_D0T ]>S^XMU[*'PQRB@(S86C)FW-[QT?2 M,\V(=BYR)HFE9=6ZEI1'6#^"WM+I@RAXPJO M(E(ND\>%H0DP9(KAZY*+P>V=SP-FE_[3NVU7UE,NM!LD=MNCR+L*;&-&I!LU_HJ$P3QD#9HTI'J-D9 ML^(_[0N910O>A3V48"P6HE-G'9?MA@)9E0+21MO0[!5*??(.M99P#R/;?+Q< M;G)B5P/P9;ML?@TH/@N[*A5LRL60AVD$LW669E[$)&5B"95J4)08(.9P@'L8 M#P/W]TB:DX.X$A3)1A<&(4?=RX>%ESCU$[(JXJHV M!<7ET:8Q-)%%:XF>.HHLV),:$]>TW([-YER:R%-8P2FLX!16< HK.(45G,(* MON>P LM$TFZ&&<@1#6Z -G;'P@8G=.2-=3Y8@;-7N<=^O(C(WSBX":BDR9QX M9;3Q9J0$]!!R2W]-0L*>Q-*_K9>,$,,\3V8GWP<.HE!9D-SNVI;, .YW;8IJ M^^X_+[GC@M"9!MO\/'"0"+P)2P0S!.Y_JZ+RTN?-('_Q0L6[JW8_W+\L+UV; M+4\DO72VVD2]84-0<$=T\=G^9:V1&&!' FG-D>OJ?%E=6NX2O/)(<""G10/L#'=34@^G51%2P_'S]L_N;Z(66CQ,9KT\KWX,.U8*WVSU1 M6&,('(Q=!G@N?AG?F;5*>]'KH+*.;%@I(&N\B0.Q[,UR5?E#MUN*RA^@4SO! MVR]?)LWY'7\M3#;""[;I=LIHO\1Q\$K"D"NO;[@%1Z[JB]!9JSHU4QUA6..< M!(W;LSF.6[%+L0IZ]^BVXVES(P1[O)9QYH4.18-M@NQ.06&GH+!34)A] ]F^ M1F8>\^R=2FM%QVF4J;(>2^L-)D!,A=)MW1^ 4H:&<4FDSB%]6!8X#,Q0?[SN#R3 JWF4]5"8:,3X M!JAJ>V'6O0M DG/4Z :=IAU[T)OCN7/"7^0(W)[)970/9^_?_7^'2X6U:C?ZU ,:&%-K9!T-\(T!9<#0U,X:"!7M^W&]L" M!]PP>&\X8MI+4ARSA#%T,<44_NX^UVRUT&BPU[?A8FNI#];:R:*/60WA#>$XAG3^;F<1Q&VC4.U]BXS7F$-] WQH\9'A5@5I< MKVQGRIO2PW?MD20?*R.-):=)\RQIEH.F9 OZ0%\.,.HQ0H'E_\B3+!=0#*U) MV P:]?A5H)'52"%:B[[OQ59W:"^CQSU^NV=D@Y:%TCP OP]6>Y0#>BLXG'Y) MXM0H0?9!533N1R2CH>7HP!I&<+O8G_U[BN?K\);,98&M.M71N,>OS\0VH O- M7G Y8%YTJQFQQTZZ:*5X=IXXE[6LRO$NT[8R/_S826>L%JY2^VX[8K]A>CCS MXR6^E2_J>^70V$FWZ1&&4H(58_Y%QGOWO M_CK)CS-7;_XS%0N^QR^LVP5U.ZU"#T;>BF1>N)D+C>G$1?FQF,=1]Z.J!#NU M&CN]'.M@W#92C\B'_;V])SN1C)](QD\DXUQ /8M^/UI@#5)C5])']^[$="SW M?94IT R(GM=F ..)7=RE.7EH=S<]/LA!L=J>B,1EU)1?O>0O>OJC-7?'QJ[, M5]6/_KWLZ]J:-20TK+#1[YLUM\"P;''04Q0!(XVR,V; M\3=VP:Z/$[KMRL@+EIMA-Q^&?C0*3;$ODDGS"&"'B43YS(%QY!\-V=LX6CSB M9,FNB3N:2I7]@'X0"S^U:HFH>?3QX"R\6RK2'L> =4=%:I%E_/AL-J1[9V/B MTM/U\^GZ^73]?+I^/ET_GZZ?3]?/I^MG]P9E.VS20[E[5J%T_/+9#ITT,.NI M2D5\S8J@N#V:FQ$1P]YR"C7"5R"O^VXKSP87..S%G:$*!0@234G M4+86*-=G:W:IA>]"S\^W'QKS-:\"]$6*IJI$$[@(DMNZ_19G^$\OH9)0J_6H M+/2E0R.-CR2UH$DY!4H2#% YCB&H=EI+M=Q:T&R:-50KQ.'Z M03A'=UY+M]Q:T*R8-70KQ.'ZF3='=U%+M]Q:T#25-70KQ.'XKJE =U5+M]Q: MT&22-70KQ&&-M=;2I>QFFIE%6%-?&K6@B1>U]*6)PQK_:V]B)FZ;/@P&)D?L MZ&5PA2NQ+V.UW1C&3?"B*IRPTT[TFH1Q?&18, (:1/*5RG5L0?=>T,#KW3]7 M:T#Q. +I7GFY?2B;85K+;)VEF19N83*4:%!-DO^WF0$#0GGQ9O/S&QG^/ M: _W@JJGBP3G;M"BF#1.7K<1*'[)7EA+/7$-X9WS_BE!F) MQYHO!):KGH-1;\E2U$1C&)=F[RWH0$;6CG*P5]"5J_DU\U#0?U3&RTU4N:K7 MC!E2-8/&,'[57AF8J<"L.8WZ8FUW"?'QW6:-U[.LO2IH#./![:L5'0EG&(F$ M*@CWTB91F6'&8$T1&\]0&@VA"8R_N:_6I2FR@:0!VEO\[[QDEN1Q+T4F28TY M2Z\!- %\(]P7&],7E;4T0Y 9.W)50.GQ6/JHX] M\&NBR7?LFS:049L9CZ!Y:AA73^4:,IY/ V_%2-&N0[)X9FF#C).?M,;NE$HN MD76JG=AG .ZX!8H0+=LGGID3S\R)9^;$,],_GIDOF#9+O$?L/__NO3R0Y3HL MMAIQ',K#&M4U'66?T0(VH.P"ISPHAM&.@%0TIL&.!QOAV?%&N&DDH_$7G,I6 M8A_[($+*MLG3K^/D(9YGKPJG\7%I(/J;%M0I,V5HXF4V%VB03>60K#(N^5 M=$FNU1@4ATXWYE!;)-9"R2"M1;Z^UVL-BHZGG_:RDXFU.+!#@^GHRC1'\DQ% M2C]?,(@"W83F.ZV]CC Z-(V[4'G%?M^&%OV]B=B.,\V*@.A9PO[/W)$6[THU M/@1\DZI48_.[5#TAN'W_)L=X_OY(.Z"X>M5MPIV[6$W%"YPY^N(8LNDPF)H< M]>HF@"]R351:QRCV@+IM%,U([6$O?$V4Q%O=U@U!7K,*.8R@@(^9,- M807HY"O6%<6Y\Y6"[YEF+TF"?5I84Z^"XM"95[K0J@1ZWQYI%!F%7KTD*#N; M*ICCA36@,Z]TH5HY>L<]=_J?H7Q>Y0OQ'H;"Y=;1C- M)#(@&U+N!(\+0V>!,=256N$[6#U;SA^RA'9R0?QI\$+2.'D_C^FL5LQERB5 M614ZXXM !=P970M,CY[(I=C_:1&_? PP8>/RC/W %'Q6&8[T5^@6+[SP*LJ( M<,[FE()._=+VI"R ++Z$:5='12^$$^5A$:C4+2*I'-GDI>H6I!Z'BBMAZ&J^'H60W);MW83KP.EW.A\ MCI<)P/&H@J9IV8%R9NBIAJ]./HJ^^01:R27:N[R^XR//C2:. 7"E<":M_6DJ M/9RG;NOQ;^FV"I59HNOYO*&(' \KLI<=$BA5A"TU"E8',=@>G?*W3BT2O5"@ M3/F3S<],[9.*VHO?HIO\?VRE_--+Z$8X2Z_><.*35,C]H5<1*I=#.T:@C]G: M[3$D] MJ+LD]C$.TFLJX5Q2D4\W:O*4#-IUH9(RM#M1:,&VYB,.\)Q$>=>_K$G O@6P MM8S81)A3KU1V4,6O,QR,I)M,15TT@?4GMK7=U( ]C!R(&TR$2F;_5+\WGZY8 M]I.M3)3V8M0:FO2.6]B:!1D+8B!9$AG0 N+E.B'1X@XG) ZJT!G';AZ"R-W0 MU&L(36#=GBUN;(UDT!K=%;P)Y1QP%BR(WPZ:P+IB.S4@L0BLI38,2.J'<;I. M<(W-CRP@^QC-C@E.<4K2JXXFL$[7-LY'^LBMI2*T>4C>YJ7>/0FY)@G7Z2XK MCLZ&Y!Y5(>UK*L%["C0A?K;9$Q60[]8).XUEC_'6KS>;;SU](BT;-X3.AN09 MK2\#>XD$VQCCA:LW3I2CNRR(SH;DU!1C+/76V(%I=T0?6]DNH:5(B;(ZZ&QP M#DH5W%*UC1V2_3W\'>B_ MX6PVIZ>;.2;9FG\JL-4T.ANB(]2&5$K+@V'WMV1Y;(2=>VF>H1O%Q#F]*F;=\D\6V=IYD4L$8\T#$A:$WT:DL/4 '1I&#U+"'JW3OQG;Q/T MNCN#R6.^-&NB3X/SHNJ!+I4-$Q?:9C#@X:-)XXC PP;0IR&Y9LVQE[9B/7"T MHW1B^Y.?<2HQT;RTUZHJ-3V_-&@BL+PGY^_Y>SC]K%Y'M8!2=,FE*MK"2F&X M_:BZ:[*VOI#[ M5:%P>XMC/XU<[XA)A.PQ8*U:$PG$N:/NIX8"31YEK5@AC M$%G_;*:! TX39:Y:(0S7"3CMIWR#]1V9JU8(8QAOHEO(\0;K/S+7L! &&,^6 M]$!S)7QOK7.P4=6&SK1D>,+1@>-X4CZ[K-C *9?J.8YD:%S?%[=,<0VE05/EJ2G(+YVN6C<5J8MOG+@?$>-U"J&Y+A' M2D[T>O[.TL[HT$T?7=L4=DU IUXRTFH=P]B'ZO;\ M7QQ%IK7.T-Q:4*F=+&I?@<[Q1:&R,FK,_YS24*FF&DWU AR.^SA-#ER<#"ZP MWBZ12I0*W'7?[;EW2WI[$6(JL$ YZW++0R>"XNM%L*R* PB2"I_NZPQI>Z5 M T_T5&!X?Y7/U5/I>/9=$%-#S8\0.GVK75PN?@TXG=6P2@KU52]C= M7@D..#J4*P&W/'@ZJ;94R[=/*J9C&W M(D2.YQ(Z@*7I?SDH#YYV2JDDF8>% \;MT5MYKZJ$$NN$KT,N +?U M5YKS@X\C+R&Q[JQ;+0^=UJG9;'N(Q/40A VM\MH-0&7IJ:55DRCGI:^1 M]MR62?#9[/?HP:.@LK@)'++-&H1*(-/09.I"M9=CT^Y.O$[F'X=<9OSNVTL[ M:?L47,>\-N]-(V$RY8;-0F5^:;)C;PQX$.D?-^\=MI$G6U%9S8AL2V=4HMS#ZY)R/2P3#7N)$V#O/"FO,QC-4/5K>1)7' MK7K',&4SZ)-#/K.Z .TE5K0[AF7Q.L6OK^/DPDN?1>-:NP'TR37/FA$T>]D8 M;6;.%$"8!@$I.B=WFVI61Y\<\I^9 K.73;$#Q>;=WHN^RHE;#F045YXI23;F M-K^!/CGD?VL%O;U$C: ;A$O\E-U$5'3K/,7(+M9C)Y-\;R0+D-9N WURT'%G MA,Y>2L;N]@5&UO^ 7[#P1MSN5]!GAWQV+>$O[0DF[JYM:WJDGVE_OH8D62 MDB+]0:V:3E/W9/$LO2:P^!7TV44/I5W\I>TU=F "WCA-P[QQ'/"%<_7&?I3% MF^@U@#X[Y.HTA[9[W67;%#Y6!79+>WDH1/:[/2E2>#@*=G%_1W)<>E1R:1R^ MX)_\>%E\]FJY"N-W7-RKSO*^IY MN4*>*L,TE; -V&D8_0S 2K,EC2C5@Y,7LHE>/9[("G/-#S3WV(\7$?F;XL@W MKSFXG&Y"MCZT\3T$2W/46.FBM:0E6;G-U7+/5E(%&U99!O6%(=RR!OD&4X4] M "6KV4=WI1 LC]*>Y"7**3OKMGJ^DH@LUTNE@O;*(5AZI /Y\Y5TV&''U>2] MZ:FI6@[!LB+IJ>F@PXYGPKC<=%%P9/R39,\W4FXW9>$%?DH*MLW#NA7,11OB=.Q9+09">V\1$$2V/> M@3GQ[=BJ!-U>03D^"W5V%%$=!,M];E>M M.18!^()31:06XUR$4M?PGU)1]B M)VNP?>&YGANY[H7$M4>2_-'C-$W7R\)=.XV"KSA[CH,XC!?O&O[0#KZ.1L!D M]?8MSO+5DIDL;4W3D"_8;4J*7<&PV_PM"=^]ETD=W&U_&XV 2?T[,L,.!H%( MO,/@TVU#4G_$(6TF9/2# ,-@_^MH!.S<']Y .!:P-8_#<,;"/4G_NDXPWJ;V M[7(D\+Z-1L Y)(8S#D3BM78&@-X4/:D%]60R83SB9"E[<]+>1]$(.-L&O-6W M)E=K1-+]BS0:G4*-X$.-&GJV]6.,;'QH\,%%EH3DMGMWN%>P?8F LF5F,'>O MK@=4N7;U"GNDZ<":6K]Z=3W&S.[5*^QAP:Y:3:]>70]C:S@:=>Y<;7T".'C. MD=6V*B['0YIJNP$VQ])*)H;[. ROXX3]L0UWHO2#P(%Z-NW)LIM0);;O^Z[H M6#H%+ULW!EQ\"SA,KSW+:MV22_G9,N)5P6*0>4GFIB%OWH*SU:]U0S[Z%G!\ MH&N&S).?M=V$\Y;\)6EN1)&^ABVE3^6UGX_R MIE(M@0XA/Z[;AS57@_9Z"F)<.>UEP-N^O-<:T26->8 MW-!Q2ZXHXT_,V+]P,'W!B;? VTU;P2U(%37OTD6LV1GH8#RG_,<&,OW.HZ_- M9 <_(M (^/H/QDA!1PR3^&KD>FUK MN-CK!1H-YIZS@R%C5^[6O/+]WH>IA+:5"_BH,>H(&@WF7K4' \=8]*>+!@W? M--!NK5&_T&@P=[WP>[C&FCC=;+CD*!@/YHH:?N@8R/QT<>*:GV \F$MP^(%B M('/X>QE13KL:,DAS(:1*E=QC]L*&_G[[&F?MA>Q-/&<8@/4%C0=S?UY_0(!* M?SLT8+)X 7.!*&<2D>1:(0FIWQLT'LSEO:5UI7OY;P=2X[1JPQA(-U1")$J) MG].S=#1>#CZ*QHZ2ZO1\6'#$O+7^QHG=^G$3,Z0Q<+K$[TC,N]O(-HX9\&13 MXQ/9%#S95/T;#WV>J8;?&#S%5'/YN,U@\4@R)H9=#**"$XI;OC=,3A:TR3<8 M$>R!*9^%H^9CBRT5SV3U&%]%&E?Q*ABT!DR@)M:FI?"4X*+,095+?; 12 MNOFZ) GV:44A8Y&B!C!?40U=<#QT4G@#2#.@5#*_(#!'4&/="E$Y3N6S2;ZN M6)HKI7J3W:ZU!7D?[##TJUQE]\H!D\L<*$"JI8&D7!,8.M&=T^2L -(#550WX\36V8 =E*\#4)=;LH K(VI3=;T.@G[,Q)53: M@281L6<-^YB&P"\S7*YN:,J/]G>4'4C0\82-KC%U Q-Z=&%0?%.V*T.W-^UV MR;J!F34L*U9@/3+T;AO#/1.98B4MRT!31W2PYNUAM?8<"E"WRJ%=*07-B; O M?(F"=MUU>_1])1%9KI=*'>V5@WZ/?Z@!OIZ.NNRXIKPW/4U5RT$_ ]?4U&&7 M'?<=UP[*NM5(/M&\I+X7W;L6R80E$-)Z5$ M@\A1Y@#%0<$4N)E6E'.HY<\Y^TI7VVQ;$-B *.L:2.=;'+UT:\""+SK[@+8+ M&Y;(; CW)(VY7IRCR'+U<:R5?89=.7[7M#T[_I5++VN%!F'_"\X^1VUU@WPL M(UB2&T'<+WO0.IMO+NQ%H;Y[A9Q]9BE3-Q^F-<85%Z<1)]*,N/KC5;0 M>("W(C7E8(\) CKOY7,<4B1I$4-VCU]8=_(_/*Q"(J-8T*B-)D.^D-##7UJ* MVQ<,EW0^?*'B>]FPL9!T$P3XD"7D+Z535:FL[FFY[,DGOFL5:1LH@K ;&LB*0I M,&QI_]V.=S.+"X:]RI&K@:^Z:M\'H"FC*%_8^XL]R4N44W;6;?74"QR%O7,X MD#]?28<==EQ-M2*Q>Q NKU3308==#^Y=/Z4D(%[R_N#E,:SLP*%8IX1U@$E! MZJQ;,BRNJW8'Z)NWI#^R5]$IW8 1C4>2ZLK ["!2Q0ETK8/)[6GW6YSAC?TK MI]ZCLL!D('KJX:N6AV40H<3<.>U6XV&%O"(PWT>=F5H)R/&W[[5=1NS*-N<5 MGJ;I>KGE'EYA/\/!)7NUBZ/@OJ50+MUO0U.*J(W')QR;*LS%WNATLW>ZV7/5Y6+7 M@]K#%;JV!]7UF\"V':C [YYD>JOM0'7]>K&9 Q7X:9.6>G0=J/9N( ?I0(6] MJFS!@6KQ*A/^"-3@W5,EA]Q]'(;719ZX-L[MT@_V\2YUSU@LG]55PA@NJWL= MV12D#=T89?$MZ.O>UNRJ=3LNY6?+A/N1];2!<"J9,5LWY*-O0=]R.V;(//E9 MVR@X;\E0I'*.OIX"LN$CX7T7#$=.,S, QPNX9N%: FU^;_!K8?417K#DN&[: M/>PN&CK+B6-VS16@-28D7N9TARP9=AL-'$S@FB5S!6B-(Y\\Y@KJ'A!XJ!S ?E-:[S2DJIOWO,HIWI M[[?9JM=>R)Y/C56#IMO>.)MDK;4!U+W\K64P@-^<-1">>/81":^5!Z'U>^-L MKK<^#J6:\K>6%Z+F4++-O9_6GEE$ST\!NN)L7CB; P-2^(/)1Y'N"<-\CK Y M*)KVQ=FD<[T8%3:D#YL*HW>[KALJ(!*EQ,_9'SK:7!U\U-G4?#W?0W'$;"_G M1S_N+(*&\:!=O61?0TLN+] M)J91]-QM$HM[!Y)-J!3 GY"JO1Z CDYI)OJJGE.:"7>.8:=<$PXIBYY4LGSK M6.2Y8_O*.,I]"@K*-%D](+*4>FN8"HGC:2<.4"F)TKCEH=E&5"KB:U8$Q>VE M4)<.;9\^##:&2J@)ON(.NSX(YK/2B#?/P[2(*45U@!@G&LZP'!2.9XFH(E). MK<>%P7D59)KA*Y,/PNTI]0$G!*=7=]NNYN"4$ZRD%C2O@$!)@N$IQS&(R?=\ MG9((I^G4IRM12G)UR*=>00VH=_;U9EX)"&M1\#!#EH>,_9A@K)R'E76A'Y#+ MU*:OZ"-(4).TP*]]F=#-X/2%Y-*]B).5<,:5%8=^#ZTG>8ZW6X)G $Z@>QPR M3J([+\G>*[S'Z?E[]2\JI[AV(U!O?6NZS8UP67N( >19KT!23LW'A:&?I!KJ M2JWP':R>S<<7%-4ZS&2^!6XYZ->- N%RIEQ>ST'G6J4F9I'X4DI4%/K!7!U] M['4>UJ^NU,GC:ZRKD[(H]-NL.CK9ZSPL1:= )W_@*(@3N3*J9: ?^.AKX;#7 MT&^6M4-3;B6I'%15H!Z-F&WB=%!8>Q((Y ]K&&?V!TZIF1>\>K-Y7E3JY6[A MN@ :)8220PA@.(2)^2%BN1E M$\A+TK\*X ]90OY2<@/H5(=Z"-# :'1A#8'YG4OW68G[5M\("JM"1;\WT+P. M).C=K.V1SQY1S>;;5U5:HWV_"AKW*F+*;(0?0['FL;2@WQ3[/RWBEX\D7X68 M=B>;GYE>)Q6]%K]%-_G_V"JV%8>*YT6O(AK#N,EJZ%@?D+6#3N/YVXJ>MUQB ME_S4\)HUT1C& 6=7TX>(K#%SV/0 ;?>4>]W>/1DZ=#X(BJ-QK\*I9 I3P8 F M?;"]M-[&=#<1[?ZMM;@>5D(3&+^?E>65!\8:B4%?M$R\)Q*2C.#T8ITPD>KI M^:@:FO3*A6BH:2X<>76@V7M];M>[OPUMH=U](E$N]'OLQXN(_(V#FX *CLP) YR3*0Z&^K$G@1?34U'VT M/1URB\)76>EH?AU&D03YUQW]8&6 M!N0XA;E, ,7OK^/D 2-UB#%KK=PE\2)< -S5!!-G''^B0&4RFGL[;.[3SW>T;S_ MF9 LP]%L/G^,-Z"WODMA?+E1*VCBC(^O)KI2VS ./XL3]7,<4B1I\0CU'K^P M[N1_>%A1.:BF9WEM-''&=6B(JM1_8UZ\'#OCN42S4OK MH3/GW(E*/*6VW78I3L.\<1SP>=NNWMB/,B>R7@/HS#DWHSZPTA0:>QR/3:$C M%CBV;8FHB1&\)8+39X"S8XC;'KQ?DM0/XW2=8 EWG$8M(R8YRQCNO=>OU'02 MXH6R29-;'HAW3D^B@K$B C*(I] EN#_CY*^;Z"Z)Z=E+2ZU[%8!XZNSH]1#) M$ (12W#7]-R;/N/@2QP'6GK=JP#,:]=,KX=(AI%3L83'=G ;YW^*DQ>I:TE< M"9@6KYF&>6B:AQ/^6F@YP@NV0P+6\C>LM46@Q8!)\YIILNB_M5#!+,Z\L/N= MYEV"5QX)-MMG\]VFP*5UT*R*=EA0'&#/N.G)342M(7>ZBBWYL"@D0[%8@ (S MYG0>>':#=6:-9\ B!M0<>0*OZ+AZ:1!MK)3C]#8?! M/$[HSM,+L:V5?OFJK.*JNBOT"T]UX17U)B%C$N<4D!; +' #]85;H^%6FE7 MP$4?A.Q&AT6@%FZ^R([E>M!7"T(5WMS[)*5MW<4DRA[>4W:'H6"!$]: 6C@Y M\N+>OTOZW3,BJ*\X"+_&3R3$O\4A>[.9WD2^7"V2*D!."DV]R#L.QOTNT,P5 MWX%5W2#3=*MA!M'7!B(>U]W'99VW/'< M"3M0L]<(!^=>R%P]2NX0634@(GZYEL2>6@F, =#*L!/ 8_S5RW)WQ.Z@]T"7 M@JV3XAY[(7ME\87.6+?R)P)UF@,B\J]C#S7A-9\#>G$[LUQY)"GBIF[C:'%+ M7G!0O+9YC,_Q)4E7<8J#V5PV+^BV 946H-8L80)J"'0O!VD\]UF-& L&W412 M:83O+,!=X!:IW1948H$ZEE$+G#W/(9R%Y'$E.$BOJ?B8=VDVG[YX)&00-_ZF MW>0I=0_K-P.5EJ".79CBLG=%?& 2'3F39W^%WC,]\3QB_SF*PWC!$B$M6: ] M6RL+^G?Z19S8KZ,@-QPL'4K\"I!N:#,! M"T:2$-8@ A4YCYX?,KRJ)%HH7B_9PPF@+9_L"@%?#W##+I M"X:<&;Q!;!Z.()>!P^PAU*LB-%&C-OC[!QMVP(4U#(?=$=8*VXT\PEI1$_R! MA W%'T&RMYI"16P=KJ:/M)TU[?]I437&4&L-'=:2.?P54HQ0R8-KVH2+:Z4! MMF&L_AP;^%E/3)9)(W: M 5TVL9?B]'J=T?Y\)1%9KI>;Q"CIY5KC88!90\#+JZE6E/.M)N8!Q)]H8KZ) M'E_C_\(>EV^L=EO BW*W9K,'>PBO_?5QTZ]B>\93M@:\WG=N/E7@PWBNIHW] M.EXGUBRH; R8AJ!K ZKB'D*0BSYP\F)O_BD; Z8^Z-QZ*KA;S*[4FR,*D//N M>SFIY.9&>\8>9'NAFA6/6WX8YPX1M'ZR.12YUO(^BT*W*D71$O3]5QH6'LM/?P]#*;?.[H+>&]LP0;U$S>9W-V>Q8%7I3ECV<%H8:F M3;B]_:V!=AA)/\L=VY8D0V=7NRT[L$UK!59K,=IP)YH;NJU=1F1._$)/BP3C M8D.N%>Q7HS6@=[GMGFDT@<,F$A6M" S!5RJ(Y_#](DZ%T?*'Y8">[%J=VX\A M64L &@(<.",6K%S'U1%2;KG(C\ M1UX!^/BHDJI@=A-BZ0,?D$6=GK^?TQGC>>DE?PDH@W2K@A]"10K35/ QG*&I M>@M/R%^D6Q7\I*I6G:[2CX"YK?2I[\=KNA^@9S1,7M@($#+'J*J 'US5JA)X M(,2 W%8N>S*;LAP^T1I_PYE2L]SRX&?3NFH5H1F&K_!(+K<2$B%U)? C9L/% MN JD;^1<6X*#[:M<97; LB#X>5$F9<[AD =@$#'11Y+8O7(=F8RW2C4@PJ\D._L [P:5^D(($Z)2C)A<%N'#YCE+YS>;;N:8U,?[L2UH$_N7!4)1J84Q0!"_PN M%[64RZT%?7XW5JX(Q1"B\PN$E[6TRZT%?6XWUJX(Q1 8( N$5[6TRZT%??XW MUJX(Q3!B? J,U[7TRZT%[0,PUJ\(!6R8C\#OQNWR+!+?<&C4 J)E-M&8'@K8 MN)IV/ WT>ZKC*;\&%*]RS=.I&(3CO/H<9,I#JK .%"6RCIJT%;N#XOB9=1^: M>M'DE8+F*H]QAJNDDY-5#(V ?4SU/H0A* M+W+3U%?Q 2SE;,PMCT:P#B:UDOC*%8)Q>RYF8<",6U7G\')4%HU@_4EBG8CN M+#D AC#W[D]3MQK1'Z(J: 3K1&JT^]U#84Z(='BCI[B MXJ!(C/$-O^9_DB^L.@V@$:Q;2:I!T3*K"\S6T,XS4),7N'B3%SJWT)YO#OME M5TT@G4[U="_%J:NXT\^LJX^>2FF__A_4$L! A0#% @ M0()D2(#/3;O-_P 8<@1 !$ ( ! &1R;F4M,C Q-3$R M,S$N>&UL4$L! A0#% @ 0()D2.4//HR2$P 1_4 !$ M ( !_/\ &1R;F4M,C Q-3$R,S$N>'-D4$L! A0#% @ 0()D2-@@M"IE M"P \:8 !4 ( !O1,! &1R;F4M,C Q-3$R,S%?8V%L+GAM M;%!+ 0(4 Q0 ( $""9$B)'^X>2#\ %G"! 5 " 54? M 0!D&UL M4$L! A0#% @ 0()D2"BPCV=96 U<$& !4 ( !/. ! L &1R;F4M,C Q-3$R,S%?<')E+GAM;%!+!08 !@ & (H! #(. ( ! end